data_2k6x_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k6x _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.515 ' HB3' HG12 ' A' ' 31' ' ' ILE . 65.9 mtt . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 120.818 0.342 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.476 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 15.5 Cg_exo -67.94 -25.07 38.97 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.661 2.241 . . . . 0.0 111.105 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.436 ' HB2' ' OE2' ' A' ' 62' ' ' GLU . 12.3 pt20 -66.2 -25.1 66.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.389 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.576 ' O ' HG13 ' A' ' 35' ' ' ILE . 28.8 mm -65.17 -49.88 76.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.587 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -55.69 -46.54 77.6 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.202 0.525 . . . . 0.0 110.492 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 12.6 mmm180 -67.56 -44.34 78.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.025 -177.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.687 HH11 HD22 ' A' ' 68' ' ' LEU . 29.6 ttm180 -61.74 -37.93 86.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.215 -175.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 31' ' ' ILE . 89.8 mt -59.83 -46.32 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.555 ' HD3' HD13 ' A' ' 81' ' ' ILE . 26.5 mmtm -67.03 -37.29 83.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.27 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.517 ' HD2' ' HA ' ' A' ' 34' ' ' ARG . 94.4 mttt -62.57 -40.93 98.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.875 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.579 ' HB3' HD12 ' A' ' 53' ' ' ILE . 73.8 mt -64.93 -45.84 84.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.664 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.619 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.6 mp -66.37 -35.38 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 121.033 0.444 . . . . 0.0 109.953 177.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.701 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 33.3 t -65.96 -42.09 90.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.922 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.708 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 93.3 mt -60.15 -43.12 95.99 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.474 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.41 -35.23 89.87 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -36.82 83.36 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.888 -0.656 . . . . 0.0 109.703 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.701 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -68.78 -41.13 79.2 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.883 0.849 . . . . 0.0 110.03 175.141 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.708 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 70.3 mmtt -68.95 -31.56 70.53 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.014 -1.448 . . . . 0.0 111.277 -176.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.54 -58.8 0.44 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.246 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -119.68 146.81 45.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.119 0.485 . . . . 0.0 110.667 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.06 86.48 2.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.347 0.594 . . . . 0.0 109.697 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.45 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.0 m -141.79 148.08 38.33 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.407 -170.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -57.12 -42.24 80.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.061 0.458 . . . . 0.0 110.119 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -70.06 -32.68 70.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.697 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.736 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 1.3 m-20 -68.23 -29.44 68.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.266 0.555 . . . . 0.0 111.3 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' A' ' 38' ' ' LEU . 17.7 mt -65.71 -44.02 93.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 121.075 0.464 . . . . 0.0 110.187 170.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.33 -39.36 75.69 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.497 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.736 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.66 -15.43 59.18 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.832 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.678 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -75.39 -18.49 59.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.073 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.516 ' CD2' ' HD3' ' A' ' 59' ' ' PRO . 43.6 t80 -50.1 136.01 21.81 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.829 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 71.5 Cg_endo -75.03 137.72 51.95 Favored 'Cis proline' 0 C--N 1.345 0.374 0 C-N-CA 123.528 -1.447 . . . . 0.0 112.836 1.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.516 ' HD3' ' CD2' ' A' ' 57' ' ' PHE . 17.0 Cg_endo -98.87 -165.25 0.07 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 124.141 3.227 . . . . 0.0 110.245 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -97.38 13.92 28.04 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.012 0.434 . . . . 0.0 110.734 -176.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.454 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 5.2 p90 -63.25 120.74 12.12 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.625 0.726 . . . . 0.0 111.358 -173.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.436 ' OE2' ' HB2' ' A' ' 30' ' ' GLN . 2.3 mp0 -80.93 -22.26 39.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.736 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.02 146.96 14.2 Favored Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 -174.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -100.99 120.57 40.37 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.484 173.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -134.67 132.64 39.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.715 0.293 . . . . 0.0 110.61 -170.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.8 m -63.78 -31.94 73.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.405 0.622 . . . . 0.0 109.746 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.537 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 14.0 m120 -62.31 -38.67 90.33 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.643 175.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.687 HD22 HH11 ' A' ' 34' ' ' ARG . 52.2 tp -59.69 -39.01 83.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.613 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.7 mm -61.08 -46.53 96.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.557 0.218 . . . . 0.0 111.107 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -70.59 -34.56 72.3 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.669 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 19.4 mmt180 -70.41 -32.62 70.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.512 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.583 HG13 ' O ' ' A' ' 68' ' ' LEU . 82.4 mt -61.75 -49.56 83.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.834 0.35 . . . . 0.0 110.143 175.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.527 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 77.3 m80 -67.46 -34.92 78.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.754 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -67.62 -48.88 65.48 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.699 177.129 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -58.6 -29.52 66.52 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.004 0.43 . . . . 0.0 110.624 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.923 ' HA ' HG23 ' A' ' 81' ' ' ILE . 2.9 tp -57.6 -44.82 85.71 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.299 173.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -84.02 -52.66 6.13 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.754 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 3.6 ptmm? -72.93 -39.77 66.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -93.1 -26.98 17.22 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.942 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.16 23.09 23.31 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.77 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.923 HG23 ' HA ' ' A' ' 76' ' ' LEU . 6.2 tt -74.33 123.5 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 117.731 0.765 . . . . 0.0 110.108 -174.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -82.51 118.26 23.12 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.974 -0.454 . . . . 0.0 111.306 -172.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.619 ' HB ' HG13 ' A' ' 39' ' ' ILE . 5.5 tp -156.95 137.61 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.12 152.2 10.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.265 0.555 . . . . 0.0 110.789 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -88.23 -25.91 22.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.974 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 N--CA 1.468 0.459 0 O-C-N 124.202 0.939 . . . . 0.0 109.799 -178.555 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.582 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.625 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 9.3 Cg_exo -72.01 -36.32 6.08 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.625 2.217 . . . . 0.0 112.492 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.454 ' HB2' HH21 ' A' ' 34' ' ' ARG . 5.1 pp0? -64.96 -32.88 74.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.156 -174.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.686 HG13 HD13 ' A' ' 68' ' ' LEU . 10.7 tp -71.98 -35.52 54.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.62 -47.38 66.82 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.219 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.625 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 22.5 mmm180 -62.96 -35.37 79.93 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.532 ' HG2' ' CD1' ' A' ' 61' ' ' PHE . 6.4 tpp180 -60.63 -37.03 80.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.978 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 31' ' ' ILE . 30.9 mt -60.48 -44.87 97.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.508 ' HA ' ' HB ' ' A' ' 39' ' ' ILE . 2.2 mppt? -67.95 -34.03 75.8 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.014 175.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -58.59 -42.56 88.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.168 0.509 . . . . 0.0 109.931 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.602 HD12 HG23 ' A' ' 53' ' ' ILE . 4.1 mm? -70.08 -35.05 73.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.723 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.622 HD13 HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -60.69 -37.97 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.236 0.541 . . . . 0.0 109.738 173.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.668 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 36.6 t -66.97 -48.38 68.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.028 176.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.686 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 91.5 mt -60.8 -45.93 92.51 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.055 -176.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.08 -39.04 84.34 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -175.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.44 -34.15 67.58 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.668 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -61.34 -41.23 96.71 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.918 172.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.811 ' HZ2' ' HA ' ' A' ' 56' ' ' ALA . 31.7 mmtp -68.41 -21.7 64.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.485 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.01 -66.1 0.25 Allowed Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.363 -0.923 . . . . 0.0 112.522 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -142.57 171.67 13.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.16 0.505 . . . . 0.0 111.116 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.486 HG22 ' CD1' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -87.63 86.16 2.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.453 0.644 . . . . 0.0 109.952 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.597 ' O ' HG12 ' A' ' 53' ' ' ILE . 9.7 m -143.26 145.62 32.9 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.525 -171.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -60.6 -34.94 74.95 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 32.1 mt-10 -67.63 -35.03 78.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.092 176.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.679 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 11.8 m-20 -71.68 -30.32 65.57 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.444 0.64 . . . . 0.0 110.972 176.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.602 HG23 HD12 ' A' ' 38' ' ' LEU . 50.9 mm -66.5 -45.34 89.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.566 0.698 . . . . 0.0 109.818 169.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.504 ' HA ' ' CE2' ' A' ' 57' ' ' PHE . 21.4 t70 -57.43 -36.89 71.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.715 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.679 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 5.9 ptpt -77.88 -16.58 58.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.781 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.811 ' HA ' ' HZ2' ' A' ' 45' ' ' LYS . . . -76.82 -19.17 57.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.796 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.573 ' CD1' ' HG3' ' A' ' 59' ' ' PRO . 19.8 m-85 -66.62 147.32 99.03 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.933 178.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 2.9 Cg_exo -76.1 143.46 76.65 Favored 'Cis proline' 0 C--N 1.342 0.214 0 C-N-CA 123.955 -1.269 . . . . 0.0 112.358 0.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.685 ' HG2' ' HD2' ' A' ' 61' ' ' PHE . 53.1 Cg_endo -100.92 -173.0 0.11 Allowed 'Trans proline' 0 N--CA 1.438 -1.757 0 C-N-CA 124.328 3.352 . . . . 0.0 110.772 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -98.65 16.53 21.72 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.685 ' HD2' ' HG2' ' A' ' 59' ' ' PRO . 36.4 m-85 -58.43 119.48 7.06 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.925 0.393 . . . . 0.0 110.404 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.58 -20.93 45.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.335 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.71 124.63 1.28 Allowed Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -112.88 144.51 42.32 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.603 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 18.2 t70 -149.56 160.74 43.24 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.867 -172.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 t -62.97 -32.22 73.5 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 120.975 0.416 . . . . 0.0 110.982 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 3.3 t-20 -61.69 -31.86 72.02 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.686 HD13 HG13 ' A' ' 31' ' ' ILE . 26.6 tp -54.63 -38.79 67.26 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.052 175.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.9 mm -61.9 -40.79 88.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.31 0.576 . . . . 0.0 109.866 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.569 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 15.7 mt-10 -68.14 -41.08 82.16 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.534 ' HD2' ' HA ' ' A' ' 68' ' ' LEU . 85.9 mtt180 -60.05 -38.75 83.72 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.939 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 68' ' ' LEU . 80.5 mt -61.3 -51.1 76.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.809 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.569 ' CD2' ' HA ' ' A' ' 70' ' ' GLU . 27.9 p80 -69.0 -32.33 71.81 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.543 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 47.3 mt-10 -59.2 -49.46 77.78 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -63.89 -34.22 77.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.666 175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.499 ' HA ' HG21 ' A' ' 81' ' ' ILE . 18.2 tp -57.48 -41.94 81.64 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.346 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -84.46 -49.82 8.32 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -71.97 -44.69 63.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.05 -26.67 15.96 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.361 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.02 23.44 32.54 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.908 -1.139 . . . . 0.0 112.985 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.499 HG21 ' HA ' ' A' ' 76' ' ' LEU . 11.9 tt -72.32 119.25 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.625 0.726 . . . . 0.0 110.909 -170.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -99.99 118.58 36.69 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.872 -170.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.622 HG12 HD13 ' A' ' 39' ' ' ILE . 3.3 mt -146.16 128.21 8.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 86' ' ' ASN . 0.4 OUTLIER -95.27 153.31 3.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.823 -172.002 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -87.11 -23.72 24.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.926 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.495 ' N ' HG12 ' A' ' 84' ' ' VAL . 60.2 t30 . . . . . 0 C--N 1.332 -0.177 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.939 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.723 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 87.9 mtp . . . . . 0 CA--C 1.535 0.37 0 CA-C-O 119.761 -0.161 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.723 ' HD3' ' HB2' ' A' ' 28' ' ' MET . 43.7 Cg_exo -59.05 -34.24 98.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.107 1.871 . . . . 0.0 112.412 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.494 ' HB2' HH21 ' A' ' 34' ' ' ARG . 21.1 pt20 -67.09 -25.12 66.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.683 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.631 ' O ' HG13 ' A' ' 35' ' ' ILE . 26.6 mm -69.81 -46.07 75.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.227 175.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -55.69 -45.06 77.87 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.254 0.55 . . . . 0.0 110.009 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 2.9 mmp_? -64.93 -39.76 94.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.022 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.953 ' HD2' ' HA ' ' A' ' 61' ' ' PHE . 5.5 tpp180 -67.16 -39.21 86.46 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.232 -173.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.631 HG13 ' O ' ' A' ' 31' ' ' ILE . 41.5 mt -61.14 -44.87 99.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.495 ' HD3' HD13 ' A' ' 81' ' ' ILE . 14.5 mmtp -66.87 -38.77 86.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.207 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.569 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 54.9 mttm -61.02 -43.36 99.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.9 175.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.495 ' HB3' HD12 ' A' ' 53' ' ' ILE . 65.9 mt -63.73 -47.13 82.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.391 -177.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.531 ' CG1' ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -63.41 -34.76 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.066 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.431 ' C ' ' HE3' ' A' ' 44' ' ' LYS . 33.1 t -65.57 -47.89 74.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.551 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.929 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 71.2 mt -59.22 -47.07 86.7 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.636 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.33 -35.81 92.17 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -74.99 -38.79 61.55 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.509 0.671 . . . . 0.0 109.878 -173.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.929 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 3.9 ptpt -70.55 -26.17 63.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.485 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 69.4 mmtt -86.95 -4.48 59.18 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.981 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.88 -71.78 0.3 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.78 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -141.14 164.83 29.21 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 121.213 0.53 . . . . 0.0 111.928 -170.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -85.24 85.27 2.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.22 0.533 . . . . 0.0 109.764 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 5.9 m -142.92 146.6 34.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.404 -171.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.33 -36.12 77.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.065 0.46 . . . . 0.0 110.112 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.483 ' H ' HG23 ' A' ' 49' ' ' THR . 32.9 mt-10 -67.42 -34.36 77.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.183 0.516 . . . . 0.0 110.118 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.76 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 1.5 m-20 -67.2 -30.03 69.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.282 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.495 HD12 ' HB3' ' A' ' 38' ' ' LEU . 39.1 mm -60.08 -50.24 80.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.448 0.642 . . . . 0.0 110.341 173.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.36 -38.24 90.4 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.344 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.76 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -75.41 -14.97 60.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.716 -178.277 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.85 -18.92 60.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.117 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.412 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 80.4 t80 -58.69 134.55 86.32 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.813 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.473 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 57.9 Cg_endo -72.87 132.16 25.31 Favored 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 123.591 -1.42 . . . . 0.0 112.024 -1.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.474 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 19.2 Cg_endo -98.61 -158.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.732 0 C-N-CA 124.259 3.306 . . . . 0.0 111.11 -173.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.463 ' H ' HD11 ' A' ' 41' ' ' LEU . 2.5 t70 -98.96 14.19 29.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.325 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.953 ' HA ' ' HD2' ' A' ' 34' ' ' ARG . 4.3 p90 -69.68 120.13 14.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.386 0.612 . . . . 0.0 111.251 -172.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -82.38 -23.55 34.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.651 172.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.74 125.74 1.5 Allowed Glycine 0 N--CA 1.436 -1.34 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -176.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -113.27 134.26 54.69 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.468 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 18.4 t70 -151.59 155.28 38.11 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.4 m -63.05 -27.91 69.73 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.94 0.4 . . . . 0.0 111.371 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -61.34 -32.7 72.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.382 0.611 . . . . 0.0 109.937 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.618 ' O ' HG13 ' A' ' 72' ' ' ILE . 63.9 tp -60.66 -39.11 87.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.084 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.6 mm -62.82 -46.65 95.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.791 0.329 . . . . 0.0 110.884 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.459 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 9.4 pt-20 -68.41 -32.55 72.67 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.496 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 5.9 tpp180 -70.2 -35.96 74.28 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.341 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.618 HG13 ' O ' ' A' ' 68' ' ' LEU . 72.0 mt -59.92 -50.94 78.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.762 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.56 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 26.5 p80 -68.69 -33.48 74.04 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.618 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -60.01 -50.54 73.33 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.712 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.559 ' OE1' ' HD2' ' A' ' 78' ' ' LYS . 8.3 mm-40 -65.72 -25.71 67.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.226 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 1.032 ' HA ' HG23 ' A' ' 81' ' ' ILE . 7.9 tp -56.0 -47.62 77.41 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.066 174.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -83.56 -50.5 8.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.525 0.678 . . . . 0.0 111.199 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.559 ' HD2' ' OE1' ' A' ' 75' ' ' GLU . 23.7 ttmt -68.18 -43.58 77.83 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.998 -172.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.63 -24.68 17.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.772 0.32 . . . . 0.0 110.329 -177.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.37 22.56 24.22 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.114 -1.041 . . . . 0.0 113.27 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 1.032 HG23 ' HA ' ' A' ' 76' ' ' LEU . 10.0 tt -75.66 146.32 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 117.407 0.603 . . . . 0.0 110.219 -174.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.14 128.31 51.8 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.095 -0.378 . . . . 0.0 110.867 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.531 ' HB ' ' CG1' ' A' ' 39' ' ' ILE . 4.7 tp -167.25 137.87 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -109.61 151.68 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.253 -177.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -89.66 -23.92 21.75 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.48 ' HB2' HG22 ' A' ' 49' ' ' THR . 63.5 t30 . . . . . 0 N--CA 1.463 0.187 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.505 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.535 ' O ' HG23 ' A' ' 31' ' ' ILE . 59.4 mtt . . . . . 0 N--CA 1.452 -0.355 0 CA-C-O 120.738 0.304 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.89 -24.64 53.4 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.767 2.312 . . . . 0.0 111.382 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -60.66 -31.45 70.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.2 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.615 ' O ' HG13 ' A' ' 35' ' ' ILE . 10.5 tp -69.75 -35.46 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.476 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.84 -42.62 76.91 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.168 0.508 . . . . 0.0 110.238 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -63.65 -38.59 91.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.083 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -60.56 -35.01 75.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.103 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.655 HG21 HG12 ' A' ' 72' ' ' ILE . 52.1 mt -60.37 -46.98 94.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.059 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.569 ' HD3' HD13 ' A' ' 81' ' ' ILE . 28.2 mmtm -66.68 -37.28 84.42 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.237 0.541 . . . . 0.0 109.969 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.552 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 15.9 tptm -64.49 -44.39 91.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.409 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.48 HD22 ' HZ ' ' A' ' 61' ' ' PHE . 16.5 tp -67.06 -45.55 77.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.029 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.55 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -62.7 -34.68 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.892 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.718 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 23.2 t -67.1 -45.43 77.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.071 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.625 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 90.0 mt -59.38 -42.9 92.74 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.541 -176.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.457 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -66.69 -34.83 88.64 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.379 -0.915 . . . . 0.0 110.844 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 10.4 tptm -68.43 -38.7 81.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.46 0.648 . . . . 0.0 109.798 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.718 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -66.03 -41.48 90.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.424 175.245 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.816 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . 73.9 mmtt -68.2 -32.71 73.12 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.424 -177.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.66 -65.6 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.552 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -144.16 155.15 43.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.831 0.348 . . . . 0.0 110.84 -175.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -73.99 91.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.552 0.691 . . . . 0.0 110.66 -178.654 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 51' ' ' GLU . 86.6 m -149.07 145.43 27.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.93 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -58.25 -39.37 78.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.803 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 49' ' ' THR . 15.8 mm-40 -64.16 -39.03 93.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.531 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.649 ' CG ' ' HD3' ' A' ' 55' ' ' LYS . 9.9 t0 -72.17 -36.96 69.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.372 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.407 HG22 HD11 ' A' ' 38' ' ' LEU . 26.6 mt -59.92 -45.63 94.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.967 0.413 . . . . 0.0 110.659 172.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -59.59 -31.41 69.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.652 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.816 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -74.71 -26.84 60.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.005 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.611 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -66.74 -19.61 65.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.628 -176.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.454 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 18.2 m-85 -50.99 134.95 28.9 Favored Pre-proline 0 N--CA 1.468 0.451 0 O-C-N 123.236 0.335 . . . . 0.0 111.249 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 57' ' ' PHE . 15.4 Cg_exo -68.78 140.32 56.76 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 123.971 -1.262 . . . . 0.0 112.445 1.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.457 ' HG2' ' HD2' ' A' ' 61' ' ' PHE . 26.5 Cg_endo -98.69 -168.51 0.1 Allowed 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 124.288 3.326 . . . . 0.0 110.957 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -98.44 12.08 36.16 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.196 0.522 . . . . 0.0 111.504 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.48 ' HZ ' HD22 ' A' ' 38' ' ' LEU . 41.5 m-85 -70.95 121.29 17.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.076 0.465 . . . . 0.0 111.67 -174.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -79.11 -30.43 43.76 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 165.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.96 125.91 1.4 Allowed Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 173.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -107.72 143.58 36.04 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 117.438 0.619 . . . . 0.0 110.592 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 15.6 t70 -141.5 159.75 41.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.193 -173.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.5 m -61.37 -26.86 68.11 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.015 0.436 . . . . 0.0 111.346 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.67 -33.54 72.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.7 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.598 ' O ' HG13 ' A' ' 72' ' ' ILE . 35.6 tp -55.64 -41.14 73.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.111 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.4 mm -64.05 -40.37 88.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.265 0.555 . . . . 0.0 109.952 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -67.78 -42.73 81.23 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 10.6 tpt180 -67.89 -34.72 77.2 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.148 -174.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.655 HG12 HG21 ' A' ' 35' ' ' ILE . 76.8 mt -60.62 -48.72 87.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.543 ' HA ' HD12 ' A' ' 76' ' ' LEU . 40.6 t-80 -66.18 -34.64 78.49 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.21 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.32 -49.33 78.24 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 71' ' ' ARG . 34.2 mm-40 -63.67 -29.55 70.77 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.482 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.819 HD21 HG21 ' A' ' 83' ' ' ILE . 77.0 mt -60.9 -50.19 74.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.887 0.375 . . . . 0.0 111.161 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -84.34 -49.74 8.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.191 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -71.88 -44.16 64.22 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 -176.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -96.29 -24.52 16.16 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.449 -172.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.34 21.71 47.46 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.224 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.699 HG23 HD22 ' A' ' 76' ' ' LEU . 5.1 tt -73.82 146.94 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 117.717 0.758 . . . . 0.0 108.991 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -115.3 127.33 55.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.183 0.516 . . . . 0.0 111.81 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.819 HG21 HD21 ' A' ' 76' ' ' LEU . 5.4 tp -155.95 132.45 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.674 176.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -99.12 151.07 4.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -92.08 -24.99 18.98 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.436 ' HB2' HG21 ' A' ' 49' ' ' THR . 16.2 t-20 . . . . . 0 N--CA 1.467 0.412 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.636 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 48.6 tpp . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.125 0.488 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.88 -25.0 6.57 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.931 2.421 . . . . 0.0 112.298 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 11.5 pt20 -69.57 -26.77 64.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.136 -176.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.632 ' O ' HG13 ' A' ' 35' ' ' ILE . 7.5 mm -66.61 -39.58 84.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.26 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.455 ' HG2' ' HE ' ' A' ' 71' ' ' ARG . 40.6 mt-10 -62.72 -45.47 92.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.071 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 26.2 ptt180 -68.9 -32.4 72.02 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.016 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.564 ' HD3' HD12 ' A' ' 68' ' ' LEU . 29.9 ttt-85 -59.3 -37.42 77.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.165 176.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.632 HG13 ' O ' ' A' ' 31' ' ' ILE . 45.3 mt -65.55 -44.59 93.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.02 0.438 . . . . 0.0 110.227 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.461 ' HD3' HD11 ' A' ' 81' ' ' ILE . 1.3 mppt? -66.65 -34.52 78.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.022 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.483 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 96.4 mttt -58.34 -44.6 88.81 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 173.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.536 HD12 ' NH1' ' A' ' 34' ' ' ARG . 48.0 mt -59.26 -50.37 74.25 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.22 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.861 HD13 ' HB ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -61.99 -34.98 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.519 -177.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 71.1 m -67.18 -47.89 69.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.736 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.592 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 96.6 mt -59.69 -42.08 92.16 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.316 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.33 -37.07 85.81 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.155 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.568 ' HG2' HG21 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -71.6 -34.0 69.5 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.345 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.525 ' HE2' ' N ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -68.74 -39.44 80.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.28 174.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 1.03 ' HE3' ' HA ' ' A' ' 56' ' ' ALA . 72.2 mmtt -68.67 -26.89 65.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.02 -178.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.42 -63.74 0.3 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.035 177.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -132.37 161.45 33.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.94 0.4 . . . . 0.0 110.916 -173.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.619 HG22 HD12 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -84.73 84.27 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.166 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.681 HG21 ' H ' ' A' ' 52' ' ' ASP . 4.8 t -150.93 153.81 35.96 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.226 -174.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.421 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 36.3 t80 -63.55 -29.26 70.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.087 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.21 -39.2 86.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.242 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.704 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.8 OUTLIER -71.73 -30.36 65.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.87 176.156 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 49' ' ' THR . 44.8 mm -59.44 -48.89 85.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.01 0.434 . . . . 0.0 110.095 172.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -58.66 -36.32 73.96 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.431 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.823 ' HD3' ' HB3' ' A' ' 45' ' ' LYS . 10.4 ptmt -75.92 -17.76 59.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.041 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 1.03 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -71.32 -18.65 62.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.392 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.446 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 87.6 t80 -56.05 135.49 74.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.333 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 5.9 Cg_exo -75.07 139.54 62.22 Favored 'Cis proline' 0 C--N 1.346 0.437 0 C-N-CA 123.749 -1.355 . . . . 0.0 111.779 -1.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 15.1 Cg_endo -98.2 -173.37 0.17 Allowed 'Trans proline' 0 N--CA 1.436 -1.911 0 C-N-CA 123.738 2.958 . . . . 0.0 110.802 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -97.73 18.9 14.6 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.45 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -57.01 119.05 5.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 122.05 0.928 . . . . 0.0 110.948 -168.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -81.29 -26.36 35.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.555 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.51 132.68 2.67 Favored Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -112.12 123.89 51.24 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 117.673 0.736 . . . . 0.0 109.82 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 0.9 OUTLIER -159.69 168.57 25.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.026 0.441 . . . . 0.0 112.07 -175.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 t -64.75 -28.63 69.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.406 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 71' ' ' ARG . 5.2 m120 -62.02 -33.85 75.13 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.825 0.345 . . . . 0.0 110.127 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.564 HD12 ' HD3' ' A' ' 34' ' ' ARG . 23.1 tp -65.54 -47.34 76.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.133 172.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.2 mm -58.3 -46.31 89.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.896 0.379 . . . . 0.0 110.812 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 8.6 pt-20 -67.71 -35.01 78.0 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 15.1 tpt180 -71.06 -36.61 72.35 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.169 -174.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.621 ' HA ' HD13 ' A' ' 35' ' ' ILE . 79.7 mt -60.86 -50.36 80.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.539 0.209 . . . . 0.0 110.534 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.476 ' HA ' HD13 ' A' ' 76' ' ' LEU . 45.6 t60 -65.38 -35.64 81.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.868 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 38.8 mt-10 -59.7 -49.27 78.4 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.402 ' HG3' HD11 ' A' ' 35' ' ' ILE . 8.4 mm-40 -64.26 -29.66 70.75 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.693 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.796 HD21 HG21 ' A' ' 81' ' ' ILE . 93.9 mt -64.16 -52.66 57.94 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.134 0.493 . . . . 0.0 111.659 176.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -86.01 -50.04 7.36 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.124 -175.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -74.28 -42.41 59.62 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.21 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -95.09 -32.56 13.05 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.525 -174.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.86 21.41 21.17 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.921 -1.133 . . . . 0.0 114.226 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.796 HG21 HD21 ' A' ' 76' ' ' LEU . 4.8 tt -72.9 139.96 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 119.292 1.546 . . . . 0.0 108.023 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.57 136.46 53.26 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.787 -175.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.861 ' HB ' HD13 ' A' ' 39' ' ' ILE . 18.9 tt -168.04 126.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.369 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -98.75 155.34 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-O 121.439 0.638 . . . . 0.0 110.094 -169.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -85.29 -22.72 28.45 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.557 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.517 ' N ' HG13 ' A' ' 84' ' ' VAL . 64.0 t30 . . . . . 0 N--CA 1.462 0.161 0 CA-C-N 114.427 -1.261 . . . . 0.0 110.113 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.607 ' HE1' HG13 ' A' ' 31' ' ' ILE . 33.8 ttp . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.187 0.518 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -62.16 -23.82 75.81 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.476 2.784 . . . . 0.0 112.773 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.499 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 11.3 pt20 -59.86 -25.4 65.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.32 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.607 HG13 ' HE1' ' A' ' 28' ' ' MET . 17.2 mm -68.94 -48.88 67.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.829 0.347 . . . . 0.0 110.102 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -56.08 -45.29 79.41 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.172 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 10.4 ptm180 -67.92 -38.42 82.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.901 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.574 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -67.37 -38.05 84.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.676 -175.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 31' ' ' ILE . 75.6 mt -59.97 -43.56 92.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.178 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.535 ' CD ' HD13 ' A' ' 81' ' ' ILE . 19.9 mmtm -66.38 -36.06 81.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.491 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.434 ' HE2' ' HB3' ' A' ' 37' ' ' LYS . 32.1 mtpt -68.72 -38.09 79.97 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.177 176.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 82.8 mt -61.29 -47.73 84.65 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.407 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.58 HG12 HG12 ' A' ' 81' ' ' ILE . 1.5 mp -62.64 -34.75 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.185 0.517 . . . . 0.0 109.814 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.0 t -66.2 -48.1 71.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.956 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 95.1 mt -59.85 -36.45 76.88 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.244 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.49 -38.99 95.39 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.462 ' HB2' HG22 ' A' ' 48' ' ' ILE . 33.1 tptt -65.61 -39.58 91.68 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.303 0.573 . . . . 0.0 109.577 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.526 ' HE2' ' N ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -63.07 -42.92 99.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.218 173.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.972 ' HE3' ' HA ' ' A' ' 56' ' ' ALA . 71.6 mmtt -68.09 -26.31 65.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.681 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.83 -64.07 0.32 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.747 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -130.94 158.22 40.84 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.642 HD13 HG12 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -87.86 79.05 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.681 -175.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 1.012 ' HB ' HG11 ' A' ' 84' ' ' VAL . 5.1 t -147.0 160.02 42.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -168.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -56.05 -37.74 69.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.248 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -67.91 -38.99 83.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.394 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.682 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -71.88 -29.89 64.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.363 176.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.664 HG12 ' O ' ' A' ' 49' ' ' THR . 49.4 mm -59.21 -49.64 82.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.417 0.627 . . . . 0.0 109.66 171.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -62.03 -34.22 75.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.154 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.811 ' HD3' ' HB3' ' A' ' 45' ' ' LYS . 11.4 ptmt -75.86 -21.33 57.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.906 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.972 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -76.5 -20.41 56.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.287 0.565 . . . . 0.0 110.08 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.516 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 72.7 t80 -72.5 140.46 81.95 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.449 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.482 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 73.8 Cg_endo -79.83 127.28 14.19 Favored 'Cis proline' 0 C--N 1.345 0.362 0 C-N-CA 123.423 -1.49 . . . . 0.0 112.525 -2.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.516 ' HD3' ' CD1' ' A' ' 57' ' ' PHE . 72.3 Cg_endo -105.53 -139.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.889 0 C-N-CA 124.657 3.572 . . . . 0.0 110.887 -176.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 59' ' ' PRO . 21.0 p-10 -97.63 16.69 19.72 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -173.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.574 ' HA ' ' HD3' ' A' ' 34' ' ' ARG . 14.0 m-85 -57.42 118.28 4.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.189 0.519 . . . . 0.0 111.519 -173.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.99 -24.74 40.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.974 172.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.17 127.26 1.6 Allowed Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -99.07 131.79 44.86 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.618 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 7.3 t70 -147.36 138.59 23.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.833 0.349 . . . . 0.0 110.587 -169.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.9 m -63.47 -35.78 81.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.241 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.541 ' HB3' ' OD2' ' A' ' 65' ' ' ASP . 0.5 OUTLIER -62.17 -33.0 73.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.112 176.142 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.621 ' O ' HG13 ' A' ' 72' ' ' ILE . 33.3 tp -56.49 -39.59 73.5 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.795 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.9 mm -63.7 -40.64 89.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.999 0.428 . . . . 0.0 110.296 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.619 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 15.8 mt-10 -67.2 -40.82 86.55 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -65.13 -35.23 80.45 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.942 -176.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.621 HG13 ' O ' ' A' ' 68' ' ' LEU . 82.2 mt -60.16 -49.95 82.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.47 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.619 ' CE1' ' HA ' ' A' ' 70' ' ' GLU . 4.7 p-80 -67.41 -31.57 71.87 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.471 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.577 ' HB3' ' HE3' ' A' ' 78' ' ' LYS . 32.8 mt-10 -60.99 -50.49 73.16 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.562 ' OE2' ' HD2' ' A' ' 78' ' ' LYS . 23.2 mm-40 -62.07 -31.5 71.93 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.971 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.676 ' HA ' HG23 ' A' ' 81' ' ' ILE . 15.1 tp -58.09 -45.36 87.31 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.536 175.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -83.52 -51.67 7.14 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.577 ' HE3' ' HB3' ' A' ' 74' ' ' GLU . 18.8 ptpt -74.06 -42.49 60.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.676 0.274 . . . . 0.0 111.189 -174.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -94.84 -21.13 18.89 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.302 -175.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.94 24.35 41.82 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.863 -1.16 . . . . 0.0 112.971 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.676 HG23 ' HA ' ' A' ' 76' ' ' LEU . 7.6 tt -73.78 123.36 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 117.447 0.623 . . . . 0.0 110.44 -173.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -80.48 120.22 24.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.154 0.502 . . . . 0.0 111.794 -172.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.0 tp -156.69 115.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 122.073 0.94 . . . . 0.0 110.16 -178.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 1.012 HG11 ' HB ' ' A' ' 49' ' ' THR . 2.3 p -86.37 154.77 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.739 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.0 -31.57 14.19 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.725 0.298 . . . . 0.0 110.616 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 61.5 t30 . . . . . 0 N--CA 1.468 0.449 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.766 170.483 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.441 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 20.7 ptp . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 28' ' ' MET . 19.9 Cg_exo -66.12 -29.72 47.62 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.352 2.035 . . . . 0.0 111.609 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -64.29 -25.92 68.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.704 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.751 HG22 HD11 ' A' ' 68' ' ' LEU . 18.4 mm -63.67 -49.01 84.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.043 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -55.37 -45.28 76.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.554 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -68.85 -37.75 79.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.231 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.544 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -67.6 -38.98 84.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.1 -177.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.607 HG13 ' O ' ' A' ' 31' ' ' ILE . 70.8 mt -61.22 -39.31 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-O 120.76 0.314 . . . . 0.0 110.519 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.54 ' HD3' HD11 ' A' ' 81' ' ' ILE . 21.2 mmtm -65.55 -35.41 80.77 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.363 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.54 ' HG3' HH21 ' A' ' 34' ' ' ARG . 13.0 mmmm -67.92 -39.07 83.59 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.525 175.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 78.4 mt -61.81 -48.76 79.17 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.117 0.484 . . . . 0.0 110.438 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.577 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -65.09 -35.27 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.378 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -66.9 -48.45 68.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.229 0.538 . . . . 0.0 109.759 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.665 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 83.1 mt -62.01 -41.15 97.77 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.872 -177.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.23 -35.1 87.65 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -69.05 -44.27 72.97 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.467 0.651 . . . . 0.0 109.728 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HE2' ' N ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -60.93 -38.04 84.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.701 174.021 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.894 ' HZ1' ' HA ' ' A' ' 56' ' ' ALA . 28.2 mmtp -69.52 -20.45 63.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.258 -177.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.03 -63.3 0.33 Allowed Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.897 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -135.92 150.74 49.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.994 0.426 . . . . 0.0 111.076 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.479 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -80.79 86.02 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 172.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.502 HG23 ' H ' ' A' ' 52' ' ' ASP . 5.4 t -151.07 158.73 44.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.128 -176.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -57.24 -39.8 76.28 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.374 0.421 . . . . 0.0 110.693 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -62.61 -41.15 98.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.825 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.807 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -71.05 -29.35 65.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.788 -176.09 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.4 mm -59.38 -50.39 80.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.358 0.599 . . . . 0.0 109.987 171.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.4 -39.91 84.91 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.809 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.807 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.73 -15.48 59.11 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.902 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.894 ' HA ' ' HZ1' ' A' ' 45' ' ' LYS . . . -79.18 -19.55 50.6 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.435 175.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.414 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 73.7 t80 -60.86 137.16 93.51 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.027 175.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.502 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 13.1 Cg_endo -88.38 139.3 17.01 Favored 'Cis proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.609 -1.413 . . . . 0.0 113.07 3.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.676 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 27.7 Cg_endo -100.29 -150.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 124.458 3.439 . . . . 0.0 110.189 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.2 15.86 21.5 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.815 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.676 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 4.3 p90 -58.58 118.64 5.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 122.144 0.973 . . . . 0.0 111.038 -168.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -81.43 -22.28 38.31 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.267 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.75 126.6 1.5 Allowed Glycine 0 N--CA 1.434 -1.488 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -109.66 135.62 50.33 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 13.8 t70 -149.04 158.16 43.96 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.281 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 p -63.89 -35.65 81.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.962 0.41 . . . . 0.0 111.045 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -62.01 -34.79 76.85 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.751 HD11 HG22 ' A' ' 31' ' ' ILE . 26.7 tp -60.29 -40.23 89.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.213 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.448 ' O ' ' HD2' ' A' ' 73' ' ' HIS . 48.4 mm -64.25 -40.98 90.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.914 0.388 . . . . 0.0 110.288 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.7 -40.21 84.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -61.03 -34.91 75.59 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.671 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 68' ' ' LEU . 82.5 mt -60.84 -45.83 97.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.448 ' HD2' ' O ' ' A' ' 69' ' ' ILE . 74.1 m-70 -59.9 -44.2 94.4 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.243 0.545 . . . . 0.0 110.061 175.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -59.31 -47.34 85.76 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.389 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.469 ' C ' HG21 ' A' ' 81' ' ' ILE . 30.0 mm-40 -55.64 -29.8 59.88 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.84 HD23 HG21 ' A' ' 83' ' ' ILE . 53.7 mt -60.45 -48.92 79.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.27 0.557 . . . . 0.0 110.91 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -83.99 -48.49 9.89 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.309 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -70.9 -46.27 62.83 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.44 -173.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.51 -24.37 15.16 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.898 -177.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.1 20.79 41.11 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.44 -0.885 . . . . 0.0 112.995 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.831 HG23 HD21 ' A' ' 76' ' ' LEU . 7.5 tt -76.05 147.08 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.444 HD21 ' HA ' ' A' ' 82' ' ' ASN . 6.8 m120 -116.94 133.31 56.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.339 0.59 . . . . 0.0 112.378 -177.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.84 HG21 HD23 ' A' ' 76' ' ' LEU . 5.2 tp -167.68 130.85 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.576 -1.193 . . . . 0.0 107.978 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.498 HG12 ' CB ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -88.27 155.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 120.919 0.39 . . . . 0.0 109.995 -177.332 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 39.6 mt-10 -94.53 -23.07 17.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.711 -170.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 6.4 t-20 . . . . . 0 N--CA 1.465 0.315 0 O-C-N 124.525 1.14 . . . . 0.0 109.676 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.79 -27.8 73.34 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.494 2.129 . . . . 0.0 111.368 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.507 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 28.4 tt0 -68.83 -35.43 76.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.607 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.669 ' O ' HG13 ' A' ' 35' ' ' ILE . 9.1 mm -68.12 -48.38 74.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.676 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -60.45 -46.07 91.4 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.469 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 10.8 ptm180 -66.29 -33.15 75.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.505 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.783 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -69.84 -34.53 73.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.518 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.803 HG21 HG12 ' A' ' 72' ' ' ILE . 62.5 mt -58.69 -51.38 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.462 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.535 ' HD3' ' N ' ' A' ' 36' ' ' LYS . 1.8 mppt? -69.28 -35.78 76.4 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.632 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -64.97 -43.68 91.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.985 0.421 . . . . 0.0 109.882 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.474 ' HG ' HG21 ' A' ' 53' ' ' ILE . 6.0 tp -66.73 -45.5 78.46 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.343 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.509 ' HB ' HD11 ' A' ' 81' ' ' ILE . 1.4 mp -62.11 -35.48 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.541 ' C ' ' HE2' ' A' ' 44' ' ' LYS . 53.9 m -67.92 -48.58 65.58 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.191 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.709 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 79.5 mt -59.46 -40.08 85.72 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.929 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.54 -34.38 88.21 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.467 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -73.43 -38.21 65.61 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -177.757 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.541 ' HE2' ' C ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -64.5 -29.95 70.99 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.49 174.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.709 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 74.5 mmtt -74.73 -11.6 60.21 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.039 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.06 -68.3 0.31 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.285 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.73 170.95 14.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.894 0.378 . . . . 0.0 110.382 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.77 85.88 2.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.198 0.523 . . . . 0.0 109.793 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.511 ' CG2' ' HB2' ' A' ' 86' ' ' ASN . 4.9 m -141.17 146.6 37.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.101 -175.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.454 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 90.8 t80 -60.33 -33.71 72.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.172 0.51 . . . . 0.0 109.908 174.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.494 ' H ' HG23 ' A' ' 49' ' ' THR . 35.9 mt-10 -67.59 -37.33 82.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.574 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 1.007 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.2 m-20 -65.2 -31.27 72.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.006 0.432 . . . . 0.0 110.679 174.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.474 HG21 ' HG ' ' A' ' 38' ' ' LEU . 32.0 mm -64.96 -49.84 77.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.167 0.508 . . . . 0.0 110.545 172.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -61.63 -32.78 72.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.803 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 1.007 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 2.9 ptmt -74.69 -17.27 60.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.017 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.514 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -77.67 -19.76 54.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.514 -175.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.481 ' HA ' ' CD ' ' A' ' 59' ' ' PRO . 44.5 m-85 -59.57 130.81 88.09 Favored Pre-proline 0 N--CA 1.462 0.171 0 O-C-N 123.322 0.389 . . . . 0.0 111.23 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 3.9 Cg_exo -77.03 123.93 10.07 Favored 'Cis proline' 0 C--O 1.234 0.315 0 C-N-CA 123.998 -1.251 . . . . 0.0 112.33 0.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.545 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 34.8 Cg_endo -100.93 -156.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.687 0 C-N-CA 124.361 3.374 . . . . 0.0 110.751 -177.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -97.73 12.81 32.53 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.023 0.44 . . . . 0.0 111.459 -177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.545 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 3.7 p90 -66.17 120.62 13.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.273 0.559 . . . . 0.0 109.919 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.535 ' HG3' HH11 ' A' ' 34' ' ' ARG . 43.4 mt-10 -81.42 -23.62 37.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.378 0.609 . . . . 0.0 110.346 177.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.29 127.63 1.66 Allowed Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -100.84 136.87 40.02 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.58 -0.448 . . . . 0.0 109.819 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 10.3 t70 -150.0 142.71 24.62 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.1 t -63.74 -27.13 68.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.56 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -66.06 -33.59 76.15 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.99 0.424 . . . . 0.0 109.898 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.617 HD13 HG21 ' A' ' 31' ' ' ILE . 46.2 tp -59.63 -40.69 88.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.669 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.3 mm -60.83 -41.62 89.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.09 0.471 . . . . 0.0 110.48 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.27 -43.5 73.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.553 0.692 . . . . 0.0 109.156 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.611 ' HG3' HD13 ' A' ' 35' ' ' ILE . 11.5 tpp180 -62.41 -36.51 82.58 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.638 -176.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.803 HG12 HG21 ' A' ' 35' ' ' ILE . 79.9 mt -64.72 -48.22 85.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.505 176.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.494 ' HA ' HD12 ' A' ' 76' ' ' LEU . 32.9 m80 -63.09 -41.12 99.32 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.386 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.25 -42.84 99.68 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.926 -0.309 . . . . 0.0 110.224 176.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.426 ' CD ' ' HZ2' ' A' ' 36' ' ' LYS . 10.3 mt-10 -64.53 -28.55 69.72 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 178.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.957 HD23 HG22 ' A' ' 81' ' ' ILE . 78.4 mt -56.97 -47.99 79.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.071 0.462 . . . . 0.0 110.77 176.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -83.87 -50.34 8.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.949 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -74.11 -43.28 58.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.058 -173.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -95.68 -21.85 17.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.246 0.546 . . . . 0.0 110.474 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.11 20.35 57.57 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.936 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.957 HG22 HD23 ' A' ' 76' ' ' LEU . 7.1 tt -75.58 146.58 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.475 HD21 ' HA ' ' A' ' 82' ' ' ASN . 5.3 m120 -113.89 129.18 56.62 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.632 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.836 HG21 HD22 ' A' ' 76' ' ' LEU . 7.3 tp -159.59 121.33 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 172.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.478 HG11 ' N ' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -96.84 158.84 3.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.466 0.65 . . . . 0.0 111.274 -168.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -87.17 -22.93 25.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.961 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.511 ' HB2' ' CG2' ' A' ' 49' ' ' THR . 66.2 t30 . . . . . 0 N--CA 1.468 0.469 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.396 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.871 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 59.2 ttp . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 119.478 -0.296 . . . . 0.0 111.621 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.871 ' HD3' ' HB3' ' A' ' 28' ' ' MET . 17.3 Cg_exo -66.18 -32.53 42.48 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 121.85 1.7 . . . . 0.0 111.669 -176.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.547 ' HA ' ' HG2' ' A' ' 33' ' ' ARG . 19.3 pt20 -67.59 -27.6 67.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.92 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.719 ' O ' HG12 ' A' ' 35' ' ' ILE . 34.4 mm -69.29 -51.54 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.64 -44.52 85.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.928 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.547 ' HG2' ' HA ' ' A' ' 30' ' ' GLN . 23.6 ptt180 -69.01 -37.02 78.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.334 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.661 ' NH1' HD13 ' A' ' 38' ' ' LEU . 4.6 tmt_? -67.49 -41.68 84.15 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 121.27 -0.172 . . . . 0.0 111.126 -177.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.719 HG12 ' O ' ' A' ' 31' ' ' ILE . 20.0 mm -59.67 -48.15 88.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 121.18 0.514 . . . . 0.0 110.077 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.419 ' HD3' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -67.39 -35.12 78.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.8 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 33' ' ' ARG . 40.5 mtpt -60.21 -38.5 83.53 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.029 -0.269 . . . . 0.0 110.87 175.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.661 HD13 ' NH1' ' A' ' 34' ' ' ARG . 71.9 mt -59.64 -43.75 93.74 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.197 0.523 . . . . 0.0 110.249 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.641 HD13 HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -61.86 -39.19 82.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.267 178.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.632 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 25.0 t -67.37 -49.68 62.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.993 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.592 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 87.7 mt -68.81 -41.94 77.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.978 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.81 -38.49 85.36 Favored Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -63.73 -44.99 91.93 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.632 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -58.26 -38.36 76.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.492 173.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.913 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -69.32 -21.96 63.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.274 -178.123 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.26 -57.51 0.51 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.507 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.432 ' HB2' ' OD2' ' A' ' 52' ' ' ASP . 99.3 m-85 -134.12 163.36 29.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.121 0.486 . . . . 0.0 110.528 -174.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -96.86 85.7 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.533 0.682 . . . . 0.0 109.552 174.022 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 27.0 p -139.41 159.84 41.22 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.645 -175.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -57.69 -37.91 74.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.065 0.46 . . . . 0.0 110.003 176.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -66.14 -46.09 78.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.418 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.754 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 5.1 m-20 -66.7 -31.43 72.09 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.648 HG12 ' O ' ' A' ' 49' ' ' THR . 48.6 mm -63.99 -48.77 84.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.369 0.604 . . . . 0.0 109.963 172.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.541 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 21.4 t70 -61.93 -37.05 83.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.58 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.754 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.34 -15.26 59.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.73 178.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.422 ' HB1' ' CB ' ' A' ' 41' ' ' LEU . . . -76.68 -18.9 58.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.907 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.688 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 24.2 m-85 -68.12 165.2 35.23 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.389 176.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.688 ' HA ' ' HB3' ' A' ' 57' ' ' PHE . 96.7 Cg_endo -82.57 157.07 77.31 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 123.895 -1.294 . . . . 0.0 112.672 -0.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -104.49 -173.99 0.07 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.6 0 C-N-CA 124.425 3.416 . . . . 0.0 111.359 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -98.56 16.5 21.67 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.745 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.798 ' HE2' HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -59.58 124.13 19.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.979 -169.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -79.12 -13.44 59.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.372 -170.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.12 125.55 1.38 Allowed Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -105.98 130.65 53.87 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 11.7 t70 -148.91 155.04 40.29 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -176.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.1 t -63.73 -25.9 68.41 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.21 0.529 . . . . 0.0 110.99 176.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 29.1 t-20 -60.7 -33.32 72.69 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.112 0.482 . . . . 0.0 109.867 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.798 HD21 ' HE2' ' A' ' 61' ' ' PHE . 26.0 tp -54.37 -38.37 66.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.074 173.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.9 mm -62.03 -38.06 79.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.2 0.524 . . . . 0.0 110.125 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.669 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 6.7 mm-40 -66.27 -45.06 81.81 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 26.5 mmt180 -60.27 -38.26 83.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.393 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 68' ' ' LEU . 79.3 mt -61.26 -51.29 74.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.807 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.669 ' CE1' ' HA ' ' A' ' 70' ' ' GLU . 4.5 p-80 -68.73 -30.88 69.6 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.405 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.585 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 44.0 mt-10 -59.33 -50.26 74.65 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.699 173.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.657 ' HG3' HG13 ' A' ' 35' ' ' ILE . 8.3 mm-40 -60.4 -29.85 69.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 120.952 0.406 . . . . 0.0 110.677 176.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.679 ' HA ' HG23 ' A' ' 81' ' ' ILE . 19.3 tp -61.54 -45.29 94.79 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 174.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -83.36 -53.06 6.01 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 49.1 pttt -74.54 -38.07 62.86 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -173.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.41 -24.82 17.18 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.881 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.9 23.99 43.42 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.746 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.679 HG23 ' HA ' ' A' ' 76' ' ' LEU . 8.0 tt -72.55 121.97 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.429 0.633 . . . . 0.0 111.001 -169.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.546 ' O ' HD13 ' A' ' 39' ' ' ILE . 19.7 m120 -99.72 117.25 33.66 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -171.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.641 HG12 HD13 ' A' ' 39' ' ' ILE . 1.8 mt -149.34 132.25 6.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.705 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -90.09 153.9 3.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -177.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -87.47 -31.98 19.71 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.033 0.444 . . . . 0.0 110.949 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 42.3 t30 . . . . . 0 C--N 1.332 -0.164 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.269 -176.973 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.438 ' HB2' HG12 ' A' ' 31' ' ' ILE . 65.1 mtt . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.5 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 36.3 Cg_exo -57.8 -27.11 76.79 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.74 2.293 . . . . 0.0 111.638 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 14.9 pt20 -64.27 -25.07 67.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.092 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.641 ' O ' HG13 ' A' ' 35' ' ' ILE . 23.9 mm -68.46 -48.34 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.278 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -56.0 -46.36 78.76 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.085 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 21.5 mmm180 -67.25 -40.88 86.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.243 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.534 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -66.87 -36.36 82.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.187 -175.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.641 HG13 ' O ' ' A' ' 31' ' ' ILE . 74.7 mt -59.89 -44.38 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.564 ' HD3' HD11 ' A' ' 81' ' ' ILE . 26.5 mmtm -67.32 -35.77 80.1 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.142 0.496 . . . . 0.0 110.118 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.598 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 39.7 ttmt -65.99 -38.27 88.07 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.535 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.683 HD11 ' CZ ' ' A' ' 61' ' ' PHE . 93.4 mt -61.08 -50.57 72.74 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.041 0.448 . . . . 0.0 110.085 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.533 ' HB ' HD12 ' A' ' 81' ' ' ILE . 1.5 mp -66.19 -35.14 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.336 -177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.517 ' HG ' ' HA ' ' A' ' 37' ' ' LYS . 22.7 p -70.22 -43.37 70.8 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.263 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.638 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 78.4 mt -58.82 -35.41 72.83 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.676 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.59 -32.97 85.96 Favored Glycine 0 CA--C 1.496 -1.152 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.38 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -30.45 65.86 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.552 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.87 -43.73 74.76 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.167 171.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 32.3 mmmt -66.97 -31.94 72.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.555 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.46 -63.86 0.31 Allowed Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.353 175.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -142.77 154.33 44.13 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.457 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -81.93 105.36 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.364 0.602 . . . . 0.0 111.089 -177.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.678 HG21 ' H ' ' A' ' 52' ' ' ASP . 2.5 t -155.48 158.34 38.39 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.393 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -56.81 -29.9 63.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.288 0.566 . . . . 0.0 109.753 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -63.56 -42.18 98.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.498 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.7 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -64.54 -37.67 88.35 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.008 -176.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.485 HD11 ' HB3' ' A' ' 38' ' ' LEU . 40.8 mm -59.77 -49.18 84.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.577 0.703 . . . . 0.0 109.772 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -66.93 -34.58 78.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.294 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.7 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 9.5 ptmt -76.46 -20.38 57.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.051 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.2 -19.59 60.48 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.527 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.479 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 39.9 t80 -55.47 139.09 67.79 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.756 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 57' ' ' PHE . 22.9 Cg_exo -66.07 145.3 68.83 Favored 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 124.011 -1.245 . . . . 0.0 112.247 -0.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -95.12 -175.33 0.35 Allowed 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 123.743 2.962 . . . . 0.0 110.029 -173.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -98.5 12.73 34.21 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.225 0.536 . . . . 0.0 111.127 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.683 ' CZ ' HD11 ' A' ' 38' ' ' LEU . 32.0 m-85 -63.64 117.78 7.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.066 0.46 . . . . 0.0 111.999 -176.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -82.22 -21.88 36.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.177 170.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.15 127.98 1.69 Allowed Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -104.4 145.06 30.8 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.982 0.391 . . . . 0.0 110.58 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.62 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 11.0 t70 -145.18 156.11 43.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.561 0.22 . . . . 0.0 110.732 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.5 m -63.49 -34.55 78.01 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.212 0.529 . . . . 0.0 111.021 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -61.49 -32.01 72.01 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.983 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.62 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 11.5 tp -56.4 -43.27 79.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.351 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.5 mm -61.56 -47.29 94.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.892 0.377 . . . . 0.0 110.57 -176.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -69.93 -33.74 72.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.868 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.1 tpp85 -70.74 -33.52 70.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.291 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 68' ' ' LEU . 80.2 mt -61.7 -50.54 79.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 176.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.488 ' HA ' HD13 ' A' ' 76' ' ' LEU . 15.4 t-80 -67.1 -34.34 77.42 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.547 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 36.2 mt-10 -58.87 -50.13 75.16 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 173.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.549 ' HG2' ' HE3' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -59.62 -35.19 73.87 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.494 -179.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.815 HD21 HG23 ' A' ' 83' ' ' ILE . 81.5 mt -58.97 -52.2 66.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.05 0.452 . . . . 0.0 111.776 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -85.15 -48.46 9.13 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.251 0.548 . . . . 0.0 112.383 -177.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 18.3 ttmt -71.9 -44.48 63.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.988 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -96.43 -26.96 15.13 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.146 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.26 21.39 35.38 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 119.865 -1.16 . . . . 0.0 113.516 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.75 HG21 HD22 ' A' ' 76' ' ' LEU . 6.5 tt -73.15 144.85 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -113.67 128.61 56.49 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.93 -0.708 . . . . 0.0 112.193 -173.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.815 HG23 HD21 ' A' ' 76' ' ' LEU . 7.0 tp -156.11 133.18 2.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -102.7 166.72 2.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -174.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -93.63 -33.56 13.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.659 0.743 . . . . 0.0 109.592 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.544 ' N ' HG12 ' A' ' 84' ' ' VAL . 24.0 t30 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 113.864 -1.516 . . . . 0.0 109.981 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.616 ' O ' HG22 ' A' ' 31' ' ' ILE . 47.7 ttm . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -60.78 -24.6 79.32 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.816 2.344 . . . . 0.0 112.792 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.471 ' HG3' ' HG2' ' A' ' 28' ' ' MET . 1.5 pp0? -64.58 -29.59 70.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.31 -174.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 28' ' ' MET . 11.3 tp -70.22 -45.85 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.861 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.796 ' HG2' ' HD3' ' A' ' 71' ' ' ARG . 25.6 mt-10 -70.85 -41.2 71.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.753 0.311 . . . . 0.0 110.771 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 11.7 ptt180 -62.22 -32.53 73.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.569 HH11 HD21 ' A' ' 68' ' ' LEU . 25.1 ttm180 -64.29 -37.81 88.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.039 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.536 HG21 ' CD1' ' A' ' 81' ' ' ILE . 15.6 mm -60.33 -50.48 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.539 ' HD3' HD12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -68.21 -35.24 77.67 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.482 179.021 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.52 ' HG2' ' HB2' ' A' ' 60' ' ' ASP . 2.6 tppp? -64.7 -42.35 95.35 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.42 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.646 ' HB3' HD13 ' A' ' 53' ' ' ILE . 75.3 mt -59.66 -48.53 81.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.948 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 1.04 HD11 ' HB ' ' A' ' 83' ' ' ILE . 0.5 OUTLIER -65.71 -36.55 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.419 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.652 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 47.6 t -68.09 -50.37 55.38 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.824 -176.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.675 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 36.2 mt -69.39 -41.56 76.28 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.016 -176.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.04 -39.99 94.99 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.89 -40.33 72.28 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.652 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -59.93 -37.32 79.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.186 174.458 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 73.5 mmtt -68.56 -31.98 71.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.784 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.11 -68.0 0.17 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.584 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -132.4 163.86 27.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.369 0.604 . . . . 0.0 111.534 -171.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.492 HG23 HD13 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -93.51 84.07 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.808 178.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.738 HG21 ' H ' ' A' ' 52' ' ' ASP . 10.0 t -155.45 158.28 38.31 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.452 -174.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.41 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 17.9 t80 -57.38 -37.06 72.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.883 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -64.31 -41.75 96.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.512 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.738 ' H ' HG21 ' A' ' 49' ' ' THR . 0.9 OUTLIER -71.97 -29.99 64.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.348 177.338 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.646 HD13 ' HB3' ' A' ' 38' ' ' LEU . 45.4 mm -59.47 -49.02 85.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.176 0.512 . . . . 0.0 110.321 172.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.779 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 16.9 t70 -58.52 -37.94 76.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.459 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.688 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.29 -15.51 59.4 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.794 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.81 -20.02 33.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.996 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.818 ' HD1' ' HD3' ' A' ' 59' ' ' PRO . 16.3 m-85 -61.7 145.35 92.01 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.163 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 22.3 Cg_endo -95.8 128.71 3.66 Favored 'Cis proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.275 -1.135 . . . . 0.0 112.104 -3.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.818 ' HD3' ' HD1' ' A' ' 57' ' ' PHE . 77.5 Cg_endo -106.6 -108.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.944 0 C-N-CA 123.667 2.911 . . . . 0.0 112.785 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.52 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -100.45 10.86 40.62 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -170.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.744 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 12.9 p90 -79.52 117.87 20.86 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 118.891 -1.124 . . . . 0.0 110.186 -177.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.445 ' HB2' ' NE2' ' A' ' 30' ' ' GLN . 97.8 mt-10 -81.11 -26.08 36.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.587 173.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.57 127.26 1.59 Allowed Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -76.18 135.45 39.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 117.402 0.601 . . . . 0.0 109.38 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 10.6 p-10 -151.5 151.2 31.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.983 0.421 . . . . 0.0 111.472 -168.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.7 m -64.02 -29.66 70.79 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.146 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.584 ' ND2' HG12 ' A' ' 31' ' ' ILE . 1.7 t30 -61.49 -33.85 74.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.426 177.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.569 HD21 HH11 ' A' ' 34' ' ' ARG . 46.3 tp -56.36 -41.89 76.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.964 175.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.4 mm -59.95 -42.97 91.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.007 0.432 . . . . 0.0 110.327 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 12.6 mt-10 -68.85 -43.9 74.49 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.796 ' HD3' ' HG2' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -59.51 -40.98 88.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.029 -174.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.557 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 82.7 mt -61.11 -49.48 84.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.512 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.469 ' HA ' HD11 ' A' ' 76' ' ' LEU . 32.2 m170 -65.9 -38.46 88.8 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.439 -177.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.506 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 51.4 mt-10 -62.75 -47.14 84.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.455 177.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 79' ' ' HIS . 12.1 mm-40 -59.35 -29.6 67.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.84 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.659 HD23 HG22 ' A' ' 81' ' ' ILE . 91.6 mt -58.04 -48.03 81.33 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.783 0.325 . . . . 0.0 110.397 175.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -84.32 -52.03 6.53 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 19.8 pttp -73.23 -37.56 66.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -174.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 30.5 t60 -94.03 -34.73 12.91 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.548 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.79 22.59 30.43 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.837 -175.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.659 HG22 HD23 ' A' ' 76' ' ' LEU . 6.6 tt -72.73 138.73 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -175.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.403 HD21 ' HA ' ' A' ' 82' ' ' ASN . 9.3 m120 -117.06 124.67 49.85 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.387 -174.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 1.04 ' HB ' HD11 ' A' ' 39' ' ' ILE . 19.8 tt -159.3 132.49 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.753 -174.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.543 HG13 ' HB ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -98.24 154.27 3.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.121 0.486 . . . . 0.0 110.729 -172.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -86.43 -34.63 20.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.438 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.617 ' HB2' ' HG1' ' A' ' 49' ' ' THR . 2.7 t-20 . . . . . 0 N--CA 1.469 0.518 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.211 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.45 ' SD ' HG12 ' A' ' 31' ' ' ILE . 54.7 ttm . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.711 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 57.7 Cg_exo -52.63 -32.74 55.79 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.984 2.456 . . . . 0.0 112.521 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -58.72 -39.22 80.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.766 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.659 ' O ' HG13 ' A' ' 35' ' ' ILE . 16.7 mm -67.69 -45.33 84.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.677 177.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -56.54 -45.17 81.32 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.861 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.711 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 14.4 mmt180 -65.36 -39.53 92.43 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.444 0.64 . . . . 0.0 109.918 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.449 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -66.26 -35.85 81.47 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.23 -176.528 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.659 HG13 ' O ' ' A' ' 31' ' ' ILE . 62.6 mt -59.57 -44.11 92.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.577 ' HD3' HD11 ' A' ' 81' ' ' ILE . 48.2 mmtt -67.02 -42.38 85.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.56 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.607 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 8.7 mtpm? -62.14 -39.15 91.64 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.488 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.609 HD11 ' HZ ' ' A' ' 61' ' ' PHE . 55.2 mt -60.43 -47.74 84.8 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.461 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.642 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.4 mp -62.28 -35.37 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.075 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.616 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 22.5 t -67.02 -47.48 71.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.206 177.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.722 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 88.6 mt -59.96 -44.96 94.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.682 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.61 -37.07 84.53 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 15.4 tptm -65.33 -43.88 89.54 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.206 0.526 . . . . 0.0 110.08 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.616 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -59.32 -35.37 73.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.538 174.459 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.961 ' HE2' ' HA ' ' A' ' 56' ' ' ALA . 44.1 mmtm -68.62 -25.27 64.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.829 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.22 -62.31 0.31 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.432 -0.89 . . . . 0.0 113.076 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -134.71 157.75 45.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.995 0.426 . . . . 0.0 110.261 -175.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.486 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -81.12 86.43 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-O 121.077 0.465 . . . . 0.0 109.814 175.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 10.1 t -152.11 153.33 33.69 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.386 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -61.42 -30.31 70.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.984 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -67.49 -38.02 83.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.341 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.977 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -71.99 -31.53 66.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.163 176.245 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 49' ' ' THR . 49.0 mm -60.88 -49.75 83.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.383 0.611 . . . . 0.0 110.072 172.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -57.02 -38.9 73.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.346 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.977 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 7.4 ptmt -75.83 -15.75 60.19 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.979 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.961 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -77.14 -18.84 57.59 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.929 -178.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.629 ' CD1' ' HG3' ' A' ' 59' ' ' PRO . 18.5 m-30 -61.0 145.67 88.95 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 7.0 Cg_exo -73.82 144.61 81.55 Favored 'Cis proline' 0 C--N 1.347 0.496 0 C-N-CA 124.26 -1.142 . . . . 0.0 112.53 0.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.696 ' HG2' ' CD2' ' A' ' 61' ' ' PHE . 37.4 Cg_endo -104.4 -157.47 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.565 0 C-N-CA 124.64 3.56 . . . . 0.0 111.054 -176.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.44 11.16 37.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.846 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.696 ' CD2' ' HG2' ' A' ' 59' ' ' PRO . 23.2 m-85 -63.14 117.64 6.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.28 0.562 . . . . 0.0 112.254 -171.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -81.61 -21.93 38.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.666 168.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.57 126.9 1.54 Allowed Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -103.25 144.85 30.8 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 117.091 0.445 . . . . 0.0 110.384 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -151.36 156.33 40.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.841 0.353 . . . . 0.0 110.962 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 m -63.07 -24.57 67.97 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.285 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.658 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 26.2 t30 -57.23 -38.55 73.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.197 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.535 ' O ' HG13 ' A' ' 72' ' ' ILE . 27.8 tp -57.47 -39.86 77.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.414 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.5 mm -62.25 -41.54 91.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.162 0.506 . . . . 0.0 110.192 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -68.17 -42.1 80.51 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.678 0.752 . . . . 0.0 109.107 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.658 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 13.5 mmt180 -68.34 -34.63 76.45 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.503 -174.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 68' ' ' LEU . 75.6 mt -61.59 -49.0 86.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.676 0.274 . . . . 0.0 110.754 177.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -64.09 -39.53 94.26 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.092 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -59.11 -49.8 76.47 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -56.59 -29.76 62.43 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.819 HD23 HG23 ' A' ' 81' ' ' ILE . 85.9 mt -58.65 -50.08 75.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.92 0.391 . . . . 0.0 111.247 176.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -85.1 -48.06 9.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.512 0.673 . . . . 0.0 111.617 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -69.61 -45.17 69.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.533 -173.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.97 -31.69 11.68 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.963 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.92 22.04 19.1 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.264 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.819 HG23 HD23 ' A' ' 76' ' ' LEU . 6.8 tt -73.69 145.56 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 118.507 1.153 . . . . 0.0 108.188 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -116.73 130.31 56.65 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.091 -0.644 . . . . 0.0 112.457 -174.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.66 HG21 HD22 ' A' ' 76' ' ' LEU . 4.2 tp -168.49 133.79 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.24 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -91.95 150.46 3.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -96.29 -23.15 16.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.882 0.372 . . . . 0.0 110.487 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 60.1 t30 . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.503 -178.457 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 45.7 ttm . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.74 -24.76 76.93 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.443 2.762 . . . . 0.0 113.159 -174.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -60.55 -25.77 66.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.417 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.62 ' O ' HG13 ' A' ' 35' ' ' ILE . 26.1 mm -66.44 -49.94 71.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 177.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -54.84 -45.9 74.55 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.156 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -66.94 -42.47 85.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.286 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.681 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -63.19 -40.21 96.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.212 -175.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.699 HD11 ' HA ' ' A' ' 72' ' ' ILE . 54.2 mt -59.51 -40.53 82.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.011 0.434 . . . . 0.0 109.934 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.582 ' HD3' HD13 ' A' ' 81' ' ' ILE . 32.5 mmtm -66.89 -39.49 87.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.696 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.482 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 87.7 mttt -64.76 -43.61 92.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.978 176.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.79 -44.03 97.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.334 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.543 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -62.88 -36.09 74.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.38 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.409 ' C ' ' HE3' ' A' ' 44' ' ' LYS . 48.9 m -66.28 -46.32 77.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.099 0.476 . . . . 0.0 110.023 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.718 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 97.6 mt -58.89 -47.32 85.37 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.219 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.16 -33.71 86.73 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.464 ' HB2' HG23 ' A' ' 48' ' ' ILE . 12.2 tptt -73.39 -40.0 64.67 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.414 -0.893 . . . . 0.0 109.44 -174.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.718 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 5.4 ptpt -75.98 -31.77 59.15 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.752 -177.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -76.83 -9.75 58.9 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.105 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.69 -70.31 0.31 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.883 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -133.97 148.44 51.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.222 0.534 . . . . 0.0 111.455 -168.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -78.53 86.83 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.237 0.541 . . . . 0.0 109.901 176.029 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.624 HG22 ' H ' ' A' ' 52' ' ' ASP . 8.9 t -156.75 158.21 36.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.467 -175.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -63.62 -30.48 71.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 110.871 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.5 -41.11 93.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.557 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.903 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -71.95 -29.13 63.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.04 177.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 49' ' ' THR . 48.1 mm -59.4 -50.59 79.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.157 0.503 . . . . 0.0 109.972 172.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.508 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 0.5 OUTLIER -57.58 -34.43 69.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.69 177.493 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.903 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 4.5 ptmt -75.81 -18.86 59.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.025 -178.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.97 -20.11 42.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.547 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.508 ' CD2' ' HA ' ' A' ' 54' ' ' ASP . 80.2 m-85 -62.67 142.95 96.81 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.872 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 86.3 Cg_endo -84.24 143.19 41.13 Favored 'Cis proline' 0 C--N 1.345 0.362 0 C-N-CA 123.394 -1.502 . . . . 0.0 112.779 -1.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.58 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 39.8 Cg_endo -103.87 -156.72 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 124.785 3.656 . . . . 0.0 111.104 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -97.98 16.03 22.23 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.177 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.681 ' HA ' ' HD3' ' A' ' 34' ' ' ARG . 7.0 p90 -58.43 121.21 10.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 122.083 0.944 . . . . 0.0 111.723 -167.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -79.33 -24.93 42.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.408 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.1 127.34 1.59 Allowed Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -111.1 128.81 56.0 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -153.0 157.87 41.19 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 -175.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -27.05 65.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.513 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.438 ' OD1' ' HD2' ' A' ' 71' ' ' ARG . 10.5 t-20 -61.52 -35.16 76.92 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.335 176.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.652 ' O ' HG13 ' A' ' 72' ' ' ILE . 57.6 tp -64.08 -39.53 94.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.891 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.2 mm -64.06 -46.78 92.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.712 0.291 . . . . 0.0 110.701 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.478 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 16.6 pt-20 -68.99 -33.1 73.13 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.559 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 42.4 mtt180 -72.27 -29.59 64.03 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.18 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.699 ' HA ' HD11 ' A' ' 35' ' ' ILE . 64.3 mt -58.87 -50.56 79.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.537 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 30.7 p80 -69.82 -32.79 71.42 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.986 176.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.559 ' HB2' ' HA ' ' A' ' 71' ' ' ARG . 13.4 mt-10 -59.48 -50.25 74.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.981 0.419 . . . . 0.0 110.452 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.714 ' HA ' ' HG2' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -67.86 -27.42 66.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.688 178.07 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.928 ' HA ' HG22 ' A' ' 81' ' ' ILE . 12.6 tp -56.54 -45.31 81.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.863 172.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -83.1 -51.55 7.43 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.714 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 11.7 ptpt -72.06 -39.1 69.29 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -173.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -94.14 -32.13 13.87 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.635 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.37 24.87 15.09 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.421 -1.371 . . . . 0.0 113.131 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.928 HG22 ' HA ' ' A' ' 76' ' ' LEU . 5.9 tt -72.23 144.44 13.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 117.202 0.501 . . . . 0.0 109.858 -174.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -102.6 123.14 45.77 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.337 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.543 ' HB ' HG13 ' A' ' 39' ' ' ILE . 4.5 tp -162.31 137.15 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.539 HG13 ' HB ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -103.14 156.09 5.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.115 0.483 . . . . 0.0 110.353 -176.31 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 7.0 mm-40 -89.83 -25.36 21.09 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.733 -175.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.56 ' HB2' ' HG1' ' A' ' 49' ' ' THR . 8.3 t30 . . . . . 0 N--CA 1.463 0.183 0 O-C-N 124.571 1.17 . . . . 0.0 110.185 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.54 ' O ' HG23 ' A' ' 31' ' ' ILE . 28.0 ttt . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 121.007 0.432 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.63 -24.48 75.01 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.837 2.358 . . . . 0.0 112.742 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.632 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 23.6 tm0? -65.58 -39.17 91.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.963 0.411 . . . . 0.0 110.857 -175.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.651 HD11 ' HB2' ' A' ' 68' ' ' LEU . 10.4 tp -71.89 -38.78 66.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.207 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.31 -40.52 74.15 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.964 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.632 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 3.2 ptm180 -61.32 -36.04 79.03 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.699 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.59 ' HD2' ' HA ' ' A' ' 61' ' ' PHE . 48.1 ttp85 -65.07 -35.76 82.18 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.812 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.589 HD12 ' HG3' ' A' ' 75' ' ' GLU . 21.8 mt -60.48 -45.2 97.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 110.579 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.57 ' HZ3' ' HB ' ' A' ' 35' ' ' ILE . 0.6 OUTLIER -67.11 -39.71 86.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.371 177.474 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.544 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 14.4 mmmm -61.75 -39.6 92.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.185 0.517 . . . . 0.0 109.616 176.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 54.9 mt -63.59 -46.82 84.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.359 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.566 HD11 ' HB ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -62.06 -35.57 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.41 -178.443 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.6 p -67.61 -45.89 74.13 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.689 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.729 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 96.4 mt -59.26 -45.8 90.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.219 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.74 -34.82 78.74 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -42.04 87.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.04 0.924 . . . . 0.0 109.068 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.439 ' HE2' ' N ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -64.1 -39.99 95.25 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 113.815 -1.539 . . . . 0.0 110.583 175.115 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.756 ' HE2' ' HA ' ' A' ' 56' ' ' ALA . 45.4 mmtm -67.91 -31.5 71.32 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.774 -178.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.01 -67.55 0.17 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.236 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -137.63 171.18 14.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.851 0.358 . . . . 0.0 110.733 -171.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.568 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -83.55 86.07 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 122.486 1.136 . . . . 0.0 108.863 173.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.569 ' O ' HG12 ' A' ' 53' ' ' ILE . 6.0 m -145.79 151.74 38.43 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.258 -174.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -59.43 -36.02 75.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.962 0.41 . . . . 0.0 110.113 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.481 ' H ' HG21 ' A' ' 49' ' ' THR . 35.5 mt-10 -58.71 -40.99 85.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.484 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.679 ' HA ' ' CD ' ' A' ' 55' ' ' LYS . 5.2 m-20 -71.68 -32.35 67.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.233 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 49' ' ' THR . 39.6 mm -66.89 -49.65 72.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.79 0.805 . . . . 0.0 109.781 174.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.64 -33.74 76.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.278 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.679 ' CD ' ' HA ' ' A' ' 52' ' ' ASP . 15.6 ptmt -76.33 -19.99 57.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.985 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.756 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -74.2 -18.95 60.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.875 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -57.25 132.55 81.0 Favored Pre-proline 0 N--CA 1.466 0.352 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.119 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 57.2 Cg_endo -71.85 133.4 28.68 Favored 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 123.707 -1.372 . . . . 0.0 112.705 0.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.56 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 35.2 Cg_endo -101.51 -157.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 124.347 3.365 . . . . 0.0 111.27 -175.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -97.17 13.62 28.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.622 -175.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.59 ' HA ' ' HD2' ' A' ' 34' ' ' ARG . 8.2 p90 -63.06 120.15 10.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.453 0.644 . . . . 0.0 110.933 -175.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.579 ' HB2' ' NE2' ' A' ' 30' ' ' GLN . 24.5 mt-10 -79.55 -26.74 41.32 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.8 135.52 3.74 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -95.64 130.04 42.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 117.452 0.626 . . . . 0.0 110.018 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -137.01 145.3 43.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.567 -171.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.6 t -65.36 -27.1 68.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.674 0.749 . . . . 0.0 109.682 170.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -61.15 -32.24 71.96 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.819 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.651 ' HB2' HD11 ' A' ' 31' ' ' ILE . 3.3 tm? -54.38 -41.85 69.68 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.467 176.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 23.0 mm -65.31 -42.68 94.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-O 121.687 0.756 . . . . 0.0 110.052 -177.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 12.4 mt-10 -64.63 -45.05 88.48 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.555 ' HG2' HG22 ' A' ' 31' ' ' ILE . 15.5 tpt180 -71.16 -32.09 68.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.949 -170.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.563 ' HA ' HD11 ' A' ' 35' ' ' ILE . 24.3 pt -63.63 -46.66 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.597 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.532 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 28.5 p80 -68.52 -33.3 73.88 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 118.976 -1.089 . . . . 0.0 111.918 177.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.684 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 4.2 mm-40 -65.06 -50.02 67.81 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.974 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.589 ' HG3' HD12 ' A' ' 35' ' ' ILE . 4.0 mm-40 -63.0 -28.22 69.95 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.899 176.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.587 ' HA ' HG23 ' A' ' 81' ' ' ILE . 11.3 tp -57.73 -40.89 80.68 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.116 172.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -83.79 -51.77 6.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 9.8 ptmm? -72.33 -42.82 64.96 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -174.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.45 ' HB2' ' OE1' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -95.62 -22.7 17.43 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.136 -178.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.56 23.98 41.02 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.242 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.587 HG23 ' HA ' ' A' ' 76' ' ' LEU . 6.0 tt -73.52 119.93 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.633 0.73 . . . . 0.0 111.492 -170.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.82 129.12 36.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.668 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.568 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 17.7 tt -173.5 131.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -175.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -90.84 151.82 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 121.179 0.514 . . . . 0.0 110.227 -173.636 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -90.74 -23.47 20.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.042 -172.537 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 4.1 t-20 . . . . . 0 N--CA 1.467 0.414 0 O-C-N 124.542 1.151 . . . . 0.0 109.666 -177.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.543 ' HB3' HG12 ' A' ' 31' ' ' ILE . 59.7 mtt . . . . . 0 C--O 1.234 0.263 0 CA-C-O 120.449 0.166 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.469 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 33.2 Cg_exo -60.26 -25.39 80.01 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.322 2.014 . . . . 0.0 111.018 173.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 10.6 pt20 -59.18 -35.02 72.82 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.895 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.565 ' O ' HG13 ' A' ' 35' ' ' ILE . 36.7 mm -66.44 -42.9 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.204 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.438 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 38.6 tt0 -58.02 -45.75 86.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.106 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 31.9 mmt-85 -66.06 -44.19 85.26 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.994 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.649 ' HD3' ' O ' ' A' ' 60' ' ' ASP . 0.1 OUTLIER -64.91 -37.89 89.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.559 -173.154 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.565 HG13 ' O ' ' A' ' 31' ' ' ILE . 70.0 mt -64.67 -37.79 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.513 ' HD3' HD11 ' A' ' 81' ' ' ILE . 15.9 mmtm -66.74 -35.7 80.74 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.142 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.69 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 34.6 mtpt -65.63 -40.99 93.16 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.352 175.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.557 HD11 ' HE2' ' A' ' 61' ' ' PHE . 14.6 tp -59.66 -50.0 75.55 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.564 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -61.95 -34.93 65.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.212 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.715 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 23.1 t -66.11 -44.63 83.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.768 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 77.6 mt -58.8 -37.53 76.57 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.81 -38.62 89.61 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 43' ' ' LYS . 13.7 tppt? -67.94 -35.24 78.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.194 0.521 . . . . 0.0 110.149 178.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.715 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -69.92 -38.54 76.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.688 0.756 . . . . 0.0 109.717 175.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.697 ' HB3' ' HD3' ' A' ' 55' ' ' LYS . 29.8 mmtm -68.6 -29.04 67.47 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.809 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.39 -65.92 0.26 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.849 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -136.14 157.21 47.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.053 0.454 . . . . 0.0 110.947 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.9 86.58 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.17 0.51 . . . . 0.0 109.981 177.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.785 ' HG1' ' HB2' ' A' ' 86' ' ' ASN . 8.5 t -153.78 155.64 36.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.599 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -57.58 -40.4 78.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.424 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.9 -34.34 76.46 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.745 0.307 . . . . 0.0 110.891 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.931 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -72.52 -30.94 64.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.932 0.396 . . . . 0.0 111.057 174.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.4 mm -64.49 -49.2 81.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.213 0.53 . . . . 0.0 110.169 171.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -57.32 -33.73 68.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.762 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.931 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 1.2 ptmt -76.66 -22.08 54.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.31 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.46 -19.27 42.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.003 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.438 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 67.6 t80 -56.41 140.69 72.49 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.399 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 86.3 Cg_endo -83.49 148.69 61.43 Favored 'Cis proline' 0 C--N 1.347 0.456 0 C-N-CA 123.781 -1.341 . . . . 0.0 112.904 0.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.578 ' HG2' ' HD2' ' A' ' 61' ' ' PHE . 36.7 Cg_endo -102.43 -160.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 124.412 3.408 . . . . 0.0 110.432 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.649 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 22.8 m-20 -97.8 11.26 37.85 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.578 ' HD2' ' HG2' ' A' ' 59' ' ' PRO . 60.2 m-85 -62.79 118.32 7.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.42 0.629 . . . . 0.0 111.217 -175.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -82.36 -12.12 58.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.563 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.62 124.28 1.33 Allowed Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -114.78 136.37 53.15 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.835 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 31.7 t70 -160.63 168.32 25.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.743 -0.208 . . . . 0.0 110.57 178.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.0 m -58.5 -32.31 68.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.681 0.277 . . . . 0.0 111.097 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.445 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . 5.1 t-20 -61.26 -34.08 74.58 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.153 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.608 ' O ' HG13 ' A' ' 72' ' ' ILE . 54.5 tp -58.96 -41.6 87.86 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.549 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.69 -39.41 83.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.247 0.546 . . . . 0.0 110.241 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 16.6 mt-10 -68.15 -42.98 79.29 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -64.58 -32.8 74.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.458 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.608 HG13 ' O ' ' A' ' 68' ' ' LEU . 80.3 mt -61.6 -51.35 73.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.583 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.497 ' CD2' ' HA ' ' A' ' 70' ' ' GLU . 29.4 p80 -68.77 -32.77 72.76 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.041 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -59.29 -47.24 86.11 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.542 ' HG3' HD11 ' A' ' 35' ' ' ILE . 25.2 mm-40 -64.31 -32.9 74.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.883 0.373 . . . . 0.0 110.859 175.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.628 ' HA ' HG21 ' A' ' 81' ' ' ILE . 22.3 tp -60.98 -46.77 89.4 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.922 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -82.62 -51.57 7.62 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -73.31 -45.22 56.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.265 -174.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -96.44 -16.24 21.3 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.65 -176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.74 24.5 49.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 119.678 -1.249 . . . . 0.0 113.835 171.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.628 HG21 ' HA ' ' A' ' 76' ' ' LEU . 7.8 tt -72.35 119.59 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 117.99 0.895 . . . . 0.0 110.716 -173.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -81.31 125.02 29.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.033 0.444 . . . . 0.0 111.119 -172.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.564 ' HB ' HG13 ' A' ' 39' ' ' ILE . 3.6 tp -166.61 123.15 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.426 -176.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.784 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -89.79 152.36 3.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -95.38 -25.36 16.31 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.935 0.397 . . . . 0.0 110.246 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.785 ' HB2' ' HG1' ' A' ' 49' ' ' THR . 56.1 t30 . . . . . 0 N--CA 1.463 0.176 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.027 -177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.566 ' CG ' ' HG2' ' A' ' 30' ' ' GLN . 58.7 tpp . . . . . 0 N--CA 1.457 -0.086 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.423 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 65.9 Cg_exo -53.61 -26.95 39.38 Favored 'Trans proline' 0 N--CA 1.477 0.51 0 C-N-CA 123.496 2.797 . . . . 0.0 113.635 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.566 ' HG2' ' CG ' ' A' ' 28' ' ' MET . 10.7 pt20 -64.91 -25.4 67.87 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 121.224 -0.19 . . . . 0.0 110.56 177.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.778 HD12 HD11 ' A' ' 68' ' ' LEU . 36.1 mm -65.4 -46.58 89.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.348 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -55.62 -47.27 76.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.41 177.505 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 33.7 mtp180 -67.69 -44.92 76.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.47 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.887 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -58.38 -47.21 84.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.905 -173.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.694 HD13 ' HG3' ' A' ' 75' ' ' GLU . 56.9 mt -64.51 -37.3 79.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.119 -177.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 24.7 mmtm -68.18 -35.12 77.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.173 0.511 . . . . 0.0 110.372 176.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.544 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 8.0 mttm -66.05 -37.7 86.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.459 174.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 89.0 mt -61.58 -38.2 86.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.813 174.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.548 HD11 ' O ' ' A' ' 82' ' ' ASN . 0.3 OUTLIER -62.63 -35.21 69.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.471 177.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 14.0 m -64.78 -44.3 90.44 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.998 ' HA ' ' HE2' ' A' ' 44' ' ' LYS . 61.7 mt -59.29 -47.16 86.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.697 174.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.604 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -68.41 -33.01 76.28 Favored Glycine 0 CA--C 1.509 -0.298 0 CA-C-O 121.972 0.762 . . . . 0.0 112.114 -173.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.77 -43.92 52.34 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 122.872 1.32 . . . . 0.0 107.954 -174.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.998 ' HE2' ' HA ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -77.21 -26.88 53.19 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 112.669 -2.06 . . . . 0.0 110.879 -172.44 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.516 ' HB2' ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -76.48 -32.89 58.64 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.14 174.258 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.67 -64.03 0.25 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.725 173.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -134.15 147.53 50.82 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.705 -0.291 . . . . 0.0 110.893 -170.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.412 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -73.93 100.25 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.282 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.641 ' O ' HG12 ' A' ' 53' ' ' ILE . 91.6 m -156.18 145.01 20.29 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.861 -171.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -60.03 -39.83 87.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.213 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.499 ' H ' HG22 ' A' ' 49' ' ' THR . 39.5 mt-10 -68.3 -34.23 75.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.991 177.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.947 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 10.2 t70 -71.38 -37.8 71.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.102 0.477 . . . . 0.0 110.931 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.641 HG12 ' O ' ' A' ' 49' ' ' THR . 42.4 mm -59.8 -46.46 93.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.565 0.697 . . . . 0.0 109.839 173.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.404 ' O ' ' HD1' ' A' ' 57' ' ' PHE . 35.2 t70 -63.01 -32.41 73.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.247 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.947 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -74.49 -17.09 60.82 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.864 -178.356 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -66.32 -16.81 64.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.519 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.473 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 36.1 p90 -42.9 134.84 2.91 Favored Pre-proline 0 N--CA 1.472 0.645 0 O-C-N 123.825 0.703 . . . . 0.0 112.106 -176.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 57' ' ' PHE . 21.9 Cg_exo -66.0 140.7 48.29 Favored 'Cis proline' 0 C--N 1.346 0.416 0 C-N-CA 123.668 -1.388 . . . . 0.0 112.14 -2.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 13.1 Cg_endo -95.86 -169.28 0.15 Allowed 'Trans proline' 0 N--CA 1.44 -1.632 0 C-N-CA 123.999 3.132 . . . . 0.0 110.204 -175.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.544 ' OD2' ' HD3' ' A' ' 37' ' ' LYS . 19.9 t70 -98.34 5.14 48.49 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.985 0.421 . . . . 0.0 111.349 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.887 ' HA ' ' HD3' ' A' ' 34' ' ' ARG . 57.3 m-85 -64.65 118.23 8.58 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -171.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -80.89 -31.85 35.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.155 166.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.95 126.1 1.43 Allowed Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -113.96 144.38 43.17 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.938 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.608 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 1.7 p30 -147.76 164.37 33.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.627 0.251 . . . . 0.0 110.966 176.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 m -65.53 -32.29 73.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.735 0.303 . . . . 0.0 111.432 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.433 ' HA ' ' OE2' ' A' ' 70' ' ' GLU . 26.2 t-20 -62.39 -34.67 77.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.35 0.595 . . . . 0.0 109.816 177.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.778 HD11 HD12 ' A' ' 31' ' ' ILE . 22.6 tp -57.29 -39.91 76.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.041 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.0 mm -63.02 -37.37 79.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.335 0.588 . . . . 0.0 110.358 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 17.9 mt-10 -67.83 -41.68 82.66 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.421 ' HE ' ' HG3' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -64.14 -32.43 74.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.559 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 68' ' ' LEU . 74.6 mt -61.09 -46.3 96.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.648 0.261 . . . . 0.0 110.682 178.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.405 ' HA ' HD12 ' A' ' 76' ' ' LEU . 1.7 p-80 -65.78 -33.51 76.03 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.904 178.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 5.9 mm-40 -61.03 -49.92 75.44 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.81 176.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.694 ' HG3' HD13 ' A' ' 35' ' ' ILE . 79.8 mm-40 -55.62 -31.23 62.11 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.889 -178.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.738 HD22 HG21 ' A' ' 81' ' ' ILE . 86.8 mt -57.9 -46.83 84.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.979 0.419 . . . . 0.0 110.562 173.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -83.67 -50.26 8.36 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.511 ' HD2' ' CD ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -73.6 -42.47 61.49 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -175.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.411 ' CG ' ' HE2' ' A' ' 36' ' ' LYS . 56.2 t-80 -95.47 -29.86 14.17 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.608 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.93 23.19 33.48 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 119.842 -1.17 . . . . 0.0 112.568 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.738 HG21 HD22 ' A' ' 76' ' ' LEU . 6.3 tt -72.5 146.63 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.548 ' O ' HD11 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -117.2 119.61 35.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.195 0.522 . . . . 0.0 111.794 -175.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.7 mt -153.85 116.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -82.44 151.66 4.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.345 0.593 . . . . 0.0 110.292 -175.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.41 -30.09 23.86 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.661 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.449 ' HB2' HG21 ' A' ' 49' ' ' THR . 2.3 t-20 . . . . . 0 N--CA 1.464 0.255 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.225 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.467 ' O ' HG22 ' A' ' 31' ' ' ILE . 24.6 ttt . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.27 0.557 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.694 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 26.1 Cg_exo -62.9 -30.87 77.57 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.037 2.491 . . . . 0.0 112.203 -172.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -58.31 -38.83 77.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.131 -177.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.7 ' O ' HG13 ' A' ' 35' ' ' ILE . 5.9 tp -67.11 -35.69 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -177.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.414 ' HG2' ' NH2' ' A' ' 71' ' ' ARG . 18.7 mt-10 -65.45 -45.93 81.84 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.586 0.707 . . . . 0.0 109.907 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.694 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 39.5 mtt180 -68.64 -37.9 80.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.286 -176.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.601 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 0.3 OUTLIER -66.07 -36.19 82.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.021 -177.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.7 HG13 ' O ' ' A' ' 31' ' ' ILE . 86.4 mt -60.88 -42.71 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.555 ' CD ' HD11 ' A' ' 81' ' ' ILE . 20.0 mmtm -65.74 -36.46 83.63 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.032 0.444 . . . . 0.0 110.278 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.456 ' HE3' HD21 ' A' ' 41' ' ' LEU . 45.3 tptt -64.13 -46.46 84.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.749 175.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.84 -44.22 93.81 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.585 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.523 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -62.82 -35.93 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.977 177.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.722 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 22.8 t -67.06 -47.36 71.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.356 -0.537 . . . . 0.0 109.658 178.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.694 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 83.7 mt -59.62 -43.67 93.71 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.551 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.98 -37.39 93.16 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -177.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.56 ' HB2' HG23 ' A' ' 48' ' ' ILE . 25.7 tptt -70.04 -38.43 75.85 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 120.942 0.401 . . . . 0.0 110.342 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.722 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -61.06 -36.92 80.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.733 0.778 . . . . 0.0 109.965 173.056 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.924 ' HE3' ' HA ' ' A' ' 56' ' ' ALA . 74.4 mmtt -67.52 -30.38 70.03 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.383 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.31 -63.45 0.3 Allowed Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.668 175.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -126.76 155.22 43.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.228 0.537 . . . . 0.0 110.593 -175.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.8 OUTLIER -86.33 88.28 2.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.352 0.596 . . . . 0.0 109.634 176.376 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.612 ' O ' HG12 ' A' ' 53' ' ' ILE . 9.8 t -158.23 163.4 37.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.926 -171.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -60.04 -39.14 84.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.92 0.391 . . . . 0.0 110.982 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -57.69 -45.43 85.65 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.461 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.768 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -73.26 -31.08 63.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.493 -179.511 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 49' ' ' THR . 46.3 mm -61.66 -50.13 81.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.235 0.54 . . . . 0.0 110.103 173.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.405 ' HA ' ' CD1' ' A' ' 57' ' ' PHE . 10.7 t70 -59.11 -38.21 79.04 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.489 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.768 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 10.7 ptmt -75.65 -18.31 59.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.101 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.924 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -75.7 -23.09 56.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.126 177.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 54' ' ' ASP . 63.3 m-85 -61.95 142.84 95.01 Favored Pre-proline 0 N--CA 1.464 0.268 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.509 176.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.509 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 96.3 Cg_endo -84.02 137.11 27.15 Favored 'Cis proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.584 -1.423 . . . . 0.0 112.818 0.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 56.9 Cg_endo -102.81 -152.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 124.466 3.444 . . . . 0.0 110.953 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.77 13.31 28.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 178.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.14 117.15 6.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.013 0.435 . . . . 0.0 111.168 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -81.88 -25.81 34.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.363 173.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.61 125.76 1.48 Allowed Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -106.56 144.95 32.49 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.531 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 16.9 t70 -150.0 157.52 43.24 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.85 -174.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.6 m -63.63 -26.78 68.83 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.861 0.362 . . . . 0.0 111.161 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -60.72 -33.44 72.9 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.568 ' O ' HG13 ' A' ' 72' ' ' ILE . 25.1 tp -54.57 -39.29 67.62 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.027 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.6 mm -62.33 -42.67 96.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.233 0.539 . . . . 0.0 109.868 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 11.8 mt-10 -66.83 -45.53 77.99 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.528 ' HD2' ' OE2' ' A' ' 74' ' ' GLU . 18.4 mmm-85 -65.65 -34.46 78.26 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.482 -1.235 . . . . 0.0 111.89 -174.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 68' ' ' LEU . 71.1 mt -61.1 -50.07 82.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.589 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 18.7 m170 -69.07 -34.9 75.89 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.544 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.528 ' OE2' ' HD2' ' A' ' 71' ' ' ARG . 43.4 mt-10 -60.67 -49.01 79.24 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 175.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -64.73 -31.94 73.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.953 0.406 . . . . 0.0 110.675 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.687 ' HA ' HG21 ' A' ' 81' ' ' ILE . 16.5 tp -64.66 -42.37 95.45 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.755 176.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -82.2 -52.15 7.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.948 0.404 . . . . 0.0 111.836 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -75.54 -44.91 41.06 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.586 -174.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -95.5 -17.02 21.8 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.315 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.44 23.78 57.85 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.698 -1.239 . . . . 0.0 113.348 173.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.687 HG21 ' HA ' ' A' ' 76' ' ' LEU . 4.5 tt -71.61 124.05 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 117.605 0.702 . . . . 0.0 110.64 -171.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.402 HD21 ' HA ' ' A' ' 82' ' ' ASN . 10.5 m120 -78.42 117.08 19.3 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.463 0.649 . . . . 0.0 111.414 -175.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.567 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 5.6 tp -161.91 139.48 2.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.53 HG13 ' HB ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -110.22 154.25 11.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-O 121.004 0.43 . . . . 0.0 110.443 -175.377 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -83.2 -23.68 32.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.068 -175.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.458 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 3.3 t30 . . . . . 0 N--CA 1.464 0.258 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.464 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.8 mtm . . . . . 0 N--CA 1.442 -0.842 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.764 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 50.0 Cg_exo -52.63 -33.21 57.81 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.923 2.415 . . . . 0.0 112.663 -173.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -25.0 58.88 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.076 -173.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.628 HD12 ' HB2' ' A' ' 68' ' ' LEU . 9.5 mm -69.76 -46.51 74.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 174.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -61.91 -45.24 94.59 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.094 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.764 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 29.7 mtm180 -61.79 -43.15 99.42 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.866 176.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.485 HH12 ' HB2' ' A' ' 64' ' ' PHE . 73.8 ttt180 -58.66 -36.1 73.62 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.517 -178.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.613 HG13 ' O ' ' A' ' 31' ' ' ILE . 63.6 mt -58.44 -51.71 68.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.492 ' HD3' HD11 ' A' ' 81' ' ' ILE . 1.4 mppt? -69.28 -40.14 77.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.52 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.401 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.8 mmtm -59.22 -38.42 79.9 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.114 0.259 . . . . 0.0 110.721 177.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.496 ' HB3' HD11 ' A' ' 53' ' ' ILE . 30.8 mt -65.34 -49.79 68.07 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.12 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.64 HG12 HG12 ' A' ' 81' ' ' ILE . 1.5 mp -62.77 -34.93 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.238 0.542 . . . . 0.0 109.72 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.8 m -67.0 -47.99 69.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.4 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.577 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 72.3 mt -59.49 -39.22 83.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.632 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.691 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -65.83 -34.21 88.04 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.553 ' HD2' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -71.73 -29.84 64.97 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 122.042 0.925 . . . . 0.0 109.184 -177.241 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.497 ' HE2' ' N ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -75.69 -46.03 33.5 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.736 -1.574 . . . . 0.0 110.428 174.559 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.765 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . 72.4 mmtt -68.17 -33.62 74.8 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.96 -174.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.47 -66.15 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.384 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -142.25 164.17 30.86 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -175.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.702 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -89.25 79.99 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.889 -170.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 1.074 ' HB ' HG11 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -139.0 154.32 48.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.402 -169.501 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -57.29 -39.28 75.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.515 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -68.27 -35.56 78.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.673 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.783 ' HB2' HG22 ' A' ' 49' ' ' THR . 9.4 t0 -71.61 -34.43 69.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.302 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 49' ' ' THR . 49.2 mm -58.87 -49.32 83.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.57 0.7 . . . . 0.0 110.196 174.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -61.03 -32.9 72.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.473 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.765 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -75.61 -25.43 56.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.312 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.69 -23.74 60.91 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.789 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.518 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 64.2 t80 -64.26 138.17 97.34 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.652 176.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.434 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 6.0 Cg_exo -80.04 137.22 40.98 Favored 'Cis proline' 0 C--N 1.347 0.48 0 C-N-CA 124.151 -1.187 . . . . 0.0 112.543 0.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.553 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 57.2 Cg_endo -105.61 -158.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 124.723 3.615 . . . . 0.0 111.266 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.81 16.5 22.06 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.892 -177.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.553 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 13.5 p90 -58.85 121.46 11.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.653 0.74 . . . . 0.0 111.726 -170.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -80.81 -18.51 47.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.814 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.32 135.9 3.93 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -174.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.485 ' HB2' HH12 ' A' ' 34' ' ' ARG . 78.8 t80 -112.87 138.6 49.48 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.258 174.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -158.53 153.85 25.73 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.3 t -63.24 -25.64 68.42 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.282 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.56 ' O ' ' HB2' ' A' ' 71' ' ' ARG . 10.2 m120 -60.92 -31.36 70.89 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.33 177.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.628 ' HB2' HD12 ' A' ' 31' ' ' ILE . 48.8 tp -58.84 -40.47 84.33 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.047 176.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.1 mm -63.85 -46.46 94.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.947 0.404 . . . . 0.0 110.565 -177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -69.4 -34.11 74.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.758 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -68.26 -41.21 81.43 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.555 -176.571 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.569 HG12 HG23 ' A' ' 35' ' ' ILE . 76.2 mt -60.75 -45.11 98.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.705 0.288 . . . . 0.0 110.938 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.467 ' HA ' HD13 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -63.98 -41.46 97.52 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.456 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 12.8 pt-20 -69.69 -34.09 73.44 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.991 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 71' ' ' ARG . 63.7 mm-40 -61.48 -29.86 70.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.563 0.22 . . . . 0.0 111.115 173.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.697 HD21 HG23 ' A' ' 83' ' ' ILE . 98.2 mt -60.04 -49.03 79.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.829 0.347 . . . . 0.0 110.909 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -82.95 -50.12 8.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.202 0.525 . . . . 0.0 111.752 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 8.8 ttmt -69.8 -44.75 69.4 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.205 -175.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -96.13 -25.61 15.8 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.525 -174.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.59 21.59 53.34 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 119.93 -1.129 . . . . 0.0 112.011 -175.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.64 HG12 HG12 ' A' ' 39' ' ' ILE . 9.8 tt -72.49 145.35 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -178.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.72 136.17 53.18 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.309 -173.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.697 HG23 HD21 ' A' ' 76' ' ' LEU . 1.6 tp -162.42 129.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.134 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 1.074 HG11 ' HB ' ' A' ' 49' ' ' THR . 2.2 p -97.57 151.03 4.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.832 -175.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -93.74 -26.49 16.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.06 0.457 . . . . 0.0 110.316 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 63.7 t30 . . . . . 0 N--CA 1.464 0.238 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.983 176.097 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.581 ' O ' HG23 ' A' ' 31' ' ' ILE . 22.3 ptt? . . . . . 0 CA--C 1.536 0.415 0 CA-C-O 120.781 0.324 . . . . 0.0 111.618 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.462 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 4.7 Cg_exo -80.87 -27.29 3.16 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.315 2.01 . . . . 0.0 111.19 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.58 ' HB2' ' OE1' ' A' ' 62' ' ' GLU . 13.5 pt20 -69.03 -29.63 67.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.604 -177.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.665 ' O ' HG13 ' A' ' 35' ' ' ILE . 10.0 tp -69.05 -36.42 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.044 -176.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -65.2 -46.31 81.23 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.121 0.486 . . . . 0.0 110.046 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 61.1 mtp180 -60.74 -45.03 95.85 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.117 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.428 ' HD3' ' OE1' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -63.33 -31.39 72.53 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.886 -176.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.665 HG13 ' O ' ' A' ' 31' ' ' ILE . 63.6 mt -58.68 -48.35 86.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.82 176.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.485 ' CD ' HD11 ' A' ' 81' ' ' ILE . 1.9 mppt? -67.54 -33.84 75.87 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.909 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 16.6 tptp -63.24 -40.36 97.21 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.211 176.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.6 ' HA ' HD11 ' A' ' 41' ' ' LEU . 5.9 mp -70.24 -40.14 74.62 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.443 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.689 HG12 HG12 ' A' ' 81' ' ' ILE . 1.5 mp -63.3 -34.53 67.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.997 174.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.408 ' C ' ' HE3' ' A' ' 44' ' ' LYS . 45.5 t -61.06 -43.06 99.46 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.836 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 89.9 mt -58.24 -46.15 86.47 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.992 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.663 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -60.67 -32.29 78.15 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.12 -39.72 48.42 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.935 0.874 . . . . 0.0 109.273 -175.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.836 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 4.4 ptpt -76.68 -36.94 56.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.092 -176.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.69 ' HB2' ' OD1' ' A' ' 52' ' ' ASP . 30.8 mmmt -72.05 -20.98 61.59 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.733 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.23 -72.97 0.21 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.025 -0.989 . . . . 0.0 113.589 174.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -143.93 145.96 32.63 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.386 0.136 . . . . 0.0 110.741 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.531 ' HB ' HD12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -66.91 108.51 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 122.042 0.925 . . . . 0.0 109.816 -176.038 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.681 HG23 ' H ' ' A' ' 51' ' ' GLU . 54.5 m -160.71 145.51 14.22 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.597 -173.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -57.73 -39.99 78.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.216 0.531 . . . . 0.0 110.474 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.681 ' H ' HG23 ' A' ' 49' ' ' THR . 44.4 mm-40 -68.37 -33.59 74.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.627 177.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.692 ' CG ' ' HD3' ' A' ' 55' ' ' LYS . 10.0 t70 -71.72 -32.55 67.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.365 0.603 . . . . 0.0 109.71 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 49' ' ' THR . 50.0 mm -61.4 -49.42 84.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.419 0.628 . . . . 0.0 109.776 170.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -33.47 69.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.54 176.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.692 ' HD3' ' CG ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -75.12 -24.29 58.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.993 -179.516 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.503 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -71.91 -19.7 61.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.311 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.52 ' CD2' ' HD3' ' A' ' 59' ' ' PRO . 55.3 t80 -63.79 133.05 95.42 Favored Pre-proline 0 C--O 1.235 0.317 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.44 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.49 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 53.9 Cg_endo -69.88 127.44 11.0 Favored 'Cis proline' 0 C--N 1.35 0.605 0 C-N-CA 123.392 -1.503 . . . . 0.0 112.165 1.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.52 ' HD3' ' CD2' ' A' ' 57' ' ' PHE . 13.9 Cg_endo -96.74 -165.65 0.1 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 123.74 2.96 . . . . 0.0 110.711 -172.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -98.35 15.23 25.32 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.402 -175.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.462 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 9.6 p90 -62.87 126.49 27.5 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.291 0.567 . . . . 0.0 111.121 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.58 ' OE1' ' HB2' ' A' ' 30' ' ' GLN . 48.7 mt-10 -80.82 -24.84 38.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.874 176.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.21 126.94 1.53 Allowed Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -106.31 123.72 48.48 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 117.523 0.662 . . . . 0.0 109.801 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 20.7 t70 -147.23 162.16 39.46 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.07 -175.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.8 t -64.37 -31.38 72.56 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.2 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -62.2 -34.46 76.5 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.248 0.547 . . . . 0.0 109.816 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.598 ' O ' HG13 ' A' ' 72' ' ' ILE . 32.9 tp -59.94 -42.18 93.46 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.749 177.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.2 mm -59.62 -43.48 91.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.033 0.444 . . . . 0.0 110.745 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -67.99 -40.97 82.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.564 ' HG3' ' CD1' ' A' ' 35' ' ' ILE . 9.5 tpp180 -66.43 -32.88 74.52 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.019 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.598 HG13 ' O ' ' A' ' 68' ' ' LEU . 76.0 mt -61.37 -50.59 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.852 -0.158 . . . . 0.0 110.629 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.575 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 22.1 p80 -67.1 -33.51 75.62 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.136 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -59.45 -49.52 77.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.344 0.593 . . . . 0.0 109.604 174.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.56 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 59.8 mm-40 -66.71 -28.98 68.86 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.821 176.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 1.02 ' HA ' HG22 ' A' ' 81' ' ' ILE . 13.5 tp -69.58 -51.55 34.29 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.363 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -84.49 -53.03 5.7 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.286 0.565 . . . . 0.0 111.625 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -76.29 -38.94 55.43 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.052 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.56 ' HB2' ' HA ' ' A' ' 75' ' ' GLU . 3.1 t60 -94.62 -16.42 23.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.577 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.24 23.03 42.1 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.398 -0.906 . . . . 0.0 114.106 172.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 1.02 HG22 ' HA ' ' A' ' 76' ' ' LEU . 7.9 tt -75.34 145.63 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 117.727 0.763 . . . . 0.0 109.322 -176.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.472 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.9 OUTLIER -108.31 128.06 54.41 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -173.393 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.662 HG12 HG13 ' A' ' 39' ' ' ILE . 9.2 mm -162.14 119.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 124.37 1.068 . . . . 0.0 108.61 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -88.17 152.36 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 CA-C-O 121.671 0.748 . . . . 0.0 109.454 -179.546 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -79.03 -31.44 44.64 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.146 -177.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.528 ' HB2' HG22 ' A' ' 49' ' ' THR . 11.8 t-20 . . . . . 0 N--CA 1.464 0.242 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.05 176.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.456 -0.141 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.412 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 22.8 Cg_exo -63.88 -25.32 67.5 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.566 2.177 . . . . 0.0 111.546 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -66.6 -24.8 66.38 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.57 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.53 HG23 HD11 ' A' ' 68' ' ' LEU . 8.1 mm -65.22 -43.94 95.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.503 0.192 . . . . 0.0 111.494 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -69.71 -37.52 76.6 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 49.9 mtp180 -66.26 -34.12 77.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.792 175.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.583 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 2.0 tpm_? -59.06 -39.31 81.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.534 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.775 HD11 ' HG3' ' A' ' 71' ' ' ARG . 22.7 mt -59.54 -49.0 85.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.275 0.559 . . . . 0.0 109.857 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.53 ' HA ' HD12 ' A' ' 81' ' ' ILE . 14.3 mmmt -65.69 -36.2 82.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.173 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.56 ' HD2' ' HA ' ' A' ' 34' ' ' ARG . 48.3 mttm -60.96 -41.68 96.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.378 174.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 70.8 mt -67.41 -42.27 83.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.591 -176.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.618 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.6 mp -68.62 -34.91 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.981 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.675 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 32.2 t -66.44 -47.5 72.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.966 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 96.9 mt -60.15 -40.02 88.4 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.781 -177.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.527 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -67.0 -38.42 92.75 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.469 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 11.2 tptt -73.35 -34.89 65.87 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.874 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.675 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -62.6 -45.2 93.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.089 173.714 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.815 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . 45.3 mmtm -69.23 -35.23 75.94 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.82 -177.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.9 -65.99 0.1 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.086 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -137.0 158.57 44.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.416 0.627 . . . . 0.0 111.154 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.501 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.8 OUTLIER -83.64 88.98 2.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.334 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 10.6 t -153.61 155.24 35.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.829 -176.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -58.35 -41.98 85.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.043 0.449 . . . . 0.0 111.215 -173.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.68 -32.64 72.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.882 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.637 ' OD1' ' HB2' ' A' ' 45' ' ' LYS . 11.1 t0 -71.61 -39.26 70.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.214 0.53 . . . . 0.0 110.223 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.1 mt -60.23 -45.42 96.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.355 0.598 . . . . 0.0 110.017 173.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.0 -34.36 69.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.325 176.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.815 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -75.73 -23.05 56.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.092 -178.006 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.774 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -69.63 -18.93 63.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.571 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 80.5 t80 -62.74 137.14 96.58 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 176.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 90.0 Cg_endo -85.49 140.25 28.21 Favored 'Cis proline' 0 C--N 1.346 0.396 0 C-N-CA 123.594 -1.419 . . . . 0.0 113.441 1.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.609 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 37.3 Cg_endo -103.65 -157.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.744 0 C-N-CA 124.742 3.628 . . . . 0.0 110.896 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -98.09 14.52 27.24 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.044 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.609 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 10.1 p90 -61.51 125.9 25.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.464 0.649 . . . . 0.0 110.826 -174.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -79.08 -30.14 43.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.686 174.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.28 126.79 1.48 Allowed Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -108.2 144.57 35.47 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 24.3 t70 -142.66 161.37 38.24 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.32 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -63.07 -30.93 71.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.953 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -61.07 -34.08 74.35 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.124 0.488 . . . . 0.0 110.268 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.65 ' O ' HG13 ' A' ' 72' ' ' ILE . 58.1 tp -60.58 -39.42 87.99 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.906 177.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.6 mm -62.89 -41.43 92.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.244 0.545 . . . . 0.0 110.314 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.412 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 17.6 mt-10 -68.25 -36.99 80.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.902 0.858 . . . . 0.0 108.959 177.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.775 ' HG3' HD11 ' A' ' 35' ' ' ILE . 23.0 tpt180 -70.06 -33.99 72.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.153 -178.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 68' ' ' LEU . 86.2 mt -61.0 -50.38 80.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.002 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.412 ' CD2' ' HA ' ' A' ' 70' ' ' GLU . 34.3 p80 -66.73 -31.94 72.92 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.91 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.697 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 25.6 mt-10 -58.54 -53.38 59.01 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 121.377 0.608 . . . . 0.0 109.773 173.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.48 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 47.3 tp10 -59.88 -33.52 71.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.529 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.873 ' HA ' HG22 ' A' ' 81' ' ' ILE . 9.0 tp -66.57 -49.56 65.98 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.809 177.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -83.9 -53.35 5.65 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -173.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.697 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 34.3 pttt -76.97 -40.1 48.11 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.575 -176.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -93.8 -21.14 19.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.059 -176.582 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.32 25.24 24.38 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.358 -1.401 . . . . 0.0 114.772 172.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.873 HG22 ' HA ' ' A' ' 76' ' ' LEU . 5.4 tt -73.06 119.59 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 118.847 1.324 . . . . 0.0 109.628 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -81.8 126.94 32.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.434 0.635 . . . . 0.0 111.505 -171.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.618 ' HB ' HG13 ' A' ' 39' ' ' ILE . 4.8 tp -167.87 140.02 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.464 -176.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -100.73 153.4 4.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -92.62 -29.73 15.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.491 -174.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.478 ' HB2' ' HG1' ' A' ' 49' ' ' THR . 24.0 t-20 . . . . . 0 N--CA 1.466 0.351 0 O-C-N 123.939 0.774 . . . . 0.0 110.192 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 112.231 -0.347 . . . . 0.0 112.231 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.8 p -129.5 -160.15 1.01 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 60.0 68.51 0.77 Allowed 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.364 0.602 . . . . 0.0 109.851 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.515 ' HB3' HG12 ' A' ' 31' ' ' ILE . 65.9 mtt -130.74 76.47 77.2 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.487 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.476 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 15.5 Cg_exo -67.94 -25.07 38.97 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.661 2.241 . . . . 0.0 111.105 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.436 ' HB2' ' OE2' ' A' ' 62' ' ' GLU . 12.3 pt20 -66.2 -25.1 66.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.389 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.576 ' O ' HG13 ' A' ' 35' ' ' ILE . 28.8 mm -65.17 -49.88 76.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.587 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -55.69 -46.54 77.6 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.202 0.525 . . . . 0.0 110.492 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 12.6 mmm180 -67.56 -44.34 78.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.025 -177.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.687 HH11 HD22 ' A' ' 68' ' ' LEU . 29.6 ttm180 -61.74 -37.93 86.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.215 -175.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 31' ' ' ILE . 89.8 mt -59.83 -46.32 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.555 ' HD3' HD13 ' A' ' 81' ' ' ILE . 26.5 mmtm -67.03 -37.29 83.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.27 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.517 ' HD2' ' HA ' ' A' ' 34' ' ' ARG . 94.4 mttt -62.57 -40.93 98.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.875 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.579 ' HB3' HD12 ' A' ' 53' ' ' ILE . 73.8 mt -64.93 -45.84 84.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.664 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.619 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.6 mp -66.37 -35.38 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 121.033 0.444 . . . . 0.0 109.953 177.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.701 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 33.3 t -65.96 -42.09 90.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.922 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.708 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 93.3 mt -60.15 -43.12 95.99 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.474 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.41 -35.23 89.87 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -36.82 83.36 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.888 -0.656 . . . . 0.0 109.703 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.701 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -68.78 -41.13 79.2 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.883 0.849 . . . . 0.0 110.03 175.141 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.708 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 70.3 mmtt -68.95 -31.56 70.53 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.014 -1.448 . . . . 0.0 111.277 -176.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.54 -58.8 0.44 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.246 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -119.68 146.81 45.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.119 0.485 . . . . 0.0 110.667 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.06 86.48 2.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.347 0.594 . . . . 0.0 109.697 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.45 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.0 m -141.79 148.08 38.33 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.407 -170.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -57.12 -42.24 80.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.061 0.458 . . . . 0.0 110.119 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -70.06 -32.68 70.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.697 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.736 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 1.3 m-20 -68.23 -29.44 68.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.266 0.555 . . . . 0.0 111.3 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' A' ' 38' ' ' LEU . 17.7 mt -65.71 -44.02 93.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 121.075 0.464 . . . . 0.0 110.187 170.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.33 -39.36 75.69 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.497 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.736 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.66 -15.43 59.18 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.832 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.678 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -75.39 -18.49 59.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.073 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.516 ' CD2' ' HD3' ' A' ' 59' ' ' PRO . 43.6 t80 -50.1 136.01 21.81 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.829 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 71.5 Cg_endo -75.03 137.72 51.95 Favored 'Cis proline' 0 C--N 1.345 0.374 0 C-N-CA 123.528 -1.447 . . . . 0.0 112.836 1.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.516 ' HD3' ' CD2' ' A' ' 57' ' ' PHE . 17.0 Cg_endo -98.87 -165.25 0.07 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 124.141 3.227 . . . . 0.0 110.245 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -97.38 13.92 28.04 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.012 0.434 . . . . 0.0 110.734 -176.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.454 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 5.2 p90 -63.25 120.74 12.12 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.625 0.726 . . . . 0.0 111.358 -173.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.436 ' OE2' ' HB2' ' A' ' 30' ' ' GLN . 2.3 mp0 -80.93 -22.26 39.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.736 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.02 146.96 14.2 Favored Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 -174.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -100.99 120.57 40.37 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.484 173.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -134.67 132.64 39.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.715 0.293 . . . . 0.0 110.61 -170.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.8 m -63.78 -31.94 73.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.405 0.622 . . . . 0.0 109.746 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.537 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 14.0 m120 -62.31 -38.67 90.33 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.643 175.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.687 HD22 HH11 ' A' ' 34' ' ' ARG . 52.2 tp -59.69 -39.01 83.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.613 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.7 mm -61.08 -46.53 96.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.557 0.218 . . . . 0.0 111.107 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -70.59 -34.56 72.3 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.669 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 19.4 mmt180 -70.41 -32.62 70.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.512 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.583 HG13 ' O ' ' A' ' 68' ' ' LEU . 82.4 mt -61.75 -49.56 83.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.834 0.35 . . . . 0.0 110.143 175.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.527 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 77.3 m80 -67.46 -34.92 78.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.754 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -67.62 -48.88 65.48 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.699 177.129 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -58.6 -29.52 66.52 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.004 0.43 . . . . 0.0 110.624 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.923 ' HA ' HG23 ' A' ' 81' ' ' ILE . 2.9 tp -57.6 -44.82 85.71 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.299 173.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -84.02 -52.66 6.13 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.754 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 3.6 ptmm? -72.93 -39.77 66.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -93.1 -26.98 17.22 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.942 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.16 23.09 23.31 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.77 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.923 HG23 ' HA ' ' A' ' 76' ' ' LEU . 6.2 tt -74.33 123.5 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 117.731 0.765 . . . . 0.0 110.108 -174.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -82.51 118.26 23.12 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.974 -0.454 . . . . 0.0 111.306 -172.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.619 ' HB ' HG13 ' A' ' 39' ' ' ILE . 5.5 tp -156.95 137.61 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.12 152.2 10.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.265 0.555 . . . . 0.0 110.789 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 87' ' ' GLU . 51.0 mm-40 -88.23 -25.91 22.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.974 -176.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.3 t30 77.57 -12.49 1.06 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 124.202 0.939 . . . . 0.0 109.799 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' A' ' 85' ' ' GLU . 6.2 tp10 -82.1 130.59 59.47 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.964 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.22 69.12 3.28 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.17 1.913 . . . . 0.0 112.236 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.77 15.55 10.96 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.974 0.893 . . . . 0.0 109.905 175.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -120.63 79.7 1.52 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.46 -1.246 . . . . 0.0 107.741 172.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.18 154.38 46.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.606 -170.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -139.8 -80.88 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.91 0.386 . . . . 0.0 111.499 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.414 ' O ' HG12 ' A' ' 93' ' ' ILE . 14.6 tt -106.75 12.91 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 121.574 0.702 . . . . 0.0 111.124 -172.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.8 m 57.24 56.13 5.39 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.223 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.91 63.16 0.99 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.33 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.762 0 CA-C-O 118.884 -0.953 . . . . 0.0 111.638 179.206 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.885 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -113.91 -33.41 5.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.922 0.361 . . . . 0.0 111.861 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -87.91 50.16 1.94 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.25 0.548 . . . . 0.0 110.506 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.582 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -172.08 77.27 0.47 Allowed Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.647 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.625 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 9.3 Cg_exo -72.01 -36.32 6.08 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.625 2.217 . . . . 0.0 112.492 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.454 ' HB2' HH21 ' A' ' 34' ' ' ARG . 5.1 pp0? -64.96 -32.88 74.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.156 -174.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.686 HG13 HD13 ' A' ' 68' ' ' LEU . 10.7 tp -71.98 -35.52 54.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.62 -47.38 66.82 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.219 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.625 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 22.5 mmm180 -62.96 -35.37 79.93 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.532 ' HG2' ' CD1' ' A' ' 61' ' ' PHE . 6.4 tpp180 -60.63 -37.03 80.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.978 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 31' ' ' ILE . 30.9 mt -60.48 -44.87 97.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.508 ' HA ' ' HB ' ' A' ' 39' ' ' ILE . 2.2 mppt? -67.95 -34.03 75.8 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.014 175.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -58.59 -42.56 88.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.168 0.509 . . . . 0.0 109.931 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.602 HD12 HG23 ' A' ' 53' ' ' ILE . 4.1 mm? -70.08 -35.05 73.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.723 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.622 HD13 HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -60.69 -37.97 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.236 0.541 . . . . 0.0 109.738 173.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.668 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 36.6 t -66.97 -48.38 68.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.028 176.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.686 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 91.5 mt -60.8 -45.93 92.51 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.055 -176.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.08 -39.04 84.34 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -175.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.44 -34.15 67.58 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.668 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -61.34 -41.23 96.71 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.918 172.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.811 ' HZ2' ' HA ' ' A' ' 56' ' ' ALA . 31.7 mmtp -68.41 -21.7 64.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.485 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.01 -66.1 0.25 Allowed Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.363 -0.923 . . . . 0.0 112.522 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -142.57 171.67 13.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.16 0.505 . . . . 0.0 111.116 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.486 HG22 ' CD1' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -87.63 86.16 2.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.453 0.644 . . . . 0.0 109.952 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.597 ' O ' HG12 ' A' ' 53' ' ' ILE . 9.7 m -143.26 145.62 32.9 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.525 -171.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -60.6 -34.94 74.95 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 32.1 mt-10 -67.63 -35.03 78.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.092 176.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.679 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 11.8 m-20 -71.68 -30.32 65.57 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.444 0.64 . . . . 0.0 110.972 176.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.602 HG23 HD12 ' A' ' 38' ' ' LEU . 50.9 mm -66.5 -45.34 89.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.566 0.698 . . . . 0.0 109.818 169.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.504 ' HA ' ' CE2' ' A' ' 57' ' ' PHE . 21.4 t70 -57.43 -36.89 71.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.715 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.679 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 5.9 ptpt -77.88 -16.58 58.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.781 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.811 ' HA ' ' HZ2' ' A' ' 45' ' ' LYS . . . -76.82 -19.17 57.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.796 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.573 ' CD1' ' HG3' ' A' ' 59' ' ' PRO . 19.8 m-85 -66.62 147.32 99.03 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.933 178.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 2.9 Cg_exo -76.1 143.46 76.65 Favored 'Cis proline' 0 C--N 1.342 0.214 0 C-N-CA 123.955 -1.269 . . . . 0.0 112.358 0.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.685 ' HG2' ' HD2' ' A' ' 61' ' ' PHE . 53.1 Cg_endo -100.92 -173.0 0.11 Allowed 'Trans proline' 0 N--CA 1.438 -1.757 0 C-N-CA 124.328 3.352 . . . . 0.0 110.772 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -98.65 16.53 21.72 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.685 ' HD2' ' HG2' ' A' ' 59' ' ' PRO . 36.4 m-85 -58.43 119.48 7.06 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.925 0.393 . . . . 0.0 110.404 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.58 -20.93 45.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.335 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.71 124.63 1.28 Allowed Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -112.88 144.51 42.32 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.603 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 18.2 t70 -149.56 160.74 43.24 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.867 -172.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 t -62.97 -32.22 73.5 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 120.975 0.416 . . . . 0.0 110.982 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 3.3 t-20 -61.69 -31.86 72.02 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.686 HD13 HG13 ' A' ' 31' ' ' ILE . 26.6 tp -54.63 -38.79 67.26 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.052 175.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.9 mm -61.9 -40.79 88.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.31 0.576 . . . . 0.0 109.866 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.569 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 15.7 mt-10 -68.14 -41.08 82.16 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.534 ' HD2' ' HA ' ' A' ' 68' ' ' LEU . 85.9 mtt180 -60.05 -38.75 83.72 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.939 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 68' ' ' LEU . 80.5 mt -61.3 -51.1 76.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.809 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.569 ' CD2' ' HA ' ' A' ' 70' ' ' GLU . 27.9 p80 -69.0 -32.33 71.81 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.543 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 47.3 mt-10 -59.2 -49.46 77.78 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -63.89 -34.22 77.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.666 175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.499 ' HA ' HG21 ' A' ' 81' ' ' ILE . 18.2 tp -57.48 -41.94 81.64 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.346 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -84.46 -49.82 8.32 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -71.97 -44.69 63.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.05 -26.67 15.96 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.361 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.02 23.44 32.54 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.908 -1.139 . . . . 0.0 112.985 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.499 HG21 ' HA ' ' A' ' 76' ' ' LEU . 11.9 tt -72.32 119.25 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.625 0.726 . . . . 0.0 110.909 -170.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -99.99 118.58 36.69 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.872 -170.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.622 HG12 HD13 ' A' ' 39' ' ' ILE . 3.3 mt -146.16 128.21 8.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 86' ' ' ASN . 0.4 OUTLIER -95.27 153.31 3.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.823 -172.002 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.408 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 8.0 mm-40 -87.11 -23.72 24.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.926 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.495 ' N ' HG12 ' A' ' 84' ' ' VAL . 60.2 t30 77.25 18.84 1.37 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.939 177.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.47 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 9.9 pt-20 -104.04 128.19 27.69 Favored Pre-proline 0 N--CA 1.448 -0.536 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.899 171.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 11.1 Cg_exo -71.68 -22.35 24.19 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.373 2.715 . . . . 0.0 113.248 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 57.61 56.76 4.69 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.56 0.695 . . . . 0.0 109.257 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -114.61 93.74 4.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.259 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -138.58 72.71 1.41 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 172.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -118.81 -59.87 1.82 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.646 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.7 mm -77.74 -34.27 19.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.157 175.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.9 m 71.83 -53.31 0.69 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.666 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -151.78 142.07 22.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.139 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.92 0 CA-C-O 118.796 -1.002 . . . . 0.0 111.568 -178.894 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.685 0 N-CA-C 112.063 -0.415 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.3 p -83.63 -4.66 58.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.6 0.238 . . . . 0.0 111.261 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.3 m80 70.37 22.97 5.12 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.858 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.723 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 87.9 mtp -114.5 -54.42 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.916 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.723 ' HD3' ' HB2' ' A' ' 28' ' ' MET . 43.7 Cg_exo -59.05 -34.24 98.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.107 1.871 . . . . 0.0 112.412 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.494 ' HB2' HH21 ' A' ' 34' ' ' ARG . 21.1 pt20 -67.09 -25.12 66.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.683 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.631 ' O ' HG13 ' A' ' 35' ' ' ILE . 26.6 mm -69.81 -46.07 75.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.227 175.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -55.69 -45.06 77.87 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.254 0.55 . . . . 0.0 110.009 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 2.9 mmp_? -64.93 -39.76 94.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.022 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.953 ' HD2' ' HA ' ' A' ' 61' ' ' PHE . 5.5 tpp180 -67.16 -39.21 86.46 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.232 -173.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.631 HG13 ' O ' ' A' ' 31' ' ' ILE . 41.5 mt -61.14 -44.87 99.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.495 ' HD3' HD13 ' A' ' 81' ' ' ILE . 14.5 mmtp -66.87 -38.77 86.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.207 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.569 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 54.9 mttm -61.02 -43.36 99.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.9 175.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.495 ' HB3' HD12 ' A' ' 53' ' ' ILE . 65.9 mt -63.73 -47.13 82.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.391 -177.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.531 ' CG1' ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -63.41 -34.76 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.066 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.431 ' C ' ' HE3' ' A' ' 44' ' ' LYS . 33.1 t -65.57 -47.89 74.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.551 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.929 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 71.2 mt -59.22 -47.07 86.7 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.636 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.33 -35.81 92.17 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -74.99 -38.79 61.55 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.509 0.671 . . . . 0.0 109.878 -173.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.929 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 3.9 ptpt -70.55 -26.17 63.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.485 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 69.4 mmtt -86.95 -4.48 59.18 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.981 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.88 -71.78 0.3 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.78 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -141.14 164.83 29.21 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 121.213 0.53 . . . . 0.0 111.928 -170.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -85.24 85.27 2.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.22 0.533 . . . . 0.0 109.764 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 5.9 m -142.92 146.6 34.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.404 -171.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.33 -36.12 77.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.065 0.46 . . . . 0.0 110.112 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.483 ' H ' HG23 ' A' ' 49' ' ' THR . 32.9 mt-10 -67.42 -34.36 77.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.183 0.516 . . . . 0.0 110.118 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.76 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 1.5 m-20 -67.2 -30.03 69.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.282 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.495 HD12 ' HB3' ' A' ' 38' ' ' LEU . 39.1 mm -60.08 -50.24 80.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.448 0.642 . . . . 0.0 110.341 173.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.36 -38.24 90.4 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.344 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.76 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -75.41 -14.97 60.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.716 -178.277 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.85 -18.92 60.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.117 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.412 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 80.4 t80 -58.69 134.55 86.32 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.813 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.473 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 57.9 Cg_endo -72.87 132.16 25.31 Favored 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 123.591 -1.42 . . . . 0.0 112.024 -1.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.474 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 19.2 Cg_endo -98.61 -158.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.732 0 C-N-CA 124.259 3.306 . . . . 0.0 111.11 -173.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.463 ' H ' HD11 ' A' ' 41' ' ' LEU . 2.5 t70 -98.96 14.19 29.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.325 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.953 ' HA ' ' HD2' ' A' ' 34' ' ' ARG . 4.3 p90 -69.68 120.13 14.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.386 0.612 . . . . 0.0 111.251 -172.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -82.38 -23.55 34.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.651 172.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.74 125.74 1.5 Allowed Glycine 0 N--CA 1.436 -1.34 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -176.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -113.27 134.26 54.69 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.468 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 18.4 t70 -151.59 155.28 38.11 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.4 m -63.05 -27.91 69.73 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.94 0.4 . . . . 0.0 111.371 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -61.34 -32.7 72.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.382 0.611 . . . . 0.0 109.937 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.618 ' O ' HG13 ' A' ' 72' ' ' ILE . 63.9 tp -60.66 -39.11 87.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.084 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.6 mm -62.82 -46.65 95.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.791 0.329 . . . . 0.0 110.884 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.459 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 9.4 pt-20 -68.41 -32.55 72.67 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.496 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 5.9 tpp180 -70.2 -35.96 74.28 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.341 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.618 HG13 ' O ' ' A' ' 68' ' ' LEU . 72.0 mt -59.92 -50.94 78.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.762 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.56 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 26.5 p80 -68.69 -33.48 74.04 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.618 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -60.01 -50.54 73.33 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.712 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.559 ' OE1' ' HD2' ' A' ' 78' ' ' LYS . 8.3 mm-40 -65.72 -25.71 67.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.226 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 1.032 ' HA ' HG23 ' A' ' 81' ' ' ILE . 7.9 tp -56.0 -47.62 77.41 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.066 174.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -83.56 -50.5 8.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.525 0.678 . . . . 0.0 111.199 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.559 ' HD2' ' OE1' ' A' ' 75' ' ' GLU . 23.7 ttmt -68.18 -43.58 77.83 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.998 -172.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.63 -24.68 17.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.772 0.32 . . . . 0.0 110.329 -177.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.37 22.56 24.22 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.114 -1.041 . . . . 0.0 113.27 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 1.032 HG23 ' HA ' ' A' ' 76' ' ' LEU . 10.0 tt -75.66 146.32 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 117.407 0.603 . . . . 0.0 110.219 -174.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.14 128.31 51.8 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.095 -0.378 . . . . 0.0 110.867 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.531 ' HB ' ' CG1' ' A' ' 39' ' ' ILE . 4.7 tp -167.25 137.87 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -109.61 151.68 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.253 -177.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -89.66 -23.92 21.75 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.48 ' HB2' HG22 ' A' ' 49' ' ' THR . 63.5 t30 75.83 2.48 3.69 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.505 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -115.38 127.51 26.74 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.857 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -91.79 152.53 3.4 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.266 2.644 . . . . 0.0 111.743 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -79.76 66.41 5.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.354 0.597 . . . . 0.0 110.211 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 50.22 51.83 15.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.862 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.402 ' HB3' ' HA ' ' A' ' 94' ' ' SER . 41.9 mt-10 -84.74 145.9 27.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.346 177.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -109.39 -47.71 3.35 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.822 0.344 . . . . 0.0 110.734 -173.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.707 ' H ' HD12 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -100.11 20.8 2.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 172.092 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.402 ' HA ' ' HB3' ' A' ' 91' ' ' GLU . 22.5 p 48.37 35.43 5.71 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.535 -174.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.38 32.61 0.98 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.529 0 CA-C-O 118.021 -1.433 . . . . 0.0 110.413 -168.409 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.718 0 N-CA-C 112.039 -0.425 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 t -137.54 127.82 26.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 57.07 66.94 1.06 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.573 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.535 ' O ' HG23 ' A' ' 31' ' ' ILE . 59.4 mtt -131.36 83.84 58.14 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.205 178.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.89 -24.64 53.4 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.767 2.312 . . . . 0.0 111.382 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -60.66 -31.45 70.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.2 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.615 ' O ' HG13 ' A' ' 35' ' ' ILE . 10.5 tp -69.75 -35.46 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.476 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.84 -42.62 76.91 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.168 0.508 . . . . 0.0 110.238 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -63.65 -38.59 91.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.083 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -60.56 -35.01 75.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.103 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.655 HG21 HG12 ' A' ' 72' ' ' ILE . 52.1 mt -60.37 -46.98 94.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.059 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.569 ' HD3' HD13 ' A' ' 81' ' ' ILE . 28.2 mmtm -66.68 -37.28 84.42 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.237 0.541 . . . . 0.0 109.969 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.552 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 15.9 tptm -64.49 -44.39 91.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.409 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.48 HD22 ' HZ ' ' A' ' 61' ' ' PHE . 16.5 tp -67.06 -45.55 77.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.029 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.55 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -62.7 -34.68 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.892 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.718 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 23.2 t -67.1 -45.43 77.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.071 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.625 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 90.0 mt -59.38 -42.9 92.74 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.541 -176.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.457 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -66.69 -34.83 88.64 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.379 -0.915 . . . . 0.0 110.844 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 10.4 tptm -68.43 -38.7 81.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.46 0.648 . . . . 0.0 109.798 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.718 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -66.03 -41.48 90.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.424 175.245 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.816 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . 73.9 mmtt -68.2 -32.71 73.12 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.424 -177.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.66 -65.6 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.552 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -144.16 155.15 43.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.831 0.348 . . . . 0.0 110.84 -175.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -73.99 91.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.552 0.691 . . . . 0.0 110.66 -178.654 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 51' ' ' GLU . 86.6 m -149.07 145.43 27.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.93 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -58.25 -39.37 78.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.803 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 49' ' ' THR . 15.8 mm-40 -64.16 -39.03 93.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.531 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.649 ' CG ' ' HD3' ' A' ' 55' ' ' LYS . 9.9 t0 -72.17 -36.96 69.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.372 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.407 HG22 HD11 ' A' ' 38' ' ' LEU . 26.6 mt -59.92 -45.63 94.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.967 0.413 . . . . 0.0 110.659 172.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -59.59 -31.41 69.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.652 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.816 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -74.71 -26.84 60.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.005 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.611 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -66.74 -19.61 65.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.628 -176.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.454 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 18.2 m-85 -50.99 134.95 28.9 Favored Pre-proline 0 N--CA 1.468 0.451 0 O-C-N 123.236 0.335 . . . . 0.0 111.249 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 57' ' ' PHE . 15.4 Cg_exo -68.78 140.32 56.76 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 123.971 -1.262 . . . . 0.0 112.445 1.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.457 ' HG2' ' HD2' ' A' ' 61' ' ' PHE . 26.5 Cg_endo -98.69 -168.51 0.1 Allowed 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 124.288 3.326 . . . . 0.0 110.957 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -98.44 12.08 36.16 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.196 0.522 . . . . 0.0 111.504 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.48 ' HZ ' HD22 ' A' ' 38' ' ' LEU . 41.5 m-85 -70.95 121.29 17.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.076 0.465 . . . . 0.0 111.67 -174.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -79.11 -30.43 43.76 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 165.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.96 125.91 1.4 Allowed Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 173.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -107.72 143.58 36.04 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 117.438 0.619 . . . . 0.0 110.592 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 15.6 t70 -141.5 159.75 41.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.193 -173.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.5 m -61.37 -26.86 68.11 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.015 0.436 . . . . 0.0 111.346 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.67 -33.54 72.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.7 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.598 ' O ' HG13 ' A' ' 72' ' ' ILE . 35.6 tp -55.64 -41.14 73.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.111 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.4 mm -64.05 -40.37 88.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.265 0.555 . . . . 0.0 109.952 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -67.78 -42.73 81.23 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 10.6 tpt180 -67.89 -34.72 77.2 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.148 -174.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.655 HG12 HG21 ' A' ' 35' ' ' ILE . 76.8 mt -60.62 -48.72 87.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.543 ' HA ' HD12 ' A' ' 76' ' ' LEU . 40.6 t-80 -66.18 -34.64 78.49 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.21 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.32 -49.33 78.24 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 71' ' ' ARG . 34.2 mm-40 -63.67 -29.55 70.77 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.482 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.819 HD21 HG21 ' A' ' 83' ' ' ILE . 77.0 mt -60.9 -50.19 74.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.887 0.375 . . . . 0.0 111.161 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -84.34 -49.74 8.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.191 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -71.88 -44.16 64.22 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 -176.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -96.29 -24.52 16.16 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.449 -172.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.34 21.71 47.46 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.224 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.699 HG23 HD22 ' A' ' 76' ' ' LEU . 5.1 tt -73.82 146.94 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 117.717 0.758 . . . . 0.0 108.991 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -115.3 127.33 55.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.183 0.516 . . . . 0.0 111.81 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.819 HG21 HD21 ' A' ' 76' ' ' LEU . 5.4 tp -155.95 132.45 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.674 176.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -99.12 151.07 4.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -92.08 -24.99 18.98 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.436 ' HB2' HG21 ' A' ' 49' ' ' THR . 16.2 t-20 72.03 8.06 5.89 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.636 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -82.01 127.21 72.77 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.408 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.57 127.78 7.45 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.329 2.019 . . . . 0.0 112.651 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.14 16.76 21.71 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.469 0.652 . . . . 0.0 109.808 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.88 71.5 10.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.89 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -145.38 141.24 28.29 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 175.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -177.35 -71.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 123.637 0.586 . . . . 0.0 109.874 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.7 tt -96.25 -20.53 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.157 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.1 m 61.23 38.09 16.87 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.815 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.85 -6.67 59.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.521 -174.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.318 -1.268 . . . . 0.0 111.601 178.715 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.613 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.2 p -71.31 118.96 14.77 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -77.79 -10.28 59.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.442 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 48.6 tpp -154.27 74.47 6.07 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 121.125 0.488 . . . . 0.0 110.797 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.88 -25.0 6.57 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.931 2.421 . . . . 0.0 112.298 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 11.5 pt20 -69.57 -26.77 64.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.136 -176.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.632 ' O ' HG13 ' A' ' 35' ' ' ILE . 7.5 mm -66.61 -39.58 84.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.26 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.455 ' HG2' ' HE ' ' A' ' 71' ' ' ARG . 40.6 mt-10 -62.72 -45.47 92.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.071 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 26.2 ptt180 -68.9 -32.4 72.02 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.016 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.564 ' HD3' HD12 ' A' ' 68' ' ' LEU . 29.9 ttt-85 -59.3 -37.42 77.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.165 176.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.632 HG13 ' O ' ' A' ' 31' ' ' ILE . 45.3 mt -65.55 -44.59 93.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.02 0.438 . . . . 0.0 110.227 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.461 ' HD3' HD11 ' A' ' 81' ' ' ILE . 1.3 mppt? -66.65 -34.52 78.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.022 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.483 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 96.4 mttt -58.34 -44.6 88.81 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 173.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.536 HD12 ' NH1' ' A' ' 34' ' ' ARG . 48.0 mt -59.26 -50.37 74.25 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.22 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.861 HD13 ' HB ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -61.99 -34.98 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.519 -177.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 71.1 m -67.18 -47.89 69.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.736 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.592 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 96.6 mt -59.69 -42.08 92.16 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.316 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.33 -37.07 85.81 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.155 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.568 ' HG2' HG21 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -71.6 -34.0 69.5 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.345 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.525 ' HE2' ' N ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -68.74 -39.44 80.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.28 174.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 1.03 ' HE3' ' HA ' ' A' ' 56' ' ' ALA . 72.2 mmtt -68.67 -26.89 65.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.02 -178.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.42 -63.74 0.3 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.035 177.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -132.37 161.45 33.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.94 0.4 . . . . 0.0 110.916 -173.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.619 HG22 HD12 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -84.73 84.27 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.166 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.681 HG21 ' H ' ' A' ' 52' ' ' ASP . 4.8 t -150.93 153.81 35.96 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.226 -174.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.421 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 36.3 t80 -63.55 -29.26 70.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.087 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.21 -39.2 86.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.242 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.704 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.8 OUTLIER -71.73 -30.36 65.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.87 176.156 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 49' ' ' THR . 44.8 mm -59.44 -48.89 85.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.01 0.434 . . . . 0.0 110.095 172.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -58.66 -36.32 73.96 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.431 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.823 ' HD3' ' HB3' ' A' ' 45' ' ' LYS . 10.4 ptmt -75.92 -17.76 59.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.041 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 1.03 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -71.32 -18.65 62.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.392 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.446 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 87.6 t80 -56.05 135.49 74.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.333 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 5.9 Cg_exo -75.07 139.54 62.22 Favored 'Cis proline' 0 C--N 1.346 0.437 0 C-N-CA 123.749 -1.355 . . . . 0.0 111.779 -1.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 15.1 Cg_endo -98.2 -173.37 0.17 Allowed 'Trans proline' 0 N--CA 1.436 -1.911 0 C-N-CA 123.738 2.958 . . . . 0.0 110.802 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -97.73 18.9 14.6 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.45 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -57.01 119.05 5.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 122.05 0.928 . . . . 0.0 110.948 -168.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -81.29 -26.36 35.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.555 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.51 132.68 2.67 Favored Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -112.12 123.89 51.24 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 117.673 0.736 . . . . 0.0 109.82 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 0.9 OUTLIER -159.69 168.57 25.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.026 0.441 . . . . 0.0 112.07 -175.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 t -64.75 -28.63 69.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.406 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 71' ' ' ARG . 5.2 m120 -62.02 -33.85 75.13 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.825 0.345 . . . . 0.0 110.127 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.564 HD12 ' HD3' ' A' ' 34' ' ' ARG . 23.1 tp -65.54 -47.34 76.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.133 172.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.2 mm -58.3 -46.31 89.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.896 0.379 . . . . 0.0 110.812 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 8.6 pt-20 -67.71 -35.01 78.0 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 15.1 tpt180 -71.06 -36.61 72.35 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.169 -174.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.621 ' HA ' HD13 ' A' ' 35' ' ' ILE . 79.7 mt -60.86 -50.36 80.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.539 0.209 . . . . 0.0 110.534 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.476 ' HA ' HD13 ' A' ' 76' ' ' LEU . 45.6 t60 -65.38 -35.64 81.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.868 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 38.8 mt-10 -59.7 -49.27 78.4 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.402 ' HG3' HD11 ' A' ' 35' ' ' ILE . 8.4 mm-40 -64.26 -29.66 70.75 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.693 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.796 HD21 HG21 ' A' ' 81' ' ' ILE . 93.9 mt -64.16 -52.66 57.94 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.134 0.493 . . . . 0.0 111.659 176.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -86.01 -50.04 7.36 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.124 -175.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -74.28 -42.41 59.62 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.21 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -95.09 -32.56 13.05 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.525 -174.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.86 21.41 21.17 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.921 -1.133 . . . . 0.0 114.226 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.796 HG21 HD21 ' A' ' 76' ' ' LEU . 4.8 tt -72.9 139.96 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 119.292 1.546 . . . . 0.0 108.023 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.57 136.46 53.26 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.787 -175.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.861 ' HB ' HD13 ' A' ' 39' ' ' ILE . 18.9 tt -168.04 126.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.369 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -98.75 155.34 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-O 121.439 0.638 . . . . 0.0 110.094 -169.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.563 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 1.7 pm0 -85.29 -22.72 28.45 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.557 173.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.517 ' N ' HG13 ' A' ' 84' ' ' VAL . 64.0 t30 74.91 8.6 4.14 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 114.427 -1.261 . . . . 0.0 110.113 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.563 ' HG2' ' HB2' ' A' ' 85' ' ' GLU . 14.6 pt-20 -118.86 137.29 24.83 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.169 174.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 2.5 Cg_endo -82.12 15.32 2.01 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.888 2.392 . . . . 0.0 112.195 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 71.04 -62.06 0.46 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.999 0.812 . . . . 0.0 111.322 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -145.48 91.87 2.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.425 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 73.09 162.94 0.27 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.803 0.811 . . . . 0.0 112.902 175.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -170.36 -49.27 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.394 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.8 tt -71.99 -24.34 22.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.409 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 m 64.93 61.95 0.76 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.928 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -162.77 -57.85 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.54 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.611 -1.105 . . . . 0.0 111.914 179.679 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.951 0 N-CA-C 112.573 -0.211 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.2 m -121.81 78.14 1.43 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.078 0.466 . . . . 0.0 109.776 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -92.42 -33.67 14.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.629 -175.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.607 ' HE1' HG13 ' A' ' 31' ' ' ILE . 33.8 ttp -139.9 75.33 30.42 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.187 0.518 . . . . 0.0 110.683 -174.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -62.16 -23.82 75.81 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.476 2.784 . . . . 0.0 112.773 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.499 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 11.3 pt20 -59.86 -25.4 65.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.32 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.607 HG13 ' HE1' ' A' ' 28' ' ' MET . 17.2 mm -68.94 -48.88 67.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.829 0.347 . . . . 0.0 110.102 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -56.08 -45.29 79.41 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.172 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 10.4 ptm180 -67.92 -38.42 82.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.901 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.574 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -67.37 -38.05 84.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.676 -175.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 31' ' ' ILE . 75.6 mt -59.97 -43.56 92.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.178 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.535 ' CD ' HD13 ' A' ' 81' ' ' ILE . 19.9 mmtm -66.38 -36.06 81.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.491 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.434 ' HE2' ' HB3' ' A' ' 37' ' ' LYS . 32.1 mtpt -68.72 -38.09 79.97 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.177 176.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 82.8 mt -61.29 -47.73 84.65 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.407 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.58 HG12 HG12 ' A' ' 81' ' ' ILE . 1.5 mp -62.64 -34.75 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.185 0.517 . . . . 0.0 109.814 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.0 t -66.2 -48.1 71.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.956 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 95.1 mt -59.85 -36.45 76.88 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.244 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.49 -38.99 95.39 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.462 ' HB2' HG22 ' A' ' 48' ' ' ILE . 33.1 tptt -65.61 -39.58 91.68 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.303 0.573 . . . . 0.0 109.577 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.526 ' HE2' ' N ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -63.07 -42.92 99.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.218 173.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.972 ' HE3' ' HA ' ' A' ' 56' ' ' ALA . 71.6 mmtt -68.09 -26.31 65.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.681 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.83 -64.07 0.32 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.747 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -130.94 158.22 40.84 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.642 HD13 HG12 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -87.86 79.05 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.681 -175.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 1.012 ' HB ' HG11 ' A' ' 84' ' ' VAL . 5.1 t -147.0 160.02 42.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -168.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -56.05 -37.74 69.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.248 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -67.91 -38.99 83.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.394 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.682 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -71.88 -29.89 64.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.363 176.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.664 HG12 ' O ' ' A' ' 49' ' ' THR . 49.4 mm -59.21 -49.64 82.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.417 0.627 . . . . 0.0 109.66 171.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -62.03 -34.22 75.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.154 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.811 ' HD3' ' HB3' ' A' ' 45' ' ' LYS . 11.4 ptmt -75.86 -21.33 57.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.906 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.972 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -76.5 -20.41 56.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.287 0.565 . . . . 0.0 110.08 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.516 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 72.7 t80 -72.5 140.46 81.95 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.449 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.482 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 73.8 Cg_endo -79.83 127.28 14.19 Favored 'Cis proline' 0 C--N 1.345 0.362 0 C-N-CA 123.423 -1.49 . . . . 0.0 112.525 -2.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.516 ' HD3' ' CD1' ' A' ' 57' ' ' PHE . 72.3 Cg_endo -105.53 -139.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.889 0 C-N-CA 124.657 3.572 . . . . 0.0 110.887 -176.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 59' ' ' PRO . 21.0 p-10 -97.63 16.69 19.72 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -173.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.574 ' HA ' ' HD3' ' A' ' 34' ' ' ARG . 14.0 m-85 -57.42 118.28 4.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.189 0.519 . . . . 0.0 111.519 -173.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.99 -24.74 40.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.974 172.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.17 127.26 1.6 Allowed Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -99.07 131.79 44.86 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.618 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 7.3 t70 -147.36 138.59 23.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.833 0.349 . . . . 0.0 110.587 -169.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.9 m -63.47 -35.78 81.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.241 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.541 ' HB3' ' OD2' ' A' ' 65' ' ' ASP . 0.5 OUTLIER -62.17 -33.0 73.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.112 176.142 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.621 ' O ' HG13 ' A' ' 72' ' ' ILE . 33.3 tp -56.49 -39.59 73.5 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.795 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.9 mm -63.7 -40.64 89.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.999 0.428 . . . . 0.0 110.296 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.619 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 15.8 mt-10 -67.2 -40.82 86.55 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -65.13 -35.23 80.45 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.942 -176.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.621 HG13 ' O ' ' A' ' 68' ' ' LEU . 82.2 mt -60.16 -49.95 82.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.47 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.619 ' CE1' ' HA ' ' A' ' 70' ' ' GLU . 4.7 p-80 -67.41 -31.57 71.87 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.471 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.577 ' HB3' ' HE3' ' A' ' 78' ' ' LYS . 32.8 mt-10 -60.99 -50.49 73.16 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.562 ' OE2' ' HD2' ' A' ' 78' ' ' LYS . 23.2 mm-40 -62.07 -31.5 71.93 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.971 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.676 ' HA ' HG23 ' A' ' 81' ' ' ILE . 15.1 tp -58.09 -45.36 87.31 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.536 175.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -83.52 -51.67 7.14 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.577 ' HE3' ' HB3' ' A' ' 74' ' ' GLU . 18.8 ptpt -74.06 -42.49 60.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.676 0.274 . . . . 0.0 111.189 -174.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -94.84 -21.13 18.89 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.302 -175.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.94 24.35 41.82 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.863 -1.16 . . . . 0.0 112.971 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.676 HG23 ' HA ' ' A' ' 76' ' ' LEU . 7.6 tt -73.78 123.36 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 117.447 0.623 . . . . 0.0 110.44 -173.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -80.48 120.22 24.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.154 0.502 . . . . 0.0 111.794 -172.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.0 tp -156.69 115.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 122.073 0.94 . . . . 0.0 110.16 -178.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 1.012 HG11 ' HB ' ' A' ' 49' ' ' THR . 2.3 p -86.37 154.77 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.739 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.0 -31.57 14.19 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.725 0.298 . . . . 0.0 110.616 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 61.5 t30 70.08 7.71 6.34 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.766 170.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.67 128.84 75.92 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.872 0.368 . . . . 0.0 110.782 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -73.89 94.27 0.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.908 2.405 . . . . 0.0 112.205 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -62.72 -30.89 71.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.312 175.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -93.46 75.68 4.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.446 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 64.86 -97.15 0.05 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 123.973 0.796 . . . . 0.0 110.996 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -147.46 -68.49 0.25 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 15.0 tt -101.7 -1.53 9.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.049 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.0 m 69.24 48.12 0.68 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.181 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.13 -34.04 38.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.818 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.739 -1.034 . . . . 0.0 112.1 178.709 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.0 m -98.76 16.7 21.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.9 0.381 . . . . 0.0 111.164 -175.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -91.89 -19.57 22.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.997 -175.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.441 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 20.7 ptp -141.74 60.6 11.61 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 28' ' ' MET . 19.9 Cg_exo -66.12 -29.72 47.62 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.352 2.035 . . . . 0.0 111.609 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -64.29 -25.92 68.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.704 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.751 HG22 HD11 ' A' ' 68' ' ' LEU . 18.4 mm -63.67 -49.01 84.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.043 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -55.37 -45.28 76.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.554 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -68.85 -37.75 79.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.231 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.544 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -67.6 -38.98 84.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.1 -177.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.607 HG13 ' O ' ' A' ' 31' ' ' ILE . 70.8 mt -61.22 -39.31 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-O 120.76 0.314 . . . . 0.0 110.519 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.54 ' HD3' HD11 ' A' ' 81' ' ' ILE . 21.2 mmtm -65.55 -35.41 80.77 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.363 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.54 ' HG3' HH21 ' A' ' 34' ' ' ARG . 13.0 mmmm -67.92 -39.07 83.59 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.525 175.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 78.4 mt -61.81 -48.76 79.17 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.117 0.484 . . . . 0.0 110.438 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.577 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -65.09 -35.27 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.378 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -66.9 -48.45 68.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.229 0.538 . . . . 0.0 109.759 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.665 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 83.1 mt -62.01 -41.15 97.77 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.872 -177.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.23 -35.1 87.65 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -69.05 -44.27 72.97 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.467 0.651 . . . . 0.0 109.728 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HE2' ' N ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -60.93 -38.04 84.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.701 174.021 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.894 ' HZ1' ' HA ' ' A' ' 56' ' ' ALA . 28.2 mmtp -69.52 -20.45 63.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.258 -177.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.03 -63.3 0.33 Allowed Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.897 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -135.92 150.74 49.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.994 0.426 . . . . 0.0 111.076 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.479 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -80.79 86.02 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 172.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.502 HG23 ' H ' ' A' ' 52' ' ' ASP . 5.4 t -151.07 158.73 44.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.128 -176.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -57.24 -39.8 76.28 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.374 0.421 . . . . 0.0 110.693 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -62.61 -41.15 98.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.825 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.807 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -71.05 -29.35 65.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.788 -176.09 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.4 mm -59.38 -50.39 80.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.358 0.599 . . . . 0.0 109.987 171.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.4 -39.91 84.91 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.809 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.807 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.73 -15.48 59.11 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.902 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.894 ' HA ' ' HZ1' ' A' ' 45' ' ' LYS . . . -79.18 -19.55 50.6 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.435 175.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.414 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 73.7 t80 -60.86 137.16 93.51 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.027 175.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.502 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 13.1 Cg_endo -88.38 139.3 17.01 Favored 'Cis proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.609 -1.413 . . . . 0.0 113.07 3.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.676 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 27.7 Cg_endo -100.29 -150.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 124.458 3.439 . . . . 0.0 110.189 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.2 15.86 21.5 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.815 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.676 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 4.3 p90 -58.58 118.64 5.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 122.144 0.973 . . . . 0.0 111.038 -168.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -81.43 -22.28 38.31 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.267 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.75 126.6 1.5 Allowed Glycine 0 N--CA 1.434 -1.488 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -109.66 135.62 50.33 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 13.8 t70 -149.04 158.16 43.96 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.281 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 p -63.89 -35.65 81.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.962 0.41 . . . . 0.0 111.045 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -62.01 -34.79 76.85 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.751 HD11 HG22 ' A' ' 31' ' ' ILE . 26.7 tp -60.29 -40.23 89.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.213 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.448 ' O ' ' HD2' ' A' ' 73' ' ' HIS . 48.4 mm -64.25 -40.98 90.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.914 0.388 . . . . 0.0 110.288 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.7 -40.21 84.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -61.03 -34.91 75.59 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.671 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 68' ' ' LEU . 82.5 mt -60.84 -45.83 97.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.448 ' HD2' ' O ' ' A' ' 69' ' ' ILE . 74.1 m-70 -59.9 -44.2 94.4 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.243 0.545 . . . . 0.0 110.061 175.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -59.31 -47.34 85.76 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.389 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.469 ' C ' HG21 ' A' ' 81' ' ' ILE . 30.0 mm-40 -55.64 -29.8 59.88 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.84 HD23 HG21 ' A' ' 83' ' ' ILE . 53.7 mt -60.45 -48.92 79.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.27 0.557 . . . . 0.0 110.91 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -83.99 -48.49 9.89 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.309 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -70.9 -46.27 62.83 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.44 -173.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.51 -24.37 15.16 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.898 -177.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.1 20.79 41.11 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.44 -0.885 . . . . 0.0 112.995 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.831 HG23 HD21 ' A' ' 76' ' ' LEU . 7.5 tt -76.05 147.08 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.444 HD21 ' HA ' ' A' ' 82' ' ' ASN . 6.8 m120 -116.94 133.31 56.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.339 0.59 . . . . 0.0 112.378 -177.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.84 HG21 HD23 ' A' ' 76' ' ' LEU . 5.2 tp -167.68 130.85 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.576 -1.193 . . . . 0.0 107.978 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.498 HG12 ' CB ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -88.27 155.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 120.919 0.39 . . . . 0.0 109.995 -177.332 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 39.6 mt-10 -94.53 -23.07 17.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.711 -170.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 6.4 t-20 81.75 -4.07 1.56 Allowed 'General case' 0 N--CA 1.465 0.315 0 O-C-N 124.525 1.14 . . . . 0.0 109.676 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 31.0 mt-10 -83.89 129.91 57.23 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.481 174.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 51.7 Cg_exo -54.8 119.53 6.62 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.938 2.425 . . . . 0.0 112.347 -178.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -72.95 -38.58 66.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.069 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -133.97 80.41 1.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.095 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -122.63 150.96 41.97 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.598 ' HG3' HG13 ' A' ' 93' ' ' ILE . 9.1 pt-20 -146.83 -59.61 0.29 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.6 -177.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.598 HG13 ' HG3' ' A' ' 92' ' ' GLU . 31.6 mt -100.82 -1.05 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.35 0.595 . . . . 0.0 110.48 -175.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.5 m 65.89 29.98 10.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.293 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.74 128.17 54.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.285 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.812 -0.993 . . . . 0.0 111.818 -178.758 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.8 t -152.81 161.65 42.29 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -122.88 132.74 54.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.063 0.458 . . . . 0.0 110.914 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.4 mtt -120.82 115.9 31.83 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.19 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.79 -27.8 73.34 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.494 2.129 . . . . 0.0 111.368 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.507 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 28.4 tt0 -68.83 -35.43 76.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.607 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.669 ' O ' HG13 ' A' ' 35' ' ' ILE . 9.1 mm -68.12 -48.38 74.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.676 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -60.45 -46.07 91.4 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.469 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 10.8 ptm180 -66.29 -33.15 75.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.505 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.783 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -69.84 -34.53 73.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.518 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.803 HG21 HG12 ' A' ' 72' ' ' ILE . 62.5 mt -58.69 -51.38 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.462 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.535 ' HD3' ' N ' ' A' ' 36' ' ' LYS . 1.8 mppt? -69.28 -35.78 76.4 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.632 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -64.97 -43.68 91.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.985 0.421 . . . . 0.0 109.882 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.474 ' HG ' HG21 ' A' ' 53' ' ' ILE . 6.0 tp -66.73 -45.5 78.46 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.343 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.509 ' HB ' HD11 ' A' ' 81' ' ' ILE . 1.4 mp -62.11 -35.48 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.541 ' C ' ' HE2' ' A' ' 44' ' ' LYS . 53.9 m -67.92 -48.58 65.58 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.191 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.709 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 79.5 mt -59.46 -40.08 85.72 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.929 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.54 -34.38 88.21 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.467 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -73.43 -38.21 65.61 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -177.757 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.541 ' HE2' ' C ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -64.5 -29.95 70.99 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.49 174.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.709 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 74.5 mmtt -74.73 -11.6 60.21 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.039 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.06 -68.3 0.31 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.285 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.73 170.95 14.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.894 0.378 . . . . 0.0 110.382 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.77 85.88 2.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.198 0.523 . . . . 0.0 109.793 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.511 ' CG2' ' HB2' ' A' ' 86' ' ' ASN . 4.9 m -141.17 146.6 37.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.101 -175.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.454 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 90.8 t80 -60.33 -33.71 72.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.172 0.51 . . . . 0.0 109.908 174.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.494 ' H ' HG23 ' A' ' 49' ' ' THR . 35.9 mt-10 -67.59 -37.33 82.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.574 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 1.007 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.2 m-20 -65.2 -31.27 72.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.006 0.432 . . . . 0.0 110.679 174.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.474 HG21 ' HG ' ' A' ' 38' ' ' LEU . 32.0 mm -64.96 -49.84 77.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.167 0.508 . . . . 0.0 110.545 172.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -61.63 -32.78 72.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.803 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 1.007 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 2.9 ptmt -74.69 -17.27 60.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.017 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.514 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -77.67 -19.76 54.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.514 -175.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.481 ' HA ' ' CD ' ' A' ' 59' ' ' PRO . 44.5 m-85 -59.57 130.81 88.09 Favored Pre-proline 0 N--CA 1.462 0.171 0 O-C-N 123.322 0.389 . . . . 0.0 111.23 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 3.9 Cg_exo -77.03 123.93 10.07 Favored 'Cis proline' 0 C--O 1.234 0.315 0 C-N-CA 123.998 -1.251 . . . . 0.0 112.33 0.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.545 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 34.8 Cg_endo -100.93 -156.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.687 0 C-N-CA 124.361 3.374 . . . . 0.0 110.751 -177.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -97.73 12.81 32.53 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.023 0.44 . . . . 0.0 111.459 -177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.545 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 3.7 p90 -66.17 120.62 13.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.273 0.559 . . . . 0.0 109.919 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.535 ' HG3' HH11 ' A' ' 34' ' ' ARG . 43.4 mt-10 -81.42 -23.62 37.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.378 0.609 . . . . 0.0 110.346 177.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.29 127.63 1.66 Allowed Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -100.84 136.87 40.02 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.58 -0.448 . . . . 0.0 109.819 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 10.3 t70 -150.0 142.71 24.62 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.1 t -63.74 -27.13 68.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.56 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -66.06 -33.59 76.15 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.99 0.424 . . . . 0.0 109.898 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.617 HD13 HG21 ' A' ' 31' ' ' ILE . 46.2 tp -59.63 -40.69 88.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.669 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.3 mm -60.83 -41.62 89.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.09 0.471 . . . . 0.0 110.48 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.27 -43.5 73.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.553 0.692 . . . . 0.0 109.156 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.611 ' HG3' HD13 ' A' ' 35' ' ' ILE . 11.5 tpp180 -62.41 -36.51 82.58 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.638 -176.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.803 HG12 HG21 ' A' ' 35' ' ' ILE . 79.9 mt -64.72 -48.22 85.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.505 176.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.494 ' HA ' HD12 ' A' ' 76' ' ' LEU . 32.9 m80 -63.09 -41.12 99.32 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.386 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.25 -42.84 99.68 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.926 -0.309 . . . . 0.0 110.224 176.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.426 ' CD ' ' HZ2' ' A' ' 36' ' ' LYS . 10.3 mt-10 -64.53 -28.55 69.72 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 178.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.957 HD23 HG22 ' A' ' 81' ' ' ILE . 78.4 mt -56.97 -47.99 79.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.071 0.462 . . . . 0.0 110.77 176.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -83.87 -50.34 8.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.949 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -74.11 -43.28 58.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.058 -173.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -95.68 -21.85 17.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.246 0.546 . . . . 0.0 110.474 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.11 20.35 57.57 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.936 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.957 HG22 HD23 ' A' ' 76' ' ' LEU . 7.1 tt -75.58 146.58 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.475 HD21 ' HA ' ' A' ' 82' ' ' ASN . 5.3 m120 -113.89 129.18 56.62 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.632 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.836 HG21 HD22 ' A' ' 76' ' ' LEU . 7.3 tp -159.59 121.33 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 172.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.478 HG11 ' N ' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -96.84 158.84 3.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.466 0.65 . . . . 0.0 111.274 -168.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -87.17 -22.93 25.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.961 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.511 ' HB2' ' CG2' ' A' ' 49' ' ' THR . 66.2 t30 75.77 4.3 3.89 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.396 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -124.87 134.21 25.48 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.595 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.453 ' HB2' ' OE2' ' A' ' 90' ' ' GLU . 37.6 Cg_endo -68.28 123.39 10.52 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.747 2.298 . . . . 0.0 110.924 173.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.75 5.45 51.82 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -169.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.453 ' OE2' ' HB2' ' A' ' 88' ' ' PRO . 6.7 pm0 -74.9 139.48 43.13 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.152 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 59.22 35.91 23.63 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.789 -175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -134.45 -64.81 0.67 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.507 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 50.8 mt -71.95 -17.2 19.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.136 0.494 . . . . 0.0 110.21 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.0 m 69.09 28.1 5.12 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.812 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -158.64 149.34 20.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.211 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.253 -1.304 . . . . 0.0 111.478 -177.604 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.676 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.4 t -117.09 130.05 56.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.828 0.347 . . . . 0.0 111.751 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 75.8 m80 53.9 30.92 12.35 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.157 171.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.871 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 59.2 ttp -128.07 -64.33 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.439 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.621 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.871 ' HD3' ' HB3' ' A' ' 28' ' ' MET . 17.3 Cg_exo -66.18 -32.53 42.48 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 121.85 1.7 . . . . 0.0 111.669 -176.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.547 ' HA ' ' HG2' ' A' ' 33' ' ' ARG . 19.3 pt20 -67.59 -27.6 67.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.92 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.719 ' O ' HG12 ' A' ' 35' ' ' ILE . 34.4 mm -69.29 -51.54 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.64 -44.52 85.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.928 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.547 ' HG2' ' HA ' ' A' ' 30' ' ' GLN . 23.6 ptt180 -69.01 -37.02 78.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.334 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.661 ' NH1' HD13 ' A' ' 38' ' ' LEU . 4.6 tmt_? -67.49 -41.68 84.15 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 121.27 -0.172 . . . . 0.0 111.126 -177.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.719 HG12 ' O ' ' A' ' 31' ' ' ILE . 20.0 mm -59.67 -48.15 88.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 121.18 0.514 . . . . 0.0 110.077 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.419 ' HD3' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -67.39 -35.12 78.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.8 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 33' ' ' ARG . 40.5 mtpt -60.21 -38.5 83.53 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.029 -0.269 . . . . 0.0 110.87 175.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.661 HD13 ' NH1' ' A' ' 34' ' ' ARG . 71.9 mt -59.64 -43.75 93.74 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.197 0.523 . . . . 0.0 110.249 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.641 HD13 HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -61.86 -39.19 82.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.267 178.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.632 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 25.0 t -67.37 -49.68 62.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.993 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.592 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 87.7 mt -68.81 -41.94 77.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.978 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.81 -38.49 85.36 Favored Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -63.73 -44.99 91.93 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.632 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -58.26 -38.36 76.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.492 173.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.913 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -69.32 -21.96 63.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.274 -178.123 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.26 -57.51 0.51 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.507 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.432 ' HB2' ' OD2' ' A' ' 52' ' ' ASP . 99.3 m-85 -134.12 163.36 29.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.121 0.486 . . . . 0.0 110.528 -174.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -96.86 85.7 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.533 0.682 . . . . 0.0 109.552 174.022 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 27.0 p -139.41 159.84 41.22 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.645 -175.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -57.69 -37.91 74.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.065 0.46 . . . . 0.0 110.003 176.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -66.14 -46.09 78.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.418 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.754 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 5.1 m-20 -66.7 -31.43 72.09 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.648 HG12 ' O ' ' A' ' 49' ' ' THR . 48.6 mm -63.99 -48.77 84.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.369 0.604 . . . . 0.0 109.963 172.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.541 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 21.4 t70 -61.93 -37.05 83.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.58 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.754 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.34 -15.26 59.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.73 178.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.422 ' HB1' ' CB ' ' A' ' 41' ' ' LEU . . . -76.68 -18.9 58.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.907 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.688 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 24.2 m-85 -68.12 165.2 35.23 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.389 176.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.688 ' HA ' ' HB3' ' A' ' 57' ' ' PHE . 96.7 Cg_endo -82.57 157.07 77.31 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 123.895 -1.294 . . . . 0.0 112.672 -0.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -104.49 -173.99 0.07 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.6 0 C-N-CA 124.425 3.416 . . . . 0.0 111.359 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -98.56 16.5 21.67 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.745 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.798 ' HE2' HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -59.58 124.13 19.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.979 -169.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -79.12 -13.44 59.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.372 -170.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.12 125.55 1.38 Allowed Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -105.98 130.65 53.87 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 11.7 t70 -148.91 155.04 40.29 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -176.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.1 t -63.73 -25.9 68.41 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.21 0.529 . . . . 0.0 110.99 176.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 29.1 t-20 -60.7 -33.32 72.69 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.112 0.482 . . . . 0.0 109.867 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.798 HD21 ' HE2' ' A' ' 61' ' ' PHE . 26.0 tp -54.37 -38.37 66.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.074 173.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.9 mm -62.03 -38.06 79.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.2 0.524 . . . . 0.0 110.125 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.669 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 6.7 mm-40 -66.27 -45.06 81.81 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 26.5 mmt180 -60.27 -38.26 83.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.393 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 68' ' ' LEU . 79.3 mt -61.26 -51.29 74.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.807 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.669 ' CE1' ' HA ' ' A' ' 70' ' ' GLU . 4.5 p-80 -68.73 -30.88 69.6 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.405 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.585 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 44.0 mt-10 -59.33 -50.26 74.65 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.699 173.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.657 ' HG3' HG13 ' A' ' 35' ' ' ILE . 8.3 mm-40 -60.4 -29.85 69.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 120.952 0.406 . . . . 0.0 110.677 176.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.679 ' HA ' HG23 ' A' ' 81' ' ' ILE . 19.3 tp -61.54 -45.29 94.79 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 174.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -83.36 -53.06 6.01 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 49.1 pttt -74.54 -38.07 62.86 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -173.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.41 -24.82 17.18 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.881 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.9 23.99 43.42 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.746 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.679 HG23 ' HA ' ' A' ' 76' ' ' LEU . 8.0 tt -72.55 121.97 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.429 0.633 . . . . 0.0 111.001 -169.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.546 ' O ' HD13 ' A' ' 39' ' ' ILE . 19.7 m120 -99.72 117.25 33.66 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -171.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.641 HG12 HD13 ' A' ' 39' ' ' ILE . 1.8 mt -149.34 132.25 6.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.705 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -90.09 153.9 3.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -177.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -87.47 -31.98 19.71 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.033 0.444 . . . . 0.0 110.949 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 42.3 t30 69.86 15.99 7.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.269 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.0 mm-40 -76.35 136.99 68.07 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.595 177.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 8.3 Cg_exo -72.65 142.59 36.28 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.827 2.352 . . . . 0.0 111.87 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -81.9 71.23 8.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.462 0.649 . . . . 0.0 109.473 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -126.71 133.03 51.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.647 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.426 ' HA ' ' OE1' ' A' ' 91' ' ' GLU . 6.2 mm-40 -90.65 -45.31 8.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.175 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 179.64 86.14 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 O-C-N 123.633 0.583 . . . . 0.0 110.787 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 15.7 mm 58.1 36.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.778 0.799 . . . . 0.0 110.155 174.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.4 m 59.17 56.07 4.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.109 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.23 124.67 24.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.647 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 119.03 -0.872 . . . . 0.0 111.476 -178.289 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 112.434 -0.266 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.4 p -99.49 39.21 1.32 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.922 -0.163 . . . . 0.0 111.263 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.415 ' HD2' ' HG3' ' A' ' 28' ' ' MET . 16.6 t60 71.49 -59.7 0.54 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.311 0.644 . . . . 0.0 109.918 -175.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.438 ' HB2' HG12 ' A' ' 31' ' ' ILE . 65.1 mtt -147.46 105.85 3.78 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.5 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 36.3 Cg_exo -57.8 -27.11 76.79 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.74 2.293 . . . . 0.0 111.638 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 14.9 pt20 -64.27 -25.07 67.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.092 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.641 ' O ' HG13 ' A' ' 35' ' ' ILE . 23.9 mm -68.46 -48.34 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.278 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -56.0 -46.36 78.76 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.085 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 21.5 mmm180 -67.25 -40.88 86.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.243 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.534 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -66.87 -36.36 82.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.187 -175.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.641 HG13 ' O ' ' A' ' 31' ' ' ILE . 74.7 mt -59.89 -44.38 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.564 ' HD3' HD11 ' A' ' 81' ' ' ILE . 26.5 mmtm -67.32 -35.77 80.1 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.142 0.496 . . . . 0.0 110.118 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.598 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 39.7 ttmt -65.99 -38.27 88.07 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.535 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.683 HD11 ' CZ ' ' A' ' 61' ' ' PHE . 93.4 mt -61.08 -50.57 72.74 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.041 0.448 . . . . 0.0 110.085 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.533 ' HB ' HD12 ' A' ' 81' ' ' ILE . 1.5 mp -66.19 -35.14 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.336 -177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.517 ' HG ' ' HA ' ' A' ' 37' ' ' LYS . 22.7 p -70.22 -43.37 70.8 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.263 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.638 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 78.4 mt -58.82 -35.41 72.83 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.676 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.59 -32.97 85.96 Favored Glycine 0 CA--C 1.496 -1.152 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.38 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -30.45 65.86 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.552 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.87 -43.73 74.76 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.167 171.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 32.3 mmmt -66.97 -31.94 72.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.555 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.46 -63.86 0.31 Allowed Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.353 175.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -142.77 154.33 44.13 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.457 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -81.93 105.36 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.364 0.602 . . . . 0.0 111.089 -177.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.678 HG21 ' H ' ' A' ' 52' ' ' ASP . 2.5 t -155.48 158.34 38.39 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.393 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -56.81 -29.9 63.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.288 0.566 . . . . 0.0 109.753 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -63.56 -42.18 98.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.498 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.7 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -64.54 -37.67 88.35 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.008 -176.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.485 HD11 ' HB3' ' A' ' 38' ' ' LEU . 40.8 mm -59.77 -49.18 84.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.577 0.703 . . . . 0.0 109.772 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -66.93 -34.58 78.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.294 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.7 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 9.5 ptmt -76.46 -20.38 57.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.051 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.2 -19.59 60.48 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.527 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.479 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 39.9 t80 -55.47 139.09 67.79 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.756 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 57' ' ' PHE . 22.9 Cg_exo -66.07 145.3 68.83 Favored 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 124.011 -1.245 . . . . 0.0 112.247 -0.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -95.12 -175.33 0.35 Allowed 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 123.743 2.962 . . . . 0.0 110.029 -173.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -98.5 12.73 34.21 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.225 0.536 . . . . 0.0 111.127 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.683 ' CZ ' HD11 ' A' ' 38' ' ' LEU . 32.0 m-85 -63.64 117.78 7.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.066 0.46 . . . . 0.0 111.999 -176.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -82.22 -21.88 36.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.177 170.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.15 127.98 1.69 Allowed Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -104.4 145.06 30.8 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.982 0.391 . . . . 0.0 110.58 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.62 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 11.0 t70 -145.18 156.11 43.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.561 0.22 . . . . 0.0 110.732 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.5 m -63.49 -34.55 78.01 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.212 0.529 . . . . 0.0 111.021 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -61.49 -32.01 72.01 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.983 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.62 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 11.5 tp -56.4 -43.27 79.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.351 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.5 mm -61.56 -47.29 94.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.892 0.377 . . . . 0.0 110.57 -176.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -69.93 -33.74 72.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.868 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.1 tpp85 -70.74 -33.52 70.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.291 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 68' ' ' LEU . 80.2 mt -61.7 -50.54 79.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 176.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.488 ' HA ' HD13 ' A' ' 76' ' ' LEU . 15.4 t-80 -67.1 -34.34 77.42 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.547 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 36.2 mt-10 -58.87 -50.13 75.16 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 173.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.549 ' HG2' ' HE3' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -59.62 -35.19 73.87 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.494 -179.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.815 HD21 HG23 ' A' ' 83' ' ' ILE . 81.5 mt -58.97 -52.2 66.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.05 0.452 . . . . 0.0 111.776 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -85.15 -48.46 9.13 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.251 0.548 . . . . 0.0 112.383 -177.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 18.3 ttmt -71.9 -44.48 63.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.988 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -96.43 -26.96 15.13 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.146 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.26 21.39 35.38 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 119.865 -1.16 . . . . 0.0 113.516 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.75 HG21 HD22 ' A' ' 76' ' ' LEU . 6.5 tt -73.15 144.85 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -113.67 128.61 56.49 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.93 -0.708 . . . . 0.0 112.193 -173.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.815 HG23 HD21 ' A' ' 76' ' ' LEU . 7.0 tp -156.11 133.18 2.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -102.7 166.72 2.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -174.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -93.63 -33.56 13.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.659 0.743 . . . . 0.0 109.592 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.544 ' N ' HG12 ' A' ' 84' ' ' VAL . 24.0 t30 68.74 17.71 8.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 113.864 -1.516 . . . . 0.0 109.981 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 7.6 mm-40 -72.6 135.76 81.1 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.199 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 52.8 Cg_exo -54.91 105.14 0.13 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.246 2.631 . . . . 0.0 112.408 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -88.44 38.42 0.86 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.533 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -150.38 90.76 1.68 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.959 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -125.09 60.07 1.22 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.393 0.616 . . . . 0.0 110.953 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -75.53 -71.39 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.2 mt -104.02 -34.1 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.2 t 74.28 -49.78 0.67 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.493 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.2 88.32 2.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.018 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.756 0 CA-C-O 119.08 -0.844 . . . . 0.0 111.681 177.853 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.5 p -84.81 -32.85 23.1 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 51.3 60.94 3.5 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.515 0.674 . . . . 0.0 110.454 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.616 ' O ' HG22 ' A' ' 31' ' ' ILE . 47.7 ttm -143.73 81.05 12.3 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.198 -178.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -60.78 -24.6 79.32 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.816 2.344 . . . . 0.0 112.792 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.471 ' HG3' ' HG2' ' A' ' 28' ' ' MET . 1.5 pp0? -64.58 -29.59 70.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.31 -174.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 28' ' ' MET . 11.3 tp -70.22 -45.85 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.861 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.796 ' HG2' ' HD3' ' A' ' 71' ' ' ARG . 25.6 mt-10 -70.85 -41.2 71.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.753 0.311 . . . . 0.0 110.771 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 11.7 ptt180 -62.22 -32.53 73.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.569 HH11 HD21 ' A' ' 68' ' ' LEU . 25.1 ttm180 -64.29 -37.81 88.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.039 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.536 HG21 ' CD1' ' A' ' 81' ' ' ILE . 15.6 mm -60.33 -50.48 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.539 ' HD3' HD12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -68.21 -35.24 77.67 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.482 179.021 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.52 ' HG2' ' HB2' ' A' ' 60' ' ' ASP . 2.6 tppp? -64.7 -42.35 95.35 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.42 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.646 ' HB3' HD13 ' A' ' 53' ' ' ILE . 75.3 mt -59.66 -48.53 81.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.948 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 1.04 HD11 ' HB ' ' A' ' 83' ' ' ILE . 0.5 OUTLIER -65.71 -36.55 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.419 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.652 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 47.6 t -68.09 -50.37 55.38 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.824 -176.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.675 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 36.2 mt -69.39 -41.56 76.28 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.016 -176.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.04 -39.99 94.99 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.89 -40.33 72.28 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.652 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -59.93 -37.32 79.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.186 174.458 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 73.5 mmtt -68.56 -31.98 71.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.784 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.11 -68.0 0.17 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.584 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -132.4 163.86 27.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.369 0.604 . . . . 0.0 111.534 -171.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.492 HG23 HD13 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -93.51 84.07 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.808 178.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.738 HG21 ' H ' ' A' ' 52' ' ' ASP . 10.0 t -155.45 158.28 38.31 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.452 -174.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.41 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 17.9 t80 -57.38 -37.06 72.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.883 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -64.31 -41.75 96.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.512 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.738 ' H ' HG21 ' A' ' 49' ' ' THR . 0.9 OUTLIER -71.97 -29.99 64.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.348 177.338 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.646 HD13 ' HB3' ' A' ' 38' ' ' LEU . 45.4 mm -59.47 -49.02 85.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.176 0.512 . . . . 0.0 110.321 172.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.779 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 16.9 t70 -58.52 -37.94 76.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.459 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.688 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.29 -15.51 59.4 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.794 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.81 -20.02 33.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.996 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.818 ' HD1' ' HD3' ' A' ' 59' ' ' PRO . 16.3 m-85 -61.7 145.35 92.01 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.163 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 22.3 Cg_endo -95.8 128.71 3.66 Favored 'Cis proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.275 -1.135 . . . . 0.0 112.104 -3.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.818 ' HD3' ' HD1' ' A' ' 57' ' ' PHE . 77.5 Cg_endo -106.6 -108.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.944 0 C-N-CA 123.667 2.911 . . . . 0.0 112.785 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.52 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -100.45 10.86 40.62 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -170.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.744 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 12.9 p90 -79.52 117.87 20.86 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 118.891 -1.124 . . . . 0.0 110.186 -177.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.445 ' HB2' ' NE2' ' A' ' 30' ' ' GLN . 97.8 mt-10 -81.11 -26.08 36.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.587 173.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.57 127.26 1.59 Allowed Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -76.18 135.45 39.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 117.402 0.601 . . . . 0.0 109.38 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 10.6 p-10 -151.5 151.2 31.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.983 0.421 . . . . 0.0 111.472 -168.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.7 m -64.02 -29.66 70.79 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.146 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.584 ' ND2' HG12 ' A' ' 31' ' ' ILE . 1.7 t30 -61.49 -33.85 74.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.426 177.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.569 HD21 HH11 ' A' ' 34' ' ' ARG . 46.3 tp -56.36 -41.89 76.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.964 175.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.4 mm -59.95 -42.97 91.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.007 0.432 . . . . 0.0 110.327 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 12.6 mt-10 -68.85 -43.9 74.49 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.796 ' HD3' ' HG2' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -59.51 -40.98 88.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.029 -174.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.557 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 82.7 mt -61.11 -49.48 84.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.512 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.469 ' HA ' HD11 ' A' ' 76' ' ' LEU . 32.2 m170 -65.9 -38.46 88.8 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.439 -177.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.506 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 51.4 mt-10 -62.75 -47.14 84.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.455 177.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 79' ' ' HIS . 12.1 mm-40 -59.35 -29.6 67.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.84 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.659 HD23 HG22 ' A' ' 81' ' ' ILE . 91.6 mt -58.04 -48.03 81.33 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.783 0.325 . . . . 0.0 110.397 175.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -84.32 -52.03 6.53 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 19.8 pttp -73.23 -37.56 66.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -174.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 30.5 t60 -94.03 -34.73 12.91 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.548 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.79 22.59 30.43 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.837 -175.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.659 HG22 HD23 ' A' ' 76' ' ' LEU . 6.6 tt -72.73 138.73 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -175.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.403 HD21 ' HA ' ' A' ' 82' ' ' ASN . 9.3 m120 -117.06 124.67 49.85 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.387 -174.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 1.04 ' HB ' HD11 ' A' ' 39' ' ' ILE . 19.8 tt -159.3 132.49 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.753 -174.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.543 HG13 ' HB ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -98.24 154.27 3.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.121 0.486 . . . . 0.0 110.729 -172.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.428 ' C ' ' H ' ' A' ' 87' ' ' GLU . 39.7 mm-40 -86.43 -34.63 20.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.438 -178.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.617 ' HB2' ' HG1' ' A' ' 49' ' ' THR . 2.7 t-20 76.81 -11.16 1.22 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.211 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 85' ' ' GLU . 79.2 mm-40 -96.32 141.53 23.26 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.532 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 23.3 Cg_exo -64.06 133.07 36.71 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.858 2.372 . . . . 0.0 112.266 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -76.75 -20.9 55.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.754 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 66.85 24.5 9.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.823 -1.08 . . . . 0.0 112.609 171.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -107.02 80.0 1.38 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 171.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -98.76 -78.37 0.5 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.1 tp -119.39 -9.43 11.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.358 176.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.5 m 63.29 -82.27 0.02 OUTLIER 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.303 -174.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.03 -43.98 0.47 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.248 0.547 . . . . 0.0 109.688 176.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 117.998 -1.446 . . . . 0.0 110.622 -178.795 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.177 -0.369 . . . . 0.0 112.177 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.0 p -72.2 136.74 46.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.857 0.36 . . . . 0.0 110.666 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -123.67 -35.53 2.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.476 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.45 ' SD ' HG12 ' A' ' 31' ' ' ILE . 54.7 ttm -169.24 99.1 0.5 Allowed Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -177.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.711 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 57.7 Cg_exo -52.63 -32.74 55.79 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.984 2.456 . . . . 0.0 112.521 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -58.72 -39.22 80.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.766 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.659 ' O ' HG13 ' A' ' 35' ' ' ILE . 16.7 mm -67.69 -45.33 84.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.677 177.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -56.54 -45.17 81.32 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.861 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.711 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 14.4 mmt180 -65.36 -39.53 92.43 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.444 0.64 . . . . 0.0 109.918 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.449 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -66.26 -35.85 81.47 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.23 -176.528 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.659 HG13 ' O ' ' A' ' 31' ' ' ILE . 62.6 mt -59.57 -44.11 92.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.577 ' HD3' HD11 ' A' ' 81' ' ' ILE . 48.2 mmtt -67.02 -42.38 85.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.56 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.607 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 8.7 mtpm? -62.14 -39.15 91.64 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.488 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.609 HD11 ' HZ ' ' A' ' 61' ' ' PHE . 55.2 mt -60.43 -47.74 84.8 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.461 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.642 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.4 mp -62.28 -35.37 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.075 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.616 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 22.5 t -67.02 -47.48 71.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.206 177.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.722 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 88.6 mt -59.96 -44.96 94.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.682 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.61 -37.07 84.53 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 15.4 tptm -65.33 -43.88 89.54 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.206 0.526 . . . . 0.0 110.08 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.616 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -59.32 -35.37 73.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.538 174.459 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.961 ' HE2' ' HA ' ' A' ' 56' ' ' ALA . 44.1 mmtm -68.62 -25.27 64.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.829 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.22 -62.31 0.31 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.432 -0.89 . . . . 0.0 113.076 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -134.71 157.75 45.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.995 0.426 . . . . 0.0 110.261 -175.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.486 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -81.12 86.43 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-O 121.077 0.465 . . . . 0.0 109.814 175.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 10.1 t -152.11 153.33 33.69 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.386 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -61.42 -30.31 70.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.984 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -67.49 -38.02 83.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.341 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.977 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -71.99 -31.53 66.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.163 176.245 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 49' ' ' THR . 49.0 mm -60.88 -49.75 83.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.383 0.611 . . . . 0.0 110.072 172.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -57.02 -38.9 73.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.346 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.977 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 7.4 ptmt -75.83 -15.75 60.19 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.979 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.961 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -77.14 -18.84 57.59 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.929 -178.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.629 ' CD1' ' HG3' ' A' ' 59' ' ' PRO . 18.5 m-30 -61.0 145.67 88.95 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 7.0 Cg_exo -73.82 144.61 81.55 Favored 'Cis proline' 0 C--N 1.347 0.496 0 C-N-CA 124.26 -1.142 . . . . 0.0 112.53 0.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.696 ' HG2' ' CD2' ' A' ' 61' ' ' PHE . 37.4 Cg_endo -104.4 -157.47 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.565 0 C-N-CA 124.64 3.56 . . . . 0.0 111.054 -176.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.44 11.16 37.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.846 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.696 ' CD2' ' HG2' ' A' ' 59' ' ' PRO . 23.2 m-85 -63.14 117.64 6.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.28 0.562 . . . . 0.0 112.254 -171.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -81.61 -21.93 38.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.666 168.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.57 126.9 1.54 Allowed Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -103.25 144.85 30.8 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 117.091 0.445 . . . . 0.0 110.384 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -151.36 156.33 40.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.841 0.353 . . . . 0.0 110.962 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 m -63.07 -24.57 67.97 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.285 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.658 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 26.2 t30 -57.23 -38.55 73.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.197 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.535 ' O ' HG13 ' A' ' 72' ' ' ILE . 27.8 tp -57.47 -39.86 77.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.414 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.5 mm -62.25 -41.54 91.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.162 0.506 . . . . 0.0 110.192 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -68.17 -42.1 80.51 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.678 0.752 . . . . 0.0 109.107 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.658 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 13.5 mmt180 -68.34 -34.63 76.45 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.503 -174.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 68' ' ' LEU . 75.6 mt -61.59 -49.0 86.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.676 0.274 . . . . 0.0 110.754 177.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -64.09 -39.53 94.26 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.092 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -59.11 -49.8 76.47 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -56.59 -29.76 62.43 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.819 HD23 HG23 ' A' ' 81' ' ' ILE . 85.9 mt -58.65 -50.08 75.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.92 0.391 . . . . 0.0 111.247 176.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -85.1 -48.06 9.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.512 0.673 . . . . 0.0 111.617 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -69.61 -45.17 69.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.533 -173.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.97 -31.69 11.68 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.963 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.92 22.04 19.1 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.264 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.819 HG23 HD23 ' A' ' 76' ' ' LEU . 6.8 tt -73.69 145.56 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 118.507 1.153 . . . . 0.0 108.188 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -116.73 130.31 56.65 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.091 -0.644 . . . . 0.0 112.457 -174.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.66 HG21 HD22 ' A' ' 76' ' ' LEU . 4.2 tp -168.49 133.79 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.24 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -91.95 150.46 3.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -96.29 -23.15 16.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.882 0.372 . . . . 0.0 110.487 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 60.1 t30 76.4 5.17 3.62 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.503 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -103.55 128.63 27.02 Favored Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.546 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -88.14 144.49 6.03 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.599 2.199 . . . . 0.0 111.933 173.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -104.12 -9.49 18.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.193 0.52 . . . . 0.0 110.052 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.644 ' HG3' ' H ' ' A' ' 91' ' ' GLU . 6.9 pt-20 -85.01 -64.44 1.16 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.221 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.644 ' H ' ' HG3' ' A' ' 90' ' ' GLU . 38.0 tt0 -83.24 72.41 10.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.532 0.682 . . . . 0.0 110.393 -177.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -152.03 -59.7 0.16 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.835 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.6 tt -74.86 -43.14 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 171.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.1 m 49.07 64.31 1.78 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.267 0.556 . . . . 0.0 111.78 177.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -112.95 158.6 20.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.45 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.493 -1.171 . . . . 0.0 111.536 179.87 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 111.981 -0.447 . . . . 0.0 111.981 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.7 t -94.49 124.29 38.43 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -94.62 25.52 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.037 0.446 . . . . 0.0 110.856 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 45.7 ttm -149.21 72.7 10.12 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.365 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.74 -24.76 76.93 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.443 2.762 . . . . 0.0 113.159 -174.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -60.55 -25.77 66.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.417 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.62 ' O ' HG13 ' A' ' 35' ' ' ILE . 26.1 mm -66.44 -49.94 71.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 177.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -54.84 -45.9 74.55 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.156 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -66.94 -42.47 85.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.286 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.681 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -63.19 -40.21 96.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.212 -175.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.699 HD11 ' HA ' ' A' ' 72' ' ' ILE . 54.2 mt -59.51 -40.53 82.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.011 0.434 . . . . 0.0 109.934 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.582 ' HD3' HD13 ' A' ' 81' ' ' ILE . 32.5 mmtm -66.89 -39.49 87.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.696 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.482 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 87.7 mttt -64.76 -43.61 92.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.978 176.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.79 -44.03 97.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.334 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.543 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -62.88 -36.09 74.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.38 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.409 ' C ' ' HE3' ' A' ' 44' ' ' LYS . 48.9 m -66.28 -46.32 77.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.099 0.476 . . . . 0.0 110.023 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.718 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 97.6 mt -58.89 -47.32 85.37 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.219 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.16 -33.71 86.73 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.464 ' HB2' HG23 ' A' ' 48' ' ' ILE . 12.2 tptt -73.39 -40.0 64.67 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.414 -0.893 . . . . 0.0 109.44 -174.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.718 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 5.4 ptpt -75.98 -31.77 59.15 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.752 -177.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -76.83 -9.75 58.9 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.105 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.69 -70.31 0.31 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.883 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -133.97 148.44 51.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.222 0.534 . . . . 0.0 111.455 -168.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -78.53 86.83 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.237 0.541 . . . . 0.0 109.901 176.029 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.624 HG22 ' H ' ' A' ' 52' ' ' ASP . 8.9 t -156.75 158.21 36.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.467 -175.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -63.62 -30.48 71.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 110.871 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.5 -41.11 93.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.557 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.903 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -71.95 -29.13 63.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.04 177.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 49' ' ' THR . 48.1 mm -59.4 -50.59 79.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.157 0.503 . . . . 0.0 109.972 172.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.508 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 0.5 OUTLIER -57.58 -34.43 69.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.69 177.493 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.903 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 4.5 ptmt -75.81 -18.86 59.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.025 -178.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.97 -20.11 42.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.547 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.508 ' CD2' ' HA ' ' A' ' 54' ' ' ASP . 80.2 m-85 -62.67 142.95 96.81 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.872 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 86.3 Cg_endo -84.24 143.19 41.13 Favored 'Cis proline' 0 C--N 1.345 0.362 0 C-N-CA 123.394 -1.502 . . . . 0.0 112.779 -1.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.58 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 39.8 Cg_endo -103.87 -156.72 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 124.785 3.656 . . . . 0.0 111.104 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -97.98 16.03 22.23 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.177 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.681 ' HA ' ' HD3' ' A' ' 34' ' ' ARG . 7.0 p90 -58.43 121.21 10.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 122.083 0.944 . . . . 0.0 111.723 -167.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -79.33 -24.93 42.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.408 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.1 127.34 1.59 Allowed Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -111.1 128.81 56.0 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -153.0 157.87 41.19 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 -175.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -27.05 65.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.513 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.438 ' OD1' ' HD2' ' A' ' 71' ' ' ARG . 10.5 t-20 -61.52 -35.16 76.92 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.335 176.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.652 ' O ' HG13 ' A' ' 72' ' ' ILE . 57.6 tp -64.08 -39.53 94.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.891 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.2 mm -64.06 -46.78 92.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.712 0.291 . . . . 0.0 110.701 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.478 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 16.6 pt-20 -68.99 -33.1 73.13 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.559 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 42.4 mtt180 -72.27 -29.59 64.03 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.18 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.699 ' HA ' HD11 ' A' ' 35' ' ' ILE . 64.3 mt -58.87 -50.56 79.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.537 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 30.7 p80 -69.82 -32.79 71.42 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.986 176.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.559 ' HB2' ' HA ' ' A' ' 71' ' ' ARG . 13.4 mt-10 -59.48 -50.25 74.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.981 0.419 . . . . 0.0 110.452 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.714 ' HA ' ' HG2' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -67.86 -27.42 66.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.688 178.07 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.928 ' HA ' HG22 ' A' ' 81' ' ' ILE . 12.6 tp -56.54 -45.31 81.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.863 172.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -83.1 -51.55 7.43 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.714 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 11.7 ptpt -72.06 -39.1 69.29 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -173.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -94.14 -32.13 13.87 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.635 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.37 24.87 15.09 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.421 -1.371 . . . . 0.0 113.131 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.928 HG22 ' HA ' ' A' ' 76' ' ' LEU . 5.9 tt -72.23 144.44 13.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 117.202 0.501 . . . . 0.0 109.858 -174.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -102.6 123.14 45.77 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.337 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.543 ' HB ' HG13 ' A' ' 39' ' ' ILE . 4.5 tp -162.31 137.15 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.539 HG13 ' HB ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -103.14 156.09 5.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.115 0.483 . . . . 0.0 110.353 -176.31 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 7.0 mm-40 -89.83 -25.36 21.09 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.733 -175.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.56 ' HB2' ' HG1' ' A' ' 49' ' ' THR . 8.3 t30 80.56 -12.17 1.06 Allowed 'General case' 0 N--CA 1.463 0.183 0 O-C-N 124.571 1.17 . . . . 0.0 110.185 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -86.65 129.11 54.05 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.316 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.5 129.05 23.98 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.661 2.241 . . . . 0.0 112.388 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -89.03 -3.04 58.82 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.238 0.542 . . . . 0.0 109.697 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.635 ' HB3' ' OXT' ' A' ' 96' ' ' GLY . 32.9 mt-10 67.31 -148.3 0.16 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.805 172.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -48.22 -39.25 20.6 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.654 ' HG3' ' H ' ' A' ' 93' ' ' ILE . 5.0 pt-20 -172.02 -72.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.85 0.357 . . . . 0.0 110.664 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.654 ' H ' ' HG3' ' A' ' 92' ' ' GLU . 1.4 pp -120.9 50.52 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.155 0.502 . . . . 0.0 110.175 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.9 m 60.36 60.73 1.94 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.016 -174.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -107.64 5.83 27.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.545 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.635 ' OXT' ' HB3' ' A' ' 90' ' ' GLU . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.532 -1.149 . . . . 0.0 111.892 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.799 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 p -71.57 145.58 48.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.678 0.275 . . . . 0.0 110.54 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -142.62 -65.27 0.4 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.659 0.266 . . . . 0.0 111.501 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.54 ' O ' HG23 ' A' ' 31' ' ' ILE . 28.0 ttt -149.78 87.13 5.18 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-O 121.007 0.432 . . . . 0.0 110.029 -173.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.63 -24.48 75.01 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.837 2.358 . . . . 0.0 112.742 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.632 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 23.6 tm0? -65.58 -39.17 91.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.963 0.411 . . . . 0.0 110.857 -175.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.651 HD11 ' HB2' ' A' ' 68' ' ' LEU . 10.4 tp -71.89 -38.78 66.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.207 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.31 -40.52 74.15 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.964 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.632 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 3.2 ptm180 -61.32 -36.04 79.03 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.699 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.59 ' HD2' ' HA ' ' A' ' 61' ' ' PHE . 48.1 ttp85 -65.07 -35.76 82.18 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.812 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.589 HD12 ' HG3' ' A' ' 75' ' ' GLU . 21.8 mt -60.48 -45.2 97.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 110.579 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.57 ' HZ3' ' HB ' ' A' ' 35' ' ' ILE . 0.6 OUTLIER -67.11 -39.71 86.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.371 177.474 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.544 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 14.4 mmmm -61.75 -39.6 92.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.185 0.517 . . . . 0.0 109.616 176.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 54.9 mt -63.59 -46.82 84.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.359 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.566 HD11 ' HB ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -62.06 -35.57 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.41 -178.443 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.6 p -67.61 -45.89 74.13 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.689 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.729 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 96.4 mt -59.26 -45.8 90.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.219 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.74 -34.82 78.74 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -42.04 87.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.04 0.924 . . . . 0.0 109.068 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.439 ' HE2' ' N ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -64.1 -39.99 95.25 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 113.815 -1.539 . . . . 0.0 110.583 175.115 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.756 ' HE2' ' HA ' ' A' ' 56' ' ' ALA . 45.4 mmtm -67.91 -31.5 71.32 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.774 -178.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.01 -67.55 0.17 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.236 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -137.63 171.18 14.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.851 0.358 . . . . 0.0 110.733 -171.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.568 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -83.55 86.07 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 122.486 1.136 . . . . 0.0 108.863 173.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.569 ' O ' HG12 ' A' ' 53' ' ' ILE . 6.0 m -145.79 151.74 38.43 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.258 -174.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -59.43 -36.02 75.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.962 0.41 . . . . 0.0 110.113 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.481 ' H ' HG21 ' A' ' 49' ' ' THR . 35.5 mt-10 -58.71 -40.99 85.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.484 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.679 ' HA ' ' CD ' ' A' ' 55' ' ' LYS . 5.2 m-20 -71.68 -32.35 67.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.233 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 49' ' ' THR . 39.6 mm -66.89 -49.65 72.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.79 0.805 . . . . 0.0 109.781 174.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.64 -33.74 76.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.278 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.679 ' CD ' ' HA ' ' A' ' 52' ' ' ASP . 15.6 ptmt -76.33 -19.99 57.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.985 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.756 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -74.2 -18.95 60.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.875 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -57.25 132.55 81.0 Favored Pre-proline 0 N--CA 1.466 0.352 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.119 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 57.2 Cg_endo -71.85 133.4 28.68 Favored 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 123.707 -1.372 . . . . 0.0 112.705 0.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.56 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 35.2 Cg_endo -101.51 -157.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 124.347 3.365 . . . . 0.0 111.27 -175.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -97.17 13.62 28.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.622 -175.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.59 ' HA ' ' HD2' ' A' ' 34' ' ' ARG . 8.2 p90 -63.06 120.15 10.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.453 0.644 . . . . 0.0 110.933 -175.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.579 ' HB2' ' NE2' ' A' ' 30' ' ' GLN . 24.5 mt-10 -79.55 -26.74 41.32 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.8 135.52 3.74 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -95.64 130.04 42.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 117.452 0.626 . . . . 0.0 110.018 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -137.01 145.3 43.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.567 -171.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.6 t -65.36 -27.1 68.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.674 0.749 . . . . 0.0 109.682 170.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -61.15 -32.24 71.96 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.819 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.651 ' HB2' HD11 ' A' ' 31' ' ' ILE . 3.3 tm? -54.38 -41.85 69.68 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.467 176.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 23.0 mm -65.31 -42.68 94.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-O 121.687 0.756 . . . . 0.0 110.052 -177.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 12.4 mt-10 -64.63 -45.05 88.48 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.555 ' HG2' HG22 ' A' ' 31' ' ' ILE . 15.5 tpt180 -71.16 -32.09 68.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.949 -170.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.563 ' HA ' HD11 ' A' ' 35' ' ' ILE . 24.3 pt -63.63 -46.66 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.597 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.532 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 28.5 p80 -68.52 -33.3 73.88 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 118.976 -1.089 . . . . 0.0 111.918 177.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.684 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 4.2 mm-40 -65.06 -50.02 67.81 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.974 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.589 ' HG3' HD12 ' A' ' 35' ' ' ILE . 4.0 mm-40 -63.0 -28.22 69.95 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.899 176.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.587 ' HA ' HG23 ' A' ' 81' ' ' ILE . 11.3 tp -57.73 -40.89 80.68 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.116 172.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -83.79 -51.77 6.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 9.8 ptmm? -72.33 -42.82 64.96 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -174.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.45 ' HB2' ' OE1' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -95.62 -22.7 17.43 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.136 -178.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.56 23.98 41.02 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.242 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.587 HG23 ' HA ' ' A' ' 76' ' ' LEU . 6.0 tt -73.52 119.93 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.633 0.73 . . . . 0.0 111.492 -170.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.82 129.12 36.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.668 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.568 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 17.7 tt -173.5 131.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -175.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -90.84 151.82 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 121.179 0.514 . . . . 0.0 110.227 -173.636 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -90.74 -23.47 20.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.042 -172.537 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 4.1 t-20 83.44 -11.59 0.9 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.542 1.151 . . . . 0.0 109.666 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -62.95 135.06 95.97 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.339 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.8 120.22 7.88 Favored 'Trans proline' 0 N--CA 1.466 -0.13 0 C-N-CA 122.639 2.226 . . . . 0.0 111.833 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -40.61 86.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.882 -174.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -133.85 -24.56 1.7 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.602 0.239 . . . . 0.0 111.564 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.474 ' HA ' ' OG ' ' A' ' 94' ' ' SER . 5.5 mm-40 -83.32 71.52 10.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.259 0.552 . . . . 0.0 111.174 -177.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -105.4 -81.45 0.54 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.6 tp -93.86 -30.43 4.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.474 ' OG ' ' HA ' ' A' ' 91' ' ' GLU . 31.8 m 46.33 61.84 2.56 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.729 174.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.57 144.65 37.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.05 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.755 0 CA-C-O 118.967 -0.907 . . . . 0.0 111.351 178.524 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.87 0 N-CA-C 112.29 -0.324 . . . . 0.0 112.29 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.3 m -73.53 -24.48 60.14 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.886 0.374 . . . . 0.0 111.15 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -86.27 83.19 7.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.133 0.492 . . . . 0.0 110.114 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.543 ' HB3' HG12 ' A' ' 31' ' ' ILE . 59.7 mtt -128.78 74.63 80.59 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.253 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.469 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 33.2 Cg_exo -60.26 -25.39 80.01 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.322 2.014 . . . . 0.0 111.018 173.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 10.6 pt20 -59.18 -35.02 72.82 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.895 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.565 ' O ' HG13 ' A' ' 35' ' ' ILE . 36.7 mm -66.44 -42.9 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.204 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.438 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 38.6 tt0 -58.02 -45.75 86.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.106 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 31.9 mmt-85 -66.06 -44.19 85.26 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.994 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.649 ' HD3' ' O ' ' A' ' 60' ' ' ASP . 0.1 OUTLIER -64.91 -37.89 89.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.559 -173.154 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.565 HG13 ' O ' ' A' ' 31' ' ' ILE . 70.0 mt -64.67 -37.79 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.513 ' HD3' HD11 ' A' ' 81' ' ' ILE . 15.9 mmtm -66.74 -35.7 80.74 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.142 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.69 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 34.6 mtpt -65.63 -40.99 93.16 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.352 175.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.557 HD11 ' HE2' ' A' ' 61' ' ' PHE . 14.6 tp -59.66 -50.0 75.55 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.564 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -61.95 -34.93 65.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.212 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.715 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 23.1 t -66.11 -44.63 83.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.768 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 77.6 mt -58.8 -37.53 76.57 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.81 -38.62 89.61 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 43' ' ' LYS . 13.7 tppt? -67.94 -35.24 78.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.194 0.521 . . . . 0.0 110.149 178.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.715 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -69.92 -38.54 76.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.688 0.756 . . . . 0.0 109.717 175.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.697 ' HB3' ' HD3' ' A' ' 55' ' ' LYS . 29.8 mmtm -68.6 -29.04 67.47 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.809 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.39 -65.92 0.26 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.849 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -136.14 157.21 47.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.053 0.454 . . . . 0.0 110.947 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.9 86.58 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.17 0.51 . . . . 0.0 109.981 177.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.785 ' HG1' ' HB2' ' A' ' 86' ' ' ASN . 8.5 t -153.78 155.64 36.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.599 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -57.58 -40.4 78.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.424 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.9 -34.34 76.46 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.745 0.307 . . . . 0.0 110.891 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.931 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -72.52 -30.94 64.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.932 0.396 . . . . 0.0 111.057 174.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.4 mm -64.49 -49.2 81.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.213 0.53 . . . . 0.0 110.169 171.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -57.32 -33.73 68.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.762 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.931 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 1.2 ptmt -76.66 -22.08 54.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.31 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.46 -19.27 42.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.003 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.438 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 67.6 t80 -56.41 140.69 72.49 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.399 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 86.3 Cg_endo -83.49 148.69 61.43 Favored 'Cis proline' 0 C--N 1.347 0.456 0 C-N-CA 123.781 -1.341 . . . . 0.0 112.904 0.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.578 ' HG2' ' HD2' ' A' ' 61' ' ' PHE . 36.7 Cg_endo -102.43 -160.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 124.412 3.408 . . . . 0.0 110.432 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.649 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 22.8 m-20 -97.8 11.26 37.85 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.578 ' HD2' ' HG2' ' A' ' 59' ' ' PRO . 60.2 m-85 -62.79 118.32 7.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.42 0.629 . . . . 0.0 111.217 -175.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -82.36 -12.12 58.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.563 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.62 124.28 1.33 Allowed Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -114.78 136.37 53.15 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.835 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 31.7 t70 -160.63 168.32 25.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.743 -0.208 . . . . 0.0 110.57 178.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.0 m -58.5 -32.31 68.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.681 0.277 . . . . 0.0 111.097 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.445 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . 5.1 t-20 -61.26 -34.08 74.58 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.153 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.608 ' O ' HG13 ' A' ' 72' ' ' ILE . 54.5 tp -58.96 -41.6 87.86 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.549 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.69 -39.41 83.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.247 0.546 . . . . 0.0 110.241 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 16.6 mt-10 -68.15 -42.98 79.29 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -64.58 -32.8 74.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.458 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.608 HG13 ' O ' ' A' ' 68' ' ' LEU . 80.3 mt -61.6 -51.35 73.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.583 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.497 ' CD2' ' HA ' ' A' ' 70' ' ' GLU . 29.4 p80 -68.77 -32.77 72.76 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.041 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -59.29 -47.24 86.11 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.542 ' HG3' HD11 ' A' ' 35' ' ' ILE . 25.2 mm-40 -64.31 -32.9 74.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.883 0.373 . . . . 0.0 110.859 175.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.628 ' HA ' HG21 ' A' ' 81' ' ' ILE . 22.3 tp -60.98 -46.77 89.4 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.922 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -82.62 -51.57 7.62 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -73.31 -45.22 56.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.265 -174.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -96.44 -16.24 21.3 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.65 -176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.74 24.5 49.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 119.678 -1.249 . . . . 0.0 113.835 171.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.628 HG21 ' HA ' ' A' ' 76' ' ' LEU . 7.8 tt -72.35 119.59 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 117.99 0.895 . . . . 0.0 110.716 -173.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -81.31 125.02 29.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.033 0.444 . . . . 0.0 111.119 -172.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.564 ' HB ' HG13 ' A' ' 39' ' ' ILE . 3.6 tp -166.61 123.15 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.426 -176.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.784 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -89.79 152.36 3.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -95.38 -25.36 16.31 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.935 0.397 . . . . 0.0 110.246 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.785 ' HB2' ' HG1' ' A' ' 49' ' ' THR . 56.1 t30 72.71 -0.73 3.23 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.027 -177.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.6 153.96 81.6 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 50.4 Cg_exo -55.04 -53.32 6.14 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 122.982 2.454 . . . . 0.0 114.404 -173.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -177.71 -47.87 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.717 -167.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -150.78 30.06 0.66 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.375 -0.829 . . . . 0.0 108.993 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.487 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . 52.8 mm-40 -124.88 28.73 6.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.658 -172.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -64.81 -63.4 1.13 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.522 HG13 ' H ' ' A' ' 95' ' ' ALA . 21.4 pt -112.91 -15.94 9.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.387 167.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.0 t 66.72 8.96 6.32 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.203 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.522 ' H ' HG13 ' A' ' 93' ' ' ILE . . . -104.11 45.75 0.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.089 0.471 . . . . 0.0 110.359 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.181 -1.344 . . . . 0.0 111.314 179.316 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 112.101 -0.4 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.7 p -83.44 -28.84 28.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.39 0.138 . . . . 0.0 111.323 -177.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.7 t60 71.67 -59.14 0.56 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.267 0.627 . . . . 0.0 111.607 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.566 ' CG ' ' HG2' ' A' ' 30' ' ' GLN . 58.7 tpp -170.32 130.67 0.9 Allowed Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 65.9 Cg_exo -53.61 -26.95 39.38 Favored 'Trans proline' 0 N--CA 1.477 0.51 0 C-N-CA 123.496 2.797 . . . . 0.0 113.635 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.566 ' HG2' ' CG ' ' A' ' 28' ' ' MET . 10.7 pt20 -64.91 -25.4 67.87 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 121.224 -0.19 . . . . 0.0 110.56 177.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.778 HD12 HD11 ' A' ' 68' ' ' LEU . 36.1 mm -65.4 -46.58 89.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.348 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -55.62 -47.27 76.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.41 177.505 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 33.7 mtp180 -67.69 -44.92 76.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.47 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.887 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -58.38 -47.21 84.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.905 -173.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.694 HD13 ' HG3' ' A' ' 75' ' ' GLU . 56.9 mt -64.51 -37.3 79.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.119 -177.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 24.7 mmtm -68.18 -35.12 77.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.173 0.511 . . . . 0.0 110.372 176.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.544 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 8.0 mttm -66.05 -37.7 86.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.459 174.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 89.0 mt -61.58 -38.2 86.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.813 174.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.548 HD11 ' O ' ' A' ' 82' ' ' ASN . 0.3 OUTLIER -62.63 -35.21 69.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.471 177.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 14.0 m -64.78 -44.3 90.44 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.998 ' HA ' ' HE2' ' A' ' 44' ' ' LYS . 61.7 mt -59.29 -47.16 86.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.697 174.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.604 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -68.41 -33.01 76.28 Favored Glycine 0 CA--C 1.509 -0.298 0 CA-C-O 121.972 0.762 . . . . 0.0 112.114 -173.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.77 -43.92 52.34 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 122.872 1.32 . . . . 0.0 107.954 -174.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.998 ' HE2' ' HA ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -77.21 -26.88 53.19 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 112.669 -2.06 . . . . 0.0 110.879 -172.44 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.516 ' HB2' ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -76.48 -32.89 58.64 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.14 174.258 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.67 -64.03 0.25 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.725 173.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -134.15 147.53 50.82 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.705 -0.291 . . . . 0.0 110.893 -170.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.412 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -73.93 100.25 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.282 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.641 ' O ' HG12 ' A' ' 53' ' ' ILE . 91.6 m -156.18 145.01 20.29 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.861 -171.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -60.03 -39.83 87.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.213 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.499 ' H ' HG22 ' A' ' 49' ' ' THR . 39.5 mt-10 -68.3 -34.23 75.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.991 177.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.947 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 10.2 t70 -71.38 -37.8 71.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.102 0.477 . . . . 0.0 110.931 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.641 HG12 ' O ' ' A' ' 49' ' ' THR . 42.4 mm -59.8 -46.46 93.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.565 0.697 . . . . 0.0 109.839 173.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.404 ' O ' ' HD1' ' A' ' 57' ' ' PHE . 35.2 t70 -63.01 -32.41 73.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.247 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.947 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -74.49 -17.09 60.82 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.864 -178.356 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -66.32 -16.81 64.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.519 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.473 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 36.1 p90 -42.9 134.84 2.91 Favored Pre-proline 0 N--CA 1.472 0.645 0 O-C-N 123.825 0.703 . . . . 0.0 112.106 -176.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 57' ' ' PHE . 21.9 Cg_exo -66.0 140.7 48.29 Favored 'Cis proline' 0 C--N 1.346 0.416 0 C-N-CA 123.668 -1.388 . . . . 0.0 112.14 -2.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 13.1 Cg_endo -95.86 -169.28 0.15 Allowed 'Trans proline' 0 N--CA 1.44 -1.632 0 C-N-CA 123.999 3.132 . . . . 0.0 110.204 -175.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.544 ' OD2' ' HD3' ' A' ' 37' ' ' LYS . 19.9 t70 -98.34 5.14 48.49 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.985 0.421 . . . . 0.0 111.349 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.887 ' HA ' ' HD3' ' A' ' 34' ' ' ARG . 57.3 m-85 -64.65 118.23 8.58 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -171.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -80.89 -31.85 35.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.155 166.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.95 126.1 1.43 Allowed Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -113.96 144.38 43.17 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.938 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.608 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 1.7 p30 -147.76 164.37 33.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.627 0.251 . . . . 0.0 110.966 176.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 m -65.53 -32.29 73.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.735 0.303 . . . . 0.0 111.432 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.433 ' HA ' ' OE2' ' A' ' 70' ' ' GLU . 26.2 t-20 -62.39 -34.67 77.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.35 0.595 . . . . 0.0 109.816 177.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.778 HD11 HD12 ' A' ' 31' ' ' ILE . 22.6 tp -57.29 -39.91 76.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.041 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.0 mm -63.02 -37.37 79.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.335 0.588 . . . . 0.0 110.358 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 17.9 mt-10 -67.83 -41.68 82.66 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.421 ' HE ' ' HG3' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -64.14 -32.43 74.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.559 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 68' ' ' LEU . 74.6 mt -61.09 -46.3 96.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.648 0.261 . . . . 0.0 110.682 178.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.405 ' HA ' HD12 ' A' ' 76' ' ' LEU . 1.7 p-80 -65.78 -33.51 76.03 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.904 178.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 5.9 mm-40 -61.03 -49.92 75.44 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.81 176.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.694 ' HG3' HD13 ' A' ' 35' ' ' ILE . 79.8 mm-40 -55.62 -31.23 62.11 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.889 -178.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.738 HD22 HG21 ' A' ' 81' ' ' ILE . 86.8 mt -57.9 -46.83 84.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.979 0.419 . . . . 0.0 110.562 173.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -83.67 -50.26 8.36 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.511 ' HD2' ' CD ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -73.6 -42.47 61.49 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -175.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.411 ' CG ' ' HE2' ' A' ' 36' ' ' LYS . 56.2 t-80 -95.47 -29.86 14.17 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.608 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.93 23.19 33.48 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 119.842 -1.17 . . . . 0.0 112.568 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.738 HG21 HD22 ' A' ' 76' ' ' LEU . 6.3 tt -72.5 146.63 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.548 ' O ' HD11 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -117.2 119.61 35.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.195 0.522 . . . . 0.0 111.794 -175.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.7 mt -153.85 116.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -82.44 151.66 4.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.345 0.593 . . . . 0.0 110.292 -175.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.416 ' C ' ' H ' ' A' ' 87' ' ' GLU . 2.8 mp0 -85.41 -30.09 23.86 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.661 -178.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.449 ' HB2' HG21 ' A' ' 49' ' ' THR . 2.3 t-20 73.21 -4.97 2.05 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.225 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' A' ' 85' ' ' GLU . 34.1 mt-10 -108.81 129.9 23.38 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.796 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 72.5 Cg_exo -49.72 -75.33 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.715 2.943 . . . . 0.0 115.122 -169.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -166.58 17.31 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -170.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -101.92 135.58 43.23 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.274 -0.571 . . . . 0.0 110.935 -175.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -63.13 -64.7 0.83 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.146 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 177.15 -46.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.406 -176.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.5 pt -102.22 39.11 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.955 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.2 t 60.99 -88.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.995 -175.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.54 127.93 46.08 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.673 -1.07 . . . . 0.0 112.29 -177.075 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.91 0 N-CA-C 112.327 -0.309 . . . . 0.0 112.327 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 t 61.9 80.03 0.24 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.235 0.541 . . . . 0.0 111.455 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -76.12 -25.36 55.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.348 175.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.467 ' O ' HG22 ' A' ' 31' ' ' ILE . 24.6 ttt 58.98 62.74 4.07 Favored Pre-proline 0 C--O 1.233 0.206 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.656 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.694 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 26.1 Cg_exo -62.9 -30.87 77.57 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.037 2.491 . . . . 0.0 112.203 -172.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -58.31 -38.83 77.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.131 -177.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.7 ' O ' HG13 ' A' ' 35' ' ' ILE . 5.9 tp -67.11 -35.69 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -177.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.414 ' HG2' ' NH2' ' A' ' 71' ' ' ARG . 18.7 mt-10 -65.45 -45.93 81.84 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.586 0.707 . . . . 0.0 109.907 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.694 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 39.5 mtt180 -68.64 -37.9 80.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.286 -176.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.601 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 0.3 OUTLIER -66.07 -36.19 82.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.021 -177.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.7 HG13 ' O ' ' A' ' 31' ' ' ILE . 86.4 mt -60.88 -42.71 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.555 ' CD ' HD11 ' A' ' 81' ' ' ILE . 20.0 mmtm -65.74 -36.46 83.63 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.032 0.444 . . . . 0.0 110.278 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.456 ' HE3' HD21 ' A' ' 41' ' ' LEU . 45.3 tptt -64.13 -46.46 84.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.749 175.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.84 -44.22 93.81 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.585 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.523 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -62.82 -35.93 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.977 177.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.722 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 22.8 t -67.06 -47.36 71.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.356 -0.537 . . . . 0.0 109.658 178.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.694 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 83.7 mt -59.62 -43.67 93.71 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.551 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.98 -37.39 93.16 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -177.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.56 ' HB2' HG23 ' A' ' 48' ' ' ILE . 25.7 tptt -70.04 -38.43 75.85 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 120.942 0.401 . . . . 0.0 110.342 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.722 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -61.06 -36.92 80.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.733 0.778 . . . . 0.0 109.965 173.056 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.924 ' HE3' ' HA ' ' A' ' 56' ' ' ALA . 74.4 mmtt -67.52 -30.38 70.03 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.383 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.31 -63.45 0.3 Allowed Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.668 175.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -126.76 155.22 43.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.228 0.537 . . . . 0.0 110.593 -175.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.8 OUTLIER -86.33 88.28 2.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.352 0.596 . . . . 0.0 109.634 176.376 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.612 ' O ' HG12 ' A' ' 53' ' ' ILE . 9.8 t -158.23 163.4 37.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.926 -171.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -60.04 -39.14 84.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.92 0.391 . . . . 0.0 110.982 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -57.69 -45.43 85.65 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.461 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.768 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -73.26 -31.08 63.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.493 -179.511 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 49' ' ' THR . 46.3 mm -61.66 -50.13 81.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.235 0.54 . . . . 0.0 110.103 173.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.405 ' HA ' ' CD1' ' A' ' 57' ' ' PHE . 10.7 t70 -59.11 -38.21 79.04 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.489 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.768 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 10.7 ptmt -75.65 -18.31 59.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.101 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.924 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -75.7 -23.09 56.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.126 177.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 54' ' ' ASP . 63.3 m-85 -61.95 142.84 95.01 Favored Pre-proline 0 N--CA 1.464 0.268 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.509 176.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.509 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 96.3 Cg_endo -84.02 137.11 27.15 Favored 'Cis proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.584 -1.423 . . . . 0.0 112.818 0.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 56.9 Cg_endo -102.81 -152.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 124.466 3.444 . . . . 0.0 110.953 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.77 13.31 28.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 178.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.14 117.15 6.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.013 0.435 . . . . 0.0 111.168 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -81.88 -25.81 34.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.363 173.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.61 125.76 1.48 Allowed Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -106.56 144.95 32.49 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.531 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 16.9 t70 -150.0 157.52 43.24 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.85 -174.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.6 m -63.63 -26.78 68.83 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.861 0.362 . . . . 0.0 111.161 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -60.72 -33.44 72.9 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.568 ' O ' HG13 ' A' ' 72' ' ' ILE . 25.1 tp -54.57 -39.29 67.62 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.027 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.6 mm -62.33 -42.67 96.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.233 0.539 . . . . 0.0 109.868 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 11.8 mt-10 -66.83 -45.53 77.99 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.528 ' HD2' ' OE2' ' A' ' 74' ' ' GLU . 18.4 mmm-85 -65.65 -34.46 78.26 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.482 -1.235 . . . . 0.0 111.89 -174.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 68' ' ' LEU . 71.1 mt -61.1 -50.07 82.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.589 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 18.7 m170 -69.07 -34.9 75.89 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.544 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.528 ' OE2' ' HD2' ' A' ' 71' ' ' ARG . 43.4 mt-10 -60.67 -49.01 79.24 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 175.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -64.73 -31.94 73.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.953 0.406 . . . . 0.0 110.675 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.687 ' HA ' HG21 ' A' ' 81' ' ' ILE . 16.5 tp -64.66 -42.37 95.45 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.755 176.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -82.2 -52.15 7.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.948 0.404 . . . . 0.0 111.836 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -75.54 -44.91 41.06 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.586 -174.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -95.5 -17.02 21.8 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.315 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.44 23.78 57.85 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.698 -1.239 . . . . 0.0 113.348 173.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.687 HG21 ' HA ' ' A' ' 76' ' ' LEU . 4.5 tt -71.61 124.05 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 117.605 0.702 . . . . 0.0 110.64 -171.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.402 HD21 ' HA ' ' A' ' 82' ' ' ASN . 10.5 m120 -78.42 117.08 19.3 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.463 0.649 . . . . 0.0 111.414 -175.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.567 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 5.6 tp -161.91 139.48 2.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.53 HG13 ' HB ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -110.22 154.25 11.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-O 121.004 0.43 . . . . 0.0 110.443 -175.377 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -83.2 -23.68 32.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.068 -175.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.458 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 3.3 t30 78.78 23.05 0.62 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.464 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 7.5 mm-40 -96.56 127.83 38.36 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.092 175.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 6.3 Cg_endo -88.06 99.77 0.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.016 2.477 . . . . 0.0 111.342 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -79.54 70.82 6.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.112 0.482 . . . . 0.0 111.402 -176.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 55.65 92.9 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.839 170.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -90.23 88.24 7.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.053 0.454 . . . . 0.0 110.009 175.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -113.95 -71.07 0.77 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.8 mt -96.69 -35.37 5.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.581 175.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.8 t 69.5 -70.12 0.15 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.99 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -166.48 -179.02 4.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.192 -1.338 . . . . 0.0 111.761 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 71.2 m -77.44 73.27 4.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.232 0.539 . . . . 0.0 111.708 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.419 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 37.5 t-80 -83.12 123.96 30.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.8 mtm -110.3 96.28 25.82 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.764 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 50.0 Cg_exo -52.63 -33.21 57.81 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.923 2.415 . . . . 0.0 112.663 -173.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -25.0 58.88 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.076 -173.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.628 HD12 ' HB2' ' A' ' 68' ' ' LEU . 9.5 mm -69.76 -46.51 74.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 174.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -61.91 -45.24 94.59 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.094 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.764 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 29.7 mtm180 -61.79 -43.15 99.42 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.866 176.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.485 HH12 ' HB2' ' A' ' 64' ' ' PHE . 73.8 ttt180 -58.66 -36.1 73.62 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.517 -178.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.613 HG13 ' O ' ' A' ' 31' ' ' ILE . 63.6 mt -58.44 -51.71 68.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.492 ' HD3' HD11 ' A' ' 81' ' ' ILE . 1.4 mppt? -69.28 -40.14 77.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.52 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.401 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.8 mmtm -59.22 -38.42 79.9 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.114 0.259 . . . . 0.0 110.721 177.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.496 ' HB3' HD11 ' A' ' 53' ' ' ILE . 30.8 mt -65.34 -49.79 68.07 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.12 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.64 HG12 HG12 ' A' ' 81' ' ' ILE . 1.5 mp -62.77 -34.93 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.238 0.542 . . . . 0.0 109.72 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.8 m -67.0 -47.99 69.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.4 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.577 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 72.3 mt -59.49 -39.22 83.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.632 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.691 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -65.83 -34.21 88.04 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.553 ' HD2' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -71.73 -29.84 64.97 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 122.042 0.925 . . . . 0.0 109.184 -177.241 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.497 ' HE2' ' N ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -75.69 -46.03 33.5 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.736 -1.574 . . . . 0.0 110.428 174.559 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.765 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . 72.4 mmtt -68.17 -33.62 74.8 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.96 -174.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.47 -66.15 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.384 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -142.25 164.17 30.86 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -175.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.702 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -89.25 79.99 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.889 -170.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 1.074 ' HB ' HG11 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -139.0 154.32 48.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.402 -169.501 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -57.29 -39.28 75.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.515 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -68.27 -35.56 78.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.673 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.783 ' HB2' HG22 ' A' ' 49' ' ' THR . 9.4 t0 -71.61 -34.43 69.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.302 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 49' ' ' THR . 49.2 mm -58.87 -49.32 83.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.57 0.7 . . . . 0.0 110.196 174.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -61.03 -32.9 72.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.473 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.765 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -75.61 -25.43 56.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.312 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.69 -23.74 60.91 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.789 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.518 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 64.2 t80 -64.26 138.17 97.34 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.652 176.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.434 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 6.0 Cg_exo -80.04 137.22 40.98 Favored 'Cis proline' 0 C--N 1.347 0.48 0 C-N-CA 124.151 -1.187 . . . . 0.0 112.543 0.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.553 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 57.2 Cg_endo -105.61 -158.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 124.723 3.615 . . . . 0.0 111.266 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.81 16.5 22.06 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.892 -177.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.553 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 13.5 p90 -58.85 121.46 11.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.653 0.74 . . . . 0.0 111.726 -170.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -80.81 -18.51 47.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.814 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.32 135.9 3.93 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -174.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.485 ' HB2' HH12 ' A' ' 34' ' ' ARG . 78.8 t80 -112.87 138.6 49.48 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.258 174.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -158.53 153.85 25.73 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.3 t -63.24 -25.64 68.42 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.282 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.56 ' O ' ' HB2' ' A' ' 71' ' ' ARG . 10.2 m120 -60.92 -31.36 70.89 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.33 177.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.628 ' HB2' HD12 ' A' ' 31' ' ' ILE . 48.8 tp -58.84 -40.47 84.33 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.047 176.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.1 mm -63.85 -46.46 94.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.947 0.404 . . . . 0.0 110.565 -177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -69.4 -34.11 74.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.758 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -68.26 -41.21 81.43 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.555 -176.571 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.569 HG12 HG23 ' A' ' 35' ' ' ILE . 76.2 mt -60.75 -45.11 98.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.705 0.288 . . . . 0.0 110.938 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.467 ' HA ' HD13 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -63.98 -41.46 97.52 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.456 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 12.8 pt-20 -69.69 -34.09 73.44 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.991 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 71' ' ' ARG . 63.7 mm-40 -61.48 -29.86 70.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.563 0.22 . . . . 0.0 111.115 173.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.697 HD21 HG23 ' A' ' 83' ' ' ILE . 98.2 mt -60.04 -49.03 79.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.829 0.347 . . . . 0.0 110.909 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -82.95 -50.12 8.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.202 0.525 . . . . 0.0 111.752 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 8.8 ttmt -69.8 -44.75 69.4 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.205 -175.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -96.13 -25.61 15.8 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.525 -174.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.59 21.59 53.34 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 119.93 -1.129 . . . . 0.0 112.011 -175.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.64 HG12 HG12 ' A' ' 39' ' ' ILE . 9.8 tt -72.49 145.35 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -178.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.72 136.17 53.18 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.309 -173.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.697 HG23 HD21 ' A' ' 76' ' ' LEU . 1.6 tp -162.42 129.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.134 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 1.074 HG11 ' HB ' ' A' ' 49' ' ' THR . 2.2 p -97.57 151.03 4.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.832 -175.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.471 ' HB2' ' HG3' ' A' ' 87' ' ' GLU . 25.5 mm-40 -93.74 -26.49 16.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.06 0.457 . . . . 0.0 110.316 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 63.7 t30 69.28 22.36 6.68 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.983 176.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.517 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 33.5 mt-10 -60.68 128.58 88.75 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 9.0 Cg_exo -72.41 132.82 19.77 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.523 2.815 . . . . 0.0 114.182 -168.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -90.81 84.18 5.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.497 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -78.89 -34.99 44.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.448 -178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -145.74 -66.9 0.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.143 0.497 . . . . 0.0 110.137 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -153.46 46.15 0.65 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.103 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 93' ' ' ILE . 26.3 mt 62.21 18.12 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.36 -178.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.3 m 51.99 46.59 26.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.939 176.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.14 162.73 32.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.547 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 CA-C-O 118.841 -0.977 . . . . 0.0 111.536 178.513 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.878 0 N-CA-C 111.951 -0.459 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.4 m -110.74 -34.87 6.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.081 0.467 . . . . 0.0 110.682 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -93.46 -23.66 18.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.356 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.581 ' O ' HG23 ' A' ' 31' ' ' ILE . 22.3 ptt? -136.92 63.37 44.75 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.618 178.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.462 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 4.7 Cg_exo -80.87 -27.29 3.16 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.315 2.01 . . . . 0.0 111.19 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.58 ' HB2' ' OE1' ' A' ' 62' ' ' GLU . 13.5 pt20 -69.03 -29.63 67.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.604 -177.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.665 ' O ' HG13 ' A' ' 35' ' ' ILE . 10.0 tp -69.05 -36.42 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.044 -176.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -65.2 -46.31 81.23 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.121 0.486 . . . . 0.0 110.046 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 61.1 mtp180 -60.74 -45.03 95.85 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.117 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.428 ' HD3' ' OE1' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -63.33 -31.39 72.53 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.886 -176.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.665 HG13 ' O ' ' A' ' 31' ' ' ILE . 63.6 mt -58.68 -48.35 86.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.82 176.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.485 ' CD ' HD11 ' A' ' 81' ' ' ILE . 1.9 mppt? -67.54 -33.84 75.87 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.909 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 16.6 tptp -63.24 -40.36 97.21 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.211 176.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.6 ' HA ' HD11 ' A' ' 41' ' ' LEU . 5.9 mp -70.24 -40.14 74.62 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.443 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.689 HG12 HG12 ' A' ' 81' ' ' ILE . 1.5 mp -63.3 -34.53 67.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.997 174.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.408 ' C ' ' HE3' ' A' ' 44' ' ' LYS . 45.5 t -61.06 -43.06 99.46 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.836 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 89.9 mt -58.24 -46.15 86.47 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.992 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.663 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -60.67 -32.29 78.15 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.12 -39.72 48.42 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.935 0.874 . . . . 0.0 109.273 -175.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.836 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 4.4 ptpt -76.68 -36.94 56.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.092 -176.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.69 ' HB2' ' OD1' ' A' ' 52' ' ' ASP . 30.8 mmmt -72.05 -20.98 61.59 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.733 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.23 -72.97 0.21 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.025 -0.989 . . . . 0.0 113.589 174.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -143.93 145.96 32.63 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.386 0.136 . . . . 0.0 110.741 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.531 ' HB ' HD12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -66.91 108.51 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 122.042 0.925 . . . . 0.0 109.816 -176.038 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.681 HG23 ' H ' ' A' ' 51' ' ' GLU . 54.5 m -160.71 145.51 14.22 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.597 -173.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -57.73 -39.99 78.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.216 0.531 . . . . 0.0 110.474 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.681 ' H ' HG23 ' A' ' 49' ' ' THR . 44.4 mm-40 -68.37 -33.59 74.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.627 177.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.692 ' CG ' ' HD3' ' A' ' 55' ' ' LYS . 10.0 t70 -71.72 -32.55 67.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.365 0.603 . . . . 0.0 109.71 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 49' ' ' THR . 50.0 mm -61.4 -49.42 84.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.419 0.628 . . . . 0.0 109.776 170.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -33.47 69.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.54 176.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.692 ' HD3' ' CG ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -75.12 -24.29 58.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.993 -179.516 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.503 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -71.91 -19.7 61.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.311 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.52 ' CD2' ' HD3' ' A' ' 59' ' ' PRO . 55.3 t80 -63.79 133.05 95.42 Favored Pre-proline 0 C--O 1.235 0.317 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.44 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.49 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 53.9 Cg_endo -69.88 127.44 11.0 Favored 'Cis proline' 0 C--N 1.35 0.605 0 C-N-CA 123.392 -1.503 . . . . 0.0 112.165 1.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.52 ' HD3' ' CD2' ' A' ' 57' ' ' PHE . 13.9 Cg_endo -96.74 -165.65 0.1 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 123.74 2.96 . . . . 0.0 110.711 -172.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -98.35 15.23 25.32 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.402 -175.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.462 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 9.6 p90 -62.87 126.49 27.5 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.291 0.567 . . . . 0.0 111.121 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.58 ' OE1' ' HB2' ' A' ' 30' ' ' GLN . 48.7 mt-10 -80.82 -24.84 38.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.874 176.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.21 126.94 1.53 Allowed Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -106.31 123.72 48.48 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 117.523 0.662 . . . . 0.0 109.801 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 20.7 t70 -147.23 162.16 39.46 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.07 -175.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.8 t -64.37 -31.38 72.56 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.2 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -62.2 -34.46 76.5 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.248 0.547 . . . . 0.0 109.816 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.598 ' O ' HG13 ' A' ' 72' ' ' ILE . 32.9 tp -59.94 -42.18 93.46 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.749 177.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.2 mm -59.62 -43.48 91.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.033 0.444 . . . . 0.0 110.745 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -67.99 -40.97 82.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.564 ' HG3' ' CD1' ' A' ' 35' ' ' ILE . 9.5 tpp180 -66.43 -32.88 74.52 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.019 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.598 HG13 ' O ' ' A' ' 68' ' ' LEU . 76.0 mt -61.37 -50.59 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.852 -0.158 . . . . 0.0 110.629 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.575 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 22.1 p80 -67.1 -33.51 75.62 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.136 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -59.45 -49.52 77.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.344 0.593 . . . . 0.0 109.604 174.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.56 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 59.8 mm-40 -66.71 -28.98 68.86 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.821 176.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 1.02 ' HA ' HG22 ' A' ' 81' ' ' ILE . 13.5 tp -69.58 -51.55 34.29 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.363 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -84.49 -53.03 5.7 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.286 0.565 . . . . 0.0 111.625 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -76.29 -38.94 55.43 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.052 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.56 ' HB2' ' HA ' ' A' ' 75' ' ' GLU . 3.1 t60 -94.62 -16.42 23.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.577 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.24 23.03 42.1 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.398 -0.906 . . . . 0.0 114.106 172.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 1.02 HG22 ' HA ' ' A' ' 76' ' ' LEU . 7.9 tt -75.34 145.63 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 117.727 0.763 . . . . 0.0 109.322 -176.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.472 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.9 OUTLIER -108.31 128.06 54.41 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -173.393 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.662 HG12 HG13 ' A' ' 39' ' ' ILE . 9.2 mm -162.14 119.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 124.37 1.068 . . . . 0.0 108.61 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -88.17 152.36 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 CA-C-O 121.671 0.748 . . . . 0.0 109.454 -179.546 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -79.03 -31.44 44.64 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.146 -177.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.528 ' HB2' HG22 ' A' ' 49' ' ' THR . 11.8 t-20 76.46 -1.96 2.8 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.05 176.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -77.27 127.7 82.5 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.498 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.7 -71.56 0.04 OUTLIER 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 123.28 2.653 . . . . 0.0 114.016 -168.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -163.03 25.54 0.09 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.454 0.645 . . . . 0.0 109.875 -177.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -93.41 88.98 6.15 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.163 -174.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.83 ' HB3' ' HA ' ' A' ' 94' ' ' SER . 0.7 OUTLIER -95.73 -166.13 1.39 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.756 179.112 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.425 ' H ' ' CG ' ' A' ' 91' ' ' GLU . 42.4 tt0 -92.16 -53.2 4.34 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.984 -0.448 . . . . 0.0 109.88 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.426 HG22 ' OE2' ' A' ' 91' ' ' GLU . 10.9 tp -92.41 -14.21 8.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.83 ' HA ' ' HB3' ' A' ' 91' ' ' GLU . 49.6 m 60.17 42.67 15.08 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 113.855 -1.52 . . . . 0.0 111.799 176.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.06 -33.42 4.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 119.09 -0.839 . . . . 0.0 111.509 -177.107 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.727 0 N-CA-C 112.393 -0.283 . . . . 0.0 112.393 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.6 m -83.74 77.94 9.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.957 0.408 . . . . 0.0 111.641 -174.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -139.96 18.03 2.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.175 0.512 . . . . 0.0 110.053 175.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.0 mmm -130.9 71.22 82.52 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.135 -177.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 22.8 Cg_exo -63.88 -25.32 67.5 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.566 2.177 . . . . 0.0 111.546 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -66.6 -24.8 66.38 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.57 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.53 HG23 HD11 ' A' ' 68' ' ' LEU . 8.1 mm -65.22 -43.94 95.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.503 0.192 . . . . 0.0 111.494 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -69.71 -37.52 76.6 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 49.9 mtp180 -66.26 -34.12 77.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.792 175.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.583 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 2.0 tpm_? -59.06 -39.31 81.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.534 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.775 HD11 ' HG3' ' A' ' 71' ' ' ARG . 22.7 mt -59.54 -49.0 85.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.275 0.559 . . . . 0.0 109.857 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.53 ' HA ' HD12 ' A' ' 81' ' ' ILE . 14.3 mmmt -65.69 -36.2 82.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.173 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.56 ' HD2' ' HA ' ' A' ' 34' ' ' ARG . 48.3 mttm -60.96 -41.68 96.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.378 174.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 70.8 mt -67.41 -42.27 83.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.591 -176.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.618 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.6 mp -68.62 -34.91 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.981 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.675 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 32.2 t -66.44 -47.5 72.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.966 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 96.9 mt -60.15 -40.02 88.4 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.781 -177.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.527 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -67.0 -38.42 92.75 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.469 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 11.2 tptt -73.35 -34.89 65.87 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.874 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.675 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -62.6 -45.2 93.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.089 173.714 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.815 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . 45.3 mmtm -69.23 -35.23 75.94 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.82 -177.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.9 -65.99 0.1 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.086 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -137.0 158.57 44.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.416 0.627 . . . . 0.0 111.154 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.501 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.8 OUTLIER -83.64 88.98 2.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.334 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 10.6 t -153.61 155.24 35.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.829 -176.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -58.35 -41.98 85.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.043 0.449 . . . . 0.0 111.215 -173.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.68 -32.64 72.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.882 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.637 ' OD1' ' HB2' ' A' ' 45' ' ' LYS . 11.1 t0 -71.61 -39.26 70.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.214 0.53 . . . . 0.0 110.223 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.1 mt -60.23 -45.42 96.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.355 0.598 . . . . 0.0 110.017 173.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.0 -34.36 69.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.325 176.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.815 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -75.73 -23.05 56.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.092 -178.006 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.774 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -69.63 -18.93 63.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.571 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 80.5 t80 -62.74 137.14 96.58 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 176.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 90.0 Cg_endo -85.49 140.25 28.21 Favored 'Cis proline' 0 C--N 1.346 0.396 0 C-N-CA 123.594 -1.419 . . . . 0.0 113.441 1.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.609 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 37.3 Cg_endo -103.65 -157.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.744 0 C-N-CA 124.742 3.628 . . . . 0.0 110.896 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -98.09 14.52 27.24 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.044 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.609 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 10.1 p90 -61.51 125.9 25.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.464 0.649 . . . . 0.0 110.826 -174.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -79.08 -30.14 43.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.686 174.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.28 126.79 1.48 Allowed Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -108.2 144.57 35.47 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 24.3 t70 -142.66 161.37 38.24 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.32 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -63.07 -30.93 71.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.953 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -61.07 -34.08 74.35 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.124 0.488 . . . . 0.0 110.268 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.65 ' O ' HG13 ' A' ' 72' ' ' ILE . 58.1 tp -60.58 -39.42 87.99 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.906 177.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.6 mm -62.89 -41.43 92.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.244 0.545 . . . . 0.0 110.314 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.412 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 17.6 mt-10 -68.25 -36.99 80.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.902 0.858 . . . . 0.0 108.959 177.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.775 ' HG3' HD11 ' A' ' 35' ' ' ILE . 23.0 tpt180 -70.06 -33.99 72.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.153 -178.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 68' ' ' LEU . 86.2 mt -61.0 -50.38 80.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.002 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.412 ' CD2' ' HA ' ' A' ' 70' ' ' GLU . 34.3 p80 -66.73 -31.94 72.92 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.91 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.697 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 25.6 mt-10 -58.54 -53.38 59.01 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 121.377 0.608 . . . . 0.0 109.773 173.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.48 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 47.3 tp10 -59.88 -33.52 71.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.529 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.873 ' HA ' HG22 ' A' ' 81' ' ' ILE . 9.0 tp -66.57 -49.56 65.98 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.809 177.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -83.9 -53.35 5.65 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -173.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.697 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 34.3 pttt -76.97 -40.1 48.11 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.575 -176.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -93.8 -21.14 19.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.059 -176.582 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.32 25.24 24.38 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.358 -1.401 . . . . 0.0 114.772 172.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.873 HG22 ' HA ' ' A' ' 76' ' ' LEU . 5.4 tt -73.06 119.59 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 118.847 1.324 . . . . 0.0 109.628 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -81.8 126.94 32.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.434 0.635 . . . . 0.0 111.505 -171.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.618 ' HB ' HG13 ' A' ' 39' ' ' ILE . 4.8 tp -167.87 140.02 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.464 -176.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -100.73 153.4 4.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -92.62 -29.73 15.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.491 -174.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.478 ' HB2' ' HG1' ' A' ' 49' ' ' THR . 24.0 t-20 74.18 -7.11 1.71 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.939 0.774 . . . . 0.0 110.192 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 43.0 tt0 -88.66 128.38 52.82 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.509 -177.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 4.0 Cg_exo -81.36 159.34 19.91 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.256 2.638 . . . . 0.0 111.682 176.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -109.69 -8.29 14.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.869 0.366 . . . . 0.0 111.245 -175.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -70.64 -27.4 64.03 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -74.54 65.24 1.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.123 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -122.18 -58.59 1.71 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 45.8 mt -95.11 65.98 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 166.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 m -67.09 -64.72 0.8 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.257 -173.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.41 -50.69 8.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.406 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.399 -1.223 . . . . 0.0 111.361 179.784 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.56 ' HB3' HG12 ' A' ' 31' ' ' ILE . 65.9 mtt . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 120.818 0.342 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.487 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 15.5 Cg_exo -67.94 -25.07 38.97 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.661 2.241 . . . . 0.0 111.105 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.454 ' HB2' ' OE2' ' A' ' 62' ' ' GLU . 12.3 pt20 -66.2 -25.1 66.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.389 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.576 ' O ' HG13 ' A' ' 35' ' ' ILE . 28.8 mm -65.17 -49.88 76.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.587 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -55.69 -46.54 77.6 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.202 0.525 . . . . 0.0 110.492 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 12.6 mmm180 -67.56 -44.34 78.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.025 -177.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.707 HH11 HD22 ' A' ' 68' ' ' LEU . 29.6 ttm180 -61.74 -37.93 86.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.215 -175.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 31' ' ' ILE . 89.8 mt -59.83 -46.32 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.687 ' HD3' HD12 ' A' ' 81' ' ' ILE . 26.5 mmtm -67.03 -37.29 83.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.27 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.535 ' HD2' ' HA ' ' A' ' 34' ' ' ARG . 94.4 mttt -62.57 -40.93 98.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.875 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.625 ' HB3' HD13 ' A' ' 53' ' ' ILE . 73.8 mt -64.93 -45.84 84.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.664 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.683 ' HB ' HD11 ' A' ' 81' ' ' ILE . 1.6 mp -66.37 -35.38 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 121.033 0.444 . . . . 0.0 109.953 177.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.694 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 33.3 t -65.96 -42.09 90.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.922 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.713 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 93.3 mt -60.15 -43.12 95.99 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.474 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.41 -35.23 89.87 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -36.82 83.36 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.888 -0.656 . . . . 0.0 109.703 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.694 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -68.78 -41.13 79.2 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.883 0.849 . . . . 0.0 110.03 175.141 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.713 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 70.3 mmtt -68.95 -31.56 70.53 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.014 -1.448 . . . . 0.0 111.277 -176.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.54 -58.8 0.44 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.246 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -119.68 146.81 45.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.119 0.485 . . . . 0.0 110.667 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.06 86.48 2.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.347 0.594 . . . . 0.0 109.697 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.458 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.0 m -141.79 148.08 38.33 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.407 -170.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -57.12 -42.24 80.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.061 0.458 . . . . 0.0 110.119 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.41 ' H ' HG22 ' A' ' 49' ' ' THR . 35.1 mt-10 -70.06 -32.68 70.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.697 177.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.746 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 1.3 m-20 -68.23 -29.44 68.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.266 0.555 . . . . 0.0 111.3 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.625 HD13 ' HB3' ' A' ' 38' ' ' LEU . 17.7 mt -65.71 -44.02 93.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 121.075 0.464 . . . . 0.0 110.187 170.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.33 -39.36 75.69 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.497 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.746 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.66 -15.43 59.18 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.832 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.697 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -75.39 -18.49 59.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.073 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.521 ' CD2' ' HD3' ' A' ' 59' ' ' PRO . 43.6 t80 -50.1 136.01 21.81 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.829 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.498 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 71.5 Cg_endo -75.03 137.72 51.95 Favored 'Cis proline' 0 C--N 1.345 0.374 0 C-N-CA 123.528 -1.447 . . . . 0.0 112.836 1.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.521 ' HD3' ' CD2' ' A' ' 57' ' ' PHE . 17.0 Cg_endo -98.87 -165.25 0.07 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 124.141 3.227 . . . . 0.0 110.245 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -97.38 13.92 28.04 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.012 0.434 . . . . 0.0 110.734 -176.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.427 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 5.2 p90 -63.25 120.74 12.12 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.625 0.726 . . . . 0.0 111.358 -173.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.454 ' OE2' ' HB2' ' A' ' 30' ' ' GLN . 2.3 mp0 -80.93 -22.26 39.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.736 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.02 146.96 14.2 Favored Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 -174.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -100.99 120.57 40.37 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.484 173.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -134.67 132.64 39.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.715 0.293 . . . . 0.0 110.61 -170.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.8 m -63.78 -31.94 73.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.405 0.622 . . . . 0.0 109.746 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.544 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 14.0 m120 -62.31 -38.67 90.33 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.643 175.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.707 HD22 HH11 ' A' ' 34' ' ' ARG . 52.2 tp -59.69 -39.01 83.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.613 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.7 mm -61.08 -46.53 96.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.557 0.218 . . . . 0.0 111.107 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 14.3 pt-20 -70.59 -34.56 72.3 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.669 177.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.549 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 19.4 mmt180 -70.41 -32.62 70.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.512 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 68' ' ' LEU . 82.4 mt -61.75 -49.56 83.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.834 0.35 . . . . 0.0 110.143 175.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.528 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 77.3 m80 -67.46 -34.92 78.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.753 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -67.62 -48.88 65.48 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.699 177.129 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -58.6 -29.52 66.52 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.004 0.43 . . . . 0.0 110.624 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.919 ' HA ' HG22 ' A' ' 81' ' ' ILE . 2.9 tp -57.6 -44.82 85.71 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.299 173.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -84.02 -52.66 6.13 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.753 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 3.6 ptmm? -72.93 -39.77 66.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -93.1 -26.98 17.22 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.942 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.16 23.09 23.31 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.77 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.919 HG22 ' HA ' ' A' ' 76' ' ' LEU . 6.2 tt -74.33 123.5 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 117.731 0.765 . . . . 0.0 110.108 -174.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -82.51 118.26 23.12 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.974 -0.454 . . . . 0.0 111.306 -172.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.638 ' HB ' HG13 ' A' ' 39' ' ' ILE . 5.5 tp -156.95 137.61 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.12 152.2 10.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.265 0.555 . . . . 0.0 110.789 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -88.23 -25.91 22.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.974 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.408 ' HB2' ' CG2' ' A' ' 49' ' ' THR . 5.3 t30 . . . . . 0 N--CA 1.468 0.459 0 O-C-N 124.202 0.939 . . . . 0.0 109.799 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.595 ' O ' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.627 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 9.3 Cg_exo -72.01 -36.32 6.08 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.625 2.217 . . . . 0.0 112.492 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.462 ' HB2' HH21 ' A' ' 34' ' ' ARG . 5.1 pp0? -64.96 -32.88 74.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.156 -174.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.698 HG13 HD13 ' A' ' 68' ' ' LEU . 10.7 tp -71.98 -35.52 54.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.62 -47.38 66.82 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.219 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 22.5 mmm180 -62.96 -35.37 79.93 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.552 ' HG2' ' CD1' ' A' ' 61' ' ' PHE . 6.4 tpp180 -60.63 -37.03 80.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.978 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 31' ' ' ILE . 30.9 mt -60.48 -44.87 97.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.517 ' HA ' ' HB ' ' A' ' 39' ' ' ILE . 2.2 mppt? -67.95 -34.03 75.8 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.014 175.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -58.59 -42.56 88.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.168 0.509 . . . . 0.0 109.931 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.615 HD12 HG23 ' A' ' 53' ' ' ILE . 4.1 mm? -70.08 -35.05 73.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.723 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.667 HD11 HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -60.69 -37.97 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.236 0.541 . . . . 0.0 109.738 173.914 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.671 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 36.6 t -66.97 -48.38 68.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.028 176.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.696 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 91.5 mt -60.8 -45.93 92.51 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.055 -176.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.08 -39.04 84.34 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -175.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.44 -34.15 67.58 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.671 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -61.34 -41.23 96.71 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.918 172.756 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 31.7 mmtp -68.41 -21.7 64.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.485 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.01 -66.1 0.25 Allowed Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.363 -0.923 . . . . 0.0 112.522 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -142.57 171.67 13.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.16 0.505 . . . . 0.0 111.116 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.496 HG22 ' CD1' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -87.63 86.16 2.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.453 0.644 . . . . 0.0 109.952 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.608 ' O ' HG12 ' A' ' 53' ' ' ILE . 9.7 m -143.26 145.62 32.9 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.525 -171.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -60.6 -34.94 74.95 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.571 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 32.1 mt-10 -67.63 -35.03 78.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.092 176.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.692 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 11.8 m-20 -71.68 -30.32 65.57 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.444 0.64 . . . . 0.0 110.972 176.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.615 HG23 HD12 ' A' ' 38' ' ' LEU . 50.9 mm -66.5 -45.34 89.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.566 0.698 . . . . 0.0 109.818 169.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.512 ' HA ' ' CE2' ' A' ' 57' ' ' PHE . 21.4 t70 -57.43 -36.89 71.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.715 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.692 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 5.9 ptpt -77.88 -16.58 58.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.781 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.561 ' HA ' ' NZ ' ' A' ' 45' ' ' LYS . . . -76.82 -19.17 57.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.796 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.568 ' CD1' ' HG3' ' A' ' 59' ' ' PRO . 19.8 m-85 -66.62 147.32 99.03 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.933 178.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 2.9 Cg_exo -76.1 143.46 76.65 Favored 'Cis proline' 0 C--N 1.342 0.214 0 C-N-CA 123.955 -1.269 . . . . 0.0 112.358 0.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.698 ' HG2' ' HD2' ' A' ' 61' ' ' PHE . 53.1 Cg_endo -100.92 -173.0 0.11 Allowed 'Trans proline' 0 N--CA 1.438 -1.757 0 C-N-CA 124.328 3.352 . . . . 0.0 110.772 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -98.65 16.53 21.72 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.698 ' HD2' ' HG2' ' A' ' 59' ' ' PRO . 36.4 m-85 -58.43 119.48 7.06 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.925 0.393 . . . . 0.0 110.404 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.58 -20.93 45.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.335 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.71 124.63 1.28 Allowed Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -112.88 144.51 42.32 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 18.2 t70 -149.56 160.74 43.24 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.867 -172.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 t -62.97 -32.22 73.5 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 120.975 0.416 . . . . 0.0 110.982 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.425 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 3.3 t-20 -61.69 -31.86 72.02 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.698 HD13 HG13 ' A' ' 31' ' ' ILE . 26.6 tp -54.63 -38.79 67.26 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.052 175.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.9 mm -61.9 -40.79 88.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.31 0.576 . . . . 0.0 109.866 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.574 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 15.7 mt-10 -68.14 -41.08 82.16 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.539 ' HD2' ' HA ' ' A' ' 68' ' ' LEU . 85.9 mtt180 -60.05 -38.75 83.72 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.939 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 68' ' ' LEU . 80.5 mt -61.3 -51.1 76.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.809 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.574 ' CD2' ' HA ' ' A' ' 70' ' ' GLU . 27.9 p80 -69.0 -32.33 71.81 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.543 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 47.3 mt-10 -59.2 -49.46 77.78 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.406 ' OE1' ' NZ ' ' A' ' 36' ' ' LYS . 20.9 mm-40 -63.89 -34.22 77.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.666 175.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.526 ' HA ' HG22 ' A' ' 81' ' ' ILE . 18.2 tp -57.48 -41.94 81.64 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.346 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -84.46 -49.82 8.32 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -71.97 -44.69 63.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.05 -26.67 15.96 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.361 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.02 23.44 32.54 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.908 -1.139 . . . . 0.0 112.985 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.526 HG22 ' HA ' ' A' ' 76' ' ' LEU . 11.9 tt -72.32 119.25 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.625 0.726 . . . . 0.0 110.909 -170.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -99.99 118.58 36.69 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.872 -170.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.667 HG12 HD11 ' A' ' 39' ' ' ILE . 3.3 mt -146.16 128.21 8.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 86' ' ' ASN . 0.4 OUTLIER -95.27 153.31 3.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.823 -172.002 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -87.11 -23.72 24.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.926 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.501 ' N ' HG13 ' A' ' 84' ' ' VAL . 60.2 t30 . . . . . 0 C--N 1.332 -0.177 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.939 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.744 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 87.9 mtp . . . . . 0 CA--C 1.535 0.37 0 CA-C-O 119.761 -0.161 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.744 ' HD3' ' HB2' ' A' ' 28' ' ' MET . 43.7 Cg_exo -59.05 -34.24 98.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.107 1.871 . . . . 0.0 112.412 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.515 ' HB2' HH21 ' A' ' 34' ' ' ARG . 21.1 pt20 -67.09 -25.12 66.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.683 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.636 ' O ' HG13 ' A' ' 35' ' ' ILE . 26.6 mm -69.81 -46.07 75.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.227 175.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -55.69 -45.06 77.87 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.254 0.55 . . . . 0.0 110.009 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 2.9 mmp_? -64.93 -39.76 94.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.022 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.945 ' HD2' ' HA ' ' A' ' 61' ' ' PHE . 5.5 tpp180 -67.16 -39.21 86.46 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.232 -173.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.636 HG13 ' O ' ' A' ' 31' ' ' ILE . 41.5 mt -61.14 -44.87 99.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.613 ' HD3' HD12 ' A' ' 81' ' ' ILE . 14.5 mmtp -66.87 -38.77 86.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.207 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.58 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 54.9 mttm -61.02 -43.36 99.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.9 175.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.513 ' HB3' HD12 ' A' ' 53' ' ' ILE . 65.9 mt -63.73 -47.13 82.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.391 -177.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.541 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -63.41 -34.76 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.066 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.441 ' C ' ' HE3' ' A' ' 44' ' ' LYS . 33.1 t -65.57 -47.89 74.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.551 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.923 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 71.2 mt -59.22 -47.07 86.7 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.636 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.33 -35.81 92.17 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -74.99 -38.79 61.55 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.509 0.671 . . . . 0.0 109.878 -173.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.923 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 3.9 ptpt -70.55 -26.17 63.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.485 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 69.4 mmtt -86.95 -4.48 59.18 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.981 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.88 -71.78 0.3 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.78 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -141.14 164.83 29.21 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 121.213 0.53 . . . . 0.0 111.928 -170.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -85.24 85.27 2.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.22 0.533 . . . . 0.0 109.764 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 51' ' ' GLU . 5.9 m -142.92 146.6 34.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.404 -171.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.33 -36.12 77.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.065 0.46 . . . . 0.0 110.112 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.521 ' H ' HG22 ' A' ' 49' ' ' THR . 32.9 mt-10 -67.42 -34.36 77.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.183 0.516 . . . . 0.0 110.118 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.766 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 1.5 m-20 -67.2 -30.03 69.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.282 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.513 HD12 ' HB3' ' A' ' 38' ' ' LEU . 39.1 mm -60.08 -50.24 80.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.448 0.642 . . . . 0.0 110.341 173.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.36 -38.24 90.4 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.344 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.766 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -75.41 -14.97 60.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.716 -178.277 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.85 -18.92 60.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.117 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.422 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 80.4 t80 -58.69 134.55 86.32 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.813 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 57.9 Cg_endo -72.87 132.16 25.31 Favored 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 123.591 -1.42 . . . . 0.0 112.024 -1.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 19.2 Cg_endo -98.61 -158.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.732 0 C-N-CA 124.259 3.306 . . . . 0.0 111.11 -173.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.509 ' H ' HD11 ' A' ' 41' ' ' LEU . 2.5 t70 -98.96 14.19 29.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.325 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.945 ' HA ' ' HD2' ' A' ' 34' ' ' ARG . 4.3 p90 -69.68 120.13 14.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.386 0.612 . . . . 0.0 111.251 -172.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -82.38 -23.55 34.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.651 172.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.74 125.74 1.5 Allowed Glycine 0 N--CA 1.436 -1.34 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -176.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -113.27 134.26 54.69 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.468 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.432 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 18.4 t70 -151.59 155.28 38.11 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.4 m -63.05 -27.91 69.73 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.94 0.4 . . . . 0.0 111.371 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -61.34 -32.7 72.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.382 0.611 . . . . 0.0 109.937 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.622 ' O ' HG13 ' A' ' 72' ' ' ILE . 63.9 tp -60.66 -39.11 87.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.084 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.6 mm -62.82 -46.65 95.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.791 0.329 . . . . 0.0 110.884 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.454 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 9.4 pt-20 -68.41 -32.55 72.67 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.491 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 5.9 tpp180 -70.2 -35.96 74.28 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.341 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 68' ' ' LEU . 72.0 mt -59.92 -50.94 78.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.762 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.565 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 26.5 p80 -68.69 -33.48 74.04 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.618 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -60.01 -50.54 73.33 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.712 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.571 ' OE1' ' HD2' ' A' ' 78' ' ' LYS . 8.3 mm-40 -65.72 -25.71 67.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.226 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.011 ' HA ' HG22 ' A' ' 81' ' ' ILE . 7.9 tp -56.0 -47.62 77.41 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.066 174.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -83.56 -50.5 8.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.525 0.678 . . . . 0.0 111.199 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.571 ' HD2' ' OE1' ' A' ' 75' ' ' GLU . 23.7 ttmt -68.18 -43.58 77.83 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.998 -172.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.63 -24.68 17.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.772 0.32 . . . . 0.0 110.329 -177.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.37 22.56 24.22 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.114 -1.041 . . . . 0.0 113.27 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.011 HG22 ' HA ' ' A' ' 76' ' ' LEU . 10.0 tt -75.66 146.32 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 117.407 0.603 . . . . 0.0 110.219 -174.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -104.14 128.31 51.8 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.095 -0.378 . . . . 0.0 110.867 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.541 ' HB ' HG13 ' A' ' 39' ' ' ILE . 4.7 tp -167.25 137.87 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -109.61 151.68 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.253 -177.214 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -89.66 -23.92 21.75 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.497 ' HB2' HG23 ' A' ' 49' ' ' THR . 63.5 t30 . . . . . 0 N--CA 1.463 0.187 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.505 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.547 ' O ' HG22 ' A' ' 31' ' ' ILE . 59.4 mtt . . . . . 0 N--CA 1.452 -0.355 0 CA-C-O 120.738 0.304 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.89 -24.64 53.4 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.767 2.312 . . . . 0.0 111.382 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -60.66 -31.45 70.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.2 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.626 ' O ' HG13 ' A' ' 35' ' ' ILE . 10.5 tp -69.75 -35.46 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.476 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.84 -42.62 76.91 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.168 0.508 . . . . 0.0 110.238 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -63.65 -38.59 91.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.083 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -60.56 -35.01 75.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.103 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.68 HG23 HG12 ' A' ' 72' ' ' ILE . 52.1 mt -60.37 -46.98 94.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.059 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.664 ' HD3' HD12 ' A' ' 81' ' ' ILE . 28.2 mmtm -66.68 -37.28 84.42 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.237 0.541 . . . . 0.0 109.969 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.567 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 15.9 tptm -64.49 -44.39 91.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.409 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.511 HD22 ' HZ ' ' A' ' 61' ' ' PHE . 16.5 tp -67.06 -45.55 77.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.029 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.569 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -62.7 -34.68 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.892 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.697 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 23.2 t -67.1 -45.43 77.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.071 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.634 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 90.0 mt -59.38 -42.9 92.74 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.541 -176.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.469 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -66.69 -34.83 88.64 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.379 -0.915 . . . . 0.0 110.844 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 10.4 tptm -68.43 -38.7 81.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.46 0.648 . . . . 0.0 109.798 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.697 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -66.03 -41.48 90.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.424 175.245 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.813 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . 73.9 mmtt -68.2 -32.71 73.12 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.424 -177.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.66 -65.6 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.552 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -144.16 155.15 43.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.831 0.348 . . . . 0.0 110.84 -175.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.472 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -73.99 91.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.552 0.691 . . . . 0.0 110.66 -178.654 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.637 HG22 ' H ' ' A' ' 51' ' ' GLU . 86.6 m -149.07 145.43 27.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.93 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -58.25 -39.37 78.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.803 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.637 ' H ' HG22 ' A' ' 49' ' ' THR . 15.8 mm-40 -64.16 -39.03 93.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.531 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.653 ' CG ' ' HD3' ' A' ' 55' ' ' LYS . 9.9 t0 -72.17 -36.96 69.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.372 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.46 HG23 HD11 ' A' ' 38' ' ' LEU . 26.6 mt -59.92 -45.63 94.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.967 0.413 . . . . 0.0 110.659 172.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -59.59 -31.41 69.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.652 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.813 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -74.71 -26.84 60.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.005 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.616 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -66.74 -19.61 65.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.628 -176.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.462 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 18.2 m-85 -50.99 134.95 28.9 Favored Pre-proline 0 N--CA 1.468 0.451 0 O-C-N 123.236 0.335 . . . . 0.0 111.249 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.499 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 15.4 Cg_exo -68.78 140.32 56.76 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 123.971 -1.262 . . . . 0.0 112.445 1.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 26.5 Cg_endo -98.69 -168.51 0.1 Allowed 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 124.288 3.326 . . . . 0.0 110.957 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.431 ' HB2' HD11 ' A' ' 41' ' ' LEU . 17.0 t70 -98.44 12.08 36.16 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.196 0.522 . . . . 0.0 111.504 -175.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.511 ' HZ ' HD22 ' A' ' 38' ' ' LEU . 41.5 m-85 -70.95 121.29 17.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.076 0.465 . . . . 0.0 111.67 -174.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -79.11 -30.43 43.76 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 165.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.96 125.91 1.4 Allowed Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 173.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -107.72 143.58 36.04 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 117.438 0.619 . . . . 0.0 110.592 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 15.6 t70 -141.5 159.75 41.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.193 -173.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.5 m -61.37 -26.86 68.11 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.015 0.436 . . . . 0.0 111.346 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.67 -33.54 72.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.7 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.604 ' O ' HG13 ' A' ' 72' ' ' ILE . 35.6 tp -55.64 -41.14 73.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.111 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.4 mm -64.05 -40.37 88.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.265 0.555 . . . . 0.0 109.952 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -67.78 -42.73 81.23 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.456 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 10.6 tpt180 -67.89 -34.72 77.2 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.148 -174.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.68 HG12 HG23 ' A' ' 35' ' ' ILE . 76.8 mt -60.62 -48.72 87.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.577 ' HA ' HD12 ' A' ' 76' ' ' LEU . 40.6 t-80 -66.18 -34.64 78.49 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.21 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.32 -49.33 78.24 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 71' ' ' ARG . 34.2 mm-40 -63.67 -29.55 70.77 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.482 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.845 HD21 HG22 ' A' ' 83' ' ' ILE . 77.0 mt -60.9 -50.19 74.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.887 0.375 . . . . 0.0 111.161 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -84.34 -49.74 8.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.191 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -71.88 -44.16 64.22 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 -176.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -96.29 -24.52 16.16 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.449 -172.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.34 21.71 47.46 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.224 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.78 HG23 HD23 ' A' ' 76' ' ' LEU . 5.1 tt -73.82 146.94 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 117.717 0.758 . . . . 0.0 108.991 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -115.3 127.33 55.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.183 0.516 . . . . 0.0 111.81 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.845 HG22 HD21 ' A' ' 76' ' ' LEU . 5.4 tp -155.95 132.45 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.674 176.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -99.12 151.07 4.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.867 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -92.08 -24.99 18.98 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.426 ' HB2' HG23 ' A' ' 49' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.412 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.636 -178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 48.6 tpp . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.125 0.488 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.88 -25.0 6.57 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.931 2.421 . . . . 0.0 112.298 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.461 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 11.5 pt20 -69.57 -26.77 64.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.136 -176.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.641 ' O ' HG13 ' A' ' 35' ' ' ILE . 7.5 mm -66.61 -39.58 84.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.26 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.483 ' HG2' ' HE ' ' A' ' 71' ' ' ARG . 40.6 mt-10 -62.72 -45.47 92.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.071 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 26.2 ptt180 -68.9 -32.4 72.02 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.016 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.593 ' HD3' HD13 ' A' ' 68' ' ' LEU . 29.9 ttt-85 -59.3 -37.42 77.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.165 176.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.648 HD13 ' HA ' ' A' ' 72' ' ' ILE . 45.3 mt -65.55 -44.59 93.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.02 0.438 . . . . 0.0 110.227 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HD3' HD12 ' A' ' 81' ' ' ILE . 1.3 mppt? -66.65 -34.52 78.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.022 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.494 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 96.4 mttt -58.34 -44.6 88.81 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 173.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.543 HD11 ' NH1' ' A' ' 34' ' ' ARG . 48.0 mt -59.26 -50.37 74.25 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.22 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.956 HD11 ' HB ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -61.99 -34.98 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.519 -177.8 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 71.1 m -67.18 -47.89 69.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.736 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.6 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 96.6 mt -59.69 -42.08 92.16 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.316 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.33 -37.07 85.81 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.155 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.604 ' HG2' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -71.6 -34.0 69.5 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.345 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HE2' ' N ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -68.74 -39.44 80.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.28 174.727 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 1.04 ' HE3' ' HA ' ' A' ' 56' ' ' ALA . 72.2 mmtt -68.67 -26.89 65.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.02 -178.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.42 -63.74 0.3 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.035 177.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -132.37 161.45 33.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.94 0.4 . . . . 0.0 110.916 -173.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.604 HG23 ' HG2' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -84.73 84.27 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.166 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.742 HG23 ' H ' ' A' ' 52' ' ' ASP . 4.8 t -150.93 153.81 35.96 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.226 -174.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.43 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 36.3 t80 -63.55 -29.26 70.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.087 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.21 -39.2 86.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.242 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.742 ' H ' HG23 ' A' ' 49' ' ' THR . 0.8 OUTLIER -71.73 -30.36 65.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.87 176.156 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.572 HG12 ' O ' ' A' ' 49' ' ' THR . 44.8 mm -59.44 -48.89 85.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.01 0.434 . . . . 0.0 110.095 172.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -58.66 -36.32 73.96 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.431 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.83 ' HD3' ' HB3' ' A' ' 45' ' ' LYS . 10.4 ptmt -75.92 -17.76 59.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.041 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 1.04 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -71.32 -18.65 62.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.392 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 87.6 t80 -56.05 135.49 74.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.333 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 5.9 Cg_exo -75.07 139.54 62.22 Favored 'Cis proline' 0 C--N 1.346 0.437 0 C-N-CA 123.749 -1.355 . . . . 0.0 111.779 -1.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 15.1 Cg_endo -98.2 -173.37 0.17 Allowed 'Trans proline' 0 N--CA 1.436 -1.911 0 C-N-CA 123.738 2.958 . . . . 0.0 110.802 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -97.73 18.9 14.6 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.45 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.412 ' HB2' ' NH2' ' A' ' 34' ' ' ARG . 13.6 p90 -57.01 119.05 5.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 122.05 0.928 . . . . 0.0 110.948 -168.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -81.29 -26.36 35.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.555 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.51 132.68 2.67 Favored Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -112.12 123.89 51.24 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 117.673 0.736 . . . . 0.0 109.82 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 0.9 OUTLIER -159.69 168.57 25.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.026 0.441 . . . . 0.0 112.07 -175.701 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 t -64.75 -28.63 69.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.406 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 71' ' ' ARG . 71.5 m-20 -62.02 -33.85 75.13 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.825 0.345 . . . . 0.0 110.127 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.593 HD13 ' HD3' ' A' ' 34' ' ' ARG . 23.1 tp -65.54 -47.34 76.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.133 172.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.2 mm -58.3 -46.31 89.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.896 0.379 . . . . 0.0 110.812 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 8.6 pt-20 -67.71 -35.01 78.0 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 15.1 tpt180 -71.06 -36.61 72.35 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.169 -174.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.648 ' HA ' HD13 ' A' ' 35' ' ' ILE . 79.7 mt -60.86 -50.36 80.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.539 0.209 . . . . 0.0 110.534 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.506 ' HA ' HD12 ' A' ' 76' ' ' LEU . 45.6 t60 -65.38 -35.64 81.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.868 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 38.8 mt-10 -59.7 -49.27 78.4 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.427 ' HG3' HD12 ' A' ' 35' ' ' ILE . 8.4 mm-40 -64.26 -29.66 70.75 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.693 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.886 HD23 HG23 ' A' ' 81' ' ' ILE . 93.9 mt -64.16 -52.66 57.94 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.134 0.493 . . . . 0.0 111.659 176.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -86.01 -50.04 7.36 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.124 -175.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -74.28 -42.41 59.62 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.21 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -95.09 -32.56 13.05 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.525 -174.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.86 21.41 21.17 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.921 -1.133 . . . . 0.0 114.226 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.886 HG23 HD23 ' A' ' 76' ' ' LEU . 4.8 tt -72.9 139.96 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 119.292 1.546 . . . . 0.0 108.023 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -117.57 136.46 53.26 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.787 -175.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.956 ' HB ' HD11 ' A' ' 39' ' ' ILE . 18.9 tt -168.04 126.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.369 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -98.75 155.34 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-O 121.439 0.638 . . . . 0.0 110.094 -169.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -85.29 -22.72 28.45 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.557 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.562 ' N ' HG13 ' A' ' 84' ' ' VAL . 64.0 t30 . . . . . 0 N--CA 1.462 0.161 0 CA-C-N 114.427 -1.261 . . . . 0.0 110.113 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.486 ' HG2' HG12 ' A' ' 31' ' ' ILE . 33.8 ttp . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.187 0.518 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -62.16 -23.82 75.81 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.476 2.784 . . . . 0.0 112.773 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.523 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 11.3 pt20 -59.86 -25.4 65.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.32 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.555 ' O ' HG13 ' A' ' 35' ' ' ILE . 17.2 mm -68.94 -48.88 67.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.829 0.347 . . . . 0.0 110.102 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -56.08 -45.29 79.41 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.172 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 10.4 ptm180 -67.92 -38.42 82.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.901 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.612 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -67.37 -38.05 84.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.676 -175.83 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 31' ' ' ILE . 75.6 mt -59.97 -43.56 92.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.178 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.626 ' HD3' HD12 ' A' ' 81' ' ' ILE . 19.9 mmtm -66.38 -36.06 81.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.491 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 37' ' ' LYS . 32.1 mtpt -68.72 -38.09 79.97 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.177 176.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 82.8 mt -61.29 -47.73 84.65 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.407 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.61 ' HB ' HD11 ' A' ' 81' ' ' ILE . 1.5 mp -62.64 -34.75 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.185 0.517 . . . . 0.0 109.814 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.0 t -66.2 -48.1 71.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.956 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.525 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 95.1 mt -59.85 -36.45 76.88 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.244 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.49 -38.99 95.39 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.476 ' HB2' HG23 ' A' ' 48' ' ' ILE . 33.1 tptt -65.61 -39.58 91.68 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.303 0.573 . . . . 0.0 109.577 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HE2' ' N ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -63.07 -42.92 99.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.218 173.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.986 ' HE3' ' HA ' ' A' ' 56' ' ' ALA . 71.6 mmtt -68.09 -26.31 65.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.681 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.83 -64.07 0.32 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.747 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -130.94 158.22 40.84 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.682 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -87.86 79.05 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.681 -175.58 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 1.036 ' HB ' HG13 ' A' ' 84' ' ' VAL . 5.1 t -147.0 160.02 42.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -168.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -56.05 -37.74 69.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.248 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -67.91 -38.99 83.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.394 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.695 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -71.88 -29.89 64.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.363 176.526 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.672 HG12 ' O ' ' A' ' 49' ' ' THR . 49.4 mm -59.21 -49.64 82.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.417 0.627 . . . . 0.0 109.66 171.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -62.03 -34.22 75.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.154 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.816 ' HD3' ' HB3' ' A' ' 45' ' ' LYS . 11.4 ptmt -75.86 -21.33 57.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.906 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.986 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -76.5 -20.41 56.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.287 0.565 . . . . 0.0 110.08 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.531 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 72.7 t80 -72.5 140.46 81.95 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.449 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.503 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 73.8 Cg_endo -79.83 127.28 14.19 Favored 'Cis proline' 0 C--N 1.345 0.362 0 C-N-CA 123.423 -1.49 . . . . 0.0 112.525 -2.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.531 ' HD3' ' CD1' ' A' ' 57' ' ' PHE . 72.3 Cg_endo -105.53 -139.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.889 0 C-N-CA 124.657 3.572 . . . . 0.0 110.887 -176.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.455 ' H ' ' HB2' ' A' ' 59' ' ' PRO . 21.0 p-10 -97.63 16.69 19.72 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -173.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.612 ' HA ' ' HD3' ' A' ' 34' ' ' ARG . 14.0 m-85 -57.42 118.28 4.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.189 0.519 . . . . 0.0 111.519 -173.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.99 -24.74 40.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.974 172.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.17 127.26 1.6 Allowed Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -99.07 131.79 44.86 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.63 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 7.3 t70 -147.36 138.59 23.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.833 0.349 . . . . 0.0 110.587 -169.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.9 m -63.47 -35.78 81.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.241 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.53 ' HB3' ' OD2' ' A' ' 65' ' ' ASP . 0.5 OUTLIER -62.17 -33.0 73.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.112 176.142 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.63 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 33.3 tp -56.49 -39.59 73.5 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.795 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.9 mm -63.7 -40.64 89.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.999 0.428 . . . . 0.0 110.296 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.46 ' OE1' ' HA ' ' A' ' 67' ' ' ASN . 15.8 mt-10 -67.2 -40.82 86.55 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -65.13 -35.23 80.45 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.942 -176.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 68' ' ' LEU . 82.2 mt -60.16 -49.95 82.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.47 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.465 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 16.7 p80 -67.41 -31.57 71.87 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.471 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.587 ' HB3' ' HE3' ' A' ' 78' ' ' LYS . 32.8 mt-10 -60.99 -50.49 73.16 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.553 ' OE2' ' HD2' ' A' ' 78' ' ' LYS . 23.2 mm-40 -62.07 -31.5 71.93 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.971 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.718 ' HA ' HG22 ' A' ' 81' ' ' ILE . 15.1 tp -58.09 -45.36 87.31 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.536 175.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -83.52 -51.67 7.14 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.587 ' HE3' ' HB3' ' A' ' 74' ' ' GLU . 18.8 ptpt -74.06 -42.49 60.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.676 0.274 . . . . 0.0 111.189 -174.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -94.84 -21.13 18.89 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.302 -175.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.94 24.35 41.82 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.863 -1.16 . . . . 0.0 112.971 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.718 HG22 ' HA ' ' A' ' 76' ' ' LEU . 7.6 tt -73.78 123.36 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 117.447 0.623 . . . . 0.0 110.44 -173.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -80.48 120.22 24.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.154 0.502 . . . . 0.0 111.794 -172.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.0 tp -156.69 115.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 122.073 0.94 . . . . 0.0 110.16 -178.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 1.036 HG13 ' HB ' ' A' ' 49' ' ' THR . 2.3 p -86.37 154.77 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.739 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.0 -31.57 14.19 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.725 0.298 . . . . 0.0 110.616 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.409 ' N ' HG22 ' A' ' 84' ' ' VAL . 61.5 t30 . . . . . 0 N--CA 1.468 0.449 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.766 170.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.444 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 20.7 ptp . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 28' ' ' MET . 19.9 Cg_exo -66.12 -29.72 47.62 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.352 2.035 . . . . 0.0 111.609 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -64.29 -25.92 68.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.704 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.737 HG23 HD13 ' A' ' 68' ' ' LEU . 18.4 mm -63.67 -49.01 84.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.043 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -55.37 -45.28 76.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.554 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -68.85 -37.75 79.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.231 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.564 HH21 ' HG3' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -67.6 -38.98 84.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.1 -177.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.605 HG13 ' O ' ' A' ' 31' ' ' ILE . 70.8 mt -61.22 -39.31 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-O 120.76 0.314 . . . . 0.0 110.519 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.626 ' HD3' HD12 ' A' ' 81' ' ' ILE . 21.2 mmtm -65.55 -35.41 80.77 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.363 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.564 ' HG3' HH21 ' A' ' 34' ' ' ARG . 13.0 mmmm -67.92 -39.07 83.59 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.525 175.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 78.4 mt -61.81 -48.76 79.17 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.117 0.484 . . . . 0.0 110.438 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.592 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -65.09 -35.27 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.378 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -66.9 -48.45 68.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.229 0.538 . . . . 0.0 109.759 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.664 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 83.1 mt -62.01 -41.15 97.77 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.872 -177.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.23 -35.1 87.65 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -69.05 -44.27 72.97 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.467 0.651 . . . . 0.0 109.728 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.523 ' HE2' ' N ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -60.93 -38.04 84.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.701 174.021 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 28.2 mmtp -69.52 -20.45 63.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.258 -177.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.03 -63.3 0.33 Allowed Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.897 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -135.92 150.74 49.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.994 0.426 . . . . 0.0 111.076 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.461 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -80.79 86.02 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 172.746 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.561 HG23 ' H ' ' A' ' 52' ' ' ASP . 5.4 t -151.07 158.73 44.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.128 -176.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -57.24 -39.8 76.28 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.374 0.421 . . . . 0.0 110.693 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -62.61 -41.15 98.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.825 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.821 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -71.05 -29.35 65.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.788 -176.09 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.4 mm -59.38 -50.39 80.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.358 0.599 . . . . 0.0 109.987 171.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.4 -39.91 84.91 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.809 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.821 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.73 -15.48 59.11 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.902 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HA ' ' NZ ' ' A' ' 45' ' ' LYS . . . -79.18 -19.55 50.6 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.435 175.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.425 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 73.7 t80 -60.86 137.16 93.51 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.027 175.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.538 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 13.1 Cg_endo -88.38 139.3 17.01 Favored 'Cis proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.609 -1.413 . . . . 0.0 113.07 3.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.676 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 27.7 Cg_endo -100.29 -150.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 124.458 3.439 . . . . 0.0 110.189 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.2 15.86 21.5 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.815 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.676 ' CD1' ' HD2' ' A' ' 59' ' ' PRO . 4.3 p90 -58.58 118.64 5.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 122.144 0.973 . . . . 0.0 111.038 -168.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -81.43 -22.28 38.31 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.267 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.75 126.6 1.5 Allowed Glycine 0 N--CA 1.434 -1.488 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -109.66 135.62 50.33 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 13.8 t70 -149.04 158.16 43.96 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.281 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 p -63.89 -35.65 81.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.962 0.41 . . . . 0.0 111.045 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -62.01 -34.79 76.85 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.737 HD13 HG23 ' A' ' 31' ' ' ILE . 26.7 tp -60.29 -40.23 89.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.213 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.4 mm -64.25 -40.98 90.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.914 0.388 . . . . 0.0 110.288 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.7 -40.21 84.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 14.2 tpt180 -61.03 -34.91 75.59 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.671 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 68' ' ' LEU . 82.5 mt -60.84 -45.83 97.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -59.9 -44.2 94.4 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.243 0.545 . . . . 0.0 110.061 175.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -59.31 -47.34 85.76 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.389 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.474 ' C ' HG22 ' A' ' 81' ' ' ILE . 30.0 mm-40 -55.64 -29.8 59.88 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.881 HD21 HG22 ' A' ' 83' ' ' ILE . 53.7 mt -60.45 -48.92 79.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.27 0.557 . . . . 0.0 110.91 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -83.99 -48.49 9.89 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.309 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -70.9 -46.27 62.83 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.44 -173.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.51 -24.37 15.16 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.898 -177.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.1 20.79 41.11 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.44 -0.885 . . . . 0.0 112.995 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.86 HG23 HD23 ' A' ' 76' ' ' LEU . 7.5 tt -76.05 147.08 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -116.94 133.31 56.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.339 0.59 . . . . 0.0 112.378 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.881 HG22 HD21 ' A' ' 76' ' ' LEU . 5.2 tp -167.68 130.85 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.576 -1.193 . . . . 0.0 107.978 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.488 HG12 ' CB ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -88.27 155.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 120.919 0.39 . . . . 0.0 109.995 -177.332 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 39.6 mt-10 -94.53 -23.07 17.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.711 -170.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 61.0 t30 . . . . . 0 N--CA 1.465 0.315 0 O-C-N 124.525 1.14 . . . . 0.0 109.676 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.79 -27.8 73.34 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.494 2.129 . . . . 0.0 111.368 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.513 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 28.4 tt0 -68.83 -35.43 76.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.607 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.678 ' O ' HG13 ' A' ' 35' ' ' ILE . 9.1 mm -68.12 -48.38 74.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.676 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -60.45 -46.07 91.4 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.469 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 10.8 ptm180 -66.29 -33.15 75.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.505 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.83 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -69.84 -34.53 73.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.518 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.796 HG23 HG12 ' A' ' 72' ' ' ILE . 62.5 mt -58.69 -51.38 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.462 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.509 ' HD3' ' N ' ' A' ' 36' ' ' LYS . 1.8 mppt? -69.28 -35.78 76.4 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.632 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -64.97 -43.68 91.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.985 0.421 . . . . 0.0 109.882 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.477 ' HG ' HG23 ' A' ' 53' ' ' ILE . 6.0 tp -66.73 -45.5 78.46 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.343 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.502 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.4 mp -62.11 -35.48 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.545 ' C ' ' HE2' ' A' ' 44' ' ' LYS . 53.9 m -67.92 -48.58 65.58 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.191 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.72 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 79.5 mt -59.46 -40.08 85.72 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.929 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.54 -34.38 88.21 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.466 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -73.43 -38.21 65.61 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -177.757 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.545 ' HE2' ' C ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -64.5 -29.95 70.99 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.49 174.548 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.72 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 74.5 mmtt -74.73 -11.6 60.21 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.039 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.06 -68.3 0.31 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.285 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.73 170.95 14.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.894 0.378 . . . . 0.0 110.382 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.77 85.88 2.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.198 0.523 . . . . 0.0 109.793 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.557 HG22 ' H ' ' A' ' 51' ' ' GLU . 4.9 m -141.17 146.6 37.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.101 -175.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.463 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 90.8 t80 -60.33 -33.71 72.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.172 0.51 . . . . 0.0 109.908 174.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.557 ' H ' HG22 ' A' ' 49' ' ' THR . 35.9 mt-10 -67.59 -37.33 82.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.574 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 1.025 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.2 m-20 -65.2 -31.27 72.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.006 0.432 . . . . 0.0 110.679 174.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.477 HG23 ' HG ' ' A' ' 38' ' ' LEU . 32.0 mm -64.96 -49.84 77.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.167 0.508 . . . . 0.0 110.545 172.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -61.63 -32.78 72.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.803 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 1.025 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 2.9 ptmt -74.69 -17.27 60.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.017 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.507 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -77.67 -19.76 54.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.514 -175.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.489 ' HA ' ' CD ' ' A' ' 59' ' ' PRO . 44.5 m-85 -59.57 130.81 88.09 Favored Pre-proline 0 N--CA 1.462 0.171 0 O-C-N 123.322 0.389 . . . . 0.0 111.23 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.524 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 3.9 Cg_exo -77.03 123.93 10.07 Favored 'Cis proline' 0 C--O 1.234 0.315 0 C-N-CA 123.998 -1.251 . . . . 0.0 112.33 0.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.529 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 34.8 Cg_endo -100.93 -156.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.687 0 C-N-CA 124.361 3.374 . . . . 0.0 110.751 -177.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -97.73 12.81 32.53 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.023 0.44 . . . . 0.0 111.459 -177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.529 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 3.7 p90 -66.17 120.62 13.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.273 0.559 . . . . 0.0 109.919 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.565 ' HG3' HH11 ' A' ' 34' ' ' ARG . 43.4 mt-10 -81.42 -23.62 37.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.378 0.609 . . . . 0.0 110.346 177.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.29 127.63 1.66 Allowed Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -100.84 136.87 40.02 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.58 -0.448 . . . . 0.0 109.819 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.512 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 10.3 t70 -150.0 142.71 24.62 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.1 t -63.74 -27.13 68.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.56 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -66.06 -33.59 76.15 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.99 0.424 . . . . 0.0 109.898 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.58 HD13 HG23 ' A' ' 31' ' ' ILE . 46.2 tp -59.63 -40.69 88.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.669 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.3 mm -60.83 -41.62 89.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.09 0.471 . . . . 0.0 110.48 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.27 -43.5 73.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.553 0.692 . . . . 0.0 109.156 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.626 ' HG3' HD11 ' A' ' 35' ' ' ILE . 11.5 tpp180 -62.41 -36.51 82.58 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.638 -176.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.796 HG12 HG23 ' A' ' 35' ' ' ILE . 79.9 mt -64.72 -48.22 85.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.505 176.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.518 ' HA ' HD12 ' A' ' 76' ' ' LEU . 32.9 m80 -63.09 -41.12 99.32 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.386 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.25 -42.84 99.68 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.926 -0.309 . . . . 0.0 110.224 176.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.419 ' C ' HG22 ' A' ' 81' ' ' ILE . 10.3 mt-10 -64.53 -28.55 69.72 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 178.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.009 HD23 HG23 ' A' ' 81' ' ' ILE . 78.4 mt -56.97 -47.99 79.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.071 0.462 . . . . 0.0 110.77 176.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -83.87 -50.34 8.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.949 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -74.11 -43.28 58.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.058 -173.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -95.68 -21.85 17.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.246 0.546 . . . . 0.0 110.474 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.11 20.35 57.57 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.936 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.009 HG23 HD23 ' A' ' 76' ' ' LEU . 7.1 tt -75.58 146.58 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -113.89 129.18 56.62 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.632 -177.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.878 HG22 HD21 ' A' ' 76' ' ' LEU . 7.3 tp -159.59 121.33 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 172.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -96.84 158.84 3.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.466 0.65 . . . . 0.0 111.274 -168.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -87.17 -22.93 25.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.961 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.519 ' HB2' ' CG2' ' A' ' 49' ' ' THR . 66.2 t30 . . . . . 0 N--CA 1.468 0.469 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.396 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.879 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 59.2 ttp . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 119.478 -0.296 . . . . 0.0 111.621 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.879 ' HD3' ' HB3' ' A' ' 28' ' ' MET . 17.3 Cg_exo -66.18 -32.53 42.48 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 121.85 1.7 . . . . 0.0 111.669 -176.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.548 ' HA ' ' HG2' ' A' ' 33' ' ' ARG . 19.3 pt20 -67.59 -27.6 67.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.92 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.728 ' O ' HG12 ' A' ' 35' ' ' ILE . 34.4 mm -69.29 -51.54 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.64 -44.52 85.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.928 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.548 ' HG2' ' HA ' ' A' ' 30' ' ' GLN . 23.6 ptt180 -69.01 -37.02 78.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.334 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.675 ' NH1' HD11 ' A' ' 38' ' ' LEU . 4.6 tmt_? -67.49 -41.68 84.15 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 121.27 -0.172 . . . . 0.0 111.126 -177.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.728 HG12 ' O ' ' A' ' 31' ' ' ILE . 20.0 mm -59.67 -48.15 88.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 121.18 0.514 . . . . 0.0 110.077 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.413 ' HD3' HD12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -67.39 -35.12 78.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.8 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 37' ' ' LYS . 40.5 mtpt -60.21 -38.5 83.53 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.029 -0.269 . . . . 0.0 110.87 175.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.675 HD11 ' NH1' ' A' ' 34' ' ' ARG . 71.9 mt -59.64 -43.75 93.74 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.197 0.523 . . . . 0.0 110.249 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.718 HD11 HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -61.86 -39.19 82.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.267 178.672 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.622 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 25.0 t -67.37 -49.68 62.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.993 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.602 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 87.7 mt -68.81 -41.94 77.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.978 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.81 -38.49 85.36 Favored Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -63.73 -44.99 91.93 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.622 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -58.26 -38.36 76.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.492 173.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.914 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -69.32 -21.96 63.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.274 -178.123 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.26 -57.51 0.51 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.507 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.446 ' HB2' ' OD2' ' A' ' 52' ' ' ASP . 99.3 m-85 -134.12 163.36 29.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.121 0.486 . . . . 0.0 110.528 -174.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -96.86 85.7 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.533 0.682 . . . . 0.0 109.552 174.022 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 27.0 p -139.41 159.84 41.22 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.645 -175.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -57.69 -37.91 74.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.065 0.46 . . . . 0.0 110.003 176.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -66.14 -46.09 78.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.418 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.767 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 5.1 m-20 -66.7 -31.43 72.09 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.664 HG12 ' O ' ' A' ' 49' ' ' THR . 48.6 mm -63.99 -48.77 84.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.369 0.604 . . . . 0.0 109.963 172.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.553 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 21.4 t70 -61.93 -37.05 83.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.58 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.767 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.34 -15.26 59.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.73 178.427 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.433 ' HB1' ' CB ' ' A' ' 41' ' ' LEU . . . -76.68 -18.9 58.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.907 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.658 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 24.2 m-85 -68.12 165.2 35.23 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.389 176.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.658 ' HA ' ' HB3' ' A' ' 57' ' ' PHE . 96.7 Cg_endo -82.57 157.07 77.31 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 123.895 -1.294 . . . . 0.0 112.672 -0.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 49.2 Cg_endo -104.49 -173.99 0.07 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.6 0 C-N-CA 124.425 3.416 . . . . 0.0 111.359 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -98.56 16.5 21.67 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.745 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.811 ' HE2' HD22 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -59.58 124.13 19.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.979 -169.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -79.12 -13.44 59.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.372 -170.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.12 125.55 1.38 Allowed Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -105.98 130.65 53.87 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.564 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 11.7 t70 -148.91 155.04 40.29 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -176.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.1 t -63.73 -25.9 68.41 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.21 0.529 . . . . 0.0 110.99 176.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.468 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 29.1 t-20 -60.7 -33.32 72.69 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.112 0.482 . . . . 0.0 109.867 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.811 HD22 ' HE2' ' A' ' 61' ' ' PHE . 26.0 tp -54.37 -38.37 66.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.074 173.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.9 mm -62.03 -38.06 79.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.2 0.524 . . . . 0.0 110.125 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 6.7 mm-40 -66.27 -45.06 81.81 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 26.5 mmt180 -60.27 -38.26 83.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.393 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.62 HG13 ' O ' ' A' ' 68' ' ' LEU . 79.3 mt -61.26 -51.29 74.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.807 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.537 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 17.2 p80 -68.73 -30.88 69.6 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.405 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.581 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 44.0 mt-10 -59.33 -50.26 74.65 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.699 173.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.692 ' HG3' HG13 ' A' ' 35' ' ' ILE . 8.3 mm-40 -60.4 -29.85 69.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 120.952 0.406 . . . . 0.0 110.677 176.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.684 ' HA ' HG22 ' A' ' 81' ' ' ILE . 19.3 tp -61.54 -45.29 94.79 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 174.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -83.36 -53.06 6.01 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.581 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 49.1 pttt -74.54 -38.07 62.86 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -173.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.41 -24.82 17.18 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.881 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.9 23.99 43.42 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.746 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.684 HG22 ' HA ' ' A' ' 76' ' ' LEU . 8.0 tt -72.55 121.97 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.429 0.633 . . . . 0.0 111.001 -169.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.533 ' O ' HD11 ' A' ' 39' ' ' ILE . 19.7 m120 -99.72 117.25 33.66 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -171.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.718 HG12 HD11 ' A' ' 39' ' ' ILE . 1.8 mt -149.34 132.25 6.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -90.09 153.9 3.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -177.317 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -87.47 -31.98 19.71 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.033 0.444 . . . . 0.0 110.949 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.4 ' H ' HG13 ' A' ' 84' ' ' VAL . 42.3 t30 . . . . . 0 C--N 1.332 -0.164 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.269 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.484 ' HB2' HG12 ' A' ' 31' ' ' ILE . 65.1 mtt . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.513 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 36.3 Cg_exo -57.8 -27.11 76.79 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.74 2.293 . . . . 0.0 111.638 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.542 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 14.9 pt20 -64.27 -25.07 67.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.092 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.646 ' O ' HG13 ' A' ' 35' ' ' ILE . 23.9 mm -68.46 -48.34 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.278 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -56.0 -46.36 78.76 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.085 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 21.5 mmm180 -67.25 -40.88 86.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.243 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -66.87 -36.36 82.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.187 -175.639 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.646 HG13 ' O ' ' A' ' 31' ' ' ILE . 74.7 mt -59.89 -44.38 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.599 ' HD3' HD12 ' A' ' 81' ' ' ILE . 26.5 mmtm -67.32 -35.77 80.1 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.142 0.496 . . . . 0.0 110.118 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.611 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 39.7 ttmt -65.99 -38.27 88.07 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.535 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.696 HD11 ' CZ ' ' A' ' 61' ' ' PHE . 93.4 mt -61.08 -50.57 72.74 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.041 0.448 . . . . 0.0 110.085 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.543 ' HB ' HD11 ' A' ' 81' ' ' ILE . 1.5 mp -66.19 -35.14 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.336 -177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' A' ' 37' ' ' LYS . 22.7 p -70.22 -43.37 70.8 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.263 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.641 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 78.4 mt -58.82 -35.41 72.83 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.676 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.59 -32.97 85.96 Favored Glycine 0 CA--C 1.496 -1.152 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.38 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -30.45 65.86 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.565 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.87 -43.73 74.76 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.167 171.516 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.641 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 32.3 mmmt -66.97 -31.94 72.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.555 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.46 -63.86 0.31 Allowed Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.353 175.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -142.77 154.33 44.13 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.441 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -81.93 105.36 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.364 0.602 . . . . 0.0 111.089 -177.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.7 HG23 ' H ' ' A' ' 52' ' ' ASP . 2.5 t -155.48 158.34 38.39 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.393 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -56.81 -29.9 63.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.288 0.566 . . . . 0.0 109.753 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -63.56 -42.18 98.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.498 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.727 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -64.54 -37.67 88.35 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.008 -176.75 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.501 HD12 ' HB3' ' A' ' 38' ' ' LEU . 40.8 mm -59.77 -49.18 84.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.577 0.703 . . . . 0.0 109.772 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -66.93 -34.58 78.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.294 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.727 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 9.5 ptmt -76.46 -20.38 57.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.051 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.2 -19.59 60.48 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.527 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.503 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 39.9 t80 -55.47 139.09 67.79 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.756 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 57' ' ' PHE . 22.9 Cg_exo -66.07 145.3 68.83 Favored 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 124.011 -1.245 . . . . 0.0 112.247 -0.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 14.7 Cg_endo -95.12 -175.33 0.35 Allowed 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 123.743 2.962 . . . . 0.0 110.029 -173.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -98.5 12.73 34.21 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.225 0.536 . . . . 0.0 111.127 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.696 ' CZ ' HD11 ' A' ' 38' ' ' LEU . 32.0 m-85 -63.64 117.78 7.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.066 0.46 . . . . 0.0 111.999 -176.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -82.22 -21.88 36.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.177 170.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.15 127.98 1.69 Allowed Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -104.4 145.06 30.8 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.982 0.391 . . . . 0.0 110.58 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.632 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 11.0 t70 -145.18 156.11 43.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.561 0.22 . . . . 0.0 110.732 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.5 m -63.49 -34.55 78.01 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.212 0.529 . . . . 0.0 111.021 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -61.49 -32.01 72.01 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.983 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.632 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 11.5 tp -56.4 -43.27 79.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.351 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.5 mm -61.56 -47.29 94.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.892 0.377 . . . . 0.0 110.57 -176.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -69.93 -33.74 72.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.868 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.1 tpp85 -70.74 -33.52 70.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.291 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 68' ' ' LEU . 80.2 mt -61.7 -50.54 79.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 176.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.496 ' HA ' HD12 ' A' ' 76' ' ' LEU . 15.4 t-80 -67.1 -34.34 77.42 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.547 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.549 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 36.2 mt-10 -58.87 -50.13 75.16 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 173.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.569 ' HG2' ' HE3' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -59.62 -35.19 73.87 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.494 -179.553 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.872 HD21 HG22 ' A' ' 83' ' ' ILE . 81.5 mt -58.97 -52.2 66.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.05 0.452 . . . . 0.0 111.776 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -85.15 -48.46 9.13 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.251 0.548 . . . . 0.0 112.383 -177.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 18.3 ttmt -71.9 -44.48 63.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.988 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -96.43 -26.96 15.13 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.146 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.26 21.39 35.38 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 119.865 -1.16 . . . . 0.0 113.516 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.803 HG23 HD23 ' A' ' 76' ' ' LEU . 6.5 tt -73.15 144.85 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -113.67 128.61 56.49 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.93 -0.708 . . . . 0.0 112.193 -173.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.872 HG22 HD21 ' A' ' 76' ' ' LEU . 7.0 tp -156.11 133.18 2.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -102.7 166.72 2.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -174.735 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -93.63 -33.56 13.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.659 0.743 . . . . 0.0 109.592 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.556 ' N ' HG13 ' A' ' 84' ' ' VAL . 24.0 t30 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 113.864 -1.516 . . . . 0.0 109.981 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.623 ' O ' HG22 ' A' ' 31' ' ' ILE . 47.7 ttm . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -60.78 -24.6 79.32 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.816 2.344 . . . . 0.0 112.792 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.508 ' HG3' ' HG2' ' A' ' 28' ' ' MET . 1.5 pp0? -64.58 -29.59 70.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.31 -174.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.623 HG22 ' O ' ' A' ' 28' ' ' MET . 11.3 tp -70.22 -45.85 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.861 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.825 ' HG2' ' HD3' ' A' ' 71' ' ' ARG . 25.6 mt-10 -70.85 -41.2 71.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.753 0.311 . . . . 0.0 110.771 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 11.7 ptt180 -62.22 -32.53 73.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.587 HH11 HD22 ' A' ' 68' ' ' LEU . 25.1 ttm180 -64.29 -37.81 88.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.039 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.535 HG22 ' CD1' ' A' ' 81' ' ' ILE . 15.6 mm -60.33 -50.48 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.641 ' HD3' HD12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -68.21 -35.24 77.67 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.482 179.021 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.53 ' HG2' ' HB2' ' A' ' 60' ' ' ASP . 2.6 tppp? -64.7 -42.35 95.35 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.42 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.675 ' HB3' HD12 ' A' ' 53' ' ' ILE . 75.3 mt -59.66 -48.53 81.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.948 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.082 HD11 ' HB ' ' A' ' 83' ' ' ILE . 0.5 OUTLIER -65.71 -36.55 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.419 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.651 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 47.6 t -68.09 -50.37 55.38 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.824 -176.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.682 HD12 ' HB3' ' A' ' 59' ' ' PRO . 36.2 mt -69.39 -41.56 76.28 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.016 -176.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.04 -39.99 94.99 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.89 -40.33 72.28 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.651 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -59.93 -37.32 79.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.186 174.458 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.678 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 73.5 mmtt -68.56 -31.98 71.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.784 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.11 -68.0 0.17 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.584 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -132.4 163.86 27.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.369 0.604 . . . . 0.0 111.534 -171.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.502 HG22 HD12 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -93.51 84.07 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.808 178.726 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.793 HG23 ' H ' ' A' ' 52' ' ' ASP . 10.0 t -155.45 158.28 38.31 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.452 -174.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.411 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 17.9 t80 -57.38 -37.06 72.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.883 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -64.31 -41.75 96.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.512 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.793 ' H ' HG23 ' A' ' 49' ' ' THR . 0.9 OUTLIER -71.97 -29.99 64.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.348 177.338 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.675 HD12 ' HB3' ' A' ' 38' ' ' LEU . 45.4 mm -59.47 -49.02 85.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.176 0.512 . . . . 0.0 110.321 172.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.789 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 16.9 t70 -58.52 -37.94 76.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.459 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.692 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.29 -15.51 59.4 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.794 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.81 -20.02 33.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.996 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.834 ' HD1' ' HD3' ' A' ' 59' ' ' PRO . 16.3 m-85 -61.7 145.35 92.01 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.163 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.497 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 22.3 Cg_endo -95.8 128.71 3.66 Favored 'Cis proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.275 -1.135 . . . . 0.0 112.104 -3.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.834 ' HD3' ' HD1' ' A' ' 57' ' ' PHE . 77.5 Cg_endo -106.6 -108.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.944 0 C-N-CA 123.667 2.911 . . . . 0.0 112.785 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.53 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -100.45 10.86 40.62 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -170.613 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.789 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 12.9 p90 -79.52 117.87 20.86 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 118.891 -1.124 . . . . 0.0 110.186 -177.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.456 ' HB2' ' NE2' ' A' ' 30' ' ' GLN . 97.8 mt-10 -81.11 -26.08 36.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.587 173.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.57 127.26 1.59 Allowed Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -76.18 135.45 39.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 117.402 0.601 . . . . 0.0 109.38 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 10.6 p-10 -151.5 151.2 31.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.983 0.421 . . . . 0.0 111.472 -168.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.7 m -64.02 -29.66 70.79 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.146 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.433 ' OD1' HG12 ' A' ' 31' ' ' ILE . 2.6 t-20 -61.49 -33.85 74.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.426 177.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.587 HD22 HH11 ' A' ' 34' ' ' ARG . 46.3 tp -56.36 -41.89 76.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.964 175.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.4 mm -59.95 -42.97 91.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.007 0.432 . . . . 0.0 110.327 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 12.6 mt-10 -68.85 -43.9 74.49 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.825 ' HD3' ' HG2' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -59.51 -40.98 88.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.029 -174.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.565 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 82.7 mt -61.11 -49.48 84.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.512 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.472 ' HA ' HD12 ' A' ' 76' ' ' LEU . 32.2 m170 -65.9 -38.46 88.8 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.439 -177.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 51.4 mt-10 -62.75 -47.14 84.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.455 177.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 79' ' ' HIS . 12.1 mm-40 -59.35 -29.6 67.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.84 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.702 HD23 HG23 ' A' ' 81' ' ' ILE . 91.6 mt -58.04 -48.03 81.33 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.783 0.325 . . . . 0.0 110.397 175.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -84.32 -52.03 6.53 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 19.8 pttp -73.23 -37.56 66.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -174.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.43 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 30.5 t60 -94.03 -34.73 12.91 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.548 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.79 22.59 30.43 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.837 -175.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.702 HG23 HD23 ' A' ' 76' ' ' LEU . 6.6 tt -72.73 138.73 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -175.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -117.06 124.67 49.85 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.387 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.082 ' HB ' HD11 ' A' ' 39' ' ' ILE . 19.8 tt -159.3 132.49 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.753 -174.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.541 HG12 ' HB ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -98.24 154.27 3.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.121 0.486 . . . . 0.0 110.729 -172.792 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -86.43 -34.63 20.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.438 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 . . . . . 0 N--CA 1.469 0.518 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.211 179.868 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.464 ' SD ' HG12 ' A' ' 31' ' ' ILE . 54.7 ttm . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.713 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 57.7 Cg_exo -52.63 -32.74 55.79 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.984 2.456 . . . . 0.0 112.521 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -58.72 -39.22 80.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.766 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.669 ' O ' HG13 ' A' ' 35' ' ' ILE . 16.7 mm -67.69 -45.33 84.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.677 177.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -56.54 -45.17 81.32 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.861 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.713 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 14.4 mmt180 -65.36 -39.53 92.43 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.444 0.64 . . . . 0.0 109.918 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.463 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -66.26 -35.85 81.47 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.23 -176.528 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.669 HG13 ' O ' ' A' ' 31' ' ' ILE . 62.6 mt -59.57 -44.11 92.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.619 ' HD3' HD12 ' A' ' 81' ' ' ILE . 48.2 mmtt -67.02 -42.38 85.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.56 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.62 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 8.7 mtpm? -62.14 -39.15 91.64 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.488 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.613 HD11 ' HZ ' ' A' ' 61' ' ' PHE . 55.2 mt -60.43 -47.74 84.8 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.461 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.66 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.4 mp -62.28 -35.37 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.075 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.61 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 22.5 t -67.02 -47.48 71.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.206 177.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.726 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 88.6 mt -59.96 -44.96 94.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.682 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.61 -37.07 84.53 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.448 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 15.4 tptm -65.33 -43.88 89.54 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.206 0.526 . . . . 0.0 110.08 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.61 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -59.32 -35.37 73.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.538 174.459 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.97 ' HE2' ' HA ' ' A' ' 56' ' ' ALA . 44.1 mmtm -68.62 -25.27 64.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.829 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.22 -62.31 0.31 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.432 -0.89 . . . . 0.0 113.076 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -134.71 157.75 45.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.995 0.426 . . . . 0.0 110.261 -175.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -81.12 86.43 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-O 121.077 0.465 . . . . 0.0 109.814 175.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.696 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 10.1 t -152.11 153.33 33.69 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.386 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -61.42 -30.31 70.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.984 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -67.49 -38.02 83.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.341 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 1.0 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -71.99 -31.53 66.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.163 176.245 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 49' ' ' THR . 49.0 mm -60.88 -49.75 83.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.383 0.611 . . . . 0.0 110.072 172.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -57.02 -38.9 73.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.346 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 1.0 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 7.4 ptmt -75.83 -15.75 60.19 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.979 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.97 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -77.14 -18.84 57.59 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.929 -178.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.631 ' CD1' ' HG3' ' A' ' 59' ' ' PRO . 18.5 m-30 -61.0 145.67 88.95 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.509 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 7.0 Cg_exo -73.82 144.61 81.55 Favored 'Cis proline' 0 C--N 1.347 0.496 0 C-N-CA 124.26 -1.142 . . . . 0.0 112.53 0.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.715 ' HG2' ' CD2' ' A' ' 61' ' ' PHE . 37.4 Cg_endo -104.4 -157.47 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.565 0 C-N-CA 124.64 3.56 . . . . 0.0 111.054 -176.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.44 11.16 37.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.846 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.715 ' CD2' ' HG2' ' A' ' 59' ' ' PRO . 23.2 m-85 -63.14 117.64 6.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.28 0.562 . . . . 0.0 112.254 -171.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -81.61 -21.93 38.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.666 168.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.57 126.9 1.54 Allowed Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -103.25 144.85 30.8 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 117.091 0.445 . . . . 0.0 110.384 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -151.36 156.33 40.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.841 0.353 . . . . 0.0 110.962 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 m -63.07 -24.57 67.97 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.285 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.664 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 26.2 t30 -57.23 -38.55 73.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.197 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.537 ' O ' HG13 ' A' ' 72' ' ' ILE . 27.8 tp -57.47 -39.86 77.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.414 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.5 mm -62.25 -41.54 91.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.162 0.506 . . . . 0.0 110.192 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -68.17 -42.1 80.51 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.678 0.752 . . . . 0.0 109.107 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 13.5 mmt180 -68.34 -34.63 76.45 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.503 -174.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 68' ' ' LEU . 75.6 mt -61.59 -49.0 86.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.676 0.274 . . . . 0.0 110.754 177.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -64.09 -39.53 94.26 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.092 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -59.11 -49.8 76.47 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.405 ' C ' HG22 ' A' ' 81' ' ' ILE . 18.0 mm-40 -56.59 -29.76 62.43 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.868 HD23 HG23 ' A' ' 81' ' ' ILE . 85.9 mt -58.65 -50.08 75.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.92 0.391 . . . . 0.0 111.247 176.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -85.1 -48.06 9.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.512 0.673 . . . . 0.0 111.617 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -69.61 -45.17 69.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.533 -173.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.97 -31.69 11.68 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.963 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.92 22.04 19.1 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.264 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.868 HG23 HD23 ' A' ' 76' ' ' LEU . 6.8 tt -73.69 145.56 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 118.507 1.153 . . . . 0.0 108.188 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -116.73 130.31 56.65 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.091 -0.644 . . . . 0.0 112.457 -174.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.691 HG22 HD21 ' A' ' 76' ' ' LEU . 4.2 tp -168.49 133.79 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.24 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -91.95 150.46 3.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.839 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -96.29 -23.15 16.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.882 0.372 . . . . 0.0 110.487 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 60.1 t30 . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.503 -178.457 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 45.7 ttm . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.74 -24.76 76.93 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.443 2.762 . . . . 0.0 113.159 -174.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -60.55 -25.77 66.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.417 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.617 ' O ' HG13 ' A' ' 35' ' ' ILE . 26.1 mm -66.44 -49.94 71.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 177.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -54.84 -45.9 74.55 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.156 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -66.94 -42.47 85.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.286 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.699 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -63.19 -40.21 96.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.212 -175.677 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.695 HD13 ' HA ' ' A' ' 72' ' ' ILE . 54.2 mt -59.51 -40.53 82.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.011 0.434 . . . . 0.0 109.934 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.732 ' HD3' HD12 ' A' ' 81' ' ' ILE . 32.5 mmtm -66.89 -39.49 87.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.696 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.498 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 87.7 mttt -64.76 -43.61 92.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.978 176.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.79 -44.03 97.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.334 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.566 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -62.88 -36.09 74.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.38 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.417 ' C ' ' HE3' ' A' ' 44' ' ' LYS . 48.9 m -66.28 -46.32 77.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.099 0.476 . . . . 0.0 110.023 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.709 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 97.6 mt -58.89 -47.32 85.37 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.219 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.16 -33.71 86.73 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.487 ' HB2' HG23 ' A' ' 48' ' ' ILE . 12.2 tptt -73.39 -40.0 64.67 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.414 -0.893 . . . . 0.0 109.44 -174.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.709 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 5.4 ptpt -75.98 -31.77 59.15 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.752 -177.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 66.8 mmtt -76.83 -9.75 58.9 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.105 177.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.69 -70.31 0.31 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.883 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -133.97 148.44 51.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.222 0.534 . . . . 0.0 111.455 -168.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -78.53 86.83 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.237 0.541 . . . . 0.0 109.901 176.029 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.683 HG23 ' H ' ' A' ' 52' ' ' ASP . 8.9 t -156.75 158.21 36.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.467 -175.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -63.62 -30.48 71.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 110.871 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.5 -41.11 93.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.557 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.929 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -71.95 -29.13 63.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.04 177.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.582 HG12 ' O ' ' A' ' 49' ' ' THR . 48.1 mm -59.4 -50.59 79.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.157 0.503 . . . . 0.0 109.972 172.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.515 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 0.5 OUTLIER -57.58 -34.43 69.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.69 177.493 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.929 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 4.5 ptmt -75.81 -18.86 59.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.025 -178.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.97 -20.11 42.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.547 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.515 ' CD2' ' HA ' ' A' ' 54' ' ' ASP . 80.2 m-85 -62.67 142.95 96.81 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.872 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.477 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 86.3 Cg_endo -84.24 143.19 41.13 Favored 'Cis proline' 0 C--N 1.345 0.362 0 C-N-CA 123.394 -1.502 . . . . 0.0 112.779 -1.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.591 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 39.8 Cg_endo -103.87 -156.72 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 124.785 3.656 . . . . 0.0 111.104 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -97.98 16.03 22.23 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.177 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.699 ' HA ' ' HD3' ' A' ' 34' ' ' ARG . 7.0 p90 -58.43 121.21 10.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 122.083 0.944 . . . . 0.0 111.723 -167.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -79.33 -24.93 42.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.408 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.1 127.34 1.59 Allowed Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -111.1 128.81 56.0 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -153.0 157.87 41.19 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 -175.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -27.05 65.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.513 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.434 ' OD1' ' HD2' ' A' ' 71' ' ' ARG . 10.5 t-20 -61.52 -35.16 76.92 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.335 176.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.657 ' O ' HG13 ' A' ' 72' ' ' ILE . 57.6 tp -64.08 -39.53 94.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.891 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.2 mm -64.06 -46.78 92.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.712 0.291 . . . . 0.0 110.701 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.483 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 16.6 pt-20 -68.99 -33.1 73.13 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.586 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 42.4 mtt180 -72.27 -29.59 64.03 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.18 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.695 ' HA ' HD13 ' A' ' 35' ' ' ILE . 64.3 mt -58.87 -50.56 79.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.542 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 30.7 p80 -69.82 -32.79 71.42 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.986 176.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 71' ' ' ARG . 13.4 mt-10 -59.48 -50.25 74.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.981 0.419 . . . . 0.0 110.452 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.731 ' HA ' ' HG2' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -67.86 -27.42 66.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.688 178.07 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.937 ' HA ' HG22 ' A' ' 81' ' ' ILE . 12.6 tp -56.54 -45.31 81.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.863 172.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -83.1 -51.55 7.43 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.731 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 11.7 ptpt -72.06 -39.1 69.29 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -173.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -94.14 -32.13 13.87 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.635 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.37 24.87 15.09 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.421 -1.371 . . . . 0.0 113.131 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.937 HG22 ' HA ' ' A' ' 76' ' ' LEU . 5.9 tt -72.23 144.44 13.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 117.202 0.501 . . . . 0.0 109.858 -174.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -102.6 123.14 45.77 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.337 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.566 ' HB ' HG13 ' A' ' 39' ' ' ILE . 4.5 tp -162.31 137.15 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.53 HG12 ' HB ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -103.14 156.09 5.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.115 0.483 . . . . 0.0 110.353 -176.31 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 7.0 mm-40 -89.83 -25.36 21.09 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.733 -175.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.534 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 8.3 t30 . . . . . 0 N--CA 1.463 0.183 0 O-C-N 124.571 1.17 . . . . 0.0 110.185 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.545 ' O ' HG22 ' A' ' 31' ' ' ILE . 28.0 ttt . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 121.007 0.432 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.63 -24.48 75.01 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.837 2.358 . . . . 0.0 112.742 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.643 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 23.6 tm0? -65.58 -39.17 91.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.963 0.411 . . . . 0.0 110.857 -175.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.664 HD11 ' HB2' ' A' ' 68' ' ' LEU . 10.4 tp -71.89 -38.78 66.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.207 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.31 -40.52 74.15 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.964 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 3.2 ptm180 -61.32 -36.04 79.03 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.699 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.623 ' HD2' ' HA ' ' A' ' 61' ' ' PHE . 48.1 ttp85 -65.07 -35.76 82.18 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.812 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.607 HD13 ' HA ' ' A' ' 72' ' ' ILE . 21.8 mt -60.48 -45.2 97.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 110.579 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.509 ' HD3' HD12 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -67.11 -39.71 86.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.371 177.474 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 33' ' ' ARG . 14.4 mmmm -61.75 -39.6 92.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.185 0.517 . . . . 0.0 109.616 176.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 54.9 mt -63.59 -46.82 84.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.359 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.586 HD11 ' HB ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -62.06 -35.57 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.41 -178.443 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.6 p -67.61 -45.89 74.13 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.689 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.737 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 96.4 mt -59.26 -45.8 90.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.219 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.74 -34.82 78.74 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -42.04 87.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.04 0.924 . . . . 0.0 109.068 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.456 ' HE2' ' N ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -64.1 -39.99 95.25 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 113.815 -1.539 . . . . 0.0 110.583 175.115 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.765 ' HE2' ' HA ' ' A' ' 56' ' ' ALA . 45.4 mmtm -67.91 -31.5 71.32 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.774 -178.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.01 -67.55 0.17 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.236 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -137.63 171.18 14.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.851 0.358 . . . . 0.0 110.733 -171.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.656 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -83.55 86.07 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 122.486 1.136 . . . . 0.0 108.863 173.746 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.58 ' O ' HG12 ' A' ' 53' ' ' ILE . 6.0 m -145.79 151.74 38.43 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.258 -174.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -59.43 -36.02 75.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.962 0.41 . . . . 0.0 110.113 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.537 ' H ' HG22 ' A' ' 49' ' ' THR . 35.5 mt-10 -58.71 -40.99 85.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.484 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.692 ' HA ' ' CD ' ' A' ' 55' ' ' LYS . 5.2 m-20 -71.68 -32.35 67.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.233 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 49' ' ' THR . 39.6 mm -66.89 -49.65 72.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.79 0.805 . . . . 0.0 109.781 174.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.64 -33.74 76.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.278 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.692 ' CD ' ' HA ' ' A' ' 52' ' ' ASP . 15.6 ptmt -76.33 -19.99 57.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.985 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.765 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -74.2 -18.95 60.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.875 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -57.25 132.55 81.0 Favored Pre-proline 0 N--CA 1.466 0.352 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.119 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 57.2 Cg_endo -71.85 133.4 28.68 Favored 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 123.707 -1.372 . . . . 0.0 112.705 0.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.554 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 35.2 Cg_endo -101.51 -157.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 124.347 3.365 . . . . 0.0 111.27 -175.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -97.17 13.62 28.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.622 -175.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.623 ' HA ' ' HD2' ' A' ' 34' ' ' ARG . 8.2 p90 -63.06 120.15 10.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.453 0.644 . . . . 0.0 110.933 -175.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.587 ' HB2' ' NE2' ' A' ' 30' ' ' GLN . 24.5 mt-10 -79.55 -26.74 41.32 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.8 135.52 3.74 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -95.64 130.04 42.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 117.452 0.626 . . . . 0.0 110.018 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -137.01 145.3 43.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.567 -171.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.6 t -65.36 -27.1 68.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.674 0.749 . . . . 0.0 109.682 170.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -61.15 -32.24 71.96 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.819 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.664 ' HB2' HD11 ' A' ' 31' ' ' ILE . 3.3 tm? -54.38 -41.85 69.68 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.467 176.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 23.0 mm -65.31 -42.68 94.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-O 121.687 0.756 . . . . 0.0 110.052 -177.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.651 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 12.4 mt-10 -64.63 -45.05 88.48 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.562 ' HG2' HG23 ' A' ' 31' ' ' ILE . 15.5 tpt180 -71.16 -32.09 68.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.949 -170.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.607 ' HA ' HD13 ' A' ' 35' ' ' ILE . 24.3 pt -63.63 -46.66 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.597 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.536 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 28.5 p80 -68.52 -33.3 73.88 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 118.976 -1.089 . . . . 0.0 111.918 177.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.69 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 4.2 mm-40 -65.06 -50.02 67.81 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.974 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.6 ' HG3' HD12 ' A' ' 35' ' ' ILE . 4.0 mm-40 -63.0 -28.22 69.95 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.899 176.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.58 ' HA ' HG22 ' A' ' 81' ' ' ILE . 11.3 tp -57.73 -40.89 80.68 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.116 172.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -83.79 -51.77 6.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.69 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 9.8 ptmm? -72.33 -42.82 64.96 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -174.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.448 ' HB2' ' OE1' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -95.62 -22.7 17.43 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.136 -178.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.56 23.98 41.02 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.242 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.58 HG22 ' HA ' ' A' ' 76' ' ' LEU . 6.0 tt -73.52 119.93 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.633 0.73 . . . . 0.0 111.492 -170.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -90.82 129.12 36.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.668 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.656 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 17.7 tt -173.5 131.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -175.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -90.84 151.82 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 121.179 0.514 . . . . 0.0 110.227 -173.636 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -90.74 -23.47 20.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.042 -172.537 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 58.4 t30 . . . . . 0 N--CA 1.467 0.414 0 O-C-N 124.542 1.151 . . . . 0.0 109.666 -177.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.579 ' HB3' HG12 ' A' ' 31' ' ' ILE . 59.7 mtt . . . . . 0 C--O 1.234 0.263 0 CA-C-O 120.449 0.166 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.478 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 33.2 Cg_exo -60.26 -25.39 80.01 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.322 2.014 . . . . 0.0 111.018 173.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 10.6 pt20 -59.18 -35.02 72.82 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.895 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.579 HG12 ' HB3' ' A' ' 28' ' ' MET . 36.7 mm -66.44 -42.9 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.204 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.453 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 38.6 tt0 -58.02 -45.75 86.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.106 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 31.9 mmt-85 -66.06 -44.19 85.26 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.994 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.663 ' HD3' ' O ' ' A' ' 60' ' ' ASP . 0.1 OUTLIER -64.91 -37.89 89.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.559 -173.154 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.569 HD12 ' HG3' ' A' ' 75' ' ' GLU . 70.0 mt -64.67 -37.79 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.581 ' HD3' HD12 ' A' ' 81' ' ' ILE . 15.9 mmtm -66.74 -35.7 80.74 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.142 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.703 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 34.6 mtpt -65.63 -40.99 93.16 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.352 175.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.568 HD13 ' HE2' ' A' ' 61' ' ' PHE . 14.6 tp -59.66 -50.0 75.55 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.586 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -61.95 -34.93 65.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.212 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.695 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 23.1 t -66.11 -44.63 83.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.768 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 77.6 mt -58.8 -37.53 76.57 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.81 -38.62 89.61 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.443 ' HD3' ' O ' ' A' ' 43' ' ' LYS . 13.7 tppt? -67.94 -35.24 78.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.194 0.521 . . . . 0.0 110.149 178.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.695 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -69.92 -38.54 76.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.688 0.756 . . . . 0.0 109.717 175.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.715 ' HB3' ' HD3' ' A' ' 55' ' ' LYS . 29.8 mmtm -68.6 -29.04 67.47 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.809 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.39 -65.92 0.26 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.849 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -136.14 157.21 47.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.053 0.454 . . . . 0.0 110.947 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.9 86.58 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.17 0.51 . . . . 0.0 109.981 177.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.792 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 8.5 t -153.78 155.64 36.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.599 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -57.58 -40.4 78.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.424 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.9 -34.34 76.46 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.745 0.307 . . . . 0.0 110.891 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.96 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -72.52 -30.94 64.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.932 0.396 . . . . 0.0 111.057 174.731 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.4 mm -64.49 -49.2 81.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.213 0.53 . . . . 0.0 110.169 171.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -57.32 -33.73 68.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.762 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.96 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 1.2 ptmt -76.66 -22.08 54.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.31 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.46 -19.27 42.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.003 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 67.6 t80 -56.41 140.69 72.49 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.399 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.479 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 86.3 Cg_endo -83.49 148.69 61.43 Favored 'Cis proline' 0 C--N 1.347 0.456 0 C-N-CA 123.781 -1.341 . . . . 0.0 112.904 0.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.575 ' HG2' ' HD2' ' A' ' 61' ' ' PHE . 36.7 Cg_endo -102.43 -160.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 124.412 3.408 . . . . 0.0 110.432 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.663 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 22.8 m-20 -97.8 11.26 37.85 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.575 ' HD2' ' HG2' ' A' ' 59' ' ' PRO . 60.2 m-85 -62.79 118.32 7.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.42 0.629 . . . . 0.0 111.217 -175.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -82.36 -12.12 58.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.563 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.62 124.28 1.33 Allowed Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -114.78 136.37 53.15 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.835 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 31.7 t70 -160.63 168.32 25.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.743 -0.208 . . . . 0.0 110.57 178.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.0 m -58.5 -32.31 68.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.681 0.277 . . . . 0.0 111.097 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.458 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . 5.1 t-20 -61.26 -34.08 74.58 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.153 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.614 ' O ' HG13 ' A' ' 72' ' ' ILE . 54.5 tp -58.96 -41.6 87.86 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.549 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.69 -39.41 83.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.247 0.546 . . . . 0.0 110.241 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 16.6 mt-10 -68.15 -42.98 79.29 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -64.58 -32.8 74.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.458 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.614 HG13 ' O ' ' A' ' 68' ' ' LEU . 80.3 mt -61.6 -51.35 73.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.583 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.497 ' CD2' ' HA ' ' A' ' 70' ' ' GLU . 29.4 p80 -68.77 -32.77 72.76 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.041 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -59.29 -47.24 86.11 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.569 ' HG3' HD12 ' A' ' 35' ' ' ILE . 25.2 mm-40 -64.31 -32.9 74.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.883 0.373 . . . . 0.0 110.859 175.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.661 ' HA ' HG22 ' A' ' 81' ' ' ILE . 22.3 tp -60.98 -46.77 89.4 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.922 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -82.62 -51.57 7.62 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -73.31 -45.22 56.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.265 -174.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -96.44 -16.24 21.3 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.65 -176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.74 24.5 49.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 119.678 -1.249 . . . . 0.0 113.835 171.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.661 HG22 ' HA ' ' A' ' 76' ' ' LEU . 7.8 tt -72.35 119.59 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 117.99 0.895 . . . . 0.0 110.716 -173.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -81.31 125.02 29.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.033 0.444 . . . . 0.0 111.119 -172.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.586 ' HB ' HG13 ' A' ' 39' ' ' ILE . 3.6 tp -166.61 123.15 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.426 -176.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.792 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -89.79 152.36 3.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -95.38 -25.36 16.31 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.935 0.397 . . . . 0.0 110.246 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.418 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 56.1 t30 . . . . . 0 N--CA 1.463 0.176 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.027 -177.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.567 ' CG ' ' HG2' ' A' ' 30' ' ' GLN . 58.7 tpp . . . . . 0 N--CA 1.457 -0.086 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.435 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 65.9 Cg_exo -53.61 -26.95 39.38 Favored 'Trans proline' 0 N--CA 1.477 0.51 0 C-N-CA 123.496 2.797 . . . . 0.0 113.635 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.567 ' HG2' ' CG ' ' A' ' 28' ' ' MET . 10.7 pt20 -64.91 -25.4 67.87 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 121.224 -0.19 . . . . 0.0 110.56 177.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.798 HD12 HD13 ' A' ' 68' ' ' LEU . 36.1 mm -65.4 -46.58 89.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.348 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.583 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -55.62 -47.27 76.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.41 177.505 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 33.7 mtp180 -67.69 -44.92 76.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.47 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.915 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -58.38 -47.21 84.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.905 -173.738 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.694 HD12 ' HG3' ' A' ' 75' ' ' GLU . 56.9 mt -64.51 -37.3 79.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.119 -177.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 24.7 mmtm -68.18 -35.12 77.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.173 0.511 . . . . 0.0 110.372 176.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.548 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 8.0 mttm -66.05 -37.7 86.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.459 174.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 89.0 mt -61.58 -38.2 86.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.813 174.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.556 HD11 ' O ' ' A' ' 82' ' ' ASN . 0.3 OUTLIER -62.63 -35.21 69.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.471 177.571 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 14.0 m -64.78 -44.3 90.44 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.02 ' HA ' ' HE2' ' A' ' 44' ' ' LYS . 61.7 mt -59.29 -47.16 86.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.697 174.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.612 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -68.41 -33.01 76.28 Favored Glycine 0 CA--C 1.509 -0.298 0 CA-C-O 121.972 0.762 . . . . 0.0 112.114 -173.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.77 -43.92 52.34 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 122.872 1.32 . . . . 0.0 107.954 -174.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 1.02 ' HE2' ' HA ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -77.21 -26.88 53.19 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 112.669 -2.06 . . . . 0.0 110.879 -172.44 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.537 ' HB2' ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -76.48 -32.89 58.64 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.14 174.258 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.67 -64.03 0.25 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.725 173.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -134.15 147.53 50.82 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.705 -0.291 . . . . 0.0 110.893 -170.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.431 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -73.93 100.25 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.282 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.651 ' O ' HG12 ' A' ' 53' ' ' ILE . 91.6 m -156.18 145.01 20.29 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.861 -171.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -60.03 -39.83 87.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.213 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.565 ' H ' HG22 ' A' ' 49' ' ' THR . 39.5 mt-10 -68.3 -34.23 75.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.991 177.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.991 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 10.2 t70 -71.38 -37.8 71.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.102 0.477 . . . . 0.0 110.931 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.651 HG12 ' O ' ' A' ' 49' ' ' THR . 42.4 mm -59.8 -46.46 93.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.565 0.697 . . . . 0.0 109.839 173.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.405 ' O ' ' HD1' ' A' ' 57' ' ' PHE . 35.2 t70 -63.01 -32.41 73.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.247 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.991 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -74.49 -17.09 60.82 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.864 -178.356 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.41 ' HB1' ' HB3' ' A' ' 41' ' ' LEU . . . -66.32 -16.81 64.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.519 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.489 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 36.1 p90 -42.9 134.84 2.91 Favored Pre-proline 0 N--CA 1.472 0.645 0 O-C-N 123.825 0.703 . . . . 0.0 112.106 -176.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 57' ' ' PHE . 21.9 Cg_exo -66.0 140.7 48.29 Favored 'Cis proline' 0 C--N 1.346 0.416 0 C-N-CA 123.668 -1.388 . . . . 0.0 112.14 -2.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 13.1 Cg_endo -95.86 -169.28 0.15 Allowed 'Trans proline' 0 N--CA 1.44 -1.632 0 C-N-CA 123.999 3.132 . . . . 0.0 110.204 -175.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.548 ' OD2' ' HD3' ' A' ' 37' ' ' LYS . 19.9 t70 -98.34 5.14 48.49 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.985 0.421 . . . . 0.0 111.349 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.915 ' HA ' ' HD3' ' A' ' 34' ' ' ARG . 57.3 m-85 -64.65 118.23 8.58 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -171.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -80.89 -31.85 35.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.155 166.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.95 126.1 1.43 Allowed Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -113.96 144.38 43.17 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.938 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 1.7 p30 -147.76 164.37 33.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.627 0.251 . . . . 0.0 110.966 176.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 m -65.53 -32.29 73.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.735 0.303 . . . . 0.0 111.432 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.441 ' HA ' ' OE2' ' A' ' 70' ' ' GLU . 26.2 t-20 -62.39 -34.67 77.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.35 0.595 . . . . 0.0 109.816 177.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.798 HD13 HD12 ' A' ' 31' ' ' ILE . 22.6 tp -57.29 -39.91 76.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.041 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.0 mm -63.02 -37.37 79.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.335 0.588 . . . . 0.0 110.358 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 17.9 mt-10 -67.83 -41.68 82.66 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.476 ' HE ' ' HG3' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -64.14 -32.43 74.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.559 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 68' ' ' LEU . 74.6 mt -61.09 -46.3 96.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.648 0.261 . . . . 0.0 110.682 178.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -65.78 -33.51 76.03 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.904 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 5.9 mm-40 -61.03 -49.92 75.44 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.81 176.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.694 ' HG3' HD12 ' A' ' 35' ' ' ILE . 79.8 mm-40 -55.62 -31.23 62.11 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.889 -178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.752 HD23 HG23 ' A' ' 81' ' ' ILE . 86.8 mt -57.9 -46.83 84.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.979 0.419 . . . . 0.0 110.562 173.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -83.67 -50.26 8.36 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HD2' ' CD ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -73.6 -42.47 61.49 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -175.757 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.432 ' CG ' ' HE2' ' A' ' 36' ' ' LYS . 56.2 t-80 -95.47 -29.86 14.17 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.608 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.93 23.19 33.48 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 119.842 -1.17 . . . . 0.0 112.568 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.752 HG23 HD23 ' A' ' 76' ' ' LEU . 6.3 tt -72.5 146.63 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.556 ' O ' HD11 ' A' ' 39' ' ' ILE . 8.2 m-20 -117.2 119.61 35.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.195 0.522 . . . . 0.0 111.794 -175.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.431 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 71.7 mt -153.85 116.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -82.44 151.66 4.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.345 0.593 . . . . 0.0 110.292 -175.171 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.41 -30.09 23.86 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.661 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.448 ' HB2' HG23 ' A' ' 49' ' ' THR . 65.3 t30 . . . . . 0 N--CA 1.464 0.255 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.225 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.481 ' O ' HG22 ' A' ' 31' ' ' ILE . 24.6 ttt . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.27 0.557 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.708 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 26.1 Cg_exo -62.9 -30.87 77.57 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.037 2.491 . . . . 0.0 112.203 -172.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -58.31 -38.83 77.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.131 -177.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.698 ' O ' HG13 ' A' ' 35' ' ' ILE . 5.9 tp -67.11 -35.69 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -177.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.407 ' HG2' ' NH2' ' A' ' 71' ' ' ARG . 18.7 mt-10 -65.45 -45.93 81.84 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.586 0.707 . . . . 0.0 109.907 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.708 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 39.5 mtt180 -68.64 -37.9 80.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.286 -176.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.634 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 0.3 OUTLIER -66.07 -36.19 82.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.021 -177.732 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.698 HG13 ' O ' ' A' ' 31' ' ' ILE . 86.4 mt -60.88 -42.71 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.636 ' CD ' HD12 ' A' ' 81' ' ' ILE . 20.0 mmtm -65.74 -36.46 83.63 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.032 0.444 . . . . 0.0 110.278 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.465 ' HE3' HD21 ' A' ' 41' ' ' LEU . 45.3 tptt -64.13 -46.46 84.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.749 175.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.84 -44.22 93.81 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.585 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.566 ' HB ' HD11 ' A' ' 81' ' ' ILE . 1.5 mp -62.82 -35.93 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.977 177.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.716 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 22.8 t -67.06 -47.36 71.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.356 -0.537 . . . . 0.0 109.658 178.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.703 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 83.7 mt -59.62 -43.67 93.71 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.551 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.98 -37.39 93.16 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -177.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.585 ' HB2' HG23 ' A' ' 48' ' ' ILE . 25.7 tptt -70.04 -38.43 75.85 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 120.942 0.401 . . . . 0.0 110.342 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.716 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -61.06 -36.92 80.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.733 0.778 . . . . 0.0 109.965 173.056 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.933 ' HE3' ' HA ' ' A' ' 56' ' ' ALA . 74.4 mmtt -67.52 -30.38 70.03 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.383 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.31 -63.45 0.3 Allowed Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.668 175.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -126.76 155.22 43.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.228 0.537 . . . . 0.0 110.593 -175.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.585 HG23 ' HB2' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -86.33 88.28 2.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.352 0.596 . . . . 0.0 109.634 176.376 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.628 ' O ' HG12 ' A' ' 53' ' ' ILE . 9.8 t -158.23 163.4 37.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.926 -171.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -60.04 -39.14 84.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.92 0.391 . . . . 0.0 110.982 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -57.69 -45.43 85.65 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.461 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.786 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -73.26 -31.08 63.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.493 -179.511 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.628 HG12 ' O ' ' A' ' 49' ' ' THR . 46.3 mm -61.66 -50.13 81.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.235 0.54 . . . . 0.0 110.103 173.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.403 ' HA ' ' CD1' ' A' ' 57' ' ' PHE . 10.7 t70 -59.11 -38.21 79.04 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.489 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.786 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 10.7 ptmt -75.65 -18.31 59.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.101 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.933 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -75.7 -23.09 56.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.126 177.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 54' ' ' ASP . 63.3 m-85 -61.95 142.84 95.01 Favored Pre-proline 0 N--CA 1.464 0.268 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.509 176.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.529 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 96.3 Cg_endo -84.02 137.11 27.15 Favored 'Cis proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.584 -1.423 . . . . 0.0 112.818 0.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.529 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 56.9 Cg_endo -102.81 -152.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 124.466 3.444 . . . . 0.0 110.953 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.77 13.31 28.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 178.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.14 117.15 6.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.013 0.435 . . . . 0.0 111.168 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -81.88 -25.81 34.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.363 173.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.61 125.76 1.48 Allowed Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -106.56 144.95 32.49 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.543 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 16.9 t70 -150.0 157.52 43.24 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.85 -174.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.6 m -63.63 -26.78 68.83 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.861 0.362 . . . . 0.0 111.161 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -60.72 -33.44 72.9 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.568 ' O ' HG13 ' A' ' 72' ' ' ILE . 25.1 tp -54.57 -39.29 67.62 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.027 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.6 mm -62.33 -42.67 96.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.233 0.539 . . . . 0.0 109.868 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 11.8 mt-10 -66.83 -45.53 77.99 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.543 ' HD2' ' OE2' ' A' ' 74' ' ' GLU . 18.4 mmm-85 -65.65 -34.46 78.26 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.482 -1.235 . . . . 0.0 111.89 -174.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 68' ' ' LEU . 71.1 mt -61.1 -50.07 82.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.59 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 18.7 m170 -69.07 -34.9 75.89 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.544 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.543 ' OE2' ' HD2' ' A' ' 71' ' ' ARG . 43.4 mt-10 -60.67 -49.01 79.24 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 175.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -64.73 -31.94 73.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.953 0.406 . . . . 0.0 110.675 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.656 ' HA ' HG22 ' A' ' 81' ' ' ILE . 16.5 tp -64.66 -42.37 95.45 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.755 176.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -82.2 -52.15 7.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.948 0.404 . . . . 0.0 111.836 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -75.54 -44.91 41.06 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.586 -174.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -95.5 -17.02 21.8 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.315 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.44 23.78 57.85 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.698 -1.239 . . . . 0.0 113.348 173.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.656 HG22 ' HA ' ' A' ' 76' ' ' LEU . 4.5 tt -71.61 124.05 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 117.605 0.702 . . . . 0.0 110.64 -171.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -78.42 117.08 19.3 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.463 0.649 . . . . 0.0 111.414 -175.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.556 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 5.6 tp -161.91 139.48 2.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.5 HG12 ' CB ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -110.22 154.25 11.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-O 121.004 0.43 . . . . 0.0 110.443 -175.377 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -83.2 -23.68 32.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.068 -175.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.482 ' H ' HG13 ' A' ' 84' ' ' VAL . 4.0 t-20 . . . . . 0 N--CA 1.464 0.258 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.464 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.8 mtm . . . . . 0 N--CA 1.442 -0.842 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.76 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 50.0 Cg_exo -52.63 -33.21 57.81 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.923 2.415 . . . . 0.0 112.663 -173.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -25.0 58.88 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.076 -173.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 68' ' ' LEU . 9.5 mm -69.76 -46.51 74.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 174.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -61.91 -45.24 94.59 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.094 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.76 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 29.7 mtm180 -61.79 -43.15 99.42 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.866 176.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.498 HH12 ' HB2' ' A' ' 64' ' ' PHE . 73.8 ttt180 -58.66 -36.1 73.62 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.517 -178.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 31' ' ' ILE . 63.6 mt -58.44 -51.71 68.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.498 ' HD3' HD12 ' A' ' 81' ' ' ILE . 1.4 mppt? -69.28 -40.14 77.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.52 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.8 mmtm -59.22 -38.42 79.9 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.114 0.259 . . . . 0.0 110.721 177.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.54 ' HB3' HD12 ' A' ' 53' ' ' ILE . 30.8 mt -65.34 -49.79 68.07 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.12 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.642 HG12 HG12 ' A' ' 81' ' ' ILE . 1.5 mp -62.77 -34.93 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.238 0.542 . . . . 0.0 109.72 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.8 m -67.0 -47.99 69.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.4 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.585 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 72.3 mt -59.49 -39.22 83.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.632 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.707 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -65.83 -34.21 88.04 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HD2' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -71.73 -29.84 64.97 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 122.042 0.925 . . . . 0.0 109.184 -177.241 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.506 ' HE2' ' N ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -75.69 -46.03 33.5 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.736 -1.574 . . . . 0.0 110.428 174.559 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.772 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . 72.4 mmtt -68.17 -33.62 74.8 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.96 -174.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.47 -66.15 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.384 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -142.25 164.17 30.86 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -175.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.732 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -89.25 79.99 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.889 -170.9 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 1.104 ' HB ' HG13 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -139.0 154.32 48.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.402 -169.501 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -57.29 -39.28 75.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.515 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -68.27 -35.56 78.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.673 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.832 ' HB2' HG23 ' A' ' 49' ' ' THR . 9.4 t0 -71.61 -34.43 69.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.302 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 49' ' ' THR . 49.2 mm -58.87 -49.32 83.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.57 0.7 . . . . 0.0 110.196 174.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -61.03 -32.9 72.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.473 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.772 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -75.61 -25.43 56.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.312 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.69 -23.74 60.91 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.789 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.531 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 64.2 t80 -64.26 138.17 97.34 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.652 176.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 6.0 Cg_exo -80.04 137.22 40.98 Favored 'Cis proline' 0 C--N 1.347 0.48 0 C-N-CA 124.151 -1.187 . . . . 0.0 112.543 0.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.54 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 57.2 Cg_endo -105.61 -158.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 124.723 3.615 . . . . 0.0 111.266 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.81 16.5 22.06 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.892 -177.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.54 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 13.5 p90 -58.85 121.46 11.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.653 0.74 . . . . 0.0 111.726 -170.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -80.81 -18.51 47.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.814 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.32 135.9 3.93 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -174.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.498 ' HB2' HH12 ' A' ' 34' ' ' ARG . 78.8 t80 -112.87 138.6 49.48 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.258 174.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -158.53 153.85 25.73 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.3 t -63.24 -25.64 68.42 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.282 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 71' ' ' ARG . 92.6 m-20 -60.92 -31.36 70.89 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.33 177.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.64 ' HB2' HD12 ' A' ' 31' ' ' ILE . 48.8 tp -58.84 -40.47 84.33 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.047 176.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.1 mm -63.85 -46.46 94.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.947 0.404 . . . . 0.0 110.565 -177.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -69.4 -34.11 74.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.758 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -68.26 -41.21 81.43 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.555 -176.571 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.592 HG12 HG23 ' A' ' 35' ' ' ILE . 76.2 mt -60.75 -45.11 98.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.705 0.288 . . . . 0.0 110.938 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.493 ' HA ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -63.98 -41.46 97.52 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.456 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.523 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 12.8 pt-20 -69.69 -34.09 73.44 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.991 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 71' ' ' ARG . 63.7 mm-40 -61.48 -29.86 70.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.563 0.22 . . . . 0.0 111.115 173.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.724 HD21 HG22 ' A' ' 83' ' ' ILE . 98.2 mt -60.04 -49.03 79.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.829 0.347 . . . . 0.0 110.909 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -82.95 -50.12 8.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.202 0.525 . . . . 0.0 111.752 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 8.8 ttmt -69.8 -44.75 69.4 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.205 -175.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -96.13 -25.61 15.8 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.525 -174.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.59 21.59 53.34 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 119.93 -1.129 . . . . 0.0 112.011 -175.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.654 HG23 HD23 ' A' ' 76' ' ' LEU . 9.8 tt -72.49 145.35 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -178.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -116.72 136.17 53.18 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.309 -173.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.724 HG22 HD21 ' A' ' 76' ' ' LEU . 1.6 tp -162.42 129.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.134 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 1.104 HG13 ' HB ' ' A' ' 49' ' ' THR . 2.2 p -97.57 151.03 4.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.832 -175.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -93.74 -26.49 16.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.06 0.457 . . . . 0.0 110.316 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 63.7 t30 . . . . . 0 N--CA 1.464 0.238 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.983 176.097 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.581 ' O ' HG22 ' A' ' 31' ' ' ILE . 22.3 ptt? . . . . . 0 CA--C 1.536 0.415 0 CA-C-O 120.781 0.324 . . . . 0.0 111.618 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.47 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 4.7 Cg_exo -80.87 -27.29 3.16 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.315 2.01 . . . . 0.0 111.19 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.587 ' HB2' ' OE1' ' A' ' 62' ' ' GLU . 13.5 pt20 -69.03 -29.63 67.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.604 -177.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.674 ' O ' HG13 ' A' ' 35' ' ' ILE . 10.0 tp -69.05 -36.42 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.044 -176.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -65.2 -46.31 81.23 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.121 0.486 . . . . 0.0 110.046 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 61.1 mtp180 -60.74 -45.03 95.85 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.117 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.431 ' HD3' ' OE1' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -63.33 -31.39 72.53 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.886 -176.946 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 31' ' ' ILE . 63.6 mt -58.68 -48.35 86.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.82 176.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.48 ' CD ' HD12 ' A' ' 81' ' ' ILE . 1.9 mppt? -67.54 -33.84 75.87 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.909 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.431 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 16.6 tptp -63.24 -40.36 97.21 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.211 176.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.618 ' HA ' HD12 ' A' ' 41' ' ' LEU . 5.9 mp -70.24 -40.14 74.62 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.443 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.686 HG12 HG12 ' A' ' 81' ' ' ILE . 1.5 mp -63.3 -34.53 67.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.997 174.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.419 ' C ' ' HE3' ' A' ' 44' ' ' LYS . 45.5 t -61.06 -43.06 99.46 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.824 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 89.9 mt -58.24 -46.15 86.47 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.992 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.671 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -60.67 -32.29 78.15 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.12 -39.72 48.42 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.935 0.874 . . . . 0.0 109.273 -175.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.824 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 4.4 ptpt -76.68 -36.94 56.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.092 -176.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.71 ' HB2' ' OD1' ' A' ' 52' ' ' ASP . 30.8 mmmt -72.05 -20.98 61.59 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.733 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.23 -72.97 0.21 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.025 -0.989 . . . . 0.0 113.589 174.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -143.93 145.96 32.63 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.386 0.136 . . . . 0.0 110.741 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.554 ' HB ' HD13 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -66.91 108.51 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 122.042 0.925 . . . . 0.0 109.816 -176.038 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.744 HG22 ' H ' ' A' ' 51' ' ' GLU . 54.5 m -160.71 145.51 14.22 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.597 -173.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -57.73 -39.99 78.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.216 0.531 . . . . 0.0 110.474 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.744 ' H ' HG22 ' A' ' 49' ' ' THR . 44.4 mm-40 -68.37 -33.59 74.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.627 177.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.71 ' OD1' ' HB2' ' A' ' 45' ' ' LYS . 10.0 t70 -71.72 -32.55 67.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.365 0.603 . . . . 0.0 109.71 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 49' ' ' THR . 50.0 mm -61.4 -49.42 84.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.419 0.628 . . . . 0.0 109.776 170.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -33.47 69.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.54 176.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.702 ' HD3' ' CG ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -75.12 -24.29 58.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.993 -179.516 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.492 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -71.91 -19.7 61.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.311 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.523 ' CD2' ' HD3' ' A' ' 59' ' ' PRO . 55.3 t80 -63.79 133.05 95.42 Favored Pre-proline 0 C--O 1.235 0.317 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.44 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.502 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 53.9 Cg_endo -69.88 127.44 11.0 Favored 'Cis proline' 0 C--N 1.35 0.605 0 C-N-CA 123.392 -1.503 . . . . 0.0 112.165 1.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.523 ' HD3' ' CD2' ' A' ' 57' ' ' PHE . 13.9 Cg_endo -96.74 -165.65 0.1 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 123.74 2.96 . . . . 0.0 110.711 -172.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -98.35 15.23 25.32 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.402 -175.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.457 ' CD1' ' HD2' ' A' ' 59' ' ' PRO . 9.6 p90 -62.87 126.49 27.5 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.291 0.567 . . . . 0.0 111.121 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.587 ' OE1' ' HB2' ' A' ' 30' ' ' GLN . 48.7 mt-10 -80.82 -24.84 38.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.874 176.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.21 126.94 1.53 Allowed Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -106.31 123.72 48.48 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 117.523 0.662 . . . . 0.0 109.801 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 20.7 t70 -147.23 162.16 39.46 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.07 -175.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.8 t -64.37 -31.38 72.56 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.2 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -62.2 -34.46 76.5 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.248 0.547 . . . . 0.0 109.816 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.604 ' O ' HG13 ' A' ' 72' ' ' ILE . 32.9 tp -59.94 -42.18 93.46 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.749 177.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.2 mm -59.62 -43.48 91.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.033 0.444 . . . . 0.0 110.745 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -67.99 -40.97 82.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.581 ' HG3' ' CD1' ' A' ' 35' ' ' ILE . 9.5 tpp180 -66.43 -32.88 74.52 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.019 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.604 HG13 ' O ' ' A' ' 68' ' ' LEU . 76.0 mt -61.37 -50.59 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.852 -0.158 . . . . 0.0 110.629 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.572 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 22.1 p80 -67.1 -33.51 75.62 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.136 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -59.45 -49.52 77.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.344 0.593 . . . . 0.0 109.604 174.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.587 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 59.8 mm-40 -66.71 -28.98 68.86 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.821 176.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.008 ' HA ' HG22 ' A' ' 81' ' ' ILE . 13.5 tp -69.58 -51.55 34.29 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.363 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -84.49 -53.03 5.7 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.286 0.565 . . . . 0.0 111.625 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -76.29 -38.94 55.43 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.052 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.587 ' HB2' ' HA ' ' A' ' 75' ' ' GLU . 3.1 t60 -94.62 -16.42 23.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.577 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.24 23.03 42.1 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.398 -0.906 . . . . 0.0 114.106 172.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.008 HG22 ' HA ' ' A' ' 76' ' ' LEU . 7.9 tt -75.34 145.63 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 117.727 0.763 . . . . 0.0 109.322 -176.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.462 ' O ' HG12 ' A' ' 83' ' ' ILE . 6.1 m-20 -108.31 128.06 54.41 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -173.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.683 HG12 HG13 ' A' ' 39' ' ' ILE . 9.2 mm -162.14 119.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 124.37 1.068 . . . . 0.0 108.61 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -88.17 152.36 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 CA-C-O 121.671 0.748 . . . . 0.0 109.454 -179.546 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -79.03 -31.44 44.64 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.146 -177.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.554 ' HB2' HG23 ' A' ' 49' ' ' THR . 11.8 t-20 . . . . . 0 N--CA 1.464 0.242 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.05 176.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.456 -0.141 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.424 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 22.8 Cg_exo -63.88 -25.32 67.5 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.566 2.177 . . . . 0.0 111.546 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -66.6 -24.8 66.38 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.57 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.532 HG23 HD13 ' A' ' 68' ' ' LEU . 8.1 mm -65.22 -43.94 95.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.503 0.192 . . . . 0.0 111.494 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -69.71 -37.52 76.6 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 49.9 mtp180 -66.26 -34.12 77.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.792 175.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.595 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 2.0 tpm_? -59.06 -39.31 81.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.534 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.807 HD11 ' HG3' ' A' ' 71' ' ' ARG . 22.7 mt -59.54 -49.0 85.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.275 0.559 . . . . 0.0 109.857 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.673 ' HD2' HD12 ' A' ' 81' ' ' ILE . 14.3 mmmt -65.69 -36.2 82.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.173 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.584 ' HD2' ' HA ' ' A' ' 34' ' ' ARG . 48.3 mttm -60.96 -41.68 96.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.378 174.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 70.8 mt -67.41 -42.27 83.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.591 -176.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.641 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.6 mp -68.62 -34.91 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.981 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.666 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 32.2 t -66.44 -47.5 72.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.966 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 96.9 mt -60.15 -40.02 88.4 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.781 -177.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.538 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -67.0 -38.42 92.75 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.501 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 11.2 tptt -73.35 -34.89 65.87 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.874 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.666 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -62.6 -45.2 93.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.089 173.714 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.814 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . 45.3 mmtm -69.23 -35.23 75.94 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.82 -177.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.9 -65.99 0.1 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.086 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -137.0 158.57 44.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.416 0.627 . . . . 0.0 111.154 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.8 OUTLIER -83.64 88.98 2.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.334 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.548 HG23 ' H ' ' A' ' 52' ' ' ASP . 10.6 t -153.61 155.24 35.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.829 -176.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -58.35 -41.98 85.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.043 0.449 . . . . 0.0 111.215 -173.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.68 -32.64 72.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.882 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.653 ' OD1' ' HB2' ' A' ' 45' ' ' LYS . 11.1 t0 -71.61 -39.26 70.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.214 0.53 . . . . 0.0 110.223 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.1 mt -60.23 -45.42 96.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.355 0.598 . . . . 0.0 110.017 173.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.0 -34.36 69.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.325 176.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.814 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -75.73 -23.05 56.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.092 -178.006 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.784 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -69.63 -18.93 63.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.571 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.434 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 80.5 t80 -62.74 137.14 96.58 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 176.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.497 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 90.0 Cg_endo -85.49 140.25 28.21 Favored 'Cis proline' 0 C--N 1.346 0.396 0 C-N-CA 123.594 -1.419 . . . . 0.0 113.441 1.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.604 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 37.3 Cg_endo -103.65 -157.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.744 0 C-N-CA 124.742 3.628 . . . . 0.0 110.896 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -98.09 14.52 27.24 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.044 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.604 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 10.1 p90 -61.51 125.9 25.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.464 0.649 . . . . 0.0 110.826 -174.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -79.08 -30.14 43.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.686 174.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.28 126.79 1.48 Allowed Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -108.2 144.57 35.47 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 24.3 t70 -142.66 161.37 38.24 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.32 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -63.07 -30.93 71.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.953 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -61.07 -34.08 74.35 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.124 0.488 . . . . 0.0 110.268 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.654 ' O ' HG13 ' A' ' 72' ' ' ILE . 58.1 tp -60.58 -39.42 87.99 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.906 177.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.6 mm -62.89 -41.43 92.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.244 0.545 . . . . 0.0 110.314 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.417 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 17.6 mt-10 -68.25 -36.99 80.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.902 0.858 . . . . 0.0 108.959 177.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.807 ' HG3' HD11 ' A' ' 35' ' ' ILE . 23.0 tpt180 -70.06 -33.99 72.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.153 -178.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.654 HG13 ' O ' ' A' ' 68' ' ' LEU . 86.2 mt -61.0 -50.38 80.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.002 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.417 ' CD2' ' HA ' ' A' ' 70' ' ' GLU . 34.3 p80 -66.73 -31.94 72.92 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.91 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.688 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 25.6 mt-10 -58.54 -53.38 59.01 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 121.377 0.608 . . . . 0.0 109.773 173.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 47.3 tp10 -59.88 -33.52 71.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.529 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.856 ' HA ' HG22 ' A' ' 81' ' ' ILE . 9.0 tp -66.57 -49.56 65.98 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.809 177.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -83.9 -53.35 5.65 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -173.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 34.3 pttt -76.97 -40.1 48.11 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.575 -176.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -93.8 -21.14 19.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.059 -176.582 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.32 25.24 24.38 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.358 -1.401 . . . . 0.0 114.772 172.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.856 HG22 ' HA ' ' A' ' 76' ' ' LEU . 5.4 tt -73.06 119.59 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 118.847 1.324 . . . . 0.0 109.628 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -81.8 126.94 32.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.434 0.635 . . . . 0.0 111.505 -171.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.641 ' HB ' HG13 ' A' ' 39' ' ' ILE . 4.8 tp -167.87 140.02 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.464 -176.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -100.73 153.4 4.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -92.62 -29.73 15.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.491 -174.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.47 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 24.0 t-20 . . . . . 0 N--CA 1.466 0.351 0 O-C-N 123.939 0.774 . . . . 0.0 110.192 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 112.231 -0.347 . . . . 0.0 112.231 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.8 p -129.5 -160.15 1.01 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 60.0 68.51 0.77 Allowed 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.364 0.602 . . . . 0.0 109.851 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.56 ' HB3' HG12 ' A' ' 31' ' ' ILE . 65.9 mtt -130.74 76.47 77.2 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.487 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.487 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 15.5 Cg_exo -67.94 -25.07 38.97 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.661 2.241 . . . . 0.0 111.105 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.454 ' HB2' ' OE2' ' A' ' 62' ' ' GLU . 12.3 pt20 -66.2 -25.1 66.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.389 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.576 ' O ' HG13 ' A' ' 35' ' ' ILE . 28.8 mm -65.17 -49.88 76.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.587 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -55.69 -46.54 77.6 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.202 0.525 . . . . 0.0 110.492 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 12.6 mmm180 -67.56 -44.34 78.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.025 -177.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.707 HH11 HD22 ' A' ' 68' ' ' LEU . 29.6 ttm180 -61.74 -37.93 86.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.215 -175.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 31' ' ' ILE . 89.8 mt -59.83 -46.32 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.687 ' HD3' HD12 ' A' ' 81' ' ' ILE . 26.5 mmtm -67.03 -37.29 83.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.27 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.535 ' HD2' ' HA ' ' A' ' 34' ' ' ARG . 94.4 mttt -62.57 -40.93 98.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.875 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.625 ' HB3' HD13 ' A' ' 53' ' ' ILE . 73.8 mt -64.93 -45.84 84.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.664 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.683 ' HB ' HD11 ' A' ' 81' ' ' ILE . 1.6 mp -66.37 -35.38 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 121.033 0.444 . . . . 0.0 109.953 177.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.694 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 33.3 t -65.96 -42.09 90.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.922 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.713 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 93.3 mt -60.15 -43.12 95.99 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.474 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.41 -35.23 89.87 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -36.82 83.36 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.888 -0.656 . . . . 0.0 109.703 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.694 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -68.78 -41.13 79.2 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.883 0.849 . . . . 0.0 110.03 175.141 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.713 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 70.3 mmtt -68.95 -31.56 70.53 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.014 -1.448 . . . . 0.0 111.277 -176.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.54 -58.8 0.44 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.246 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -119.68 146.81 45.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.119 0.485 . . . . 0.0 110.667 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.06 86.48 2.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.347 0.594 . . . . 0.0 109.697 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.458 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.0 m -141.79 148.08 38.33 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.407 -170.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -57.12 -42.24 80.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.061 0.458 . . . . 0.0 110.119 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.41 ' H ' HG22 ' A' ' 49' ' ' THR . 35.1 mt-10 -70.06 -32.68 70.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.697 177.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.746 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 1.3 m-20 -68.23 -29.44 68.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.266 0.555 . . . . 0.0 111.3 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.625 HD13 ' HB3' ' A' ' 38' ' ' LEU . 17.7 mt -65.71 -44.02 93.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 121.075 0.464 . . . . 0.0 110.187 170.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.33 -39.36 75.69 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.497 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.746 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.66 -15.43 59.18 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.832 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.697 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -75.39 -18.49 59.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.073 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.521 ' CD2' ' HD3' ' A' ' 59' ' ' PRO . 43.6 t80 -50.1 136.01 21.81 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.829 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.498 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 71.5 Cg_endo -75.03 137.72 51.95 Favored 'Cis proline' 0 C--N 1.345 0.374 0 C-N-CA 123.528 -1.447 . . . . 0.0 112.836 1.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.521 ' HD3' ' CD2' ' A' ' 57' ' ' PHE . 17.0 Cg_endo -98.87 -165.25 0.07 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 124.141 3.227 . . . . 0.0 110.245 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -97.38 13.92 28.04 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.012 0.434 . . . . 0.0 110.734 -176.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.427 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 5.2 p90 -63.25 120.74 12.12 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.625 0.726 . . . . 0.0 111.358 -173.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.454 ' OE2' ' HB2' ' A' ' 30' ' ' GLN . 2.3 mp0 -80.93 -22.26 39.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.736 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.02 146.96 14.2 Favored Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 -174.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -100.99 120.57 40.37 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.484 173.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -134.67 132.64 39.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.715 0.293 . . . . 0.0 110.61 -170.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.8 m -63.78 -31.94 73.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.405 0.622 . . . . 0.0 109.746 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.544 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 14.0 m120 -62.31 -38.67 90.33 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.643 175.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.707 HD22 HH11 ' A' ' 34' ' ' ARG . 52.2 tp -59.69 -39.01 83.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.613 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.7 mm -61.08 -46.53 96.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.557 0.218 . . . . 0.0 111.107 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 14.3 pt-20 -70.59 -34.56 72.3 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.669 177.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.549 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 19.4 mmt180 -70.41 -32.62 70.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.512 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 68' ' ' LEU . 82.4 mt -61.75 -49.56 83.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.834 0.35 . . . . 0.0 110.143 175.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.528 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 77.3 m80 -67.46 -34.92 78.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.753 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -67.62 -48.88 65.48 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.699 177.129 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -58.6 -29.52 66.52 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.004 0.43 . . . . 0.0 110.624 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.919 ' HA ' HG22 ' A' ' 81' ' ' ILE . 2.9 tp -57.6 -44.82 85.71 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.299 173.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -84.02 -52.66 6.13 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.753 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 3.6 ptmm? -72.93 -39.77 66.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -93.1 -26.98 17.22 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.942 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.16 23.09 23.31 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.77 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.919 HG22 ' HA ' ' A' ' 76' ' ' LEU . 6.2 tt -74.33 123.5 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 117.731 0.765 . . . . 0.0 110.108 -174.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -82.51 118.26 23.12 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.974 -0.454 . . . . 0.0 111.306 -172.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.638 ' HB ' HG13 ' A' ' 39' ' ' ILE . 5.5 tp -156.95 137.61 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.12 152.2 10.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.265 0.555 . . . . 0.0 110.789 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 87' ' ' GLU . 51.0 mm-40 -88.23 -25.91 22.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.974 -176.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.408 ' HB2' ' CG2' ' A' ' 49' ' ' THR . 5.3 t30 77.57 -12.49 1.06 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 124.202 0.939 . . . . 0.0 109.799 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' A' ' 85' ' ' GLU . 6.2 tp10 -82.1 130.59 59.47 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.964 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.22 69.12 3.28 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.17 1.913 . . . . 0.0 112.236 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.77 15.55 10.96 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.974 0.893 . . . . 0.0 109.905 175.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -120.63 79.7 1.52 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.46 -1.246 . . . . 0.0 107.741 172.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.18 154.38 46.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.606 -170.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -139.8 -80.88 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.91 0.386 . . . . 0.0 111.499 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.434 ' O ' HG12 ' A' ' 93' ' ' ILE . 14.6 tt -106.75 12.91 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 121.574 0.702 . . . . 0.0 111.124 -172.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.8 m 57.24 56.13 5.39 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.223 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.91 63.16 0.99 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.33 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.762 0 CA-C-O 118.884 -0.953 . . . . 0.0 111.638 179.206 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.885 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -113.91 -33.41 5.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.922 0.361 . . . . 0.0 111.861 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -87.91 50.16 1.94 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.25 0.548 . . . . 0.0 110.506 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.595 ' O ' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -172.08 77.27 0.47 Allowed Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.647 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.627 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 9.3 Cg_exo -72.01 -36.32 6.08 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.625 2.217 . . . . 0.0 112.492 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.462 ' HB2' HH21 ' A' ' 34' ' ' ARG . 5.1 pp0? -64.96 -32.88 74.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.156 -174.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.698 HG13 HD13 ' A' ' 68' ' ' LEU . 10.7 tp -71.98 -35.52 54.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.62 -47.38 66.82 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.219 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 22.5 mmm180 -62.96 -35.37 79.93 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.552 ' HG2' ' CD1' ' A' ' 61' ' ' PHE . 6.4 tpp180 -60.63 -37.03 80.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.978 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 31' ' ' ILE . 30.9 mt -60.48 -44.87 97.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.517 ' HA ' ' HB ' ' A' ' 39' ' ' ILE . 2.2 mppt? -67.95 -34.03 75.8 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.014 175.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -58.59 -42.56 88.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.168 0.509 . . . . 0.0 109.931 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.615 HD12 HG23 ' A' ' 53' ' ' ILE . 4.1 mm? -70.08 -35.05 73.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.723 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.667 HD11 HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -60.69 -37.97 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.236 0.541 . . . . 0.0 109.738 173.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.671 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 36.6 t -66.97 -48.38 68.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.028 176.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.696 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 91.5 mt -60.8 -45.93 92.51 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.055 -176.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.08 -39.04 84.34 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -175.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.44 -34.15 67.58 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.671 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -61.34 -41.23 96.71 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.918 172.756 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 31.7 mmtp -68.41 -21.7 64.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.485 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.01 -66.1 0.25 Allowed Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.363 -0.923 . . . . 0.0 112.522 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -142.57 171.67 13.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.16 0.505 . . . . 0.0 111.116 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.496 HG22 ' CD1' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -87.63 86.16 2.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.453 0.644 . . . . 0.0 109.952 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.608 ' O ' HG12 ' A' ' 53' ' ' ILE . 9.7 m -143.26 145.62 32.9 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.525 -171.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -60.6 -34.94 74.95 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.571 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 32.1 mt-10 -67.63 -35.03 78.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.092 176.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.692 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 11.8 m-20 -71.68 -30.32 65.57 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.444 0.64 . . . . 0.0 110.972 176.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.615 HG23 HD12 ' A' ' 38' ' ' LEU . 50.9 mm -66.5 -45.34 89.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.566 0.698 . . . . 0.0 109.818 169.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.512 ' HA ' ' CE2' ' A' ' 57' ' ' PHE . 21.4 t70 -57.43 -36.89 71.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.715 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.692 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 5.9 ptpt -77.88 -16.58 58.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.781 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.561 ' HA ' ' NZ ' ' A' ' 45' ' ' LYS . . . -76.82 -19.17 57.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.796 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.568 ' CD1' ' HG3' ' A' ' 59' ' ' PRO . 19.8 m-85 -66.62 147.32 99.03 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.933 178.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 2.9 Cg_exo -76.1 143.46 76.65 Favored 'Cis proline' 0 C--N 1.342 0.214 0 C-N-CA 123.955 -1.269 . . . . 0.0 112.358 0.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.698 ' HG2' ' HD2' ' A' ' 61' ' ' PHE . 53.1 Cg_endo -100.92 -173.0 0.11 Allowed 'Trans proline' 0 N--CA 1.438 -1.757 0 C-N-CA 124.328 3.352 . . . . 0.0 110.772 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -98.65 16.53 21.72 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.698 ' HD2' ' HG2' ' A' ' 59' ' ' PRO . 36.4 m-85 -58.43 119.48 7.06 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.925 0.393 . . . . 0.0 110.404 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.58 -20.93 45.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.335 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.71 124.63 1.28 Allowed Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -112.88 144.51 42.32 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 18.2 t70 -149.56 160.74 43.24 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.867 -172.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 t -62.97 -32.22 73.5 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 120.975 0.416 . . . . 0.0 110.982 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.425 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 3.3 t-20 -61.69 -31.86 72.02 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.698 HD13 HG13 ' A' ' 31' ' ' ILE . 26.6 tp -54.63 -38.79 67.26 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.052 175.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.9 mm -61.9 -40.79 88.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.31 0.576 . . . . 0.0 109.866 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.574 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 15.7 mt-10 -68.14 -41.08 82.16 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.539 ' HD2' ' HA ' ' A' ' 68' ' ' LEU . 85.9 mtt180 -60.05 -38.75 83.72 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.939 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 68' ' ' LEU . 80.5 mt -61.3 -51.1 76.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.809 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.574 ' CD2' ' HA ' ' A' ' 70' ' ' GLU . 27.9 p80 -69.0 -32.33 71.81 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.543 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 47.3 mt-10 -59.2 -49.46 77.78 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' OE1' ' NZ ' ' A' ' 36' ' ' LYS . 20.9 mm-40 -63.89 -34.22 77.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.666 175.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.526 ' HA ' HG22 ' A' ' 81' ' ' ILE . 18.2 tp -57.48 -41.94 81.64 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.346 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -84.46 -49.82 8.32 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -71.97 -44.69 63.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.05 -26.67 15.96 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.361 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.02 23.44 32.54 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.908 -1.139 . . . . 0.0 112.985 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.526 HG22 ' HA ' ' A' ' 76' ' ' LEU . 11.9 tt -72.32 119.25 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.625 0.726 . . . . 0.0 110.909 -170.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -99.99 118.58 36.69 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.872 -170.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.667 HG12 HD11 ' A' ' 39' ' ' ILE . 3.3 mt -146.16 128.21 8.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 86' ' ' ASN . 0.4 OUTLIER -95.27 153.31 3.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.823 -172.002 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.443 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 8.0 mm-40 -87.11 -23.72 24.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.926 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.501 ' N ' HG13 ' A' ' 84' ' ' VAL . 60.2 t30 77.25 18.84 1.37 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.939 177.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.489 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 9.9 pt-20 -104.04 128.19 27.69 Favored Pre-proline 0 N--CA 1.448 -0.536 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.899 171.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 11.1 Cg_exo -71.68 -22.35 24.19 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.373 2.715 . . . . 0.0 113.248 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 57.61 56.76 4.69 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.56 0.695 . . . . 0.0 109.257 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -114.61 93.74 4.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.259 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -138.58 72.71 1.41 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 172.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -118.81 -59.87 1.82 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.646 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.7 mm -77.74 -34.27 19.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.157 175.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.9 m 71.83 -53.31 0.69 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.666 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -151.78 142.07 22.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.139 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.92 0 CA-C-O 118.796 -1.002 . . . . 0.0 111.568 -178.894 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.685 0 N-CA-C 112.063 -0.415 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.3 p -83.63 -4.66 58.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.6 0.238 . . . . 0.0 111.261 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.3 m80 70.37 22.97 5.12 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.858 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.744 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 87.9 mtp -114.5 -54.42 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.916 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.744 ' HD3' ' HB2' ' A' ' 28' ' ' MET . 43.7 Cg_exo -59.05 -34.24 98.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.107 1.871 . . . . 0.0 112.412 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.515 ' HB2' HH21 ' A' ' 34' ' ' ARG . 21.1 pt20 -67.09 -25.12 66.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.683 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.636 ' O ' HG13 ' A' ' 35' ' ' ILE . 26.6 mm -69.81 -46.07 75.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.227 175.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -55.69 -45.06 77.87 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.254 0.55 . . . . 0.0 110.009 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 2.9 mmp_? -64.93 -39.76 94.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.022 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.945 ' HD2' ' HA ' ' A' ' 61' ' ' PHE . 5.5 tpp180 -67.16 -39.21 86.46 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.232 -173.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.636 HG13 ' O ' ' A' ' 31' ' ' ILE . 41.5 mt -61.14 -44.87 99.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.613 ' HD3' HD12 ' A' ' 81' ' ' ILE . 14.5 mmtp -66.87 -38.77 86.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.207 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.58 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 54.9 mttm -61.02 -43.36 99.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.9 175.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.513 ' HB3' HD12 ' A' ' 53' ' ' ILE . 65.9 mt -63.73 -47.13 82.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.391 -177.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.541 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -63.41 -34.76 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.066 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.441 ' C ' ' HE3' ' A' ' 44' ' ' LYS . 33.1 t -65.57 -47.89 74.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.551 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.923 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 71.2 mt -59.22 -47.07 86.7 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.636 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.33 -35.81 92.17 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -74.99 -38.79 61.55 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.509 0.671 . . . . 0.0 109.878 -173.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.923 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 3.9 ptpt -70.55 -26.17 63.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.485 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 69.4 mmtt -86.95 -4.48 59.18 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.981 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.88 -71.78 0.3 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.78 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -141.14 164.83 29.21 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 121.213 0.53 . . . . 0.0 111.928 -170.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -85.24 85.27 2.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.22 0.533 . . . . 0.0 109.764 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 51' ' ' GLU . 5.9 m -142.92 146.6 34.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.404 -171.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.33 -36.12 77.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.065 0.46 . . . . 0.0 110.112 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.521 ' H ' HG22 ' A' ' 49' ' ' THR . 32.9 mt-10 -67.42 -34.36 77.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.183 0.516 . . . . 0.0 110.118 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.766 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 1.5 m-20 -67.2 -30.03 69.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.282 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.513 HD12 ' HB3' ' A' ' 38' ' ' LEU . 39.1 mm -60.08 -50.24 80.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.448 0.642 . . . . 0.0 110.341 173.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.36 -38.24 90.4 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.344 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.766 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -75.41 -14.97 60.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.716 -178.277 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.85 -18.92 60.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.117 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.422 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 80.4 t80 -58.69 134.55 86.32 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.813 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 57.9 Cg_endo -72.87 132.16 25.31 Favored 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 123.591 -1.42 . . . . 0.0 112.024 -1.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 19.2 Cg_endo -98.61 -158.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.732 0 C-N-CA 124.259 3.306 . . . . 0.0 111.11 -173.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.509 ' H ' HD11 ' A' ' 41' ' ' LEU . 2.5 t70 -98.96 14.19 29.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.325 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.945 ' HA ' ' HD2' ' A' ' 34' ' ' ARG . 4.3 p90 -69.68 120.13 14.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.386 0.612 . . . . 0.0 111.251 -172.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -82.38 -23.55 34.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.651 172.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.74 125.74 1.5 Allowed Glycine 0 N--CA 1.436 -1.34 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -176.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -113.27 134.26 54.69 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.468 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.432 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 18.4 t70 -151.59 155.28 38.11 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.4 m -63.05 -27.91 69.73 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.94 0.4 . . . . 0.0 111.371 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -61.34 -32.7 72.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.382 0.611 . . . . 0.0 109.937 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.622 ' O ' HG13 ' A' ' 72' ' ' ILE . 63.9 tp -60.66 -39.11 87.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.084 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.6 mm -62.82 -46.65 95.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.791 0.329 . . . . 0.0 110.884 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.454 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 9.4 pt-20 -68.41 -32.55 72.67 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.491 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 5.9 tpp180 -70.2 -35.96 74.28 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.341 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 68' ' ' LEU . 72.0 mt -59.92 -50.94 78.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.762 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.565 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 26.5 p80 -68.69 -33.48 74.04 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.618 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -60.01 -50.54 73.33 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.712 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.571 ' OE1' ' HD2' ' A' ' 78' ' ' LYS . 8.3 mm-40 -65.72 -25.71 67.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.226 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.011 ' HA ' HG22 ' A' ' 81' ' ' ILE . 7.9 tp -56.0 -47.62 77.41 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.066 174.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -83.56 -50.5 8.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.525 0.678 . . . . 0.0 111.199 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.571 ' HD2' ' OE1' ' A' ' 75' ' ' GLU . 23.7 ttmt -68.18 -43.58 77.83 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.998 -172.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.63 -24.68 17.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.772 0.32 . . . . 0.0 110.329 -177.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.37 22.56 24.22 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.114 -1.041 . . . . 0.0 113.27 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.011 HG22 ' HA ' ' A' ' 76' ' ' LEU . 10.0 tt -75.66 146.32 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 117.407 0.603 . . . . 0.0 110.219 -174.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -104.14 128.31 51.8 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.095 -0.378 . . . . 0.0 110.867 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.541 ' HB ' HG13 ' A' ' 39' ' ' ILE . 4.7 tp -167.25 137.87 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -109.61 151.68 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.253 -177.214 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -89.66 -23.92 21.75 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.497 ' HB2' HG23 ' A' ' 49' ' ' THR . 63.5 t30 75.83 2.48 3.69 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.505 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.515 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 41.5 mt-10 -115.38 127.51 26.74 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.857 174.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.515 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 9.2 Cg_endo -91.79 152.53 3.4 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.266 2.644 . . . . 0.0 111.743 175.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -79.76 66.41 5.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.354 0.597 . . . . 0.0 110.211 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 50.22 51.83 15.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.862 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.405 ' HB3' ' HA ' ' A' ' 94' ' ' SER . 41.9 mt-10 -84.74 145.9 27.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.346 177.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -109.39 -47.71 3.35 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.822 0.344 . . . . 0.0 110.734 -173.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.788 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -100.11 20.8 2.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 172.092 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.405 ' HA ' ' HB3' ' A' ' 91' ' ' GLU . 22.5 p 48.37 35.43 5.71 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.535 -174.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.38 32.61 0.98 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.529 0 CA-C-O 118.021 -1.433 . . . . 0.0 110.413 -168.409 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.718 0 N-CA-C 112.039 -0.425 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 t -137.54 127.82 26.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 57.07 66.94 1.06 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.573 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.547 ' O ' HG22 ' A' ' 31' ' ' ILE . 59.4 mtt -131.36 83.84 58.14 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.205 178.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.89 -24.64 53.4 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.767 2.312 . . . . 0.0 111.382 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -60.66 -31.45 70.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.2 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.626 ' O ' HG13 ' A' ' 35' ' ' ILE . 10.5 tp -69.75 -35.46 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.476 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.84 -42.62 76.91 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.168 0.508 . . . . 0.0 110.238 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -63.65 -38.59 91.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.083 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -60.56 -35.01 75.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.103 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.68 HG23 HG12 ' A' ' 72' ' ' ILE . 52.1 mt -60.37 -46.98 94.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.059 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.664 ' HD3' HD12 ' A' ' 81' ' ' ILE . 28.2 mmtm -66.68 -37.28 84.42 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.237 0.541 . . . . 0.0 109.969 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.567 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 15.9 tptm -64.49 -44.39 91.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.409 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.511 HD22 ' HZ ' ' A' ' 61' ' ' PHE . 16.5 tp -67.06 -45.55 77.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.029 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.569 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -62.7 -34.68 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.892 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.697 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 23.2 t -67.1 -45.43 77.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.071 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.634 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 90.0 mt -59.38 -42.9 92.74 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.541 -176.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.469 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -66.69 -34.83 88.64 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.379 -0.915 . . . . 0.0 110.844 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 10.4 tptm -68.43 -38.7 81.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.46 0.648 . . . . 0.0 109.798 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.697 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -66.03 -41.48 90.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.424 175.245 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.813 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . 73.9 mmtt -68.2 -32.71 73.12 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.424 -177.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.66 -65.6 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.552 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -144.16 155.15 43.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.831 0.348 . . . . 0.0 110.84 -175.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.472 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -73.99 91.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.552 0.691 . . . . 0.0 110.66 -178.654 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.637 HG22 ' H ' ' A' ' 51' ' ' GLU . 86.6 m -149.07 145.43 27.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.93 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -58.25 -39.37 78.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.803 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.637 ' H ' HG22 ' A' ' 49' ' ' THR . 15.8 mm-40 -64.16 -39.03 93.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.531 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.653 ' CG ' ' HD3' ' A' ' 55' ' ' LYS . 9.9 t0 -72.17 -36.96 69.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.372 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.46 HG23 HD11 ' A' ' 38' ' ' LEU . 26.6 mt -59.92 -45.63 94.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.967 0.413 . . . . 0.0 110.659 172.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -59.59 -31.41 69.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.652 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.813 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -74.71 -26.84 60.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.005 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.616 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -66.74 -19.61 65.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.628 -176.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.462 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 18.2 m-85 -50.99 134.95 28.9 Favored Pre-proline 0 N--CA 1.468 0.451 0 O-C-N 123.236 0.335 . . . . 0.0 111.249 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.499 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 15.4 Cg_exo -68.78 140.32 56.76 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 123.971 -1.262 . . . . 0.0 112.445 1.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 26.5 Cg_endo -98.69 -168.51 0.1 Allowed 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 124.288 3.326 . . . . 0.0 110.957 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.431 ' HB2' HD11 ' A' ' 41' ' ' LEU . 17.0 t70 -98.44 12.08 36.16 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.196 0.522 . . . . 0.0 111.504 -175.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.511 ' HZ ' HD22 ' A' ' 38' ' ' LEU . 41.5 m-85 -70.95 121.29 17.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.076 0.465 . . . . 0.0 111.67 -174.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -79.11 -30.43 43.76 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 165.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.96 125.91 1.4 Allowed Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 173.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -107.72 143.58 36.04 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 117.438 0.619 . . . . 0.0 110.592 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 15.6 t70 -141.5 159.75 41.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.193 -173.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.5 m -61.37 -26.86 68.11 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.015 0.436 . . . . 0.0 111.346 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.67 -33.54 72.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.7 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.604 ' O ' HG13 ' A' ' 72' ' ' ILE . 35.6 tp -55.64 -41.14 73.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.111 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.4 mm -64.05 -40.37 88.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.265 0.555 . . . . 0.0 109.952 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -67.78 -42.73 81.23 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.456 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 10.6 tpt180 -67.89 -34.72 77.2 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.148 -174.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.68 HG12 HG23 ' A' ' 35' ' ' ILE . 76.8 mt -60.62 -48.72 87.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.577 ' HA ' HD12 ' A' ' 76' ' ' LEU . 40.6 t-80 -66.18 -34.64 78.49 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.21 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.32 -49.33 78.24 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 71' ' ' ARG . 34.2 mm-40 -63.67 -29.55 70.77 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.482 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.845 HD21 HG22 ' A' ' 83' ' ' ILE . 77.0 mt -60.9 -50.19 74.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.887 0.375 . . . . 0.0 111.161 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -84.34 -49.74 8.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.191 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -71.88 -44.16 64.22 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 -176.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -96.29 -24.52 16.16 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.449 -172.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.34 21.71 47.46 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.224 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.78 HG23 HD23 ' A' ' 76' ' ' LEU . 5.1 tt -73.82 146.94 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 117.717 0.758 . . . . 0.0 108.991 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -115.3 127.33 55.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.183 0.516 . . . . 0.0 111.81 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.845 HG22 HD21 ' A' ' 76' ' ' LEU . 5.4 tp -155.95 132.45 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.674 176.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -99.12 151.07 4.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -92.08 -24.99 18.98 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.426 ' HB2' HG23 ' A' ' 49' ' ' THR . 0.2 OUTLIER 72.03 8.06 5.89 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.636 -178.529 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -82.01 127.21 72.77 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.408 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.57 127.78 7.45 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.329 2.019 . . . . 0.0 112.651 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.14 16.76 21.71 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.469 0.652 . . . . 0.0 109.808 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.88 71.5 10.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.89 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -145.38 141.24 28.29 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 175.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -177.35 -71.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 123.637 0.586 . . . . 0.0 109.874 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.7 tt -96.25 -20.53 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.157 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.1 m 61.23 38.09 16.87 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.815 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.85 -6.67 59.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.521 -174.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.318 -1.268 . . . . 0.0 111.601 178.715 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.613 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.2 p -71.31 118.96 14.77 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -77.79 -10.28 59.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.442 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 48.6 tpp -154.27 74.47 6.07 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 121.125 0.488 . . . . 0.0 110.797 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.88 -25.0 6.57 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.931 2.421 . . . . 0.0 112.298 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.461 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 11.5 pt20 -69.57 -26.77 64.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.136 -176.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.641 ' O ' HG13 ' A' ' 35' ' ' ILE . 7.5 mm -66.61 -39.58 84.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.26 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.483 ' HG2' ' HE ' ' A' ' 71' ' ' ARG . 40.6 mt-10 -62.72 -45.47 92.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.071 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 26.2 ptt180 -68.9 -32.4 72.02 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.016 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.593 ' HD3' HD13 ' A' ' 68' ' ' LEU . 29.9 ttt-85 -59.3 -37.42 77.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.165 176.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.648 HD13 ' HA ' ' A' ' 72' ' ' ILE . 45.3 mt -65.55 -44.59 93.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.02 0.438 . . . . 0.0 110.227 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HD3' HD12 ' A' ' 81' ' ' ILE . 1.3 mppt? -66.65 -34.52 78.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.022 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.494 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 96.4 mttt -58.34 -44.6 88.81 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 173.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.543 HD11 ' NH1' ' A' ' 34' ' ' ARG . 48.0 mt -59.26 -50.37 74.25 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.22 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.956 HD11 ' HB ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -61.99 -34.98 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.519 -177.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 71.1 m -67.18 -47.89 69.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.736 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.6 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 96.6 mt -59.69 -42.08 92.16 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.316 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.33 -37.07 85.81 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.155 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.604 ' HG2' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -71.6 -34.0 69.5 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.345 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HE2' ' N ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -68.74 -39.44 80.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.28 174.727 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 1.04 ' HE3' ' HA ' ' A' ' 56' ' ' ALA . 72.2 mmtt -68.67 -26.89 65.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.02 -178.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.42 -63.74 0.3 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.035 177.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -132.37 161.45 33.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.94 0.4 . . . . 0.0 110.916 -173.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.604 HG23 ' HG2' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -84.73 84.27 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.166 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.742 HG23 ' H ' ' A' ' 52' ' ' ASP . 4.8 t -150.93 153.81 35.96 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.226 -174.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.43 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 36.3 t80 -63.55 -29.26 70.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.087 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.21 -39.2 86.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.242 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.742 ' H ' HG23 ' A' ' 49' ' ' THR . 0.8 OUTLIER -71.73 -30.36 65.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.87 176.156 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.572 HG12 ' O ' ' A' ' 49' ' ' THR . 44.8 mm -59.44 -48.89 85.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.01 0.434 . . . . 0.0 110.095 172.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -58.66 -36.32 73.96 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.431 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.83 ' HD3' ' HB3' ' A' ' 45' ' ' LYS . 10.4 ptmt -75.92 -17.76 59.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.041 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.04 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -71.32 -18.65 62.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.392 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 87.6 t80 -56.05 135.49 74.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.333 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 5.9 Cg_exo -75.07 139.54 62.22 Favored 'Cis proline' 0 C--N 1.346 0.437 0 C-N-CA 123.749 -1.355 . . . . 0.0 111.779 -1.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 15.1 Cg_endo -98.2 -173.37 0.17 Allowed 'Trans proline' 0 N--CA 1.436 -1.911 0 C-N-CA 123.738 2.958 . . . . 0.0 110.802 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -97.73 18.9 14.6 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.45 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.412 ' HB2' ' NH2' ' A' ' 34' ' ' ARG . 13.6 p90 -57.01 119.05 5.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 122.05 0.928 . . . . 0.0 110.948 -168.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -81.29 -26.36 35.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.555 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.51 132.68 2.67 Favored Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -112.12 123.89 51.24 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 117.673 0.736 . . . . 0.0 109.82 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 0.9 OUTLIER -159.69 168.57 25.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.026 0.441 . . . . 0.0 112.07 -175.701 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 t -64.75 -28.63 69.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.406 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 71' ' ' ARG . 71.5 m-20 -62.02 -33.85 75.13 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.825 0.345 . . . . 0.0 110.127 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.593 HD13 ' HD3' ' A' ' 34' ' ' ARG . 23.1 tp -65.54 -47.34 76.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.133 172.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.2 mm -58.3 -46.31 89.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.896 0.379 . . . . 0.0 110.812 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 8.6 pt-20 -67.71 -35.01 78.0 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 15.1 tpt180 -71.06 -36.61 72.35 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.169 -174.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.648 ' HA ' HD13 ' A' ' 35' ' ' ILE . 79.7 mt -60.86 -50.36 80.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.539 0.209 . . . . 0.0 110.534 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.506 ' HA ' HD12 ' A' ' 76' ' ' LEU . 45.6 t60 -65.38 -35.64 81.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.868 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 38.8 mt-10 -59.7 -49.27 78.4 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.427 ' HG3' HD12 ' A' ' 35' ' ' ILE . 8.4 mm-40 -64.26 -29.66 70.75 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.693 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.886 HD23 HG23 ' A' ' 81' ' ' ILE . 93.9 mt -64.16 -52.66 57.94 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.134 0.493 . . . . 0.0 111.659 176.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -86.01 -50.04 7.36 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.124 -175.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -74.28 -42.41 59.62 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.21 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -95.09 -32.56 13.05 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.525 -174.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.86 21.41 21.17 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.921 -1.133 . . . . 0.0 114.226 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.886 HG23 HD23 ' A' ' 76' ' ' LEU . 4.8 tt -72.9 139.96 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 119.292 1.546 . . . . 0.0 108.023 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -117.57 136.46 53.26 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.787 -175.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.956 ' HB ' HD11 ' A' ' 39' ' ' ILE . 18.9 tt -168.04 126.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.369 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -98.75 155.34 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-O 121.439 0.638 . . . . 0.0 110.094 -169.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.577 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 1.7 pm0 -85.29 -22.72 28.45 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.557 173.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.562 ' N ' HG13 ' A' ' 84' ' ' VAL . 64.0 t30 74.91 8.6 4.14 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 114.427 -1.261 . . . . 0.0 110.113 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.577 ' HG2' ' HB2' ' A' ' 85' ' ' GLU . 14.6 pt-20 -118.86 137.29 24.83 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.169 174.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 2.5 Cg_endo -82.12 15.32 2.01 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.888 2.392 . . . . 0.0 112.195 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 71.04 -62.06 0.46 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.999 0.812 . . . . 0.0 111.322 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -145.48 91.87 2.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.425 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 73.09 162.94 0.27 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.803 0.811 . . . . 0.0 112.902 175.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -170.36 -49.27 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.394 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.8 tt -71.99 -24.34 22.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.409 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 m 64.93 61.95 0.76 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.928 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -162.77 -57.85 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.54 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.611 -1.105 . . . . 0.0 111.914 179.679 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.951 0 N-CA-C 112.573 -0.211 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.2 m -121.81 78.14 1.43 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.078 0.466 . . . . 0.0 109.776 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -92.42 -33.67 14.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.629 -175.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.486 ' HG2' HG12 ' A' ' 31' ' ' ILE . 33.8 ttp -139.9 75.33 30.42 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.187 0.518 . . . . 0.0 110.683 -174.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -62.16 -23.82 75.81 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.476 2.784 . . . . 0.0 112.773 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.523 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 11.3 pt20 -59.86 -25.4 65.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.32 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.555 ' O ' HG13 ' A' ' 35' ' ' ILE . 17.2 mm -68.94 -48.88 67.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.829 0.347 . . . . 0.0 110.102 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -56.08 -45.29 79.41 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.172 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 10.4 ptm180 -67.92 -38.42 82.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.901 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.612 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -67.37 -38.05 84.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.676 -175.83 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 31' ' ' ILE . 75.6 mt -59.97 -43.56 92.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.178 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.626 ' HD3' HD12 ' A' ' 81' ' ' ILE . 19.9 mmtm -66.38 -36.06 81.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.491 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 37' ' ' LYS . 32.1 mtpt -68.72 -38.09 79.97 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.177 176.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 82.8 mt -61.29 -47.73 84.65 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.407 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.61 ' HB ' HD11 ' A' ' 81' ' ' ILE . 1.5 mp -62.64 -34.75 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.185 0.517 . . . . 0.0 109.814 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.0 t -66.2 -48.1 71.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.956 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.525 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 95.1 mt -59.85 -36.45 76.88 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.244 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.49 -38.99 95.39 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.476 ' HB2' HG23 ' A' ' 48' ' ' ILE . 33.1 tptt -65.61 -39.58 91.68 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.303 0.573 . . . . 0.0 109.577 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HE2' ' N ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -63.07 -42.92 99.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.218 173.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.986 ' HE3' ' HA ' ' A' ' 56' ' ' ALA . 71.6 mmtt -68.09 -26.31 65.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.681 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.83 -64.07 0.32 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.747 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -130.94 158.22 40.84 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.682 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -87.86 79.05 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.681 -175.58 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 1.036 ' HB ' HG13 ' A' ' 84' ' ' VAL . 5.1 t -147.0 160.02 42.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -168.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -56.05 -37.74 69.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.248 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -67.91 -38.99 83.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.394 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.695 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -71.88 -29.89 64.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.363 176.526 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.672 HG12 ' O ' ' A' ' 49' ' ' THR . 49.4 mm -59.21 -49.64 82.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.417 0.627 . . . . 0.0 109.66 171.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -62.03 -34.22 75.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.154 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.816 ' HD3' ' HB3' ' A' ' 45' ' ' LYS . 11.4 ptmt -75.86 -21.33 57.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.906 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.986 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -76.5 -20.41 56.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.287 0.565 . . . . 0.0 110.08 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.531 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 72.7 t80 -72.5 140.46 81.95 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.449 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.503 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 73.8 Cg_endo -79.83 127.28 14.19 Favored 'Cis proline' 0 C--N 1.345 0.362 0 C-N-CA 123.423 -1.49 . . . . 0.0 112.525 -2.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.531 ' HD3' ' CD1' ' A' ' 57' ' ' PHE . 72.3 Cg_endo -105.53 -139.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.889 0 C-N-CA 124.657 3.572 . . . . 0.0 110.887 -176.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.455 ' H ' ' HB2' ' A' ' 59' ' ' PRO . 21.0 p-10 -97.63 16.69 19.72 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -173.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.612 ' HA ' ' HD3' ' A' ' 34' ' ' ARG . 14.0 m-85 -57.42 118.28 4.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.189 0.519 . . . . 0.0 111.519 -173.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.99 -24.74 40.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.974 172.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.17 127.26 1.6 Allowed Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -99.07 131.79 44.86 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.63 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 7.3 t70 -147.36 138.59 23.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.833 0.349 . . . . 0.0 110.587 -169.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.9 m -63.47 -35.78 81.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.241 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.53 ' HB3' ' OD2' ' A' ' 65' ' ' ASP . 0.5 OUTLIER -62.17 -33.0 73.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.112 176.142 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.63 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 33.3 tp -56.49 -39.59 73.5 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.795 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.9 mm -63.7 -40.64 89.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.999 0.428 . . . . 0.0 110.296 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.46 ' OE1' ' HA ' ' A' ' 67' ' ' ASN . 15.8 mt-10 -67.2 -40.82 86.55 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -65.13 -35.23 80.45 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.942 -176.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 68' ' ' LEU . 82.2 mt -60.16 -49.95 82.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.47 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.465 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 16.7 p80 -67.41 -31.57 71.87 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.471 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.587 ' HB3' ' HE3' ' A' ' 78' ' ' LYS . 32.8 mt-10 -60.99 -50.49 73.16 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.553 ' OE2' ' HD2' ' A' ' 78' ' ' LYS . 23.2 mm-40 -62.07 -31.5 71.93 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.971 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.718 ' HA ' HG22 ' A' ' 81' ' ' ILE . 15.1 tp -58.09 -45.36 87.31 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.536 175.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -83.52 -51.67 7.14 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.587 ' HE3' ' HB3' ' A' ' 74' ' ' GLU . 18.8 ptpt -74.06 -42.49 60.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.676 0.274 . . . . 0.0 111.189 -174.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -94.84 -21.13 18.89 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.302 -175.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.94 24.35 41.82 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.863 -1.16 . . . . 0.0 112.971 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.718 HG22 ' HA ' ' A' ' 76' ' ' LEU . 7.6 tt -73.78 123.36 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 117.447 0.623 . . . . 0.0 110.44 -173.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -80.48 120.22 24.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.154 0.502 . . . . 0.0 111.794 -172.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.0 tp -156.69 115.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 122.073 0.94 . . . . 0.0 110.16 -178.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.036 HG13 ' HB ' ' A' ' 49' ' ' THR . 2.3 p -86.37 154.77 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.739 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.0 -31.57 14.19 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.725 0.298 . . . . 0.0 110.616 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.409 ' N ' HG22 ' A' ' 84' ' ' VAL . 61.5 t30 70.08 7.71 6.34 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.766 170.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.67 128.84 75.92 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.872 0.368 . . . . 0.0 110.782 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -73.89 94.27 0.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.908 2.405 . . . . 0.0 112.205 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -62.72 -30.89 71.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.312 175.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -93.46 75.68 4.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.446 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 64.86 -97.15 0.05 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 123.973 0.796 . . . . 0.0 110.996 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -147.46 -68.49 0.25 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 15.0 tt -101.7 -1.53 9.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.049 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.0 m 69.24 48.12 0.68 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.181 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.13 -34.04 38.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.818 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.739 -1.034 . . . . 0.0 112.1 178.709 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.0 m -98.76 16.7 21.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.9 0.381 . . . . 0.0 111.164 -175.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -91.89 -19.57 22.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.997 -175.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.444 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 20.7 ptp -141.74 60.6 11.61 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 28' ' ' MET . 19.9 Cg_exo -66.12 -29.72 47.62 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.352 2.035 . . . . 0.0 111.609 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -64.29 -25.92 68.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.704 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.737 HG23 HD13 ' A' ' 68' ' ' LEU . 18.4 mm -63.67 -49.01 84.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.043 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -55.37 -45.28 76.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.554 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -68.85 -37.75 79.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.231 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.564 HH21 ' HG3' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -67.6 -38.98 84.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.1 -177.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.605 HG13 ' O ' ' A' ' 31' ' ' ILE . 70.8 mt -61.22 -39.31 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-O 120.76 0.314 . . . . 0.0 110.519 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.626 ' HD3' HD12 ' A' ' 81' ' ' ILE . 21.2 mmtm -65.55 -35.41 80.77 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.363 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.564 ' HG3' HH21 ' A' ' 34' ' ' ARG . 13.0 mmmm -67.92 -39.07 83.59 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.525 175.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 78.4 mt -61.81 -48.76 79.17 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.117 0.484 . . . . 0.0 110.438 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.592 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -65.09 -35.27 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.378 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -66.9 -48.45 68.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.229 0.538 . . . . 0.0 109.759 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.664 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 83.1 mt -62.01 -41.15 97.77 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.872 -177.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.23 -35.1 87.65 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -69.05 -44.27 72.97 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.467 0.651 . . . . 0.0 109.728 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.523 ' HE2' ' N ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -60.93 -38.04 84.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.701 174.021 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 28.2 mmtp -69.52 -20.45 63.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.258 -177.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.03 -63.3 0.33 Allowed Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.897 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -135.92 150.74 49.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.994 0.426 . . . . 0.0 111.076 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.461 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -80.79 86.02 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 172.746 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.561 HG23 ' H ' ' A' ' 52' ' ' ASP . 5.4 t -151.07 158.73 44.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.128 -176.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -57.24 -39.8 76.28 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.374 0.421 . . . . 0.0 110.693 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -62.61 -41.15 98.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.825 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.821 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -71.05 -29.35 65.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.788 -176.09 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.4 mm -59.38 -50.39 80.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.358 0.599 . . . . 0.0 109.987 171.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.4 -39.91 84.91 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.809 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.821 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.73 -15.48 59.11 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.902 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HA ' ' NZ ' ' A' ' 45' ' ' LYS . . . -79.18 -19.55 50.6 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.435 175.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.425 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 73.7 t80 -60.86 137.16 93.51 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.027 175.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.538 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 13.1 Cg_endo -88.38 139.3 17.01 Favored 'Cis proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.609 -1.413 . . . . 0.0 113.07 3.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.676 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 27.7 Cg_endo -100.29 -150.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 124.458 3.439 . . . . 0.0 110.189 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.2 15.86 21.5 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.815 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.676 ' CD1' ' HD2' ' A' ' 59' ' ' PRO . 4.3 p90 -58.58 118.64 5.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 122.144 0.973 . . . . 0.0 111.038 -168.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -81.43 -22.28 38.31 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.267 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.75 126.6 1.5 Allowed Glycine 0 N--CA 1.434 -1.488 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -109.66 135.62 50.33 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 13.8 t70 -149.04 158.16 43.96 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.281 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 p -63.89 -35.65 81.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.962 0.41 . . . . 0.0 111.045 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -62.01 -34.79 76.85 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.737 HD13 HG23 ' A' ' 31' ' ' ILE . 26.7 tp -60.29 -40.23 89.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.213 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.4 mm -64.25 -40.98 90.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.914 0.388 . . . . 0.0 110.288 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.7 -40.21 84.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 14.2 tpt180 -61.03 -34.91 75.59 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.671 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 68' ' ' LEU . 82.5 mt -60.84 -45.83 97.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -59.9 -44.2 94.4 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.243 0.545 . . . . 0.0 110.061 175.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -59.31 -47.34 85.76 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.389 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.474 ' C ' HG22 ' A' ' 81' ' ' ILE . 30.0 mm-40 -55.64 -29.8 59.88 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.881 HD21 HG22 ' A' ' 83' ' ' ILE . 53.7 mt -60.45 -48.92 79.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.27 0.557 . . . . 0.0 110.91 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -83.99 -48.49 9.89 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.309 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -70.9 -46.27 62.83 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.44 -173.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.51 -24.37 15.16 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.898 -177.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.1 20.79 41.11 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.44 -0.885 . . . . 0.0 112.995 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.86 HG23 HD23 ' A' ' 76' ' ' LEU . 7.5 tt -76.05 147.08 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -116.94 133.31 56.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.339 0.59 . . . . 0.0 112.378 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.881 HG22 HD21 ' A' ' 76' ' ' LEU . 5.2 tp -167.68 130.85 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.576 -1.193 . . . . 0.0 107.978 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.488 HG12 ' CB ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -88.27 155.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 120.919 0.39 . . . . 0.0 109.995 -177.332 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 39.6 mt-10 -94.53 -23.07 17.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.711 -170.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 61.0 t30 81.75 -4.07 1.56 Allowed 'General case' 0 N--CA 1.465 0.315 0 O-C-N 124.525 1.14 . . . . 0.0 109.676 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 31.0 mt-10 -83.89 129.91 57.23 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.481 174.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 51.7 Cg_exo -54.8 119.53 6.62 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.938 2.425 . . . . 0.0 112.347 -178.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -72.95 -38.58 66.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.069 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -133.97 80.41 1.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.095 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 88' ' ' PRO . 9.0 tp10 -122.63 150.96 41.97 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.595 ' HG3' HG13 ' A' ' 93' ' ' ILE . 9.1 pt-20 -146.83 -59.61 0.29 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.6 -177.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.595 HG13 ' HG3' ' A' ' 92' ' ' GLU . 31.6 mt -100.82 -1.05 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.35 0.595 . . . . 0.0 110.48 -175.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.5 m 65.89 29.98 10.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.293 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.74 128.17 54.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.285 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.812 -0.993 . . . . 0.0 111.818 -178.758 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.8 t -152.81 161.65 42.29 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -122.88 132.74 54.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.063 0.458 . . . . 0.0 110.914 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.4 mtt -120.82 115.9 31.83 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.19 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.79 -27.8 73.34 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.494 2.129 . . . . 0.0 111.368 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.513 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 28.4 tt0 -68.83 -35.43 76.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.607 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.678 ' O ' HG13 ' A' ' 35' ' ' ILE . 9.1 mm -68.12 -48.38 74.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.676 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -60.45 -46.07 91.4 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.469 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 10.8 ptm180 -66.29 -33.15 75.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.505 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.83 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -69.84 -34.53 73.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.518 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.796 HG23 HG12 ' A' ' 72' ' ' ILE . 62.5 mt -58.69 -51.38 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.462 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.509 ' HD3' ' N ' ' A' ' 36' ' ' LYS . 1.8 mppt? -69.28 -35.78 76.4 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.632 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -64.97 -43.68 91.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.985 0.421 . . . . 0.0 109.882 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.477 ' HG ' HG23 ' A' ' 53' ' ' ILE . 6.0 tp -66.73 -45.5 78.46 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.343 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.502 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.4 mp -62.11 -35.48 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.545 ' C ' ' HE2' ' A' ' 44' ' ' LYS . 53.9 m -67.92 -48.58 65.58 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.191 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.72 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 79.5 mt -59.46 -40.08 85.72 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.929 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.54 -34.38 88.21 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.466 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -73.43 -38.21 65.61 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -177.757 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.545 ' HE2' ' C ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -64.5 -29.95 70.99 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.49 174.548 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.72 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 74.5 mmtt -74.73 -11.6 60.21 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.039 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.06 -68.3 0.31 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.285 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.73 170.95 14.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.894 0.378 . . . . 0.0 110.382 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.77 85.88 2.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.198 0.523 . . . . 0.0 109.793 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.557 HG22 ' H ' ' A' ' 51' ' ' GLU . 4.9 m -141.17 146.6 37.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.101 -175.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.463 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 90.8 t80 -60.33 -33.71 72.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.172 0.51 . . . . 0.0 109.908 174.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.557 ' H ' HG22 ' A' ' 49' ' ' THR . 35.9 mt-10 -67.59 -37.33 82.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.574 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 1.025 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.2 m-20 -65.2 -31.27 72.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.006 0.432 . . . . 0.0 110.679 174.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.477 HG23 ' HG ' ' A' ' 38' ' ' LEU . 32.0 mm -64.96 -49.84 77.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.167 0.508 . . . . 0.0 110.545 172.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -61.63 -32.78 72.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.803 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 1.025 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 2.9 ptmt -74.69 -17.27 60.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.017 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.507 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -77.67 -19.76 54.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.514 -175.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.489 ' HA ' ' CD ' ' A' ' 59' ' ' PRO . 44.5 m-85 -59.57 130.81 88.09 Favored Pre-proline 0 N--CA 1.462 0.171 0 O-C-N 123.322 0.389 . . . . 0.0 111.23 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.524 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 3.9 Cg_exo -77.03 123.93 10.07 Favored 'Cis proline' 0 C--O 1.234 0.315 0 C-N-CA 123.998 -1.251 . . . . 0.0 112.33 0.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.529 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 34.8 Cg_endo -100.93 -156.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.687 0 C-N-CA 124.361 3.374 . . . . 0.0 110.751 -177.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -97.73 12.81 32.53 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.023 0.44 . . . . 0.0 111.459 -177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.529 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 3.7 p90 -66.17 120.62 13.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.273 0.559 . . . . 0.0 109.919 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.565 ' HG3' HH11 ' A' ' 34' ' ' ARG . 43.4 mt-10 -81.42 -23.62 37.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.378 0.609 . . . . 0.0 110.346 177.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.29 127.63 1.66 Allowed Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -100.84 136.87 40.02 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.58 -0.448 . . . . 0.0 109.819 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.512 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 10.3 t70 -150.0 142.71 24.62 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.1 t -63.74 -27.13 68.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.56 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -66.06 -33.59 76.15 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.99 0.424 . . . . 0.0 109.898 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.58 HD13 HG23 ' A' ' 31' ' ' ILE . 46.2 tp -59.63 -40.69 88.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.669 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.3 mm -60.83 -41.62 89.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.09 0.471 . . . . 0.0 110.48 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.27 -43.5 73.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.553 0.692 . . . . 0.0 109.156 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.626 ' HG3' HD11 ' A' ' 35' ' ' ILE . 11.5 tpp180 -62.41 -36.51 82.58 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.638 -176.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.796 HG12 HG23 ' A' ' 35' ' ' ILE . 79.9 mt -64.72 -48.22 85.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.505 176.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.518 ' HA ' HD12 ' A' ' 76' ' ' LEU . 32.9 m80 -63.09 -41.12 99.32 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.386 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.25 -42.84 99.68 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.926 -0.309 . . . . 0.0 110.224 176.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.419 ' C ' HG22 ' A' ' 81' ' ' ILE . 10.3 mt-10 -64.53 -28.55 69.72 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 178.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.009 HD23 HG23 ' A' ' 81' ' ' ILE . 78.4 mt -56.97 -47.99 79.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.071 0.462 . . . . 0.0 110.77 176.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -83.87 -50.34 8.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.949 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -74.11 -43.28 58.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.058 -173.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -95.68 -21.85 17.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.246 0.546 . . . . 0.0 110.474 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.11 20.35 57.57 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.936 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.009 HG23 HD23 ' A' ' 76' ' ' LEU . 7.1 tt -75.58 146.58 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -113.89 129.18 56.62 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.632 -177.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.878 HG22 HD21 ' A' ' 76' ' ' LEU . 7.3 tp -159.59 121.33 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 172.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -96.84 158.84 3.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.466 0.65 . . . . 0.0 111.274 -168.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -87.17 -22.93 25.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.961 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.519 ' HB2' ' CG2' ' A' ' 49' ' ' THR . 66.2 t30 75.77 4.3 3.89 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.396 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -124.87 134.21 25.48 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.595 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HB2' ' OE2' ' A' ' 90' ' ' GLU . 37.6 Cg_endo -68.28 123.39 10.52 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.747 2.298 . . . . 0.0 110.924 173.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.75 5.45 51.82 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -169.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.477 ' OE2' ' HB2' ' A' ' 88' ' ' PRO . 6.7 pm0 -74.9 139.48 43.13 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.152 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 59.22 35.91 23.63 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.789 -175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -134.45 -64.81 0.67 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.507 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 50.8 mt -71.95 -17.2 19.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.136 0.494 . . . . 0.0 110.21 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.0 m 69.09 28.1 5.12 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.812 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -158.64 149.34 20.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.211 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.253 -1.304 . . . . 0.0 111.478 -177.604 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.676 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.4 t -117.09 130.05 56.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.828 0.347 . . . . 0.0 111.751 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 75.8 m80 53.9 30.92 12.35 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.157 171.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.879 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 59.2 ttp -128.07 -64.33 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.439 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.621 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.879 ' HD3' ' HB3' ' A' ' 28' ' ' MET . 17.3 Cg_exo -66.18 -32.53 42.48 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 121.85 1.7 . . . . 0.0 111.669 -176.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.548 ' HA ' ' HG2' ' A' ' 33' ' ' ARG . 19.3 pt20 -67.59 -27.6 67.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.92 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.728 ' O ' HG12 ' A' ' 35' ' ' ILE . 34.4 mm -69.29 -51.54 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.64 -44.52 85.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.928 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.548 ' HG2' ' HA ' ' A' ' 30' ' ' GLN . 23.6 ptt180 -69.01 -37.02 78.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.334 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.675 ' NH1' HD11 ' A' ' 38' ' ' LEU . 4.6 tmt_? -67.49 -41.68 84.15 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 121.27 -0.172 . . . . 0.0 111.126 -177.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.728 HG12 ' O ' ' A' ' 31' ' ' ILE . 20.0 mm -59.67 -48.15 88.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 121.18 0.514 . . . . 0.0 110.077 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.413 ' HD3' HD12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -67.39 -35.12 78.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.8 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 37' ' ' LYS . 40.5 mtpt -60.21 -38.5 83.53 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.029 -0.269 . . . . 0.0 110.87 175.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.675 HD11 ' NH1' ' A' ' 34' ' ' ARG . 71.9 mt -59.64 -43.75 93.74 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.197 0.523 . . . . 0.0 110.249 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.718 HD11 HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -61.86 -39.19 82.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.267 178.672 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.622 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 25.0 t -67.37 -49.68 62.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.993 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.602 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 87.7 mt -68.81 -41.94 77.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.978 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.81 -38.49 85.36 Favored Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -63.73 -44.99 91.93 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.622 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -58.26 -38.36 76.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.492 173.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.914 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -69.32 -21.96 63.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.274 -178.123 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.26 -57.51 0.51 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.507 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.446 ' HB2' ' OD2' ' A' ' 52' ' ' ASP . 99.3 m-85 -134.12 163.36 29.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.121 0.486 . . . . 0.0 110.528 -174.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -96.86 85.7 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.533 0.682 . . . . 0.0 109.552 174.022 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 27.0 p -139.41 159.84 41.22 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.645 -175.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -57.69 -37.91 74.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.065 0.46 . . . . 0.0 110.003 176.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -66.14 -46.09 78.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.418 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.767 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 5.1 m-20 -66.7 -31.43 72.09 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.664 HG12 ' O ' ' A' ' 49' ' ' THR . 48.6 mm -63.99 -48.77 84.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.369 0.604 . . . . 0.0 109.963 172.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.553 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 21.4 t70 -61.93 -37.05 83.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.58 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.767 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.34 -15.26 59.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.73 178.427 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.433 ' HB1' ' CB ' ' A' ' 41' ' ' LEU . . . -76.68 -18.9 58.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.907 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.658 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 24.2 m-85 -68.12 165.2 35.23 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.389 176.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.658 ' HA ' ' HB3' ' A' ' 57' ' ' PHE . 96.7 Cg_endo -82.57 157.07 77.31 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 123.895 -1.294 . . . . 0.0 112.672 -0.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 49.2 Cg_endo -104.49 -173.99 0.07 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.6 0 C-N-CA 124.425 3.416 . . . . 0.0 111.359 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -98.56 16.5 21.67 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.745 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.811 ' HE2' HD22 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -59.58 124.13 19.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.979 -169.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -79.12 -13.44 59.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.372 -170.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.12 125.55 1.38 Allowed Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -105.98 130.65 53.87 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.564 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 11.7 t70 -148.91 155.04 40.29 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -176.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.1 t -63.73 -25.9 68.41 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.21 0.529 . . . . 0.0 110.99 176.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.468 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 29.1 t-20 -60.7 -33.32 72.69 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.112 0.482 . . . . 0.0 109.867 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.811 HD22 ' HE2' ' A' ' 61' ' ' PHE . 26.0 tp -54.37 -38.37 66.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.074 173.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.9 mm -62.03 -38.06 79.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.2 0.524 . . . . 0.0 110.125 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 6.7 mm-40 -66.27 -45.06 81.81 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 26.5 mmt180 -60.27 -38.26 83.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.393 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.62 HG13 ' O ' ' A' ' 68' ' ' LEU . 79.3 mt -61.26 -51.29 74.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.807 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.537 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 17.2 p80 -68.73 -30.88 69.6 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.405 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.581 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 44.0 mt-10 -59.33 -50.26 74.65 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.699 173.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.692 ' HG3' HG13 ' A' ' 35' ' ' ILE . 8.3 mm-40 -60.4 -29.85 69.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 120.952 0.406 . . . . 0.0 110.677 176.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.684 ' HA ' HG22 ' A' ' 81' ' ' ILE . 19.3 tp -61.54 -45.29 94.79 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 174.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -83.36 -53.06 6.01 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.581 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 49.1 pttt -74.54 -38.07 62.86 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -173.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.41 -24.82 17.18 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.881 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.9 23.99 43.42 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.746 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.684 HG22 ' HA ' ' A' ' 76' ' ' LEU . 8.0 tt -72.55 121.97 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.429 0.633 . . . . 0.0 111.001 -169.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.533 ' O ' HD11 ' A' ' 39' ' ' ILE . 19.7 m120 -99.72 117.25 33.66 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -171.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.718 HG12 HD11 ' A' ' 39' ' ' ILE . 1.8 mt -149.34 132.25 6.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -90.09 153.9 3.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -177.317 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -87.47 -31.98 19.71 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.033 0.444 . . . . 0.0 110.949 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.4 ' H ' HG13 ' A' ' 84' ' ' VAL . 42.3 t30 69.86 15.99 7.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.269 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.0 mm-40 -76.35 136.99 68.07 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.595 177.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 8.3 Cg_exo -72.65 142.59 36.28 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.827 2.352 . . . . 0.0 111.87 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -81.9 71.23 8.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.462 0.649 . . . . 0.0 109.473 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' A' ' 94' ' ' SER . 10.7 tp10 -126.71 133.03 51.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.647 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.425 ' HA ' ' OE1' ' A' ' 91' ' ' GLU . 6.2 mm-40 -90.65 -45.31 8.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.175 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 179.64 86.14 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 O-C-N 123.633 0.583 . . . . 0.0 110.787 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 15.7 mm 58.1 36.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.778 0.799 . . . . 0.0 110.155 174.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.409 ' H ' ' CD ' ' A' ' 90' ' ' GLU . 19.4 m 59.17 56.07 4.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.109 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.23 124.67 24.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.647 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 119.03 -0.872 . . . . 0.0 111.476 -178.289 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 112.434 -0.266 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.4 p -99.49 39.21 1.32 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.922 -0.163 . . . . 0.0 111.263 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.6 t60 71.49 -59.7 0.54 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.311 0.644 . . . . 0.0 109.918 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.484 ' HB2' HG12 ' A' ' 31' ' ' ILE . 65.1 mtt -147.46 105.85 3.78 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.513 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 36.3 Cg_exo -57.8 -27.11 76.79 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.74 2.293 . . . . 0.0 111.638 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.542 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 14.9 pt20 -64.27 -25.07 67.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.092 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.646 ' O ' HG13 ' A' ' 35' ' ' ILE . 23.9 mm -68.46 -48.34 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.278 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -56.0 -46.36 78.76 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.085 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 21.5 mmm180 -67.25 -40.88 86.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.243 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -66.87 -36.36 82.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.187 -175.639 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.646 HG13 ' O ' ' A' ' 31' ' ' ILE . 74.7 mt -59.89 -44.38 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.599 ' HD3' HD12 ' A' ' 81' ' ' ILE . 26.5 mmtm -67.32 -35.77 80.1 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.142 0.496 . . . . 0.0 110.118 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.611 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 39.7 ttmt -65.99 -38.27 88.07 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.535 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.696 HD11 ' CZ ' ' A' ' 61' ' ' PHE . 93.4 mt -61.08 -50.57 72.74 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.041 0.448 . . . . 0.0 110.085 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.543 ' HB ' HD11 ' A' ' 81' ' ' ILE . 1.5 mp -66.19 -35.14 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.336 -177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' A' ' 37' ' ' LYS . 22.7 p -70.22 -43.37 70.8 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.263 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.641 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 78.4 mt -58.82 -35.41 72.83 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.676 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.59 -32.97 85.96 Favored Glycine 0 CA--C 1.496 -1.152 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.38 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -30.45 65.86 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.565 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.87 -43.73 74.76 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.167 171.516 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.641 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 32.3 mmmt -66.97 -31.94 72.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.555 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.46 -63.86 0.31 Allowed Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.353 175.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -142.77 154.33 44.13 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.441 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -81.93 105.36 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.364 0.602 . . . . 0.0 111.089 -177.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.7 HG23 ' H ' ' A' ' 52' ' ' ASP . 2.5 t -155.48 158.34 38.39 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.393 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -56.81 -29.9 63.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.288 0.566 . . . . 0.0 109.753 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -63.56 -42.18 98.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.498 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.727 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -64.54 -37.67 88.35 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.008 -176.75 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.501 HD12 ' HB3' ' A' ' 38' ' ' LEU . 40.8 mm -59.77 -49.18 84.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.577 0.703 . . . . 0.0 109.772 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -66.93 -34.58 78.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.294 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.727 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 9.5 ptmt -76.46 -20.38 57.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.051 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.2 -19.59 60.48 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.527 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.503 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 39.9 t80 -55.47 139.09 67.79 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.756 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 57' ' ' PHE . 22.9 Cg_exo -66.07 145.3 68.83 Favored 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 124.011 -1.245 . . . . 0.0 112.247 -0.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 14.7 Cg_endo -95.12 -175.33 0.35 Allowed 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 123.743 2.962 . . . . 0.0 110.029 -173.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -98.5 12.73 34.21 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.225 0.536 . . . . 0.0 111.127 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.696 ' CZ ' HD11 ' A' ' 38' ' ' LEU . 32.0 m-85 -63.64 117.78 7.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.066 0.46 . . . . 0.0 111.999 -176.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -82.22 -21.88 36.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.177 170.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.15 127.98 1.69 Allowed Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -104.4 145.06 30.8 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.982 0.391 . . . . 0.0 110.58 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.632 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 11.0 t70 -145.18 156.11 43.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.561 0.22 . . . . 0.0 110.732 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.5 m -63.49 -34.55 78.01 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.212 0.529 . . . . 0.0 111.021 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -61.49 -32.01 72.01 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.983 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.632 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 11.5 tp -56.4 -43.27 79.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.351 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.5 mm -61.56 -47.29 94.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.892 0.377 . . . . 0.0 110.57 -176.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -69.93 -33.74 72.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.868 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.1 tpp85 -70.74 -33.52 70.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.291 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 68' ' ' LEU . 80.2 mt -61.7 -50.54 79.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 176.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.496 ' HA ' HD12 ' A' ' 76' ' ' LEU . 15.4 t-80 -67.1 -34.34 77.42 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.547 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.549 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 36.2 mt-10 -58.87 -50.13 75.16 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 173.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.569 ' HG2' ' HE3' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -59.62 -35.19 73.87 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.494 -179.553 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.872 HD21 HG22 ' A' ' 83' ' ' ILE . 81.5 mt -58.97 -52.2 66.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.05 0.452 . . . . 0.0 111.776 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -85.15 -48.46 9.13 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.251 0.548 . . . . 0.0 112.383 -177.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 18.3 ttmt -71.9 -44.48 63.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.988 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -96.43 -26.96 15.13 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.146 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.26 21.39 35.38 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 119.865 -1.16 . . . . 0.0 113.516 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.803 HG23 HD23 ' A' ' 76' ' ' LEU . 6.5 tt -73.15 144.85 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -113.67 128.61 56.49 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.93 -0.708 . . . . 0.0 112.193 -173.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.872 HG22 HD21 ' A' ' 76' ' ' LEU . 7.0 tp -156.11 133.18 2.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -102.7 166.72 2.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -174.735 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -93.63 -33.56 13.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.659 0.743 . . . . 0.0 109.592 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.556 ' N ' HG13 ' A' ' 84' ' ' VAL . 24.0 t30 68.74 17.71 8.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 113.864 -1.516 . . . . 0.0 109.981 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 7.6 mm-40 -72.6 135.76 81.1 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.199 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 52.8 Cg_exo -54.91 105.14 0.13 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.246 2.631 . . . . 0.0 112.408 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -88.44 38.42 0.86 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.533 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -150.38 90.76 1.68 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.959 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -125.09 60.07 1.22 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.393 0.616 . . . . 0.0 110.953 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -75.53 -71.39 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.2 mt -104.02 -34.1 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.2 t 74.28 -49.78 0.67 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.493 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.2 88.32 2.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.018 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.756 0 CA-C-O 119.08 -0.844 . . . . 0.0 111.681 177.853 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.5 p -84.81 -32.85 23.1 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 51.3 60.94 3.5 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.515 0.674 . . . . 0.0 110.454 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.623 ' O ' HG22 ' A' ' 31' ' ' ILE . 47.7 ttm -143.73 81.05 12.3 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.198 -178.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -60.78 -24.6 79.32 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.816 2.344 . . . . 0.0 112.792 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.508 ' HG3' ' HG2' ' A' ' 28' ' ' MET . 1.5 pp0? -64.58 -29.59 70.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.31 -174.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.623 HG22 ' O ' ' A' ' 28' ' ' MET . 11.3 tp -70.22 -45.85 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.861 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.825 ' HG2' ' HD3' ' A' ' 71' ' ' ARG . 25.6 mt-10 -70.85 -41.2 71.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.753 0.311 . . . . 0.0 110.771 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 11.7 ptt180 -62.22 -32.53 73.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.587 HH11 HD22 ' A' ' 68' ' ' LEU . 25.1 ttm180 -64.29 -37.81 88.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.039 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.535 HG22 ' CD1' ' A' ' 81' ' ' ILE . 15.6 mm -60.33 -50.48 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.641 ' HD3' HD12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -68.21 -35.24 77.67 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.482 179.021 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.53 ' HG2' ' HB2' ' A' ' 60' ' ' ASP . 2.6 tppp? -64.7 -42.35 95.35 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.42 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.675 ' HB3' HD12 ' A' ' 53' ' ' ILE . 75.3 mt -59.66 -48.53 81.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.948 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.082 HD11 ' HB ' ' A' ' 83' ' ' ILE . 0.5 OUTLIER -65.71 -36.55 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.419 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.651 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 47.6 t -68.09 -50.37 55.38 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.824 -176.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.682 HD12 ' HB3' ' A' ' 59' ' ' PRO . 36.2 mt -69.39 -41.56 76.28 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.016 -176.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.04 -39.99 94.99 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.89 -40.33 72.28 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.651 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -59.93 -37.32 79.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.186 174.458 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.678 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 73.5 mmtt -68.56 -31.98 71.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.784 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.11 -68.0 0.17 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.584 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -132.4 163.86 27.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.369 0.604 . . . . 0.0 111.534 -171.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.502 HG22 HD12 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -93.51 84.07 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.808 178.726 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.793 HG23 ' H ' ' A' ' 52' ' ' ASP . 10.0 t -155.45 158.28 38.31 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.452 -174.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.411 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 17.9 t80 -57.38 -37.06 72.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.883 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -64.31 -41.75 96.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.512 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.793 ' H ' HG23 ' A' ' 49' ' ' THR . 0.9 OUTLIER -71.97 -29.99 64.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.348 177.338 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.675 HD12 ' HB3' ' A' ' 38' ' ' LEU . 45.4 mm -59.47 -49.02 85.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.176 0.512 . . . . 0.0 110.321 172.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.789 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 16.9 t70 -58.52 -37.94 76.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.459 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.692 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.29 -15.51 59.4 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.794 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.81 -20.02 33.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.996 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.834 ' HD1' ' HD3' ' A' ' 59' ' ' PRO . 16.3 m-85 -61.7 145.35 92.01 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.163 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.497 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 22.3 Cg_endo -95.8 128.71 3.66 Favored 'Cis proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.275 -1.135 . . . . 0.0 112.104 -3.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.834 ' HD3' ' HD1' ' A' ' 57' ' ' PHE . 77.5 Cg_endo -106.6 -108.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.944 0 C-N-CA 123.667 2.911 . . . . 0.0 112.785 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.53 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -100.45 10.86 40.62 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -170.613 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.789 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 12.9 p90 -79.52 117.87 20.86 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 118.891 -1.124 . . . . 0.0 110.186 -177.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.456 ' HB2' ' NE2' ' A' ' 30' ' ' GLN . 97.8 mt-10 -81.11 -26.08 36.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.587 173.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.57 127.26 1.59 Allowed Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -76.18 135.45 39.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 117.402 0.601 . . . . 0.0 109.38 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 10.6 p-10 -151.5 151.2 31.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.983 0.421 . . . . 0.0 111.472 -168.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.7 m -64.02 -29.66 70.79 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.146 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.433 ' OD1' HG12 ' A' ' 31' ' ' ILE . 2.6 t-20 -61.49 -33.85 74.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.426 177.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.587 HD22 HH11 ' A' ' 34' ' ' ARG . 46.3 tp -56.36 -41.89 76.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.964 175.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.4 mm -59.95 -42.97 91.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.007 0.432 . . . . 0.0 110.327 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 12.6 mt-10 -68.85 -43.9 74.49 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.825 ' HD3' ' HG2' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -59.51 -40.98 88.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.029 -174.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.565 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 82.7 mt -61.11 -49.48 84.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.512 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.472 ' HA ' HD12 ' A' ' 76' ' ' LEU . 32.2 m170 -65.9 -38.46 88.8 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.439 -177.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 51.4 mt-10 -62.75 -47.14 84.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.455 177.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 79' ' ' HIS . 12.1 mm-40 -59.35 -29.6 67.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.84 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.702 HD23 HG23 ' A' ' 81' ' ' ILE . 91.6 mt -58.04 -48.03 81.33 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.783 0.325 . . . . 0.0 110.397 175.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -84.32 -52.03 6.53 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 19.8 pttp -73.23 -37.56 66.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -174.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.43 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 30.5 t60 -94.03 -34.73 12.91 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.548 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.79 22.59 30.43 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.837 -175.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.702 HG23 HD23 ' A' ' 76' ' ' LEU . 6.6 tt -72.73 138.73 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -175.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -117.06 124.67 49.85 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.387 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.082 ' HB ' HD11 ' A' ' 39' ' ' ILE . 19.8 tt -159.3 132.49 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.753 -174.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.541 HG12 ' HB ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -98.24 154.27 3.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.121 0.486 . . . . 0.0 110.729 -172.792 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -86.43 -34.63 20.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.438 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 76.81 -11.16 1.22 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.211 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 79.2 mm-40 -96.32 141.53 23.26 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.532 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 23.3 Cg_exo -64.06 133.07 36.71 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.858 2.372 . . . . 0.0 112.266 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -76.75 -20.9 55.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.754 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 66.85 24.5 9.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.823 -1.08 . . . . 0.0 112.609 171.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -107.02 80.0 1.38 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 171.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -98.76 -78.37 0.5 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.1 tp -119.39 -9.43 11.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.358 176.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.5 m 63.29 -82.27 0.02 OUTLIER 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.303 -174.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.03 -43.98 0.47 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.248 0.547 . . . . 0.0 109.688 176.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 117.998 -1.446 . . . . 0.0 110.622 -178.795 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.177 -0.369 . . . . 0.0 112.177 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.0 p -72.2 136.74 46.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.857 0.36 . . . . 0.0 110.666 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -123.67 -35.53 2.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.476 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.464 ' SD ' HG12 ' A' ' 31' ' ' ILE . 54.7 ttm -169.24 99.1 0.5 Allowed Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -177.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.713 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 57.7 Cg_exo -52.63 -32.74 55.79 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.984 2.456 . . . . 0.0 112.521 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -58.72 -39.22 80.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.766 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.669 ' O ' HG13 ' A' ' 35' ' ' ILE . 16.7 mm -67.69 -45.33 84.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.677 177.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -56.54 -45.17 81.32 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.861 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.713 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 14.4 mmt180 -65.36 -39.53 92.43 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.444 0.64 . . . . 0.0 109.918 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.463 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -66.26 -35.85 81.47 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.23 -176.528 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.669 HG13 ' O ' ' A' ' 31' ' ' ILE . 62.6 mt -59.57 -44.11 92.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.619 ' HD3' HD12 ' A' ' 81' ' ' ILE . 48.2 mmtt -67.02 -42.38 85.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.56 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.62 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 8.7 mtpm? -62.14 -39.15 91.64 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.488 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.613 HD11 ' HZ ' ' A' ' 61' ' ' PHE . 55.2 mt -60.43 -47.74 84.8 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.461 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.66 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.4 mp -62.28 -35.37 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.075 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.61 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 22.5 t -67.02 -47.48 71.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.206 177.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.726 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 88.6 mt -59.96 -44.96 94.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.682 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.61 -37.07 84.53 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.448 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 15.4 tptm -65.33 -43.88 89.54 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.206 0.526 . . . . 0.0 110.08 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.61 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -59.32 -35.37 73.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.538 174.459 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.97 ' HE2' ' HA ' ' A' ' 56' ' ' ALA . 44.1 mmtm -68.62 -25.27 64.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.829 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.22 -62.31 0.31 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.432 -0.89 . . . . 0.0 113.076 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -134.71 157.75 45.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.995 0.426 . . . . 0.0 110.261 -175.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -81.12 86.43 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-O 121.077 0.465 . . . . 0.0 109.814 175.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.696 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 10.1 t -152.11 153.33 33.69 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.386 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -61.42 -30.31 70.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.984 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -67.49 -38.02 83.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.341 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 1.0 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -71.99 -31.53 66.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.163 176.245 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 49' ' ' THR . 49.0 mm -60.88 -49.75 83.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.383 0.611 . . . . 0.0 110.072 172.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -57.02 -38.9 73.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.346 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 1.0 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 7.4 ptmt -75.83 -15.75 60.19 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.979 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.97 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -77.14 -18.84 57.59 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.929 -178.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.631 ' CD1' ' HG3' ' A' ' 59' ' ' PRO . 18.5 m-30 -61.0 145.67 88.95 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.509 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 7.0 Cg_exo -73.82 144.61 81.55 Favored 'Cis proline' 0 C--N 1.347 0.496 0 C-N-CA 124.26 -1.142 . . . . 0.0 112.53 0.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.715 ' HG2' ' CD2' ' A' ' 61' ' ' PHE . 37.4 Cg_endo -104.4 -157.47 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.565 0 C-N-CA 124.64 3.56 . . . . 0.0 111.054 -176.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.44 11.16 37.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.846 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.715 ' CD2' ' HG2' ' A' ' 59' ' ' PRO . 23.2 m-85 -63.14 117.64 6.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.28 0.562 . . . . 0.0 112.254 -171.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -81.61 -21.93 38.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.666 168.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.57 126.9 1.54 Allowed Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -103.25 144.85 30.8 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 117.091 0.445 . . . . 0.0 110.384 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -151.36 156.33 40.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.841 0.353 . . . . 0.0 110.962 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 m -63.07 -24.57 67.97 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.285 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.664 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 26.2 t30 -57.23 -38.55 73.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.197 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.537 ' O ' HG13 ' A' ' 72' ' ' ILE . 27.8 tp -57.47 -39.86 77.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.414 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.5 mm -62.25 -41.54 91.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.162 0.506 . . . . 0.0 110.192 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -68.17 -42.1 80.51 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.678 0.752 . . . . 0.0 109.107 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 13.5 mmt180 -68.34 -34.63 76.45 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.503 -174.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 68' ' ' LEU . 75.6 mt -61.59 -49.0 86.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.676 0.274 . . . . 0.0 110.754 177.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -64.09 -39.53 94.26 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.092 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -59.11 -49.8 76.47 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.405 ' C ' HG22 ' A' ' 81' ' ' ILE . 18.0 mm-40 -56.59 -29.76 62.43 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.868 HD23 HG23 ' A' ' 81' ' ' ILE . 85.9 mt -58.65 -50.08 75.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.92 0.391 . . . . 0.0 111.247 176.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -85.1 -48.06 9.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.512 0.673 . . . . 0.0 111.617 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -69.61 -45.17 69.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.533 -173.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.97 -31.69 11.68 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.963 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.92 22.04 19.1 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.264 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.868 HG23 HD23 ' A' ' 76' ' ' LEU . 6.8 tt -73.69 145.56 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 118.507 1.153 . . . . 0.0 108.188 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -116.73 130.31 56.65 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.091 -0.644 . . . . 0.0 112.457 -174.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.691 HG22 HD21 ' A' ' 76' ' ' LEU . 4.2 tp -168.49 133.79 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.24 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -91.95 150.46 3.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -96.29 -23.15 16.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.882 0.372 . . . . 0.0 110.487 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 60.1 t30 76.4 5.17 3.62 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.503 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -103.55 128.63 27.02 Favored Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.546 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -88.14 144.49 6.03 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.599 2.199 . . . . 0.0 111.933 173.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -104.12 -9.49 18.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.193 0.52 . . . . 0.0 110.052 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.653 ' HG3' ' H ' ' A' ' 91' ' ' GLU . 6.9 pt-20 -85.01 -64.44 1.16 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.221 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.653 ' H ' ' HG3' ' A' ' 90' ' ' GLU . 38.0 tt0 -83.24 72.41 10.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.532 0.682 . . . . 0.0 110.393 -177.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -152.03 -59.7 0.16 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.835 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.6 tt -74.86 -43.14 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 171.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.1 m 49.07 64.31 1.78 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.267 0.556 . . . . 0.0 111.78 177.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -112.95 158.6 20.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.45 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.493 -1.171 . . . . 0.0 111.536 179.87 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 111.981 -0.447 . . . . 0.0 111.981 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.7 t -94.49 124.29 38.43 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -94.62 25.52 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.037 0.446 . . . . 0.0 110.856 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 45.7 ttm -149.21 72.7 10.12 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.365 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.74 -24.76 76.93 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.443 2.762 . . . . 0.0 113.159 -174.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -60.55 -25.77 66.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.417 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.617 ' O ' HG13 ' A' ' 35' ' ' ILE . 26.1 mm -66.44 -49.94 71.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 177.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -54.84 -45.9 74.55 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.156 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -66.94 -42.47 85.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.286 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.699 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -63.19 -40.21 96.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.212 -175.677 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.695 HD13 ' HA ' ' A' ' 72' ' ' ILE . 54.2 mt -59.51 -40.53 82.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.011 0.434 . . . . 0.0 109.934 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.732 ' HD3' HD12 ' A' ' 81' ' ' ILE . 32.5 mmtm -66.89 -39.49 87.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.696 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.498 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 87.7 mttt -64.76 -43.61 92.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.978 176.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.79 -44.03 97.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.334 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.566 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -62.88 -36.09 74.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.38 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.417 ' C ' ' HE3' ' A' ' 44' ' ' LYS . 48.9 m -66.28 -46.32 77.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.099 0.476 . . . . 0.0 110.023 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.709 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 97.6 mt -58.89 -47.32 85.37 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.219 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.16 -33.71 86.73 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.487 ' HB2' HG23 ' A' ' 48' ' ' ILE . 12.2 tptt -73.39 -40.0 64.67 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.414 -0.893 . . . . 0.0 109.44 -174.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.709 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 5.4 ptpt -75.98 -31.77 59.15 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.752 -177.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 66.8 mmtt -76.83 -9.75 58.9 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.105 177.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.69 -70.31 0.31 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.883 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -133.97 148.44 51.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.222 0.534 . . . . 0.0 111.455 -168.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -78.53 86.83 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.237 0.541 . . . . 0.0 109.901 176.029 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.683 HG23 ' H ' ' A' ' 52' ' ' ASP . 8.9 t -156.75 158.21 36.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.467 -175.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -63.62 -30.48 71.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 110.871 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.5 -41.11 93.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.557 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.929 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -71.95 -29.13 63.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.04 177.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.582 HG12 ' O ' ' A' ' 49' ' ' THR . 48.1 mm -59.4 -50.59 79.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.157 0.503 . . . . 0.0 109.972 172.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.515 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 0.5 OUTLIER -57.58 -34.43 69.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.69 177.493 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.929 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 4.5 ptmt -75.81 -18.86 59.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.025 -178.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.97 -20.11 42.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.547 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.515 ' CD2' ' HA ' ' A' ' 54' ' ' ASP . 80.2 m-85 -62.67 142.95 96.81 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.872 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.477 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 86.3 Cg_endo -84.24 143.19 41.13 Favored 'Cis proline' 0 C--N 1.345 0.362 0 C-N-CA 123.394 -1.502 . . . . 0.0 112.779 -1.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.591 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 39.8 Cg_endo -103.87 -156.72 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 124.785 3.656 . . . . 0.0 111.104 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -97.98 16.03 22.23 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.177 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.699 ' HA ' ' HD3' ' A' ' 34' ' ' ARG . 7.0 p90 -58.43 121.21 10.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 122.083 0.944 . . . . 0.0 111.723 -167.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -79.33 -24.93 42.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.408 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.1 127.34 1.59 Allowed Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -111.1 128.81 56.0 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -153.0 157.87 41.19 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 -175.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -27.05 65.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.513 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.434 ' OD1' ' HD2' ' A' ' 71' ' ' ARG . 10.5 t-20 -61.52 -35.16 76.92 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.335 176.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.657 ' O ' HG13 ' A' ' 72' ' ' ILE . 57.6 tp -64.08 -39.53 94.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.891 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.2 mm -64.06 -46.78 92.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.712 0.291 . . . . 0.0 110.701 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.483 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 16.6 pt-20 -68.99 -33.1 73.13 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.586 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 42.4 mtt180 -72.27 -29.59 64.03 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.18 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.695 ' HA ' HD13 ' A' ' 35' ' ' ILE . 64.3 mt -58.87 -50.56 79.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.542 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 30.7 p80 -69.82 -32.79 71.42 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.986 176.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 71' ' ' ARG . 13.4 mt-10 -59.48 -50.25 74.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.981 0.419 . . . . 0.0 110.452 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.731 ' HA ' ' HG2' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -67.86 -27.42 66.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.688 178.07 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.937 ' HA ' HG22 ' A' ' 81' ' ' ILE . 12.6 tp -56.54 -45.31 81.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.863 172.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -83.1 -51.55 7.43 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.731 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 11.7 ptpt -72.06 -39.1 69.29 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -173.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -94.14 -32.13 13.87 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.635 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.37 24.87 15.09 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.421 -1.371 . . . . 0.0 113.131 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.937 HG22 ' HA ' ' A' ' 76' ' ' LEU . 5.9 tt -72.23 144.44 13.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 117.202 0.501 . . . . 0.0 109.858 -174.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -102.6 123.14 45.77 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.337 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.566 ' HB ' HG13 ' A' ' 39' ' ' ILE . 4.5 tp -162.31 137.15 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.53 HG12 ' HB ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -103.14 156.09 5.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.115 0.483 . . . . 0.0 110.353 -176.31 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 7.0 mm-40 -89.83 -25.36 21.09 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.733 -175.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.534 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 8.3 t30 80.56 -12.17 1.06 Allowed 'General case' 0 N--CA 1.463 0.183 0 O-C-N 124.571 1.17 . . . . 0.0 110.185 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -86.65 129.11 54.05 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.316 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.5 129.05 23.98 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.661 2.241 . . . . 0.0 112.388 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -89.03 -3.04 58.82 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.238 0.542 . . . . 0.0 109.697 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.639 ' HB3' ' OXT' ' A' ' 96' ' ' GLY . 32.9 mt-10 67.31 -148.3 0.16 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.805 172.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.404 ' HG2' ' OXT' ' A' ' 96' ' ' GLY . 31.5 mm-40 -48.22 -39.25 20.6 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.675 ' HG3' ' H ' ' A' ' 93' ' ' ILE . 5.0 pt-20 -172.02 -72.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.85 0.357 . . . . 0.0 110.664 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.675 ' H ' ' HG3' ' A' ' 92' ' ' GLU . 1.4 pp -120.9 50.52 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.155 0.502 . . . . 0.0 110.175 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.9 m 60.36 60.73 1.94 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.016 -174.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -107.64 5.83 27.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.545 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.639 ' OXT' ' HB3' ' A' ' 90' ' ' GLU . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.532 -1.149 . . . . 0.0 111.892 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.799 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 p -71.57 145.58 48.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.678 0.275 . . . . 0.0 110.54 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -142.62 -65.27 0.4 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.659 0.266 . . . . 0.0 111.501 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.545 ' O ' HG22 ' A' ' 31' ' ' ILE . 28.0 ttt -149.78 87.13 5.18 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-O 121.007 0.432 . . . . 0.0 110.029 -173.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.63 -24.48 75.01 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.837 2.358 . . . . 0.0 112.742 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.643 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 23.6 tm0? -65.58 -39.17 91.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.963 0.411 . . . . 0.0 110.857 -175.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.664 HD11 ' HB2' ' A' ' 68' ' ' LEU . 10.4 tp -71.89 -38.78 66.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.207 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.31 -40.52 74.15 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.964 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 3.2 ptm180 -61.32 -36.04 79.03 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.699 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.623 ' HD2' ' HA ' ' A' ' 61' ' ' PHE . 48.1 ttp85 -65.07 -35.76 82.18 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.812 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.607 HD13 ' HA ' ' A' ' 72' ' ' ILE . 21.8 mt -60.48 -45.2 97.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 110.579 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.509 ' HD3' HD12 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -67.11 -39.71 86.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.371 177.474 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 33' ' ' ARG . 14.4 mmmm -61.75 -39.6 92.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.185 0.517 . . . . 0.0 109.616 176.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 54.9 mt -63.59 -46.82 84.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.359 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.586 HD11 ' HB ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -62.06 -35.57 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.41 -178.443 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.6 p -67.61 -45.89 74.13 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.689 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.737 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 96.4 mt -59.26 -45.8 90.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.219 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.74 -34.82 78.74 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -42.04 87.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.04 0.924 . . . . 0.0 109.068 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.456 ' HE2' ' N ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -64.1 -39.99 95.25 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 113.815 -1.539 . . . . 0.0 110.583 175.115 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.765 ' HE2' ' HA ' ' A' ' 56' ' ' ALA . 45.4 mmtm -67.91 -31.5 71.32 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.774 -178.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.01 -67.55 0.17 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.236 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -137.63 171.18 14.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.851 0.358 . . . . 0.0 110.733 -171.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.656 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -83.55 86.07 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 122.486 1.136 . . . . 0.0 108.863 173.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.58 ' O ' HG12 ' A' ' 53' ' ' ILE . 6.0 m -145.79 151.74 38.43 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.258 -174.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -59.43 -36.02 75.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.962 0.41 . . . . 0.0 110.113 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.537 ' H ' HG22 ' A' ' 49' ' ' THR . 35.5 mt-10 -58.71 -40.99 85.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.484 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.692 ' HA ' ' CD ' ' A' ' 55' ' ' LYS . 5.2 m-20 -71.68 -32.35 67.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.233 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 49' ' ' THR . 39.6 mm -66.89 -49.65 72.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.79 0.805 . . . . 0.0 109.781 174.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.64 -33.74 76.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.278 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.692 ' CD ' ' HA ' ' A' ' 52' ' ' ASP . 15.6 ptmt -76.33 -19.99 57.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.985 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.765 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -74.2 -18.95 60.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.875 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -57.25 132.55 81.0 Favored Pre-proline 0 N--CA 1.466 0.352 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.119 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 57.2 Cg_endo -71.85 133.4 28.68 Favored 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 123.707 -1.372 . . . . 0.0 112.705 0.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.554 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 35.2 Cg_endo -101.51 -157.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 124.347 3.365 . . . . 0.0 111.27 -175.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -97.17 13.62 28.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.622 -175.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.623 ' HA ' ' HD2' ' A' ' 34' ' ' ARG . 8.2 p90 -63.06 120.15 10.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.453 0.644 . . . . 0.0 110.933 -175.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.587 ' HB2' ' NE2' ' A' ' 30' ' ' GLN . 24.5 mt-10 -79.55 -26.74 41.32 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.8 135.52 3.74 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -95.64 130.04 42.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 117.452 0.626 . . . . 0.0 110.018 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -137.01 145.3 43.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.567 -171.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.6 t -65.36 -27.1 68.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.674 0.749 . . . . 0.0 109.682 170.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -61.15 -32.24 71.96 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.819 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.664 ' HB2' HD11 ' A' ' 31' ' ' ILE . 3.3 tm? -54.38 -41.85 69.68 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.467 176.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 23.0 mm -65.31 -42.68 94.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-O 121.687 0.756 . . . . 0.0 110.052 -177.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.651 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 12.4 mt-10 -64.63 -45.05 88.48 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.562 ' HG2' HG23 ' A' ' 31' ' ' ILE . 15.5 tpt180 -71.16 -32.09 68.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.949 -170.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.607 ' HA ' HD13 ' A' ' 35' ' ' ILE . 24.3 pt -63.63 -46.66 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.597 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.536 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 28.5 p80 -68.52 -33.3 73.88 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 118.976 -1.089 . . . . 0.0 111.918 177.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.69 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 4.2 mm-40 -65.06 -50.02 67.81 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.974 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.6 ' HG3' HD12 ' A' ' 35' ' ' ILE . 4.0 mm-40 -63.0 -28.22 69.95 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.899 176.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.58 ' HA ' HG22 ' A' ' 81' ' ' ILE . 11.3 tp -57.73 -40.89 80.68 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.116 172.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -83.79 -51.77 6.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.69 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 9.8 ptmm? -72.33 -42.82 64.96 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -174.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.448 ' HB2' ' OE1' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -95.62 -22.7 17.43 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.136 -178.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.56 23.98 41.02 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.242 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.58 HG22 ' HA ' ' A' ' 76' ' ' LEU . 6.0 tt -73.52 119.93 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.633 0.73 . . . . 0.0 111.492 -170.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -90.82 129.12 36.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.668 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.656 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 17.7 tt -173.5 131.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -175.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -90.84 151.82 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 121.179 0.514 . . . . 0.0 110.227 -173.636 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -90.74 -23.47 20.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.042 -172.537 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 58.4 t30 83.44 -11.59 0.9 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.542 1.151 . . . . 0.0 109.666 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -62.95 135.06 95.97 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.339 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.8 120.22 7.88 Favored 'Trans proline' 0 N--CA 1.466 -0.13 0 C-N-CA 122.639 2.226 . . . . 0.0 111.833 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -40.61 86.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.882 -174.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -133.85 -24.56 1.7 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.602 0.239 . . . . 0.0 111.564 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.493 ' HA ' ' OG ' ' A' ' 94' ' ' SER . 5.5 mm-40 -83.32 71.52 10.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.259 0.552 . . . . 0.0 111.174 -177.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -105.4 -81.45 0.54 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.6 tp -93.86 -30.43 4.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.493 ' OG ' ' HA ' ' A' ' 91' ' ' GLU . 31.8 m 46.33 61.84 2.56 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.729 174.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.57 144.65 37.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.05 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.755 0 CA-C-O 118.967 -0.907 . . . . 0.0 111.351 178.524 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.87 0 N-CA-C 112.29 -0.324 . . . . 0.0 112.29 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.3 m -73.53 -24.48 60.14 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.886 0.374 . . . . 0.0 111.15 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -86.27 83.19 7.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.133 0.492 . . . . 0.0 110.114 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.579 ' HB3' HG12 ' A' ' 31' ' ' ILE . 59.7 mtt -128.78 74.63 80.59 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.253 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.478 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 33.2 Cg_exo -60.26 -25.39 80.01 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.322 2.014 . . . . 0.0 111.018 173.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 10.6 pt20 -59.18 -35.02 72.82 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.895 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.579 HG12 ' HB3' ' A' ' 28' ' ' MET . 36.7 mm -66.44 -42.9 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.204 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.453 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 38.6 tt0 -58.02 -45.75 86.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.106 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 31.9 mmt-85 -66.06 -44.19 85.26 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.994 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.663 ' HD3' ' O ' ' A' ' 60' ' ' ASP . 0.1 OUTLIER -64.91 -37.89 89.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.559 -173.154 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.569 HD12 ' HG3' ' A' ' 75' ' ' GLU . 70.0 mt -64.67 -37.79 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.581 ' HD3' HD12 ' A' ' 81' ' ' ILE . 15.9 mmtm -66.74 -35.7 80.74 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.142 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.703 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 34.6 mtpt -65.63 -40.99 93.16 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.352 175.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.568 HD13 ' HE2' ' A' ' 61' ' ' PHE . 14.6 tp -59.66 -50.0 75.55 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.586 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -61.95 -34.93 65.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.212 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.695 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 23.1 t -66.11 -44.63 83.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.768 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 77.6 mt -58.8 -37.53 76.57 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.81 -38.62 89.61 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.443 ' HD3' ' O ' ' A' ' 43' ' ' LYS . 13.7 tppt? -67.94 -35.24 78.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.194 0.521 . . . . 0.0 110.149 178.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.695 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -69.92 -38.54 76.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.688 0.756 . . . . 0.0 109.717 175.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.715 ' HB3' ' HD3' ' A' ' 55' ' ' LYS . 29.8 mmtm -68.6 -29.04 67.47 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.809 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.39 -65.92 0.26 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.849 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -136.14 157.21 47.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.053 0.454 . . . . 0.0 110.947 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.9 86.58 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.17 0.51 . . . . 0.0 109.981 177.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.792 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 8.5 t -153.78 155.64 36.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.599 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -57.58 -40.4 78.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.424 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.9 -34.34 76.46 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.745 0.307 . . . . 0.0 110.891 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.96 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -72.52 -30.94 64.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.932 0.396 . . . . 0.0 111.057 174.731 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.4 mm -64.49 -49.2 81.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.213 0.53 . . . . 0.0 110.169 171.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -57.32 -33.73 68.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.762 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.96 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 1.2 ptmt -76.66 -22.08 54.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.31 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.46 -19.27 42.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.003 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 67.6 t80 -56.41 140.69 72.49 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.399 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.479 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 86.3 Cg_endo -83.49 148.69 61.43 Favored 'Cis proline' 0 C--N 1.347 0.456 0 C-N-CA 123.781 -1.341 . . . . 0.0 112.904 0.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.575 ' HG2' ' HD2' ' A' ' 61' ' ' PHE . 36.7 Cg_endo -102.43 -160.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 124.412 3.408 . . . . 0.0 110.432 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.663 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 22.8 m-20 -97.8 11.26 37.85 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.575 ' HD2' ' HG2' ' A' ' 59' ' ' PRO . 60.2 m-85 -62.79 118.32 7.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.42 0.629 . . . . 0.0 111.217 -175.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -82.36 -12.12 58.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.563 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.62 124.28 1.33 Allowed Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -114.78 136.37 53.15 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.835 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 31.7 t70 -160.63 168.32 25.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.743 -0.208 . . . . 0.0 110.57 178.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.0 m -58.5 -32.31 68.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.681 0.277 . . . . 0.0 111.097 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.458 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . 5.1 t-20 -61.26 -34.08 74.58 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.153 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.614 ' O ' HG13 ' A' ' 72' ' ' ILE . 54.5 tp -58.96 -41.6 87.86 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.549 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.69 -39.41 83.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.247 0.546 . . . . 0.0 110.241 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 16.6 mt-10 -68.15 -42.98 79.29 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -64.58 -32.8 74.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.458 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.614 HG13 ' O ' ' A' ' 68' ' ' LEU . 80.3 mt -61.6 -51.35 73.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.583 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.497 ' CD2' ' HA ' ' A' ' 70' ' ' GLU . 29.4 p80 -68.77 -32.77 72.76 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.041 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -59.29 -47.24 86.11 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.569 ' HG3' HD12 ' A' ' 35' ' ' ILE . 25.2 mm-40 -64.31 -32.9 74.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.883 0.373 . . . . 0.0 110.859 175.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.661 ' HA ' HG22 ' A' ' 81' ' ' ILE . 22.3 tp -60.98 -46.77 89.4 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.922 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -82.62 -51.57 7.62 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -73.31 -45.22 56.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.265 -174.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -96.44 -16.24 21.3 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.65 -176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.74 24.5 49.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 119.678 -1.249 . . . . 0.0 113.835 171.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.661 HG22 ' HA ' ' A' ' 76' ' ' LEU . 7.8 tt -72.35 119.59 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 117.99 0.895 . . . . 0.0 110.716 -173.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -81.31 125.02 29.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.033 0.444 . . . . 0.0 111.119 -172.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.586 ' HB ' HG13 ' A' ' 39' ' ' ILE . 3.6 tp -166.61 123.15 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.426 -176.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.792 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -89.79 152.36 3.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -95.38 -25.36 16.31 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.935 0.397 . . . . 0.0 110.246 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.418 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 56.1 t30 72.71 -0.73 3.23 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.027 -177.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.6 153.96 81.6 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 50.4 Cg_exo -55.04 -53.32 6.14 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 122.982 2.454 . . . . 0.0 114.404 -173.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -177.71 -47.87 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.717 -167.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -150.78 30.06 0.66 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.375 -0.829 . . . . 0.0 108.993 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.497 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . 52.8 mm-40 -124.88 28.73 6.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.658 -172.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -64.81 -63.4 1.13 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.592 HG13 ' H ' ' A' ' 95' ' ' ALA . 21.4 pt -112.91 -15.94 9.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.387 167.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.0 t 66.72 8.96 6.32 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.203 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.592 ' H ' HG13 ' A' ' 93' ' ' ILE . . . -104.11 45.75 0.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.089 0.471 . . . . 0.0 110.359 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.181 -1.344 . . . . 0.0 111.314 179.316 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 112.101 -0.4 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 27' ' ' HIS . 9.7 p -83.44 -28.84 28.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.39 0.138 . . . . 0.0 111.323 -177.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.404 ' HB3' ' O ' ' A' ' 26' ' ' SER . 4.7 t60 71.67 -59.14 0.56 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.267 0.627 . . . . 0.0 111.607 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.567 ' CG ' ' HG2' ' A' ' 30' ' ' GLN . 58.7 tpp -170.32 130.67 0.9 Allowed Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.435 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 65.9 Cg_exo -53.61 -26.95 39.38 Favored 'Trans proline' 0 N--CA 1.477 0.51 0 C-N-CA 123.496 2.797 . . . . 0.0 113.635 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.567 ' HG2' ' CG ' ' A' ' 28' ' ' MET . 10.7 pt20 -64.91 -25.4 67.87 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 121.224 -0.19 . . . . 0.0 110.56 177.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.798 HD12 HD13 ' A' ' 68' ' ' LEU . 36.1 mm -65.4 -46.58 89.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.348 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.583 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -55.62 -47.27 76.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.41 177.505 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 33.7 mtp180 -67.69 -44.92 76.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.47 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.915 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -58.38 -47.21 84.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.905 -173.738 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.694 HD12 ' HG3' ' A' ' 75' ' ' GLU . 56.9 mt -64.51 -37.3 79.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.119 -177.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 24.7 mmtm -68.18 -35.12 77.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.173 0.511 . . . . 0.0 110.372 176.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.548 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 8.0 mttm -66.05 -37.7 86.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.459 174.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 89.0 mt -61.58 -38.2 86.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.813 174.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.556 HD11 ' O ' ' A' ' 82' ' ' ASN . 0.3 OUTLIER -62.63 -35.21 69.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.471 177.571 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 14.0 m -64.78 -44.3 90.44 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.02 ' HA ' ' HE2' ' A' ' 44' ' ' LYS . 61.7 mt -59.29 -47.16 86.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.697 174.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.612 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -68.41 -33.01 76.28 Favored Glycine 0 CA--C 1.509 -0.298 0 CA-C-O 121.972 0.762 . . . . 0.0 112.114 -173.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.77 -43.92 52.34 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 122.872 1.32 . . . . 0.0 107.954 -174.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 1.02 ' HE2' ' HA ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -77.21 -26.88 53.19 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 112.669 -2.06 . . . . 0.0 110.879 -172.44 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.537 ' HB2' ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -76.48 -32.89 58.64 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.14 174.258 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.67 -64.03 0.25 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.725 173.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -134.15 147.53 50.82 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.705 -0.291 . . . . 0.0 110.893 -170.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.431 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -73.93 100.25 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.282 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.651 ' O ' HG12 ' A' ' 53' ' ' ILE . 91.6 m -156.18 145.01 20.29 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.861 -171.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -60.03 -39.83 87.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.213 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.565 ' H ' HG22 ' A' ' 49' ' ' THR . 39.5 mt-10 -68.3 -34.23 75.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.991 177.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.991 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 10.2 t70 -71.38 -37.8 71.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.102 0.477 . . . . 0.0 110.931 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.651 HG12 ' O ' ' A' ' 49' ' ' THR . 42.4 mm -59.8 -46.46 93.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.565 0.697 . . . . 0.0 109.839 173.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.405 ' O ' ' HD1' ' A' ' 57' ' ' PHE . 35.2 t70 -63.01 -32.41 73.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.247 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.991 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -74.49 -17.09 60.82 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.864 -178.356 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.41 ' HB1' ' HB3' ' A' ' 41' ' ' LEU . . . -66.32 -16.81 64.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.519 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.489 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 36.1 p90 -42.9 134.84 2.91 Favored Pre-proline 0 N--CA 1.472 0.645 0 O-C-N 123.825 0.703 . . . . 0.0 112.106 -176.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 57' ' ' PHE . 21.9 Cg_exo -66.0 140.7 48.29 Favored 'Cis proline' 0 C--N 1.346 0.416 0 C-N-CA 123.668 -1.388 . . . . 0.0 112.14 -2.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 13.1 Cg_endo -95.86 -169.28 0.15 Allowed 'Trans proline' 0 N--CA 1.44 -1.632 0 C-N-CA 123.999 3.132 . . . . 0.0 110.204 -175.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.548 ' OD2' ' HD3' ' A' ' 37' ' ' LYS . 19.9 t70 -98.34 5.14 48.49 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.985 0.421 . . . . 0.0 111.349 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.915 ' HA ' ' HD3' ' A' ' 34' ' ' ARG . 57.3 m-85 -64.65 118.23 8.58 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -171.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -80.89 -31.85 35.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.155 166.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.95 126.1 1.43 Allowed Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -113.96 144.38 43.17 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.938 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 1.7 p30 -147.76 164.37 33.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.627 0.251 . . . . 0.0 110.966 176.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 m -65.53 -32.29 73.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.735 0.303 . . . . 0.0 111.432 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.441 ' HA ' ' OE2' ' A' ' 70' ' ' GLU . 26.2 t-20 -62.39 -34.67 77.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.35 0.595 . . . . 0.0 109.816 177.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.798 HD13 HD12 ' A' ' 31' ' ' ILE . 22.6 tp -57.29 -39.91 76.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.041 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.0 mm -63.02 -37.37 79.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.335 0.588 . . . . 0.0 110.358 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 17.9 mt-10 -67.83 -41.68 82.66 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.476 ' HE ' ' HG3' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -64.14 -32.43 74.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.559 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 68' ' ' LEU . 74.6 mt -61.09 -46.3 96.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.648 0.261 . . . . 0.0 110.682 178.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -65.78 -33.51 76.03 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.904 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 5.9 mm-40 -61.03 -49.92 75.44 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.81 176.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.694 ' HG3' HD12 ' A' ' 35' ' ' ILE . 79.8 mm-40 -55.62 -31.23 62.11 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.889 -178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.752 HD23 HG23 ' A' ' 81' ' ' ILE . 86.8 mt -57.9 -46.83 84.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.979 0.419 . . . . 0.0 110.562 173.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -83.67 -50.26 8.36 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HD2' ' CD ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -73.6 -42.47 61.49 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -175.757 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.432 ' CG ' ' HE2' ' A' ' 36' ' ' LYS . 56.2 t-80 -95.47 -29.86 14.17 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.608 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.93 23.19 33.48 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 119.842 -1.17 . . . . 0.0 112.568 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.752 HG23 HD23 ' A' ' 76' ' ' LEU . 6.3 tt -72.5 146.63 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.556 ' O ' HD11 ' A' ' 39' ' ' ILE . 8.2 m-20 -117.2 119.61 35.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.195 0.522 . . . . 0.0 111.794 -175.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.431 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 71.7 mt -153.85 116.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -82.44 151.66 4.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.345 0.593 . . . . 0.0 110.292 -175.171 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.41 -30.09 23.86 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.661 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.448 ' HB2' HG23 ' A' ' 49' ' ' THR . 65.3 t30 73.21 -4.97 2.05 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.225 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 34.1 mt-10 -108.81 129.9 23.38 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.796 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 72.5 Cg_exo -49.72 -75.33 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.715 2.943 . . . . 0.0 115.122 -169.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -166.58 17.31 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -170.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -101.92 135.58 43.23 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.274 -0.571 . . . . 0.0 110.935 -175.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -63.13 -64.7 0.83 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.146 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 177.15 -46.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.406 -176.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.5 pt -102.22 39.11 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.955 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.2 t 60.99 -88.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.995 -175.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.54 127.93 46.08 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.673 -1.07 . . . . 0.0 112.29 -177.075 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.91 0 N-CA-C 112.327 -0.309 . . . . 0.0 112.327 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 t 61.9 80.03 0.24 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.235 0.541 . . . . 0.0 111.455 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -76.12 -25.36 55.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.348 175.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.481 ' O ' HG22 ' A' ' 31' ' ' ILE . 24.6 ttt 58.98 62.74 4.07 Favored Pre-proline 0 C--O 1.233 0.206 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.656 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.708 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 26.1 Cg_exo -62.9 -30.87 77.57 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.037 2.491 . . . . 0.0 112.203 -172.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -58.31 -38.83 77.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.131 -177.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.698 ' O ' HG13 ' A' ' 35' ' ' ILE . 5.9 tp -67.11 -35.69 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -177.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.407 ' HG2' ' NH2' ' A' ' 71' ' ' ARG . 18.7 mt-10 -65.45 -45.93 81.84 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.586 0.707 . . . . 0.0 109.907 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.708 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 39.5 mtt180 -68.64 -37.9 80.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.286 -176.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.634 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 0.3 OUTLIER -66.07 -36.19 82.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.021 -177.732 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.698 HG13 ' O ' ' A' ' 31' ' ' ILE . 86.4 mt -60.88 -42.71 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.636 ' CD ' HD12 ' A' ' 81' ' ' ILE . 20.0 mmtm -65.74 -36.46 83.63 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.032 0.444 . . . . 0.0 110.278 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.465 ' HE3' HD21 ' A' ' 41' ' ' LEU . 45.3 tptt -64.13 -46.46 84.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.749 175.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.84 -44.22 93.81 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.585 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.566 ' HB ' HD11 ' A' ' 81' ' ' ILE . 1.5 mp -62.82 -35.93 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.977 177.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.716 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 22.8 t -67.06 -47.36 71.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.356 -0.537 . . . . 0.0 109.658 178.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.703 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 83.7 mt -59.62 -43.67 93.71 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.551 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.98 -37.39 93.16 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -177.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.585 ' HB2' HG23 ' A' ' 48' ' ' ILE . 25.7 tptt -70.04 -38.43 75.85 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 120.942 0.401 . . . . 0.0 110.342 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.716 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -61.06 -36.92 80.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.733 0.778 . . . . 0.0 109.965 173.056 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.933 ' HE3' ' HA ' ' A' ' 56' ' ' ALA . 74.4 mmtt -67.52 -30.38 70.03 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.383 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.31 -63.45 0.3 Allowed Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.668 175.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -126.76 155.22 43.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.228 0.537 . . . . 0.0 110.593 -175.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.585 HG23 ' HB2' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -86.33 88.28 2.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.352 0.596 . . . . 0.0 109.634 176.376 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.628 ' O ' HG12 ' A' ' 53' ' ' ILE . 9.8 t -158.23 163.4 37.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.926 -171.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -60.04 -39.14 84.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.92 0.391 . . . . 0.0 110.982 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -57.69 -45.43 85.65 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.461 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.786 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -73.26 -31.08 63.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.493 -179.511 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.628 HG12 ' O ' ' A' ' 49' ' ' THR . 46.3 mm -61.66 -50.13 81.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.235 0.54 . . . . 0.0 110.103 173.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.403 ' HA ' ' CD1' ' A' ' 57' ' ' PHE . 10.7 t70 -59.11 -38.21 79.04 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.489 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.786 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 10.7 ptmt -75.65 -18.31 59.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.101 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.933 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -75.7 -23.09 56.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.126 177.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 54' ' ' ASP . 63.3 m-85 -61.95 142.84 95.01 Favored Pre-proline 0 N--CA 1.464 0.268 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.509 176.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.529 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 96.3 Cg_endo -84.02 137.11 27.15 Favored 'Cis proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.584 -1.423 . . . . 0.0 112.818 0.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.529 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 56.9 Cg_endo -102.81 -152.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 124.466 3.444 . . . . 0.0 110.953 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.77 13.31 28.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 178.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.14 117.15 6.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.013 0.435 . . . . 0.0 111.168 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -81.88 -25.81 34.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.363 173.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.61 125.76 1.48 Allowed Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -106.56 144.95 32.49 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.543 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 16.9 t70 -150.0 157.52 43.24 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.85 -174.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.6 m -63.63 -26.78 68.83 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.861 0.362 . . . . 0.0 111.161 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -60.72 -33.44 72.9 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.568 ' O ' HG13 ' A' ' 72' ' ' ILE . 25.1 tp -54.57 -39.29 67.62 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.027 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.6 mm -62.33 -42.67 96.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.233 0.539 . . . . 0.0 109.868 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 11.8 mt-10 -66.83 -45.53 77.99 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.543 ' HD2' ' OE2' ' A' ' 74' ' ' GLU . 18.4 mmm-85 -65.65 -34.46 78.26 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.482 -1.235 . . . . 0.0 111.89 -174.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 68' ' ' LEU . 71.1 mt -61.1 -50.07 82.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.59 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 18.7 m170 -69.07 -34.9 75.89 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.544 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.543 ' OE2' ' HD2' ' A' ' 71' ' ' ARG . 43.4 mt-10 -60.67 -49.01 79.24 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 175.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -64.73 -31.94 73.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.953 0.406 . . . . 0.0 110.675 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.656 ' HA ' HG22 ' A' ' 81' ' ' ILE . 16.5 tp -64.66 -42.37 95.45 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.755 176.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -82.2 -52.15 7.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.948 0.404 . . . . 0.0 111.836 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -75.54 -44.91 41.06 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.586 -174.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -95.5 -17.02 21.8 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.315 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.44 23.78 57.85 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.698 -1.239 . . . . 0.0 113.348 173.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.656 HG22 ' HA ' ' A' ' 76' ' ' LEU . 4.5 tt -71.61 124.05 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 117.605 0.702 . . . . 0.0 110.64 -171.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -78.42 117.08 19.3 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.463 0.649 . . . . 0.0 111.414 -175.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.556 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 5.6 tp -161.91 139.48 2.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.5 HG12 ' CB ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -110.22 154.25 11.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-O 121.004 0.43 . . . . 0.0 110.443 -175.377 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -83.2 -23.68 32.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.068 -175.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.482 ' H ' HG13 ' A' ' 84' ' ' VAL . 4.0 t-20 78.78 23.05 0.62 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.464 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 7.5 mm-40 -96.56 127.83 38.36 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.092 175.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 6.3 Cg_endo -88.06 99.77 0.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.016 2.477 . . . . 0.0 111.342 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -79.54 70.82 6.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.112 0.482 . . . . 0.0 111.402 -176.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 55.65 92.9 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.839 170.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -90.23 88.24 7.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.053 0.454 . . . . 0.0 110.009 175.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -113.95 -71.07 0.77 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.8 mt -96.69 -35.37 5.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.581 175.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.8 t 69.5 -70.12 0.15 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.99 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -166.48 -179.02 4.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.192 -1.338 . . . . 0.0 111.761 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 71.2 m -77.44 73.27 4.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.232 0.539 . . . . 0.0 111.708 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.435 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 37.5 t-80 -83.12 123.96 30.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.8 mtm -110.3 96.28 25.82 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.76 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 50.0 Cg_exo -52.63 -33.21 57.81 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.923 2.415 . . . . 0.0 112.663 -173.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -25.0 58.88 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.076 -173.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 68' ' ' LEU . 9.5 mm -69.76 -46.51 74.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 174.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -61.91 -45.24 94.59 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.094 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.76 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 29.7 mtm180 -61.79 -43.15 99.42 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.866 176.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.498 HH12 ' HB2' ' A' ' 64' ' ' PHE . 73.8 ttt180 -58.66 -36.1 73.62 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.517 -178.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 31' ' ' ILE . 63.6 mt -58.44 -51.71 68.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.498 ' HD3' HD12 ' A' ' 81' ' ' ILE . 1.4 mppt? -69.28 -40.14 77.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.52 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.8 mmtm -59.22 -38.42 79.9 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.114 0.259 . . . . 0.0 110.721 177.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.54 ' HB3' HD12 ' A' ' 53' ' ' ILE . 30.8 mt -65.34 -49.79 68.07 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.12 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.642 HG12 HG12 ' A' ' 81' ' ' ILE . 1.5 mp -62.77 -34.93 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.238 0.542 . . . . 0.0 109.72 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.8 m -67.0 -47.99 69.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.4 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.585 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 72.3 mt -59.49 -39.22 83.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.632 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.707 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -65.83 -34.21 88.04 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HD2' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -71.73 -29.84 64.97 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 122.042 0.925 . . . . 0.0 109.184 -177.241 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.506 ' HE2' ' N ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -75.69 -46.03 33.5 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.736 -1.574 . . . . 0.0 110.428 174.559 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.772 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . 72.4 mmtt -68.17 -33.62 74.8 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.96 -174.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.47 -66.15 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.384 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -142.25 164.17 30.86 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -175.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.732 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -89.25 79.99 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.889 -170.9 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 1.104 ' HB ' HG13 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -139.0 154.32 48.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.402 -169.501 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -57.29 -39.28 75.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.515 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -68.27 -35.56 78.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.673 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.832 ' HB2' HG23 ' A' ' 49' ' ' THR . 9.4 t0 -71.61 -34.43 69.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.302 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 49' ' ' THR . 49.2 mm -58.87 -49.32 83.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.57 0.7 . . . . 0.0 110.196 174.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -61.03 -32.9 72.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.473 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.772 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -75.61 -25.43 56.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.312 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.69 -23.74 60.91 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.789 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.531 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 64.2 t80 -64.26 138.17 97.34 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.652 176.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 6.0 Cg_exo -80.04 137.22 40.98 Favored 'Cis proline' 0 C--N 1.347 0.48 0 C-N-CA 124.151 -1.187 . . . . 0.0 112.543 0.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.54 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 57.2 Cg_endo -105.61 -158.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 124.723 3.615 . . . . 0.0 111.266 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.81 16.5 22.06 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.892 -177.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.54 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 13.5 p90 -58.85 121.46 11.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.653 0.74 . . . . 0.0 111.726 -170.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -80.81 -18.51 47.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.814 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.32 135.9 3.93 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -174.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.498 ' HB2' HH12 ' A' ' 34' ' ' ARG . 78.8 t80 -112.87 138.6 49.48 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.258 174.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -158.53 153.85 25.73 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.3 t -63.24 -25.64 68.42 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.282 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 71' ' ' ARG . 92.6 m-20 -60.92 -31.36 70.89 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.33 177.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.64 ' HB2' HD12 ' A' ' 31' ' ' ILE . 48.8 tp -58.84 -40.47 84.33 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.047 176.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.1 mm -63.85 -46.46 94.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.947 0.404 . . . . 0.0 110.565 -177.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -69.4 -34.11 74.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.758 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -68.26 -41.21 81.43 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.555 -176.571 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.592 HG12 HG23 ' A' ' 35' ' ' ILE . 76.2 mt -60.75 -45.11 98.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.705 0.288 . . . . 0.0 110.938 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.493 ' HA ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -63.98 -41.46 97.52 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.456 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.523 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 12.8 pt-20 -69.69 -34.09 73.44 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.991 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 71' ' ' ARG . 63.7 mm-40 -61.48 -29.86 70.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.563 0.22 . . . . 0.0 111.115 173.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.724 HD21 HG22 ' A' ' 83' ' ' ILE . 98.2 mt -60.04 -49.03 79.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.829 0.347 . . . . 0.0 110.909 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -82.95 -50.12 8.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.202 0.525 . . . . 0.0 111.752 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 8.8 ttmt -69.8 -44.75 69.4 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.205 -175.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -96.13 -25.61 15.8 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.525 -174.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.59 21.59 53.34 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 119.93 -1.129 . . . . 0.0 112.011 -175.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.654 HG23 HD23 ' A' ' 76' ' ' LEU . 9.8 tt -72.49 145.35 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -178.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -116.72 136.17 53.18 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.309 -173.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.724 HG22 HD21 ' A' ' 76' ' ' LEU . 1.6 tp -162.42 129.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.134 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.104 HG13 ' HB ' ' A' ' 49' ' ' THR . 2.2 p -97.57 151.03 4.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.832 -175.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.504 ' HB2' ' HG3' ' A' ' 87' ' ' GLU . 25.5 mm-40 -93.74 -26.49 16.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.06 0.457 . . . . 0.0 110.316 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 63.7 t30 69.28 22.36 6.68 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.983 176.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.529 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 33.5 mt-10 -60.68 128.58 88.75 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.529 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 9.0 Cg_exo -72.41 132.82 19.77 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.523 2.815 . . . . 0.0 114.182 -168.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -90.81 84.18 5.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.497 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -78.89 -34.99 44.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.448 -178.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -145.74 -66.9 0.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.143 0.497 . . . . 0.0 110.137 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -153.46 46.15 0.65 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.103 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 93' ' ' ILE . 26.3 mt 62.21 18.12 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.36 -178.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.3 m 51.99 46.59 26.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.939 176.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.14 162.73 32.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.547 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 CA-C-O 118.841 -0.977 . . . . 0.0 111.536 178.513 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.878 0 N-CA-C 111.951 -0.459 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.4 m -110.74 -34.87 6.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.081 0.467 . . . . 0.0 110.682 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -93.46 -23.66 18.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.356 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.581 ' O ' HG22 ' A' ' 31' ' ' ILE . 22.3 ptt? -136.92 63.37 44.75 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.618 178.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.47 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 4.7 Cg_exo -80.87 -27.29 3.16 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.315 2.01 . . . . 0.0 111.19 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.587 ' HB2' ' OE1' ' A' ' 62' ' ' GLU . 13.5 pt20 -69.03 -29.63 67.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.604 -177.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.674 ' O ' HG13 ' A' ' 35' ' ' ILE . 10.0 tp -69.05 -36.42 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.044 -176.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -65.2 -46.31 81.23 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.121 0.486 . . . . 0.0 110.046 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 61.1 mtp180 -60.74 -45.03 95.85 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.117 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.431 ' HD3' ' OE1' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -63.33 -31.39 72.53 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.886 -176.946 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 31' ' ' ILE . 63.6 mt -58.68 -48.35 86.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.82 176.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.48 ' CD ' HD12 ' A' ' 81' ' ' ILE . 1.9 mppt? -67.54 -33.84 75.87 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.909 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.431 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 16.6 tptp -63.24 -40.36 97.21 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.211 176.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.618 ' HA ' HD12 ' A' ' 41' ' ' LEU . 5.9 mp -70.24 -40.14 74.62 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.443 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.686 HG12 HG12 ' A' ' 81' ' ' ILE . 1.5 mp -63.3 -34.53 67.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.997 174.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.419 ' C ' ' HE3' ' A' ' 44' ' ' LYS . 45.5 t -61.06 -43.06 99.46 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.824 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 89.9 mt -58.24 -46.15 86.47 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.992 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.671 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -60.67 -32.29 78.15 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.12 -39.72 48.42 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.935 0.874 . . . . 0.0 109.273 -175.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.824 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 4.4 ptpt -76.68 -36.94 56.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.092 -176.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.71 ' HB2' ' OD1' ' A' ' 52' ' ' ASP . 30.8 mmmt -72.05 -20.98 61.59 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.733 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.23 -72.97 0.21 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.025 -0.989 . . . . 0.0 113.589 174.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -143.93 145.96 32.63 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.386 0.136 . . . . 0.0 110.741 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.554 ' HB ' HD13 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -66.91 108.51 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 122.042 0.925 . . . . 0.0 109.816 -176.038 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.744 HG22 ' H ' ' A' ' 51' ' ' GLU . 54.5 m -160.71 145.51 14.22 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.597 -173.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -57.73 -39.99 78.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.216 0.531 . . . . 0.0 110.474 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.744 ' H ' HG22 ' A' ' 49' ' ' THR . 44.4 mm-40 -68.37 -33.59 74.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.627 177.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.71 ' OD1' ' HB2' ' A' ' 45' ' ' LYS . 10.0 t70 -71.72 -32.55 67.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.365 0.603 . . . . 0.0 109.71 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 49' ' ' THR . 50.0 mm -61.4 -49.42 84.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.419 0.628 . . . . 0.0 109.776 170.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -33.47 69.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.54 176.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.702 ' HD3' ' CG ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -75.12 -24.29 58.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.993 -179.516 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.492 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -71.91 -19.7 61.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.311 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.523 ' CD2' ' HD3' ' A' ' 59' ' ' PRO . 55.3 t80 -63.79 133.05 95.42 Favored Pre-proline 0 C--O 1.235 0.317 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.44 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.502 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 53.9 Cg_endo -69.88 127.44 11.0 Favored 'Cis proline' 0 C--N 1.35 0.605 0 C-N-CA 123.392 -1.503 . . . . 0.0 112.165 1.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.523 ' HD3' ' CD2' ' A' ' 57' ' ' PHE . 13.9 Cg_endo -96.74 -165.65 0.1 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 123.74 2.96 . . . . 0.0 110.711 -172.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -98.35 15.23 25.32 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.402 -175.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.457 ' CD1' ' HD2' ' A' ' 59' ' ' PRO . 9.6 p90 -62.87 126.49 27.5 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.291 0.567 . . . . 0.0 111.121 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.587 ' OE1' ' HB2' ' A' ' 30' ' ' GLN . 48.7 mt-10 -80.82 -24.84 38.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.874 176.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.21 126.94 1.53 Allowed Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -106.31 123.72 48.48 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 117.523 0.662 . . . . 0.0 109.801 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 20.7 t70 -147.23 162.16 39.46 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.07 -175.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.8 t -64.37 -31.38 72.56 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.2 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -62.2 -34.46 76.5 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.248 0.547 . . . . 0.0 109.816 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.604 ' O ' HG13 ' A' ' 72' ' ' ILE . 32.9 tp -59.94 -42.18 93.46 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.749 177.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.2 mm -59.62 -43.48 91.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.033 0.444 . . . . 0.0 110.745 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -67.99 -40.97 82.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.581 ' HG3' ' CD1' ' A' ' 35' ' ' ILE . 9.5 tpp180 -66.43 -32.88 74.52 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.019 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.604 HG13 ' O ' ' A' ' 68' ' ' LEU . 76.0 mt -61.37 -50.59 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.852 -0.158 . . . . 0.0 110.629 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.572 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 22.1 p80 -67.1 -33.51 75.62 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.136 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -59.45 -49.52 77.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.344 0.593 . . . . 0.0 109.604 174.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.587 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 59.8 mm-40 -66.71 -28.98 68.86 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.821 176.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.008 ' HA ' HG22 ' A' ' 81' ' ' ILE . 13.5 tp -69.58 -51.55 34.29 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.363 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -84.49 -53.03 5.7 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.286 0.565 . . . . 0.0 111.625 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -76.29 -38.94 55.43 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.052 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.587 ' HB2' ' HA ' ' A' ' 75' ' ' GLU . 3.1 t60 -94.62 -16.42 23.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.577 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.24 23.03 42.1 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.398 -0.906 . . . . 0.0 114.106 172.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.008 HG22 ' HA ' ' A' ' 76' ' ' LEU . 7.9 tt -75.34 145.63 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 117.727 0.763 . . . . 0.0 109.322 -176.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.462 ' O ' HG12 ' A' ' 83' ' ' ILE . 6.1 m-20 -108.31 128.06 54.41 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -173.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.683 HG12 HG13 ' A' ' 39' ' ' ILE . 9.2 mm -162.14 119.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 124.37 1.068 . . . . 0.0 108.61 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -88.17 152.36 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 CA-C-O 121.671 0.748 . . . . 0.0 109.454 -179.546 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -79.03 -31.44 44.64 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.146 -177.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.554 ' HB2' HG23 ' A' ' 49' ' ' THR . 11.8 t-20 76.46 -1.96 2.8 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.05 176.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -77.27 127.7 82.5 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.498 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.7 -71.56 0.04 OUTLIER 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 123.28 2.653 . . . . 0.0 114.016 -168.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -163.03 25.54 0.09 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.454 0.645 . . . . 0.0 109.875 -177.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -93.41 88.98 6.15 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.163 -174.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.834 ' HB3' ' HA ' ' A' ' 94' ' ' SER . 0.7 OUTLIER -95.73 -166.13 1.39 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.756 179.112 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -92.16 -53.2 4.34 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.984 -0.448 . . . . 0.0 109.88 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.444 HG22 ' OE2' ' A' ' 91' ' ' GLU . 10.9 tp -92.41 -14.21 8.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.834 ' HA ' ' HB3' ' A' ' 91' ' ' GLU . 49.6 m 60.17 42.67 15.08 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 113.855 -1.52 . . . . 0.0 111.799 176.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.06 -33.42 4.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 119.09 -0.839 . . . . 0.0 111.509 -177.107 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.727 0 N-CA-C 112.393 -0.283 . . . . 0.0 112.393 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.6 m -83.74 77.94 9.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.957 0.408 . . . . 0.0 111.641 -174.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -139.96 18.03 2.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.175 0.512 . . . . 0.0 110.053 175.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.0 mmm -130.9 71.22 82.52 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.135 -177.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.424 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 22.8 Cg_exo -63.88 -25.32 67.5 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.566 2.177 . . . . 0.0 111.546 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -66.6 -24.8 66.38 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.57 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.532 HG23 HD13 ' A' ' 68' ' ' LEU . 8.1 mm -65.22 -43.94 95.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.503 0.192 . . . . 0.0 111.494 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -69.71 -37.52 76.6 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 49.9 mtp180 -66.26 -34.12 77.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.792 175.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.595 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 2.0 tpm_? -59.06 -39.31 81.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.534 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.807 HD11 ' HG3' ' A' ' 71' ' ' ARG . 22.7 mt -59.54 -49.0 85.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.275 0.559 . . . . 0.0 109.857 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.673 ' HD2' HD12 ' A' ' 81' ' ' ILE . 14.3 mmmt -65.69 -36.2 82.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.173 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.584 ' HD2' ' HA ' ' A' ' 34' ' ' ARG . 48.3 mttm -60.96 -41.68 96.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.378 174.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 70.8 mt -67.41 -42.27 83.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.591 -176.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.641 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.6 mp -68.62 -34.91 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.981 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.666 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 32.2 t -66.44 -47.5 72.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.966 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 96.9 mt -60.15 -40.02 88.4 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.781 -177.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.538 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -67.0 -38.42 92.75 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.501 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 11.2 tptt -73.35 -34.89 65.87 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.874 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.666 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -62.6 -45.2 93.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.089 173.714 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.814 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . 45.3 mmtm -69.23 -35.23 75.94 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.82 -177.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.9 -65.99 0.1 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.086 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -137.0 158.57 44.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.416 0.627 . . . . 0.0 111.154 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.8 OUTLIER -83.64 88.98 2.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.334 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.548 HG23 ' H ' ' A' ' 52' ' ' ASP . 10.6 t -153.61 155.24 35.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.829 -176.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -58.35 -41.98 85.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.043 0.449 . . . . 0.0 111.215 -173.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.68 -32.64 72.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.882 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.653 ' OD1' ' HB2' ' A' ' 45' ' ' LYS . 11.1 t0 -71.61 -39.26 70.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.214 0.53 . . . . 0.0 110.223 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.1 mt -60.23 -45.42 96.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.355 0.598 . . . . 0.0 110.017 173.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.0 -34.36 69.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.325 176.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.814 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -75.73 -23.05 56.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.092 -178.006 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.784 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -69.63 -18.93 63.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.571 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.434 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 80.5 t80 -62.74 137.14 96.58 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 176.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.497 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 90.0 Cg_endo -85.49 140.25 28.21 Favored 'Cis proline' 0 C--N 1.346 0.396 0 C-N-CA 123.594 -1.419 . . . . 0.0 113.441 1.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.604 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 37.3 Cg_endo -103.65 -157.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.744 0 C-N-CA 124.742 3.628 . . . . 0.0 110.896 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -98.09 14.52 27.24 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.044 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.604 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 10.1 p90 -61.51 125.9 25.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.464 0.649 . . . . 0.0 110.826 -174.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -79.08 -30.14 43.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.686 174.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.28 126.79 1.48 Allowed Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -108.2 144.57 35.47 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 24.3 t70 -142.66 161.37 38.24 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.32 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -63.07 -30.93 71.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.953 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -61.07 -34.08 74.35 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.124 0.488 . . . . 0.0 110.268 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.654 ' O ' HG13 ' A' ' 72' ' ' ILE . 58.1 tp -60.58 -39.42 87.99 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.906 177.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.6 mm -62.89 -41.43 92.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.244 0.545 . . . . 0.0 110.314 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.417 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 17.6 mt-10 -68.25 -36.99 80.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.902 0.858 . . . . 0.0 108.959 177.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.807 ' HG3' HD11 ' A' ' 35' ' ' ILE . 23.0 tpt180 -70.06 -33.99 72.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.153 -178.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.654 HG13 ' O ' ' A' ' 68' ' ' LEU . 86.2 mt -61.0 -50.38 80.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.002 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.417 ' CD2' ' HA ' ' A' ' 70' ' ' GLU . 34.3 p80 -66.73 -31.94 72.92 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.91 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.688 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 25.6 mt-10 -58.54 -53.38 59.01 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 121.377 0.608 . . . . 0.0 109.773 173.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 47.3 tp10 -59.88 -33.52 71.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.529 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.856 ' HA ' HG22 ' A' ' 81' ' ' ILE . 9.0 tp -66.57 -49.56 65.98 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.809 177.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -83.9 -53.35 5.65 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -173.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 34.3 pttt -76.97 -40.1 48.11 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.575 -176.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -93.8 -21.14 19.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.059 -176.582 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.32 25.24 24.38 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.358 -1.401 . . . . 0.0 114.772 172.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.856 HG22 ' HA ' ' A' ' 76' ' ' LEU . 5.4 tt -73.06 119.59 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 118.847 1.324 . . . . 0.0 109.628 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -81.8 126.94 32.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.434 0.635 . . . . 0.0 111.505 -171.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.641 ' HB ' HG13 ' A' ' 39' ' ' ILE . 4.8 tp -167.87 140.02 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.464 -176.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -100.73 153.4 4.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -92.62 -29.73 15.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.491 -174.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.47 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 24.0 t-20 74.18 -7.11 1.71 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.939 0.774 . . . . 0.0 110.192 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 43.0 tt0 -88.66 128.38 52.82 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.509 -177.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 4.0 Cg_exo -81.36 159.34 19.91 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.256 2.638 . . . . 0.0 111.682 176.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -109.69 -8.29 14.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.869 0.366 . . . . 0.0 111.245 -175.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.467 ' H ' ' CD ' ' A' ' 90' ' ' GLU . 1.7 mp0 -70.64 -27.4 64.03 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -74.54 65.24 1.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.123 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -122.18 -58.59 1.71 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 45.8 mt -95.11 65.98 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 166.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 m -67.09 -64.72 0.8 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.257 -173.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.41 -50.69 8.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.406 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.399 -1.223 . . . . 0.0 111.361 179.784 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.56 ' HB3' HG12 ' A' ' 31' ' ' ILE . 65.9 mtt . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 120.818 0.342 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.487 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 15.5 Cg_exo -67.94 -25.07 38.97 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.661 2.241 . . . . 0.0 111.105 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.454 ' HB2' ' OE2' ' A' ' 62' ' ' GLU . 12.3 pt20 -66.2 -25.1 66.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.389 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.576 ' O ' HG13 ' A' ' 35' ' ' ILE . 28.8 mm -65.17 -49.88 76.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.587 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -55.69 -46.54 77.6 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.202 0.525 . . . . 0.0 110.492 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 12.6 mmm180 -67.56 -44.34 78.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.025 -177.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.707 HH11 HD22 ' A' ' 68' ' ' LEU . 29.6 ttm180 -61.74 -37.93 86.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.215 -175.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 31' ' ' ILE . 89.8 mt -59.83 -46.32 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.687 ' HD3' HD12 ' A' ' 81' ' ' ILE . 26.5 mmtm -67.03 -37.29 83.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.27 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.535 ' HD2' ' HA ' ' A' ' 34' ' ' ARG . 94.4 mttt -62.57 -40.93 98.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.875 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.625 ' HB3' HD13 ' A' ' 53' ' ' ILE . 73.8 mt -64.93 -45.84 84.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.664 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.683 ' HB ' HD11 ' A' ' 81' ' ' ILE . 1.6 mp -66.37 -35.38 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 121.033 0.444 . . . . 0.0 109.953 177.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.694 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 33.3 t -65.96 -42.09 90.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.922 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.713 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 93.3 mt -60.15 -43.12 95.99 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.474 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.41 -35.23 89.87 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -36.82 83.36 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.888 -0.656 . . . . 0.0 109.703 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.694 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -68.78 -41.13 79.2 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.883 0.849 . . . . 0.0 110.03 175.141 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.713 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 70.3 mmtt -68.95 -31.56 70.53 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.014 -1.448 . . . . 0.0 111.277 -176.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.54 -58.8 0.44 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.246 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -119.68 146.81 45.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.119 0.485 . . . . 0.0 110.667 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.06 86.48 2.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.347 0.594 . . . . 0.0 109.697 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.458 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.0 m -141.79 148.08 38.33 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.407 -170.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -57.12 -42.24 80.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.061 0.458 . . . . 0.0 110.119 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.41 ' H ' HG22 ' A' ' 49' ' ' THR . 35.1 mt-10 -70.06 -32.68 70.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.697 177.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.746 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 1.3 m-20 -68.23 -29.44 68.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.266 0.555 . . . . 0.0 111.3 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.625 HD13 ' HB3' ' A' ' 38' ' ' LEU . 17.7 mt -65.71 -44.02 93.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 121.075 0.464 . . . . 0.0 110.187 170.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.33 -39.36 75.69 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.497 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.746 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.66 -15.43 59.18 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.832 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.697 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -75.39 -18.49 59.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.073 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.521 ' CD2' ' HD3' ' A' ' 59' ' ' PRO . 43.6 t80 -50.1 136.01 21.81 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.829 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.498 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 71.5 Cg_endo -75.03 137.72 51.95 Favored 'Cis proline' 0 C--N 1.345 0.374 0 C-N-CA 123.528 -1.447 . . . . 0.0 112.836 1.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.521 ' HD3' ' CD2' ' A' ' 57' ' ' PHE . 17.0 Cg_endo -98.87 -165.25 0.07 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 124.141 3.227 . . . . 0.0 110.245 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -97.38 13.92 28.04 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.012 0.434 . . . . 0.0 110.734 -176.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.427 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 5.2 p90 -63.25 120.74 12.12 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.625 0.726 . . . . 0.0 111.358 -173.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.454 ' OE2' ' HB2' ' A' ' 30' ' ' GLN . 2.3 mp0 -80.93 -22.26 39.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.736 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.02 146.96 14.2 Favored Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 -174.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -100.99 120.57 40.37 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.484 173.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -134.67 132.64 39.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.715 0.293 . . . . 0.0 110.61 -170.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.8 m -63.78 -31.94 73.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.405 0.622 . . . . 0.0 109.746 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.544 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 14.0 m120 -62.31 -38.67 90.33 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.643 175.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.707 HD22 HH11 ' A' ' 34' ' ' ARG . 52.2 tp -59.69 -39.01 83.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.613 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.7 mm -61.08 -46.53 96.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.557 0.218 . . . . 0.0 111.107 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 14.3 pt-20 -70.59 -34.56 72.3 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.669 177.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.549 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 19.4 mmt180 -70.41 -32.62 70.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.512 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 68' ' ' LEU . 82.4 mt -61.75 -49.56 83.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.834 0.35 . . . . 0.0 110.143 175.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.528 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 77.3 m80 -67.46 -34.92 78.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.753 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -67.62 -48.88 65.48 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.699 177.129 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -58.6 -29.52 66.52 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.004 0.43 . . . . 0.0 110.624 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.919 ' HA ' HG22 ' A' ' 81' ' ' ILE . 2.9 tp -57.6 -44.82 85.71 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.299 173.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -84.02 -52.66 6.13 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.753 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 3.6 ptmm? -72.93 -39.77 66.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -93.1 -26.98 17.22 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.942 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.16 23.09 23.31 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.77 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.919 HG22 ' HA ' ' A' ' 76' ' ' LEU . 6.2 tt -74.33 123.5 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 117.731 0.765 . . . . 0.0 110.108 -174.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -82.51 118.26 23.12 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.974 -0.454 . . . . 0.0 111.306 -172.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.638 ' HB ' HG13 ' A' ' 39' ' ' ILE . 5.5 tp -156.95 137.61 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.12 152.2 10.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.265 0.555 . . . . 0.0 110.789 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -88.23 -25.91 22.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.974 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.408 ' HB2' ' CG2' ' A' ' 49' ' ' THR . 5.3 t30 . . . . . 0 N--CA 1.468 0.459 0 O-C-N 124.202 0.939 . . . . 0.0 109.799 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.595 ' O ' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.627 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 9.3 Cg_exo -72.01 -36.32 6.08 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.625 2.217 . . . . 0.0 112.492 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.462 ' HB2' HH21 ' A' ' 34' ' ' ARG . 5.1 pp0? -64.96 -32.88 74.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.156 -174.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.698 HG13 HD13 ' A' ' 68' ' ' LEU . 10.7 tp -71.98 -35.52 54.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.62 -47.38 66.82 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.219 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 22.5 mmm180 -62.96 -35.37 79.93 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.552 ' HG2' ' CD1' ' A' ' 61' ' ' PHE . 6.4 tpp180 -60.63 -37.03 80.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.978 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 31' ' ' ILE . 30.9 mt -60.48 -44.87 97.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.517 ' HA ' ' HB ' ' A' ' 39' ' ' ILE . 2.2 mppt? -67.95 -34.03 75.8 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.014 175.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -58.59 -42.56 88.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.168 0.509 . . . . 0.0 109.931 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.615 HD12 HG23 ' A' ' 53' ' ' ILE . 4.1 mm? -70.08 -35.05 73.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.723 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.667 HD11 HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -60.69 -37.97 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.236 0.541 . . . . 0.0 109.738 173.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.671 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 36.6 t -66.97 -48.38 68.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.028 176.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.696 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 91.5 mt -60.8 -45.93 92.51 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.055 -176.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.08 -39.04 84.34 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -175.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.44 -34.15 67.58 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.671 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -61.34 -41.23 96.71 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.918 172.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 31.7 mmtp -68.41 -21.7 64.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.485 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.01 -66.1 0.25 Allowed Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.363 -0.923 . . . . 0.0 112.522 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -142.57 171.67 13.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.16 0.505 . . . . 0.0 111.116 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.496 HG22 ' CD1' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -87.63 86.16 2.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.453 0.644 . . . . 0.0 109.952 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.608 ' O ' HG12 ' A' ' 53' ' ' ILE . 9.7 m -143.26 145.62 32.9 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.525 -171.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -60.6 -34.94 74.95 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.571 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 32.1 mt-10 -67.63 -35.03 78.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.092 176.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.692 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 11.8 m-20 -71.68 -30.32 65.57 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.444 0.64 . . . . 0.0 110.972 176.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.615 HG23 HD12 ' A' ' 38' ' ' LEU . 50.9 mm -66.5 -45.34 89.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.566 0.698 . . . . 0.0 109.818 169.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.512 ' HA ' ' CE2' ' A' ' 57' ' ' PHE . 21.4 t70 -57.43 -36.89 71.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.715 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.692 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 5.9 ptpt -77.88 -16.58 58.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.781 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.561 ' HA ' ' NZ ' ' A' ' 45' ' ' LYS . . . -76.82 -19.17 57.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.796 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.568 ' CD1' ' HG3' ' A' ' 59' ' ' PRO . 19.8 m-85 -66.62 147.32 99.03 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.933 178.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 2.9 Cg_exo -76.1 143.46 76.65 Favored 'Cis proline' 0 C--N 1.342 0.214 0 C-N-CA 123.955 -1.269 . . . . 0.0 112.358 0.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.698 ' HG2' ' HD2' ' A' ' 61' ' ' PHE . 53.1 Cg_endo -100.92 -173.0 0.11 Allowed 'Trans proline' 0 N--CA 1.438 -1.757 0 C-N-CA 124.328 3.352 . . . . 0.0 110.772 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -98.65 16.53 21.72 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.698 ' HD2' ' HG2' ' A' ' 59' ' ' PRO . 36.4 m-85 -58.43 119.48 7.06 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.925 0.393 . . . . 0.0 110.404 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.58 -20.93 45.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.335 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.71 124.63 1.28 Allowed Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -112.88 144.51 42.32 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 18.2 t70 -149.56 160.74 43.24 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.867 -172.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 t -62.97 -32.22 73.5 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 120.975 0.416 . . . . 0.0 110.982 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.425 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 3.3 t-20 -61.69 -31.86 72.02 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.698 HD13 HG13 ' A' ' 31' ' ' ILE . 26.6 tp -54.63 -38.79 67.26 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.052 175.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.9 mm -61.9 -40.79 88.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.31 0.576 . . . . 0.0 109.866 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.574 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 15.7 mt-10 -68.14 -41.08 82.16 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.539 ' HD2' ' HA ' ' A' ' 68' ' ' LEU . 85.9 mtt180 -60.05 -38.75 83.72 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.939 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 68' ' ' LEU . 80.5 mt -61.3 -51.1 76.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.809 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.574 ' CD2' ' HA ' ' A' ' 70' ' ' GLU . 27.9 p80 -69.0 -32.33 71.81 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.543 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 47.3 mt-10 -59.2 -49.46 77.78 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.406 ' OE1' ' NZ ' ' A' ' 36' ' ' LYS . 20.9 mm-40 -63.89 -34.22 77.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.666 175.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.526 ' HA ' HG22 ' A' ' 81' ' ' ILE . 18.2 tp -57.48 -41.94 81.64 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.346 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -84.46 -49.82 8.32 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -71.97 -44.69 63.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.05 -26.67 15.96 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.361 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.02 23.44 32.54 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.908 -1.139 . . . . 0.0 112.985 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.526 HG22 ' HA ' ' A' ' 76' ' ' LEU . 11.9 tt -72.32 119.25 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.625 0.726 . . . . 0.0 110.909 -170.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -99.99 118.58 36.69 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.872 -170.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.667 HG12 HD11 ' A' ' 39' ' ' ILE . 3.3 mt -146.16 128.21 8.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 86' ' ' ASN . 0.4 OUTLIER -95.27 153.31 3.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.823 -172.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -87.11 -23.72 24.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.926 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.501 ' N ' HG13 ' A' ' 84' ' ' VAL . 60.2 t30 . . . . . 0 C--N 1.332 -0.177 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.939 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.744 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 87.9 mtp . . . . . 0 CA--C 1.535 0.37 0 CA-C-O 119.761 -0.161 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.744 ' HD3' ' HB2' ' A' ' 28' ' ' MET . 43.7 Cg_exo -59.05 -34.24 98.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.107 1.871 . . . . 0.0 112.412 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.515 ' HB2' HH21 ' A' ' 34' ' ' ARG . 21.1 pt20 -67.09 -25.12 66.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.683 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.636 ' O ' HG13 ' A' ' 35' ' ' ILE . 26.6 mm -69.81 -46.07 75.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.227 175.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -55.69 -45.06 77.87 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.254 0.55 . . . . 0.0 110.009 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 2.9 mmp_? -64.93 -39.76 94.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.022 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.945 ' HD2' ' HA ' ' A' ' 61' ' ' PHE . 5.5 tpp180 -67.16 -39.21 86.46 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.232 -173.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.636 HG13 ' O ' ' A' ' 31' ' ' ILE . 41.5 mt -61.14 -44.87 99.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.613 ' HD3' HD12 ' A' ' 81' ' ' ILE . 14.5 mmtp -66.87 -38.77 86.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.207 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.58 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 54.9 mttm -61.02 -43.36 99.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.9 175.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.513 ' HB3' HD12 ' A' ' 53' ' ' ILE . 65.9 mt -63.73 -47.13 82.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.391 -177.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.541 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -63.41 -34.76 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.066 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.441 ' C ' ' HE3' ' A' ' 44' ' ' LYS . 33.1 t -65.57 -47.89 74.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.551 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.923 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 71.2 mt -59.22 -47.07 86.7 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.636 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.33 -35.81 92.17 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -74.99 -38.79 61.55 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.509 0.671 . . . . 0.0 109.878 -173.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.923 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 3.9 ptpt -70.55 -26.17 63.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.485 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 69.4 mmtt -86.95 -4.48 59.18 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.981 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.88 -71.78 0.3 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.78 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -141.14 164.83 29.21 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 121.213 0.53 . . . . 0.0 111.928 -170.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -85.24 85.27 2.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.22 0.533 . . . . 0.0 109.764 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 51' ' ' GLU . 5.9 m -142.92 146.6 34.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.404 -171.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.33 -36.12 77.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.065 0.46 . . . . 0.0 110.112 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.521 ' H ' HG22 ' A' ' 49' ' ' THR . 32.9 mt-10 -67.42 -34.36 77.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.183 0.516 . . . . 0.0 110.118 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.766 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 1.5 m-20 -67.2 -30.03 69.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.282 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.513 HD12 ' HB3' ' A' ' 38' ' ' LEU . 39.1 mm -60.08 -50.24 80.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.448 0.642 . . . . 0.0 110.341 173.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.36 -38.24 90.4 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.344 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.766 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -75.41 -14.97 60.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.716 -178.277 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.85 -18.92 60.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.117 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.422 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 80.4 t80 -58.69 134.55 86.32 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.813 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 57.9 Cg_endo -72.87 132.16 25.31 Favored 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 123.591 -1.42 . . . . 0.0 112.024 -1.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 19.2 Cg_endo -98.61 -158.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.732 0 C-N-CA 124.259 3.306 . . . . 0.0 111.11 -173.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.509 ' H ' HD11 ' A' ' 41' ' ' LEU . 2.5 t70 -98.96 14.19 29.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.325 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.945 ' HA ' ' HD2' ' A' ' 34' ' ' ARG . 4.3 p90 -69.68 120.13 14.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.386 0.612 . . . . 0.0 111.251 -172.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -82.38 -23.55 34.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.651 172.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.74 125.74 1.5 Allowed Glycine 0 N--CA 1.436 -1.34 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -176.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -113.27 134.26 54.69 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.468 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.432 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 18.4 t70 -151.59 155.28 38.11 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.4 m -63.05 -27.91 69.73 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.94 0.4 . . . . 0.0 111.371 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -61.34 -32.7 72.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.382 0.611 . . . . 0.0 109.937 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.622 ' O ' HG13 ' A' ' 72' ' ' ILE . 63.9 tp -60.66 -39.11 87.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.084 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.6 mm -62.82 -46.65 95.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.791 0.329 . . . . 0.0 110.884 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.454 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 9.4 pt-20 -68.41 -32.55 72.67 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.491 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 5.9 tpp180 -70.2 -35.96 74.28 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.341 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 68' ' ' LEU . 72.0 mt -59.92 -50.94 78.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.762 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.565 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 26.5 p80 -68.69 -33.48 74.04 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.618 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -60.01 -50.54 73.33 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.712 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.571 ' OE1' ' HD2' ' A' ' 78' ' ' LYS . 8.3 mm-40 -65.72 -25.71 67.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.226 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.011 ' HA ' HG22 ' A' ' 81' ' ' ILE . 7.9 tp -56.0 -47.62 77.41 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.066 174.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -83.56 -50.5 8.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.525 0.678 . . . . 0.0 111.199 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.571 ' HD2' ' OE1' ' A' ' 75' ' ' GLU . 23.7 ttmt -68.18 -43.58 77.83 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.998 -172.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.63 -24.68 17.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.772 0.32 . . . . 0.0 110.329 -177.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.37 22.56 24.22 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.114 -1.041 . . . . 0.0 113.27 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.011 HG22 ' HA ' ' A' ' 76' ' ' LEU . 10.0 tt -75.66 146.32 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 117.407 0.603 . . . . 0.0 110.219 -174.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.14 128.31 51.8 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.095 -0.378 . . . . 0.0 110.867 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.541 ' HB ' HG13 ' A' ' 39' ' ' ILE . 4.7 tp -167.25 137.87 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -109.61 151.68 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.253 -177.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -89.66 -23.92 21.75 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.497 ' HB2' HG23 ' A' ' 49' ' ' THR . 63.5 t30 . . . . . 0 N--CA 1.463 0.187 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.505 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.547 ' O ' HG22 ' A' ' 31' ' ' ILE . 59.4 mtt . . . . . 0 N--CA 1.452 -0.355 0 CA-C-O 120.738 0.304 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.89 -24.64 53.4 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.767 2.312 . . . . 0.0 111.382 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -60.66 -31.45 70.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.2 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.626 ' O ' HG13 ' A' ' 35' ' ' ILE . 10.5 tp -69.75 -35.46 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.476 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.84 -42.62 76.91 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.168 0.508 . . . . 0.0 110.238 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -63.65 -38.59 91.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.083 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -60.56 -35.01 75.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.103 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.68 HG23 HG12 ' A' ' 72' ' ' ILE . 52.1 mt -60.37 -46.98 94.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.059 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.664 ' HD3' HD12 ' A' ' 81' ' ' ILE . 28.2 mmtm -66.68 -37.28 84.42 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.237 0.541 . . . . 0.0 109.969 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.567 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 15.9 tptm -64.49 -44.39 91.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.409 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.511 HD22 ' HZ ' ' A' ' 61' ' ' PHE . 16.5 tp -67.06 -45.55 77.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.029 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.569 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -62.7 -34.68 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.892 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.697 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 23.2 t -67.1 -45.43 77.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.071 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.634 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 90.0 mt -59.38 -42.9 92.74 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.541 -176.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.469 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -66.69 -34.83 88.64 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.379 -0.915 . . . . 0.0 110.844 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 10.4 tptm -68.43 -38.7 81.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.46 0.648 . . . . 0.0 109.798 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.697 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -66.03 -41.48 90.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.424 175.245 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.813 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . 73.9 mmtt -68.2 -32.71 73.12 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.424 -177.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.66 -65.6 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.552 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -144.16 155.15 43.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.831 0.348 . . . . 0.0 110.84 -175.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.472 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -73.99 91.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.552 0.691 . . . . 0.0 110.66 -178.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.637 HG22 ' H ' ' A' ' 51' ' ' GLU . 86.6 m -149.07 145.43 27.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.93 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -58.25 -39.37 78.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.803 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.637 ' H ' HG22 ' A' ' 49' ' ' THR . 15.8 mm-40 -64.16 -39.03 93.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.531 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.653 ' CG ' ' HD3' ' A' ' 55' ' ' LYS . 9.9 t0 -72.17 -36.96 69.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.372 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.46 HG23 HD11 ' A' ' 38' ' ' LEU . 26.6 mt -59.92 -45.63 94.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.967 0.413 . . . . 0.0 110.659 172.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -59.59 -31.41 69.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.652 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.813 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -74.71 -26.84 60.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.005 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.616 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -66.74 -19.61 65.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.628 -176.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.462 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 18.2 m-85 -50.99 134.95 28.9 Favored Pre-proline 0 N--CA 1.468 0.451 0 O-C-N 123.236 0.335 . . . . 0.0 111.249 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.499 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 15.4 Cg_exo -68.78 140.32 56.76 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 123.971 -1.262 . . . . 0.0 112.445 1.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 26.5 Cg_endo -98.69 -168.51 0.1 Allowed 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 124.288 3.326 . . . . 0.0 110.957 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.431 ' HB2' HD11 ' A' ' 41' ' ' LEU . 17.0 t70 -98.44 12.08 36.16 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.196 0.522 . . . . 0.0 111.504 -175.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.511 ' HZ ' HD22 ' A' ' 38' ' ' LEU . 41.5 m-85 -70.95 121.29 17.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.076 0.465 . . . . 0.0 111.67 -174.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -79.11 -30.43 43.76 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 165.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.96 125.91 1.4 Allowed Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 173.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -107.72 143.58 36.04 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 117.438 0.619 . . . . 0.0 110.592 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 15.6 t70 -141.5 159.75 41.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.193 -173.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.5 m -61.37 -26.86 68.11 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.015 0.436 . . . . 0.0 111.346 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.67 -33.54 72.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.7 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.604 ' O ' HG13 ' A' ' 72' ' ' ILE . 35.6 tp -55.64 -41.14 73.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.111 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.4 mm -64.05 -40.37 88.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.265 0.555 . . . . 0.0 109.952 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -67.78 -42.73 81.23 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.456 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 10.6 tpt180 -67.89 -34.72 77.2 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.148 -174.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.68 HG12 HG23 ' A' ' 35' ' ' ILE . 76.8 mt -60.62 -48.72 87.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.577 ' HA ' HD12 ' A' ' 76' ' ' LEU . 40.6 t-80 -66.18 -34.64 78.49 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.21 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.32 -49.33 78.24 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 71' ' ' ARG . 34.2 mm-40 -63.67 -29.55 70.77 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.482 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.845 HD21 HG22 ' A' ' 83' ' ' ILE . 77.0 mt -60.9 -50.19 74.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.887 0.375 . . . . 0.0 111.161 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -84.34 -49.74 8.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.191 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -71.88 -44.16 64.22 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 -176.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -96.29 -24.52 16.16 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.449 -172.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.34 21.71 47.46 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.224 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.78 HG23 HD23 ' A' ' 76' ' ' LEU . 5.1 tt -73.82 146.94 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 117.717 0.758 . . . . 0.0 108.991 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -115.3 127.33 55.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.183 0.516 . . . . 0.0 111.81 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.845 HG22 HD21 ' A' ' 76' ' ' LEU . 5.4 tp -155.95 132.45 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.674 176.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -99.12 151.07 4.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -92.08 -24.99 18.98 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.426 ' HB2' HG23 ' A' ' 49' ' ' THR . 16.2 t-20 . . . . . 0 N--CA 1.467 0.412 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.636 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 48.6 tpp . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.125 0.488 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.88 -25.0 6.57 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.931 2.421 . . . . 0.0 112.298 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.461 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 11.5 pt20 -69.57 -26.77 64.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.136 -176.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.641 ' O ' HG13 ' A' ' 35' ' ' ILE . 7.5 mm -66.61 -39.58 84.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.26 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.483 ' HG2' ' HE ' ' A' ' 71' ' ' ARG . 40.6 mt-10 -62.72 -45.47 92.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.071 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 26.2 ptt180 -68.9 -32.4 72.02 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.016 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.593 ' HD3' HD13 ' A' ' 68' ' ' LEU . 29.9 ttt-85 -59.3 -37.42 77.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.165 176.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.648 HD13 ' HA ' ' A' ' 72' ' ' ILE . 45.3 mt -65.55 -44.59 93.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.02 0.438 . . . . 0.0 110.227 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HD3' HD12 ' A' ' 81' ' ' ILE . 1.3 mppt? -66.65 -34.52 78.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.022 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.494 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 96.4 mttt -58.34 -44.6 88.81 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 173.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.543 HD11 ' NH1' ' A' ' 34' ' ' ARG . 48.0 mt -59.26 -50.37 74.25 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.22 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.956 HD11 ' HB ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -61.99 -34.98 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.519 -177.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 71.1 m -67.18 -47.89 69.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.736 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.6 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 96.6 mt -59.69 -42.08 92.16 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.316 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.33 -37.07 85.81 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.155 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.604 ' HG2' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -71.6 -34.0 69.5 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.345 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.54 ' N ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -68.74 -39.44 80.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.28 174.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 1.04 ' HE3' ' HA ' ' A' ' 56' ' ' ALA . 72.2 mmtt -68.67 -26.89 65.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.02 -178.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.42 -63.74 0.3 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.035 177.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -132.37 161.45 33.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.94 0.4 . . . . 0.0 110.916 -173.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.604 HG23 ' HG2' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -84.73 84.27 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.742 HG23 ' H ' ' A' ' 52' ' ' ASP . 4.8 t -150.93 153.81 35.96 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.226 -174.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.43 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 36.3 t80 -63.55 -29.26 70.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.087 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.21 -39.2 86.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.242 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.742 ' H ' HG23 ' A' ' 49' ' ' THR . 0.8 OUTLIER -71.73 -30.36 65.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.87 176.156 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.572 HG12 ' O ' ' A' ' 49' ' ' THR . 44.8 mm -59.44 -48.89 85.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.01 0.434 . . . . 0.0 110.095 172.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -58.66 -36.32 73.96 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.431 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.83 ' HD3' ' HB3' ' A' ' 45' ' ' LYS . 10.4 ptmt -75.92 -17.76 59.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.041 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 1.04 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -71.32 -18.65 62.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.392 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 87.6 t80 -56.05 135.49 74.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.333 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 5.9 Cg_exo -75.07 139.54 62.22 Favored 'Cis proline' 0 C--N 1.346 0.437 0 C-N-CA 123.749 -1.355 . . . . 0.0 111.779 -1.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 15.1 Cg_endo -98.2 -173.37 0.17 Allowed 'Trans proline' 0 N--CA 1.436 -1.911 0 C-N-CA 123.738 2.958 . . . . 0.0 110.802 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -97.73 18.9 14.6 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.45 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.412 ' HB2' ' NH2' ' A' ' 34' ' ' ARG . 13.6 p90 -57.01 119.05 5.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 122.05 0.928 . . . . 0.0 110.948 -168.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -81.29 -26.36 35.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.555 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.51 132.68 2.67 Favored Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -112.12 123.89 51.24 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 117.673 0.736 . . . . 0.0 109.82 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 0.9 OUTLIER -159.69 168.57 25.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.026 0.441 . . . . 0.0 112.07 -175.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 t -64.75 -28.63 69.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.406 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 71' ' ' ARG . 5.2 m120 -62.02 -33.85 75.13 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.825 0.345 . . . . 0.0 110.127 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.593 HD13 ' HD3' ' A' ' 34' ' ' ARG . 23.1 tp -65.54 -47.34 76.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.133 172.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.2 mm -58.3 -46.31 89.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.896 0.379 . . . . 0.0 110.812 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 8.6 pt-20 -67.71 -35.01 78.0 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 15.1 tpt180 -71.06 -36.61 72.35 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.169 -174.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.648 ' HA ' HD13 ' A' ' 35' ' ' ILE . 79.7 mt -60.86 -50.36 80.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.539 0.209 . . . . 0.0 110.534 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.506 ' HA ' HD12 ' A' ' 76' ' ' LEU . 45.6 t60 -65.38 -35.64 81.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.868 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 38.8 mt-10 -59.7 -49.27 78.4 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.427 ' HG3' HD12 ' A' ' 35' ' ' ILE . 8.4 mm-40 -64.26 -29.66 70.75 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.693 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.886 HD23 HG23 ' A' ' 81' ' ' ILE . 93.9 mt -64.16 -52.66 57.94 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.134 0.493 . . . . 0.0 111.659 176.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -86.01 -50.04 7.36 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.124 -175.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -74.28 -42.41 59.62 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.21 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -95.09 -32.56 13.05 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.525 -174.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.86 21.41 21.17 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.921 -1.133 . . . . 0.0 114.226 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.886 HG23 HD23 ' A' ' 76' ' ' LEU . 4.8 tt -72.9 139.96 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 119.292 1.546 . . . . 0.0 108.023 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.57 136.46 53.26 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.787 -175.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.956 ' HB ' HD11 ' A' ' 39' ' ' ILE . 18.9 tt -168.04 126.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.369 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -98.75 155.34 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-O 121.439 0.638 . . . . 0.0 110.094 -169.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -85.29 -22.72 28.45 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.557 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.562 ' N ' HG13 ' A' ' 84' ' ' VAL . 64.0 t30 . . . . . 0 N--CA 1.462 0.161 0 CA-C-N 114.427 -1.261 . . . . 0.0 110.113 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.486 ' HG2' HG12 ' A' ' 31' ' ' ILE . 33.8 ttp . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.187 0.518 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -62.16 -23.82 75.81 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.476 2.784 . . . . 0.0 112.773 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.523 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 11.3 pt20 -59.86 -25.4 65.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.32 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.555 ' O ' HG13 ' A' ' 35' ' ' ILE . 17.2 mm -68.94 -48.88 67.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.829 0.347 . . . . 0.0 110.102 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -56.08 -45.29 79.41 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.172 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 10.4 ptm180 -67.92 -38.42 82.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.901 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.612 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -67.37 -38.05 84.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.676 -175.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 31' ' ' ILE . 75.6 mt -59.97 -43.56 92.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.178 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.626 ' HD3' HD12 ' A' ' 81' ' ' ILE . 19.9 mmtm -66.38 -36.06 81.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.491 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.496 ' HB3' ' HE2' ' A' ' 37' ' ' LYS . 32.1 mtpt -68.72 -38.09 79.97 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.177 176.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 82.8 mt -61.29 -47.73 84.65 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.407 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.61 ' HB ' HD11 ' A' ' 81' ' ' ILE . 1.5 mp -62.64 -34.75 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.185 0.517 . . . . 0.0 109.814 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.0 t -66.2 -48.1 71.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.956 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.525 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 95.1 mt -59.85 -36.45 76.88 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.244 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.49 -38.99 95.39 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.476 ' HB2' HG23 ' A' ' 48' ' ' ILE . 33.1 tptt -65.61 -39.58 91.68 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.303 0.573 . . . . 0.0 109.577 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.54 ' N ' ' HE2' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -63.07 -42.92 99.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.218 173.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.986 ' HE3' ' HA ' ' A' ' 56' ' ' ALA . 71.6 mmtt -68.09 -26.31 65.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.681 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.83 -64.07 0.32 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.747 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -130.94 158.22 40.84 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.682 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -87.86 79.05 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.681 -175.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 1.036 ' HB ' HG13 ' A' ' 84' ' ' VAL . 5.1 t -147.0 160.02 42.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -168.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -56.05 -37.74 69.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.248 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -67.91 -38.99 83.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.394 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.695 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -71.88 -29.89 64.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.363 176.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.672 HG12 ' O ' ' A' ' 49' ' ' THR . 49.4 mm -59.21 -49.64 82.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.417 0.627 . . . . 0.0 109.66 171.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -62.03 -34.22 75.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.154 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.816 ' HD3' ' HB3' ' A' ' 45' ' ' LYS . 11.4 ptmt -75.86 -21.33 57.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.906 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.986 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -76.5 -20.41 56.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.287 0.565 . . . . 0.0 110.08 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.531 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 72.7 t80 -72.5 140.46 81.95 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.449 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.503 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 73.8 Cg_endo -79.83 127.28 14.19 Favored 'Cis proline' 0 C--N 1.345 0.362 0 C-N-CA 123.423 -1.49 . . . . 0.0 112.525 -2.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.531 ' HD3' ' CD1' ' A' ' 57' ' ' PHE . 72.3 Cg_endo -105.53 -139.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.889 0 C-N-CA 124.657 3.572 . . . . 0.0 110.887 -176.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.455 ' H ' ' HB2' ' A' ' 59' ' ' PRO . 21.0 p-10 -97.63 16.69 19.72 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -173.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.612 ' HA ' ' HD3' ' A' ' 34' ' ' ARG . 14.0 m-85 -57.42 118.28 4.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.189 0.519 . . . . 0.0 111.519 -173.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.99 -24.74 40.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.974 172.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.17 127.26 1.6 Allowed Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -99.07 131.79 44.86 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.63 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 7.3 t70 -147.36 138.59 23.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.833 0.349 . . . . 0.0 110.587 -169.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.9 m -63.47 -35.78 81.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.241 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.53 ' HB3' ' OD2' ' A' ' 65' ' ' ASP . 0.5 OUTLIER -62.17 -33.0 73.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.112 176.142 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.63 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 33.3 tp -56.49 -39.59 73.5 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.795 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.9 mm -63.7 -40.64 89.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.999 0.428 . . . . 0.0 110.296 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.632 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 15.8 mt-10 -67.2 -40.82 86.55 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -65.13 -35.23 80.45 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.942 -176.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 68' ' ' LEU . 82.2 mt -60.16 -49.95 82.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.47 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.632 ' CE1' ' HA ' ' A' ' 70' ' ' GLU . 4.7 p-80 -67.41 -31.57 71.87 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.471 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.587 ' HB3' ' HE3' ' A' ' 78' ' ' LYS . 32.8 mt-10 -60.99 -50.49 73.16 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.553 ' OE2' ' HD2' ' A' ' 78' ' ' LYS . 23.2 mm-40 -62.07 -31.5 71.93 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.971 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.718 ' HA ' HG22 ' A' ' 81' ' ' ILE . 15.1 tp -58.09 -45.36 87.31 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.536 175.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -83.52 -51.67 7.14 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.587 ' HE3' ' HB3' ' A' ' 74' ' ' GLU . 18.8 ptpt -74.06 -42.49 60.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.676 0.274 . . . . 0.0 111.189 -174.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -94.84 -21.13 18.89 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.302 -175.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.94 24.35 41.82 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.863 -1.16 . . . . 0.0 112.971 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.718 HG22 ' HA ' ' A' ' 76' ' ' LEU . 7.6 tt -73.78 123.36 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 117.447 0.623 . . . . 0.0 110.44 -173.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.424 HD22 ' HA ' ' A' ' 82' ' ' ASN . 11.8 m120 -80.48 120.22 24.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.154 0.502 . . . . 0.0 111.794 -172.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.0 tp -156.69 115.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 122.073 0.94 . . . . 0.0 110.16 -178.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 1.036 HG13 ' HB ' ' A' ' 49' ' ' THR . 2.3 p -86.37 154.77 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.739 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.0 -31.57 14.19 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.725 0.298 . . . . 0.0 110.616 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.409 ' N ' HG22 ' A' ' 84' ' ' VAL . 61.5 t30 . . . . . 0 N--CA 1.468 0.449 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.766 170.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.444 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 20.7 ptp . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 28' ' ' MET . 19.9 Cg_exo -66.12 -29.72 47.62 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.352 2.035 . . . . 0.0 111.609 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -64.29 -25.92 68.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.704 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.737 HG23 HD13 ' A' ' 68' ' ' LEU . 18.4 mm -63.67 -49.01 84.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.043 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -55.37 -45.28 76.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.554 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -68.85 -37.75 79.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.231 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.564 HH21 ' HG3' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -67.6 -38.98 84.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.1 -177.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.605 HG13 ' O ' ' A' ' 31' ' ' ILE . 70.8 mt -61.22 -39.31 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-O 120.76 0.314 . . . . 0.0 110.519 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.626 ' HD3' HD12 ' A' ' 81' ' ' ILE . 21.2 mmtm -65.55 -35.41 80.77 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.363 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.564 ' HG3' HH21 ' A' ' 34' ' ' ARG . 13.0 mmmm -67.92 -39.07 83.59 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.525 175.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 78.4 mt -61.81 -48.76 79.17 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.117 0.484 . . . . 0.0 110.438 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.592 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -65.09 -35.27 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.378 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -66.9 -48.45 68.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.229 0.538 . . . . 0.0 109.759 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.664 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 83.1 mt -62.01 -41.15 97.77 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.872 -177.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.23 -35.1 87.65 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -69.05 -44.27 72.97 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.467 0.651 . . . . 0.0 109.728 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.523 ' N ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -60.93 -38.04 84.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.701 174.021 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 28.2 mmtp -69.52 -20.45 63.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.258 -177.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.03 -63.3 0.33 Allowed Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.897 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -135.92 150.74 49.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.994 0.426 . . . . 0.0 111.076 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.461 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -80.79 86.02 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 172.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.561 HG23 ' H ' ' A' ' 52' ' ' ASP . 5.4 t -151.07 158.73 44.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.128 -176.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -57.24 -39.8 76.28 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.374 0.421 . . . . 0.0 110.693 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -62.61 -41.15 98.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.825 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.821 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -71.05 -29.35 65.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.788 -176.09 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.4 mm -59.38 -50.39 80.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.358 0.599 . . . . 0.0 109.987 171.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.4 -39.91 84.91 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.809 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.821 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.73 -15.48 59.11 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.902 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HA ' ' NZ ' ' A' ' 45' ' ' LYS . . . -79.18 -19.55 50.6 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.435 175.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.425 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 73.7 t80 -60.86 137.16 93.51 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.027 175.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.538 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 13.1 Cg_endo -88.38 139.3 17.01 Favored 'Cis proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.609 -1.413 . . . . 0.0 113.07 3.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.676 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 27.7 Cg_endo -100.29 -150.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 124.458 3.439 . . . . 0.0 110.189 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.2 15.86 21.5 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.815 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.676 ' CD1' ' HD2' ' A' ' 59' ' ' PRO . 4.3 p90 -58.58 118.64 5.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 122.144 0.973 . . . . 0.0 111.038 -168.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -81.43 -22.28 38.31 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.267 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.75 126.6 1.5 Allowed Glycine 0 N--CA 1.434 -1.488 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -109.66 135.62 50.33 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 13.8 t70 -149.04 158.16 43.96 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.281 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 p -63.89 -35.65 81.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.962 0.41 . . . . 0.0 111.045 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -62.01 -34.79 76.85 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.737 HD13 HG23 ' A' ' 31' ' ' ILE . 26.7 tp -60.29 -40.23 89.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.213 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.451 ' O ' ' HD2' ' A' ' 73' ' ' HIS . 48.4 mm -64.25 -40.98 90.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.914 0.388 . . . . 0.0 110.288 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.7 -40.21 84.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 14.2 tpt180 -61.03 -34.91 75.59 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.671 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 68' ' ' LEU . 82.5 mt -60.84 -45.83 97.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.451 ' HD2' ' O ' ' A' ' 69' ' ' ILE . 74.1 m-70 -59.9 -44.2 94.4 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.243 0.545 . . . . 0.0 110.061 175.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -59.31 -47.34 85.76 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.389 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.474 ' C ' HG22 ' A' ' 81' ' ' ILE . 30.0 mm-40 -55.64 -29.8 59.88 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.881 HD21 HG22 ' A' ' 83' ' ' ILE . 53.7 mt -60.45 -48.92 79.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.27 0.557 . . . . 0.0 110.91 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -83.99 -48.49 9.89 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.309 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -70.9 -46.27 62.83 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.44 -173.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.51 -24.37 15.16 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.898 -177.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.1 20.79 41.11 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.44 -0.885 . . . . 0.0 112.995 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.86 HG23 HD23 ' A' ' 76' ' ' LEU . 7.5 tt -76.05 147.08 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.428 HD22 ' HA ' ' A' ' 82' ' ' ASN . 6.8 m120 -116.94 133.31 56.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.339 0.59 . . . . 0.0 112.378 -177.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.881 HG22 HD21 ' A' ' 76' ' ' LEU . 5.2 tp -167.68 130.85 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.576 -1.193 . . . . 0.0 107.978 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.488 HG12 ' CB ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -88.27 155.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 120.919 0.39 . . . . 0.0 109.995 -177.332 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 39.6 mt-10 -94.53 -23.07 17.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.711 -170.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 6.4 t-20 . . . . . 0 N--CA 1.465 0.315 0 O-C-N 124.525 1.14 . . . . 0.0 109.676 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.79 -27.8 73.34 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.494 2.129 . . . . 0.0 111.368 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.513 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 28.4 tt0 -68.83 -35.43 76.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.607 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.678 ' O ' HG13 ' A' ' 35' ' ' ILE . 9.1 mm -68.12 -48.38 74.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.676 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -60.45 -46.07 91.4 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.469 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 10.8 ptm180 -66.29 -33.15 75.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.505 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.83 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -69.84 -34.53 73.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.518 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.796 HG23 HG12 ' A' ' 72' ' ' ILE . 62.5 mt -58.69 -51.38 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.462 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.509 ' N ' ' HD3' ' A' ' 36' ' ' LYS . 1.8 mppt? -69.28 -35.78 76.4 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.632 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -64.97 -43.68 91.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.985 0.421 . . . . 0.0 109.882 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.477 ' HG ' HG23 ' A' ' 53' ' ' ILE . 6.0 tp -66.73 -45.5 78.46 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.343 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.502 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.4 mp -62.11 -35.48 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.545 ' C ' ' HE2' ' A' ' 44' ' ' LYS . 53.9 m -67.92 -48.58 65.58 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.191 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.72 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 79.5 mt -59.46 -40.08 85.72 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.929 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.54 -34.38 88.21 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.466 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -73.43 -38.21 65.61 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -177.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.545 ' HE2' ' C ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -64.5 -29.95 70.99 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.49 174.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.72 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 74.5 mmtt -74.73 -11.6 60.21 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.039 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.06 -68.3 0.31 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.285 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.73 170.95 14.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.894 0.378 . . . . 0.0 110.382 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.77 85.88 2.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.198 0.523 . . . . 0.0 109.793 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.557 HG22 ' H ' ' A' ' 51' ' ' GLU . 4.9 m -141.17 146.6 37.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.101 -175.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.463 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 90.8 t80 -60.33 -33.71 72.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.172 0.51 . . . . 0.0 109.908 174.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.557 ' H ' HG22 ' A' ' 49' ' ' THR . 35.9 mt-10 -67.59 -37.33 82.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.574 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 1.025 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.2 m-20 -65.2 -31.27 72.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.006 0.432 . . . . 0.0 110.679 174.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.477 HG23 ' HG ' ' A' ' 38' ' ' LEU . 32.0 mm -64.96 -49.84 77.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.167 0.508 . . . . 0.0 110.545 172.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -61.63 -32.78 72.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.803 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 1.025 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 2.9 ptmt -74.69 -17.27 60.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.017 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.507 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -77.67 -19.76 54.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.514 -175.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.489 ' HA ' ' CD ' ' A' ' 59' ' ' PRO . 44.5 m-85 -59.57 130.81 88.09 Favored Pre-proline 0 N--CA 1.462 0.171 0 O-C-N 123.322 0.389 . . . . 0.0 111.23 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.524 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 3.9 Cg_exo -77.03 123.93 10.07 Favored 'Cis proline' 0 C--O 1.234 0.315 0 C-N-CA 123.998 -1.251 . . . . 0.0 112.33 0.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.529 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 34.8 Cg_endo -100.93 -156.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.687 0 C-N-CA 124.361 3.374 . . . . 0.0 110.751 -177.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -97.73 12.81 32.53 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.023 0.44 . . . . 0.0 111.459 -177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.529 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 3.7 p90 -66.17 120.62 13.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.273 0.559 . . . . 0.0 109.919 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.565 ' HG3' HH11 ' A' ' 34' ' ' ARG . 43.4 mt-10 -81.42 -23.62 37.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.378 0.609 . . . . 0.0 110.346 177.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.29 127.63 1.66 Allowed Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -100.84 136.87 40.02 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.58 -0.448 . . . . 0.0 109.819 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.512 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 10.3 t70 -150.0 142.71 24.62 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.1 t -63.74 -27.13 68.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.56 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -66.06 -33.59 76.15 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.99 0.424 . . . . 0.0 109.898 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.58 HD13 HG23 ' A' ' 31' ' ' ILE . 46.2 tp -59.63 -40.69 88.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.669 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.3 mm -60.83 -41.62 89.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.09 0.471 . . . . 0.0 110.48 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.27 -43.5 73.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.553 0.692 . . . . 0.0 109.156 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.626 ' HG3' HD11 ' A' ' 35' ' ' ILE . 11.5 tpp180 -62.41 -36.51 82.58 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.638 -176.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.796 HG12 HG23 ' A' ' 35' ' ' ILE . 79.9 mt -64.72 -48.22 85.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.505 176.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.518 ' HA ' HD12 ' A' ' 76' ' ' LEU . 32.9 m80 -63.09 -41.12 99.32 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.386 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.25 -42.84 99.68 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.926 -0.309 . . . . 0.0 110.224 176.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.419 ' C ' HG22 ' A' ' 81' ' ' ILE . 10.3 mt-10 -64.53 -28.55 69.72 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 178.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.009 HD23 HG23 ' A' ' 81' ' ' ILE . 78.4 mt -56.97 -47.99 79.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.071 0.462 . . . . 0.0 110.77 176.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -83.87 -50.34 8.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.949 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -74.11 -43.28 58.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.058 -173.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -95.68 -21.85 17.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.246 0.546 . . . . 0.0 110.474 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.11 20.35 57.57 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.936 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.009 HG23 HD23 ' A' ' 76' ' ' LEU . 7.1 tt -75.58 146.58 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.455 HD22 ' HA ' ' A' ' 82' ' ' ASN . 5.3 m120 -113.89 129.18 56.62 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.632 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.878 HG22 HD21 ' A' ' 76' ' ' LEU . 7.3 tp -159.59 121.33 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 172.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -96.84 158.84 3.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.466 0.65 . . . . 0.0 111.274 -168.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -87.17 -22.93 25.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.961 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.519 ' HB2' ' CG2' ' A' ' 49' ' ' THR . 66.2 t30 . . . . . 0 N--CA 1.468 0.469 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.396 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.879 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 59.2 ttp . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 119.478 -0.296 . . . . 0.0 111.621 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.879 ' HD3' ' HB3' ' A' ' 28' ' ' MET . 17.3 Cg_exo -66.18 -32.53 42.48 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 121.85 1.7 . . . . 0.0 111.669 -176.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.548 ' HA ' ' HG2' ' A' ' 33' ' ' ARG . 19.3 pt20 -67.59 -27.6 67.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.92 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.728 ' O ' HG12 ' A' ' 35' ' ' ILE . 34.4 mm -69.29 -51.54 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.64 -44.52 85.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.928 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.548 ' HG2' ' HA ' ' A' ' 30' ' ' GLN . 23.6 ptt180 -69.01 -37.02 78.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.334 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.675 ' NH1' HD11 ' A' ' 38' ' ' LEU . 4.6 tmt_? -67.49 -41.68 84.15 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 121.27 -0.172 . . . . 0.0 111.126 -177.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.728 HG12 ' O ' ' A' ' 31' ' ' ILE . 20.0 mm -59.67 -48.15 88.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 121.18 0.514 . . . . 0.0 110.077 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.413 ' HD3' HD12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -67.39 -35.12 78.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.8 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 37' ' ' LYS . 40.5 mtpt -60.21 -38.5 83.53 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.029 -0.269 . . . . 0.0 110.87 175.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.675 HD11 ' NH1' ' A' ' 34' ' ' ARG . 71.9 mt -59.64 -43.75 93.74 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.197 0.523 . . . . 0.0 110.249 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.718 HD11 HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -61.86 -39.19 82.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.267 178.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.622 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 25.0 t -67.37 -49.68 62.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.993 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.602 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 87.7 mt -68.81 -41.94 77.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.978 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.81 -38.49 85.36 Favored Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -63.73 -44.99 91.93 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.622 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -58.26 -38.36 76.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.492 173.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.914 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -69.32 -21.96 63.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.274 -178.123 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.26 -57.51 0.51 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.507 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.446 ' HB2' ' OD2' ' A' ' 52' ' ' ASP . 99.3 m-85 -134.12 163.36 29.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.121 0.486 . . . . 0.0 110.528 -174.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -96.86 85.7 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.533 0.682 . . . . 0.0 109.552 174.022 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 27.0 p -139.41 159.84 41.22 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.645 -175.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -57.69 -37.91 74.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.065 0.46 . . . . 0.0 110.003 176.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -66.14 -46.09 78.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.418 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.767 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 5.1 m-20 -66.7 -31.43 72.09 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.664 HG12 ' O ' ' A' ' 49' ' ' THR . 48.6 mm -63.99 -48.77 84.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.369 0.604 . . . . 0.0 109.963 172.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.553 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 21.4 t70 -61.93 -37.05 83.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.58 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.767 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.34 -15.26 59.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.73 178.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.433 ' HB1' ' CB ' ' A' ' 41' ' ' LEU . . . -76.68 -18.9 58.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.907 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.658 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 24.2 m-85 -68.12 165.2 35.23 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.389 176.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.658 ' HA ' ' HB3' ' A' ' 57' ' ' PHE . 96.7 Cg_endo -82.57 157.07 77.31 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 123.895 -1.294 . . . . 0.0 112.672 -0.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 49.2 Cg_endo -104.49 -173.99 0.07 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.6 0 C-N-CA 124.425 3.416 . . . . 0.0 111.359 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -98.56 16.5 21.67 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.745 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.811 ' HE2' HD22 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -59.58 124.13 19.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.979 -169.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -79.12 -13.44 59.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.372 -170.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.12 125.55 1.38 Allowed Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -105.98 130.65 53.87 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.564 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 11.7 t70 -148.91 155.04 40.29 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -176.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.1 t -63.73 -25.9 68.41 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.21 0.529 . . . . 0.0 110.99 176.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.468 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 29.1 t-20 -60.7 -33.32 72.69 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.112 0.482 . . . . 0.0 109.867 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.811 HD22 ' HE2' ' A' ' 61' ' ' PHE . 26.0 tp -54.37 -38.37 66.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.074 173.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.9 mm -62.03 -38.06 79.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.2 0.524 . . . . 0.0 110.125 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.677 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 6.7 mm-40 -66.27 -45.06 81.81 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 26.5 mmt180 -60.27 -38.26 83.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.393 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.62 HG13 ' O ' ' A' ' 68' ' ' LEU . 79.3 mt -61.26 -51.29 74.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.807 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.677 ' CE1' ' HA ' ' A' ' 70' ' ' GLU . 4.5 p-80 -68.73 -30.88 69.6 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.405 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.581 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 44.0 mt-10 -59.33 -50.26 74.65 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.699 173.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.692 ' HG3' HG13 ' A' ' 35' ' ' ILE . 8.3 mm-40 -60.4 -29.85 69.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 120.952 0.406 . . . . 0.0 110.677 176.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.684 ' HA ' HG22 ' A' ' 81' ' ' ILE . 19.3 tp -61.54 -45.29 94.79 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 174.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -83.36 -53.06 6.01 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.581 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 49.1 pttt -74.54 -38.07 62.86 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -173.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.41 -24.82 17.18 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.881 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.9 23.99 43.42 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.746 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.684 HG22 ' HA ' ' A' ' 76' ' ' LEU . 8.0 tt -72.55 121.97 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.429 0.633 . . . . 0.0 111.001 -169.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.533 ' O ' HD11 ' A' ' 39' ' ' ILE . 19.7 m120 -99.72 117.25 33.66 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -171.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.718 HG12 HD11 ' A' ' 39' ' ' ILE . 1.8 mt -149.34 132.25 6.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -90.09 153.9 3.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -177.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -87.47 -31.98 19.71 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.033 0.444 . . . . 0.0 110.949 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.4 ' H ' HG13 ' A' ' 84' ' ' VAL . 42.3 t30 . . . . . 0 C--N 1.332 -0.164 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.269 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.484 ' HB2' HG12 ' A' ' 31' ' ' ILE . 65.1 mtt . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.513 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 36.3 Cg_exo -57.8 -27.11 76.79 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.74 2.293 . . . . 0.0 111.638 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.542 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 14.9 pt20 -64.27 -25.07 67.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.092 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.646 ' O ' HG13 ' A' ' 35' ' ' ILE . 23.9 mm -68.46 -48.34 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.278 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -56.0 -46.36 78.76 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.085 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 21.5 mmm180 -67.25 -40.88 86.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.243 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -66.87 -36.36 82.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.187 -175.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.646 HG13 ' O ' ' A' ' 31' ' ' ILE . 74.7 mt -59.89 -44.38 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.599 ' HD3' HD12 ' A' ' 81' ' ' ILE . 26.5 mmtm -67.32 -35.77 80.1 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.142 0.496 . . . . 0.0 110.118 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.611 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 39.7 ttmt -65.99 -38.27 88.07 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.535 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.696 HD11 ' CZ ' ' A' ' 61' ' ' PHE . 93.4 mt -61.08 -50.57 72.74 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.041 0.448 . . . . 0.0 110.085 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.543 ' HB ' HD11 ' A' ' 81' ' ' ILE . 1.5 mp -66.19 -35.14 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.336 -177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' A' ' 37' ' ' LYS . 22.7 p -70.22 -43.37 70.8 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.263 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.641 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 78.4 mt -58.82 -35.41 72.83 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.676 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.59 -32.97 85.96 Favored Glycine 0 CA--C 1.496 -1.152 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.38 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -30.45 65.86 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.565 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.87 -43.73 74.76 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.167 171.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.641 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 32.3 mmmt -66.97 -31.94 72.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.555 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.46 -63.86 0.31 Allowed Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.353 175.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -142.77 154.33 44.13 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.441 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -81.93 105.36 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.364 0.602 . . . . 0.0 111.089 -177.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.7 HG23 ' H ' ' A' ' 52' ' ' ASP . 2.5 t -155.48 158.34 38.39 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.393 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -56.81 -29.9 63.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.288 0.566 . . . . 0.0 109.753 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -63.56 -42.18 98.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.498 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.727 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -64.54 -37.67 88.35 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.008 -176.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.501 HD12 ' HB3' ' A' ' 38' ' ' LEU . 40.8 mm -59.77 -49.18 84.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.577 0.703 . . . . 0.0 109.772 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -66.93 -34.58 78.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.294 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.727 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 9.5 ptmt -76.46 -20.38 57.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.051 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.2 -19.59 60.48 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.527 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.503 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 39.9 t80 -55.47 139.09 67.79 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.756 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 57' ' ' PHE . 22.9 Cg_exo -66.07 145.3 68.83 Favored 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 124.011 -1.245 . . . . 0.0 112.247 -0.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 14.7 Cg_endo -95.12 -175.33 0.35 Allowed 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 123.743 2.962 . . . . 0.0 110.029 -173.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -98.5 12.73 34.21 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.225 0.536 . . . . 0.0 111.127 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.696 ' CZ ' HD11 ' A' ' 38' ' ' LEU . 32.0 m-85 -63.64 117.78 7.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.066 0.46 . . . . 0.0 111.999 -176.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -82.22 -21.88 36.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.177 170.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.15 127.98 1.69 Allowed Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -104.4 145.06 30.8 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.982 0.391 . . . . 0.0 110.58 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.632 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 11.0 t70 -145.18 156.11 43.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.561 0.22 . . . . 0.0 110.732 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.5 m -63.49 -34.55 78.01 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.212 0.529 . . . . 0.0 111.021 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -61.49 -32.01 72.01 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.983 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.632 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 11.5 tp -56.4 -43.27 79.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.351 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.5 mm -61.56 -47.29 94.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.892 0.377 . . . . 0.0 110.57 -176.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -69.93 -33.74 72.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.868 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.1 tpp85 -70.74 -33.52 70.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.291 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 68' ' ' LEU . 80.2 mt -61.7 -50.54 79.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 176.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.496 ' HA ' HD12 ' A' ' 76' ' ' LEU . 15.4 t-80 -67.1 -34.34 77.42 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.547 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.549 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 36.2 mt-10 -58.87 -50.13 75.16 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 173.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.569 ' HG2' ' HE3' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -59.62 -35.19 73.87 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.494 -179.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.872 HD21 HG22 ' A' ' 83' ' ' ILE . 81.5 mt -58.97 -52.2 66.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.05 0.452 . . . . 0.0 111.776 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -85.15 -48.46 9.13 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.251 0.548 . . . . 0.0 112.383 -177.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 18.3 ttmt -71.9 -44.48 63.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.988 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -96.43 -26.96 15.13 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.146 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.26 21.39 35.38 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 119.865 -1.16 . . . . 0.0 113.516 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.803 HG23 HD23 ' A' ' 76' ' ' LEU . 6.5 tt -73.15 144.85 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.432 ' HA ' HD22 ' A' ' 82' ' ' ASN . 2.7 t-20 -113.67 128.61 56.49 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.93 -0.708 . . . . 0.0 112.193 -173.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.872 HG22 HD21 ' A' ' 76' ' ' LEU . 7.0 tp -156.11 133.18 2.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -102.7 166.72 2.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -174.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -93.63 -33.56 13.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.659 0.743 . . . . 0.0 109.592 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.556 ' N ' HG13 ' A' ' 84' ' ' VAL . 24.0 t30 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 113.864 -1.516 . . . . 0.0 109.981 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.623 ' O ' HG22 ' A' ' 31' ' ' ILE . 47.7 ttm . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -60.78 -24.6 79.32 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.816 2.344 . . . . 0.0 112.792 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.508 ' HG3' ' HG2' ' A' ' 28' ' ' MET . 1.5 pp0? -64.58 -29.59 70.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.31 -174.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.623 HG22 ' O ' ' A' ' 28' ' ' MET . 11.3 tp -70.22 -45.85 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.861 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.825 ' HG2' ' HD3' ' A' ' 71' ' ' ARG . 25.6 mt-10 -70.85 -41.2 71.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.753 0.311 . . . . 0.0 110.771 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 11.7 ptt180 -62.22 -32.53 73.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.587 HH11 HD22 ' A' ' 68' ' ' LEU . 25.1 ttm180 -64.29 -37.81 88.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.039 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.535 HG22 ' CD1' ' A' ' 81' ' ' ILE . 15.6 mm -60.33 -50.48 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.641 ' HD3' HD12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -68.21 -35.24 77.67 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.482 179.021 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.53 ' HG2' ' HB2' ' A' ' 60' ' ' ASP . 2.6 tppp? -64.7 -42.35 95.35 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.42 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.675 ' HB3' HD12 ' A' ' 53' ' ' ILE . 75.3 mt -59.66 -48.53 81.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.948 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.082 HD11 ' HB ' ' A' ' 83' ' ' ILE . 0.5 OUTLIER -65.71 -36.55 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.419 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.651 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 47.6 t -68.09 -50.37 55.38 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.824 -176.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.682 HD12 ' HB3' ' A' ' 59' ' ' PRO . 36.2 mt -69.39 -41.56 76.28 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.016 -176.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.04 -39.99 94.99 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.89 -40.33 72.28 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.651 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -59.93 -37.32 79.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.186 174.458 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.678 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 73.5 mmtt -68.56 -31.98 71.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.784 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.11 -68.0 0.17 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.584 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -132.4 163.86 27.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.369 0.604 . . . . 0.0 111.534 -171.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.502 HG22 HD12 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -93.51 84.07 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.808 178.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.793 HG23 ' H ' ' A' ' 52' ' ' ASP . 10.0 t -155.45 158.28 38.31 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.452 -174.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.411 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 17.9 t80 -57.38 -37.06 72.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.883 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -64.31 -41.75 96.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.512 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.793 ' H ' HG23 ' A' ' 49' ' ' THR . 0.9 OUTLIER -71.97 -29.99 64.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.348 177.338 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.675 HD12 ' HB3' ' A' ' 38' ' ' LEU . 45.4 mm -59.47 -49.02 85.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.176 0.512 . . . . 0.0 110.321 172.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.789 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 16.9 t70 -58.52 -37.94 76.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.459 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.692 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.29 -15.51 59.4 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.794 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.81 -20.02 33.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.996 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.834 ' HD1' ' HD3' ' A' ' 59' ' ' PRO . 16.3 m-85 -61.7 145.35 92.01 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.163 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.497 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 22.3 Cg_endo -95.8 128.71 3.66 Favored 'Cis proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.275 -1.135 . . . . 0.0 112.104 -3.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.834 ' HD3' ' HD1' ' A' ' 57' ' ' PHE . 77.5 Cg_endo -106.6 -108.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.944 0 C-N-CA 123.667 2.911 . . . . 0.0 112.785 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.53 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -100.45 10.86 40.62 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -170.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.789 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 12.9 p90 -79.52 117.87 20.86 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 118.891 -1.124 . . . . 0.0 110.186 -177.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.456 ' HB2' ' NE2' ' A' ' 30' ' ' GLN . 97.8 mt-10 -81.11 -26.08 36.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.587 173.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.57 127.26 1.59 Allowed Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -76.18 135.45 39.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 117.402 0.601 . . . . 0.0 109.38 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 10.6 p-10 -151.5 151.2 31.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.983 0.421 . . . . 0.0 111.472 -168.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.7 m -64.02 -29.66 70.79 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.146 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.605 HD21 HG12 ' A' ' 31' ' ' ILE . 1.7 t30 -61.49 -33.85 74.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.426 177.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.587 HD22 HH11 ' A' ' 34' ' ' ARG . 46.3 tp -56.36 -41.89 76.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.964 175.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.4 mm -59.95 -42.97 91.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.007 0.432 . . . . 0.0 110.327 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 12.6 mt-10 -68.85 -43.9 74.49 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.825 ' HD3' ' HG2' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -59.51 -40.98 88.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.029 -174.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.565 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 82.7 mt -61.11 -49.48 84.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.512 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.472 ' HA ' HD12 ' A' ' 76' ' ' LEU . 32.2 m170 -65.9 -38.46 88.8 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.439 -177.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 51.4 mt-10 -62.75 -47.14 84.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.455 177.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 79' ' ' HIS . 12.1 mm-40 -59.35 -29.6 67.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.84 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.702 HD23 HG23 ' A' ' 81' ' ' ILE . 91.6 mt -58.04 -48.03 81.33 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.783 0.325 . . . . 0.0 110.397 175.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -84.32 -52.03 6.53 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 19.8 pttp -73.23 -37.56 66.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -174.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.43 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 30.5 t60 -94.03 -34.73 12.91 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.548 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.79 22.59 30.43 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.837 -175.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.702 HG23 HD23 ' A' ' 76' ' ' LEU . 6.6 tt -72.73 138.73 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -175.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -117.06 124.67 49.85 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.387 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.082 ' HB ' HD11 ' A' ' 39' ' ' ILE . 19.8 tt -159.3 132.49 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.753 -174.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.541 HG12 ' HB ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -98.24 154.27 3.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.121 0.486 . . . . 0.0 110.729 -172.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -86.43 -34.63 20.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.438 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 . . . . . 0 N--CA 1.469 0.518 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.211 179.868 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.464 ' SD ' HG12 ' A' ' 31' ' ' ILE . 54.7 ttm . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.713 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 57.7 Cg_exo -52.63 -32.74 55.79 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.984 2.456 . . . . 0.0 112.521 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -58.72 -39.22 80.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.766 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.669 ' O ' HG13 ' A' ' 35' ' ' ILE . 16.7 mm -67.69 -45.33 84.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.677 177.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -56.54 -45.17 81.32 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.861 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.713 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 14.4 mmt180 -65.36 -39.53 92.43 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.444 0.64 . . . . 0.0 109.918 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.463 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -66.26 -35.85 81.47 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.23 -176.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.669 HG13 ' O ' ' A' ' 31' ' ' ILE . 62.6 mt -59.57 -44.11 92.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.619 ' HD3' HD12 ' A' ' 81' ' ' ILE . 48.2 mmtt -67.02 -42.38 85.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.56 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.62 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 8.7 mtpm? -62.14 -39.15 91.64 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.488 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.613 HD11 ' HZ ' ' A' ' 61' ' ' PHE . 55.2 mt -60.43 -47.74 84.8 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.461 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.66 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.4 mp -62.28 -35.37 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.075 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.61 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 22.5 t -67.02 -47.48 71.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.206 177.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.726 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 88.6 mt -59.96 -44.96 94.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.682 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.61 -37.07 84.53 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.448 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 15.4 tptm -65.33 -43.88 89.54 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.206 0.526 . . . . 0.0 110.08 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.61 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -59.32 -35.37 73.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.538 174.459 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.97 ' HE2' ' HA ' ' A' ' 56' ' ' ALA . 44.1 mmtm -68.62 -25.27 64.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.829 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.22 -62.31 0.31 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.432 -0.89 . . . . 0.0 113.076 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -134.71 157.75 45.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.995 0.426 . . . . 0.0 110.261 -175.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -81.12 86.43 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-O 121.077 0.465 . . . . 0.0 109.814 175.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.696 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 10.1 t -152.11 153.33 33.69 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.386 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -61.42 -30.31 70.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.984 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -67.49 -38.02 83.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.341 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 1.0 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -71.99 -31.53 66.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.163 176.245 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 49' ' ' THR . 49.0 mm -60.88 -49.75 83.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.383 0.611 . . . . 0.0 110.072 172.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -57.02 -38.9 73.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.346 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 1.0 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 7.4 ptmt -75.83 -15.75 60.19 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.979 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.97 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -77.14 -18.84 57.59 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.929 -178.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.631 ' CD1' ' HG3' ' A' ' 59' ' ' PRO . 18.5 m-30 -61.0 145.67 88.95 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.509 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 7.0 Cg_exo -73.82 144.61 81.55 Favored 'Cis proline' 0 C--N 1.347 0.496 0 C-N-CA 124.26 -1.142 . . . . 0.0 112.53 0.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.715 ' HG2' ' CD2' ' A' ' 61' ' ' PHE . 37.4 Cg_endo -104.4 -157.47 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.565 0 C-N-CA 124.64 3.56 . . . . 0.0 111.054 -176.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.44 11.16 37.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.846 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.715 ' CD2' ' HG2' ' A' ' 59' ' ' PRO . 23.2 m-85 -63.14 117.64 6.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.28 0.562 . . . . 0.0 112.254 -171.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -81.61 -21.93 38.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.666 168.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.57 126.9 1.54 Allowed Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -103.25 144.85 30.8 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 117.091 0.445 . . . . 0.0 110.384 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -151.36 156.33 40.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.841 0.353 . . . . 0.0 110.962 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 m -63.07 -24.57 67.97 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.285 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.664 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 26.2 t30 -57.23 -38.55 73.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.197 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.537 ' O ' HG13 ' A' ' 72' ' ' ILE . 27.8 tp -57.47 -39.86 77.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.414 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.5 mm -62.25 -41.54 91.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.162 0.506 . . . . 0.0 110.192 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -68.17 -42.1 80.51 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.678 0.752 . . . . 0.0 109.107 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 13.5 mmt180 -68.34 -34.63 76.45 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.503 -174.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 68' ' ' LEU . 75.6 mt -61.59 -49.0 86.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.676 0.274 . . . . 0.0 110.754 177.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -64.09 -39.53 94.26 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.092 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -59.11 -49.8 76.47 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.405 ' C ' HG22 ' A' ' 81' ' ' ILE . 18.0 mm-40 -56.59 -29.76 62.43 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.868 HD23 HG23 ' A' ' 81' ' ' ILE . 85.9 mt -58.65 -50.08 75.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.92 0.391 . . . . 0.0 111.247 176.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -85.1 -48.06 9.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.512 0.673 . . . . 0.0 111.617 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -69.61 -45.17 69.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.533 -173.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.97 -31.69 11.68 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.963 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.92 22.04 19.1 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.264 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.868 HG23 HD23 ' A' ' 76' ' ' LEU . 6.8 tt -73.69 145.56 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 118.507 1.153 . . . . 0.0 108.188 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -116.73 130.31 56.65 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.091 -0.644 . . . . 0.0 112.457 -174.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.691 HG22 HD21 ' A' ' 76' ' ' LEU . 4.2 tp -168.49 133.79 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.24 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -91.95 150.46 3.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -96.29 -23.15 16.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.882 0.372 . . . . 0.0 110.487 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 60.1 t30 . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.503 -178.457 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 45.7 ttm . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.74 -24.76 76.93 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.443 2.762 . . . . 0.0 113.159 -174.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -60.55 -25.77 66.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.417 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.617 ' O ' HG13 ' A' ' 35' ' ' ILE . 26.1 mm -66.44 -49.94 71.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 177.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -54.84 -45.9 74.55 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.156 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -66.94 -42.47 85.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.286 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.699 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -63.19 -40.21 96.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.212 -175.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.695 HD13 ' HA ' ' A' ' 72' ' ' ILE . 54.2 mt -59.51 -40.53 82.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.011 0.434 . . . . 0.0 109.934 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.732 ' HD3' HD12 ' A' ' 81' ' ' ILE . 32.5 mmtm -66.89 -39.49 87.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.696 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.498 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 87.7 mttt -64.76 -43.61 92.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.978 176.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.79 -44.03 97.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.334 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.566 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -62.88 -36.09 74.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.38 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.417 ' C ' ' HE3' ' A' ' 44' ' ' LYS . 48.9 m -66.28 -46.32 77.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.099 0.476 . . . . 0.0 110.023 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.709 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 97.6 mt -58.89 -47.32 85.37 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.219 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.16 -33.71 86.73 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.487 ' HB2' HG23 ' A' ' 48' ' ' ILE . 12.2 tptt -73.39 -40.0 64.67 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.414 -0.893 . . . . 0.0 109.44 -174.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.709 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 5.4 ptpt -75.98 -31.77 59.15 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.752 -177.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 66.8 mmtt -76.83 -9.75 58.9 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.105 177.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.69 -70.31 0.31 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.883 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -133.97 148.44 51.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.222 0.534 . . . . 0.0 111.455 -168.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -78.53 86.83 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.237 0.541 . . . . 0.0 109.901 176.029 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.683 HG23 ' H ' ' A' ' 52' ' ' ASP . 8.9 t -156.75 158.21 36.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.467 -175.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -63.62 -30.48 71.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 110.871 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.5 -41.11 93.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.557 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.929 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -71.95 -29.13 63.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.04 177.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.582 HG12 ' O ' ' A' ' 49' ' ' THR . 48.1 mm -59.4 -50.59 79.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.157 0.503 . . . . 0.0 109.972 172.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.515 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 0.5 OUTLIER -57.58 -34.43 69.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.69 177.493 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.929 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 4.5 ptmt -75.81 -18.86 59.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.025 -178.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.97 -20.11 42.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.547 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.515 ' CD2' ' HA ' ' A' ' 54' ' ' ASP . 80.2 m-85 -62.67 142.95 96.81 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.872 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.477 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 86.3 Cg_endo -84.24 143.19 41.13 Favored 'Cis proline' 0 C--N 1.345 0.362 0 C-N-CA 123.394 -1.502 . . . . 0.0 112.779 -1.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.591 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 39.8 Cg_endo -103.87 -156.72 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 124.785 3.656 . . . . 0.0 111.104 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -97.98 16.03 22.23 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.177 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.699 ' HA ' ' HD3' ' A' ' 34' ' ' ARG . 7.0 p90 -58.43 121.21 10.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 122.083 0.944 . . . . 0.0 111.723 -167.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -79.33 -24.93 42.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.408 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.1 127.34 1.59 Allowed Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -111.1 128.81 56.0 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -153.0 157.87 41.19 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 -175.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -27.05 65.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.513 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.434 ' OD1' ' HD2' ' A' ' 71' ' ' ARG . 10.5 t-20 -61.52 -35.16 76.92 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.335 176.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.657 ' O ' HG13 ' A' ' 72' ' ' ILE . 57.6 tp -64.08 -39.53 94.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.891 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.2 mm -64.06 -46.78 92.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.712 0.291 . . . . 0.0 110.701 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.483 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 16.6 pt-20 -68.99 -33.1 73.13 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.586 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 42.4 mtt180 -72.27 -29.59 64.03 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.18 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.695 ' HA ' HD13 ' A' ' 35' ' ' ILE . 64.3 mt -58.87 -50.56 79.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.542 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 30.7 p80 -69.82 -32.79 71.42 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.986 176.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 71' ' ' ARG . 13.4 mt-10 -59.48 -50.25 74.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.981 0.419 . . . . 0.0 110.452 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.731 ' HA ' ' HG2' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -67.86 -27.42 66.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.688 178.07 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.937 ' HA ' HG22 ' A' ' 81' ' ' ILE . 12.6 tp -56.54 -45.31 81.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.863 172.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -83.1 -51.55 7.43 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.731 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 11.7 ptpt -72.06 -39.1 69.29 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -173.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -94.14 -32.13 13.87 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.635 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.37 24.87 15.09 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.421 -1.371 . . . . 0.0 113.131 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.937 HG22 ' HA ' ' A' ' 76' ' ' LEU . 5.9 tt -72.23 144.44 13.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 117.202 0.501 . . . . 0.0 109.858 -174.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.407 ' HA ' HD22 ' A' ' 82' ' ' ASN . 10.4 m120 -102.6 123.14 45.77 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.337 -177.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.566 ' HB ' HG13 ' A' ' 39' ' ' ILE . 4.5 tp -162.31 137.15 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.53 HG12 ' HB ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -103.14 156.09 5.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.115 0.483 . . . . 0.0 110.353 -176.31 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 7.0 mm-40 -89.83 -25.36 21.09 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.733 -175.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.534 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 8.3 t30 . . . . . 0 N--CA 1.463 0.183 0 O-C-N 124.571 1.17 . . . . 0.0 110.185 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.545 ' O ' HG22 ' A' ' 31' ' ' ILE . 28.0 ttt . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 121.007 0.432 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.63 -24.48 75.01 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.837 2.358 . . . . 0.0 112.742 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.643 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 23.6 tm0? -65.58 -39.17 91.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.963 0.411 . . . . 0.0 110.857 -175.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.664 HD11 ' HB2' ' A' ' 68' ' ' LEU . 10.4 tp -71.89 -38.78 66.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.207 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.31 -40.52 74.15 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.964 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 3.2 ptm180 -61.32 -36.04 79.03 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.699 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.623 ' HD2' ' HA ' ' A' ' 61' ' ' PHE . 48.1 ttp85 -65.07 -35.76 82.18 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.812 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.607 HD13 ' HA ' ' A' ' 72' ' ' ILE . 21.8 mt -60.48 -45.2 97.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 110.579 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.509 ' HD3' HD12 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -67.11 -39.71 86.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.371 177.474 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 33' ' ' ARG . 14.4 mmmm -61.75 -39.6 92.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.185 0.517 . . . . 0.0 109.616 176.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 54.9 mt -63.59 -46.82 84.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.359 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.586 HD11 ' HB ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -62.06 -35.57 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.41 -178.443 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.6 p -67.61 -45.89 74.13 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.689 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.737 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 96.4 mt -59.26 -45.8 90.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.219 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.74 -34.82 78.74 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -42.04 87.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.04 0.924 . . . . 0.0 109.068 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.456 ' N ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -64.1 -39.99 95.25 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 113.815 -1.539 . . . . 0.0 110.583 175.115 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.765 ' HE2' ' HA ' ' A' ' 56' ' ' ALA . 45.4 mmtm -67.91 -31.5 71.32 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.774 -178.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.01 -67.55 0.17 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.236 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -137.63 171.18 14.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.851 0.358 . . . . 0.0 110.733 -171.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.656 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -83.55 86.07 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 122.486 1.136 . . . . 0.0 108.863 173.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.58 ' O ' HG12 ' A' ' 53' ' ' ILE . 6.0 m -145.79 151.74 38.43 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.258 -174.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -59.43 -36.02 75.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.962 0.41 . . . . 0.0 110.113 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.537 ' H ' HG22 ' A' ' 49' ' ' THR . 35.5 mt-10 -58.71 -40.99 85.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.484 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.692 ' HA ' ' CD ' ' A' ' 55' ' ' LYS . 5.2 m-20 -71.68 -32.35 67.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.233 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 49' ' ' THR . 39.6 mm -66.89 -49.65 72.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.79 0.805 . . . . 0.0 109.781 174.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.64 -33.74 76.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.278 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.692 ' CD ' ' HA ' ' A' ' 52' ' ' ASP . 15.6 ptmt -76.33 -19.99 57.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.985 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.765 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -74.2 -18.95 60.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.875 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -57.25 132.55 81.0 Favored Pre-proline 0 N--CA 1.466 0.352 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.119 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 57.2 Cg_endo -71.85 133.4 28.68 Favored 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 123.707 -1.372 . . . . 0.0 112.705 0.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.554 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 35.2 Cg_endo -101.51 -157.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 124.347 3.365 . . . . 0.0 111.27 -175.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -97.17 13.62 28.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.622 -175.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.623 ' HA ' ' HD2' ' A' ' 34' ' ' ARG . 8.2 p90 -63.06 120.15 10.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.453 0.644 . . . . 0.0 110.933 -175.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.587 ' HB2' ' NE2' ' A' ' 30' ' ' GLN . 24.5 mt-10 -79.55 -26.74 41.32 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.8 135.52 3.74 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -95.64 130.04 42.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 117.452 0.626 . . . . 0.0 110.018 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -137.01 145.3 43.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.567 -171.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.6 t -65.36 -27.1 68.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.674 0.749 . . . . 0.0 109.682 170.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -61.15 -32.24 71.96 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.819 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.664 ' HB2' HD11 ' A' ' 31' ' ' ILE . 3.3 tm? -54.38 -41.85 69.68 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.467 176.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 23.0 mm -65.31 -42.68 94.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-O 121.687 0.756 . . . . 0.0 110.052 -177.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.651 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 12.4 mt-10 -64.63 -45.05 88.48 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.562 ' HG2' HG23 ' A' ' 31' ' ' ILE . 15.5 tpt180 -71.16 -32.09 68.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.949 -170.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.607 ' HA ' HD13 ' A' ' 35' ' ' ILE . 24.3 pt -63.63 -46.66 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.597 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.536 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 28.5 p80 -68.52 -33.3 73.88 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 118.976 -1.089 . . . . 0.0 111.918 177.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.69 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 4.2 mm-40 -65.06 -50.02 67.81 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.974 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.6 ' HG3' HD12 ' A' ' 35' ' ' ILE . 4.0 mm-40 -63.0 -28.22 69.95 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.899 176.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.58 ' HA ' HG22 ' A' ' 81' ' ' ILE . 11.3 tp -57.73 -40.89 80.68 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.116 172.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -83.79 -51.77 6.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.69 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 9.8 ptmm? -72.33 -42.82 64.96 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -174.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.448 ' HB2' ' OE1' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -95.62 -22.7 17.43 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.136 -178.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.56 23.98 41.02 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.242 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.58 HG22 ' HA ' ' A' ' 76' ' ' LEU . 6.0 tt -73.52 119.93 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.633 0.73 . . . . 0.0 111.492 -170.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.82 129.12 36.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.668 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.656 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 17.7 tt -173.5 131.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -175.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -90.84 151.82 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 121.179 0.514 . . . . 0.0 110.227 -173.636 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -90.74 -23.47 20.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.042 -172.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 4.1 t-20 . . . . . 0 N--CA 1.467 0.414 0 O-C-N 124.542 1.151 . . . . 0.0 109.666 -177.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.579 ' HB3' HG12 ' A' ' 31' ' ' ILE . 59.7 mtt . . . . . 0 C--O 1.234 0.263 0 CA-C-O 120.449 0.166 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.478 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 33.2 Cg_exo -60.26 -25.39 80.01 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.322 2.014 . . . . 0.0 111.018 173.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 10.6 pt20 -59.18 -35.02 72.82 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.895 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.579 HG12 ' HB3' ' A' ' 28' ' ' MET . 36.7 mm -66.44 -42.9 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.204 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.453 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 38.6 tt0 -58.02 -45.75 86.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.106 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 31.9 mmt-85 -66.06 -44.19 85.26 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.994 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.663 ' HD3' ' O ' ' A' ' 60' ' ' ASP . 0.1 OUTLIER -64.91 -37.89 89.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.559 -173.154 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.569 HD12 ' HG3' ' A' ' 75' ' ' GLU . 70.0 mt -64.67 -37.79 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.581 ' HD3' HD12 ' A' ' 81' ' ' ILE . 15.9 mmtm -66.74 -35.7 80.74 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.142 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.703 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 34.6 mtpt -65.63 -40.99 93.16 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.352 175.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.568 HD13 ' HE2' ' A' ' 61' ' ' PHE . 14.6 tp -59.66 -50.0 75.55 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.586 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -61.95 -34.93 65.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.212 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.695 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 23.1 t -66.11 -44.63 83.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.768 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 77.6 mt -58.8 -37.53 76.57 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.81 -38.62 89.61 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.443 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 13.7 tppt? -67.94 -35.24 78.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.194 0.521 . . . . 0.0 110.149 178.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.695 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -69.92 -38.54 76.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.688 0.756 . . . . 0.0 109.717 175.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.715 ' HB3' ' HD3' ' A' ' 55' ' ' LYS . 29.8 mmtm -68.6 -29.04 67.47 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.809 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.39 -65.92 0.26 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.849 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -136.14 157.21 47.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.053 0.454 . . . . 0.0 110.947 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.9 86.58 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.17 0.51 . . . . 0.0 109.981 177.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.792 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 8.5 t -153.78 155.64 36.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.599 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -57.58 -40.4 78.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.424 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.9 -34.34 76.46 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.745 0.307 . . . . 0.0 110.891 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.96 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -72.52 -30.94 64.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.932 0.396 . . . . 0.0 111.057 174.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.4 mm -64.49 -49.2 81.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.213 0.53 . . . . 0.0 110.169 171.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -57.32 -33.73 68.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.762 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.96 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 1.2 ptmt -76.66 -22.08 54.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.31 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.46 -19.27 42.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.003 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 67.6 t80 -56.41 140.69 72.49 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.399 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.479 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 86.3 Cg_endo -83.49 148.69 61.43 Favored 'Cis proline' 0 C--N 1.347 0.456 0 C-N-CA 123.781 -1.341 . . . . 0.0 112.904 0.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.575 ' HG2' ' HD2' ' A' ' 61' ' ' PHE . 36.7 Cg_endo -102.43 -160.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 124.412 3.408 . . . . 0.0 110.432 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.663 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 22.8 m-20 -97.8 11.26 37.85 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.575 ' HD2' ' HG2' ' A' ' 59' ' ' PRO . 60.2 m-85 -62.79 118.32 7.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.42 0.629 . . . . 0.0 111.217 -175.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -82.36 -12.12 58.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.563 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.62 124.28 1.33 Allowed Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -114.78 136.37 53.15 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.835 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 31.7 t70 -160.63 168.32 25.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.743 -0.208 . . . . 0.0 110.57 178.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.0 m -58.5 -32.31 68.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.681 0.277 . . . . 0.0 111.097 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.458 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . 5.1 t-20 -61.26 -34.08 74.58 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.153 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.614 ' O ' HG13 ' A' ' 72' ' ' ILE . 54.5 tp -58.96 -41.6 87.86 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.549 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.69 -39.41 83.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.247 0.546 . . . . 0.0 110.241 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 16.6 mt-10 -68.15 -42.98 79.29 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -64.58 -32.8 74.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.458 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.614 HG13 ' O ' ' A' ' 68' ' ' LEU . 80.3 mt -61.6 -51.35 73.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.583 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.497 ' CD2' ' HA ' ' A' ' 70' ' ' GLU . 29.4 p80 -68.77 -32.77 72.76 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.041 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -59.29 -47.24 86.11 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.569 ' HG3' HD12 ' A' ' 35' ' ' ILE . 25.2 mm-40 -64.31 -32.9 74.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.883 0.373 . . . . 0.0 110.859 175.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.661 ' HA ' HG22 ' A' ' 81' ' ' ILE . 22.3 tp -60.98 -46.77 89.4 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.922 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -82.62 -51.57 7.62 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -73.31 -45.22 56.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.265 -174.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -96.44 -16.24 21.3 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.65 -176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.74 24.5 49.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 119.678 -1.249 . . . . 0.0 113.835 171.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.661 HG22 ' HA ' ' A' ' 76' ' ' LEU . 7.8 tt -72.35 119.59 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 117.99 0.895 . . . . 0.0 110.716 -173.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -81.31 125.02 29.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.033 0.444 . . . . 0.0 111.119 -172.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.586 ' HB ' HG13 ' A' ' 39' ' ' ILE . 3.6 tp -166.61 123.15 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.426 -176.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.792 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -89.79 152.36 3.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -95.38 -25.36 16.31 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.935 0.397 . . . . 0.0 110.246 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.418 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 56.1 t30 . . . . . 0 N--CA 1.463 0.176 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.027 -177.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.567 ' CG ' ' HG2' ' A' ' 30' ' ' GLN . 58.7 tpp . . . . . 0 N--CA 1.457 -0.086 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.435 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 65.9 Cg_exo -53.61 -26.95 39.38 Favored 'Trans proline' 0 N--CA 1.477 0.51 0 C-N-CA 123.496 2.797 . . . . 0.0 113.635 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.567 ' HG2' ' CG ' ' A' ' 28' ' ' MET . 10.7 pt20 -64.91 -25.4 67.87 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 121.224 -0.19 . . . . 0.0 110.56 177.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.798 HD12 HD13 ' A' ' 68' ' ' LEU . 36.1 mm -65.4 -46.58 89.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.348 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.583 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -55.62 -47.27 76.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.41 177.505 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 33.7 mtp180 -67.69 -44.92 76.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.47 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.915 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -58.38 -47.21 84.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.905 -173.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.694 HD12 ' HG3' ' A' ' 75' ' ' GLU . 56.9 mt -64.51 -37.3 79.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.119 -177.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 24.7 mmtm -68.18 -35.12 77.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.173 0.511 . . . . 0.0 110.372 176.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.548 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 8.0 mttm -66.05 -37.7 86.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.459 174.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 89.0 mt -61.58 -38.2 86.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.813 174.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.556 HD11 ' O ' ' A' ' 82' ' ' ASN . 0.3 OUTLIER -62.63 -35.21 69.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.471 177.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 14.0 m -64.78 -44.3 90.44 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.02 ' HA ' ' HE2' ' A' ' 44' ' ' LYS . 61.7 mt -59.29 -47.16 86.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.697 174.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.612 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -68.41 -33.01 76.28 Favored Glycine 0 CA--C 1.509 -0.298 0 CA-C-O 121.972 0.762 . . . . 0.0 112.114 -173.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.77 -43.92 52.34 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 122.872 1.32 . . . . 0.0 107.954 -174.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 1.02 ' HE2' ' HA ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -77.21 -26.88 53.19 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 112.669 -2.06 . . . . 0.0 110.879 -172.44 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.537 ' HB2' ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -76.48 -32.89 58.64 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.14 174.258 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.67 -64.03 0.25 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.725 173.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -134.15 147.53 50.82 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.705 -0.291 . . . . 0.0 110.893 -170.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.431 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -73.93 100.25 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.282 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.651 ' O ' HG12 ' A' ' 53' ' ' ILE . 91.6 m -156.18 145.01 20.29 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.861 -171.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -60.03 -39.83 87.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.213 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.565 ' H ' HG22 ' A' ' 49' ' ' THR . 39.5 mt-10 -68.3 -34.23 75.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.991 177.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.991 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 10.2 t70 -71.38 -37.8 71.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.102 0.477 . . . . 0.0 110.931 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.651 HG12 ' O ' ' A' ' 49' ' ' THR . 42.4 mm -59.8 -46.46 93.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.565 0.697 . . . . 0.0 109.839 173.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.405 ' O ' ' HD1' ' A' ' 57' ' ' PHE . 35.2 t70 -63.01 -32.41 73.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.247 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.991 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -74.49 -17.09 60.82 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.864 -178.356 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.41 ' HB1' ' HB3' ' A' ' 41' ' ' LEU . . . -66.32 -16.81 64.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.519 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.489 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 36.1 p90 -42.9 134.84 2.91 Favored Pre-proline 0 N--CA 1.472 0.645 0 O-C-N 123.825 0.703 . . . . 0.0 112.106 -176.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 57' ' ' PHE . 21.9 Cg_exo -66.0 140.7 48.29 Favored 'Cis proline' 0 C--N 1.346 0.416 0 C-N-CA 123.668 -1.388 . . . . 0.0 112.14 -2.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 13.1 Cg_endo -95.86 -169.28 0.15 Allowed 'Trans proline' 0 N--CA 1.44 -1.632 0 C-N-CA 123.999 3.132 . . . . 0.0 110.204 -175.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.548 ' OD2' ' HD3' ' A' ' 37' ' ' LYS . 19.9 t70 -98.34 5.14 48.49 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.985 0.421 . . . . 0.0 111.349 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.915 ' HA ' ' HD3' ' A' ' 34' ' ' ARG . 57.3 m-85 -64.65 118.23 8.58 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -171.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -80.89 -31.85 35.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.155 166.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.95 126.1 1.43 Allowed Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -113.96 144.38 43.17 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.938 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 1.7 p30 -147.76 164.37 33.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.627 0.251 . . . . 0.0 110.966 176.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 m -65.53 -32.29 73.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.735 0.303 . . . . 0.0 111.432 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.441 ' HA ' ' OE2' ' A' ' 70' ' ' GLU . 26.2 t-20 -62.39 -34.67 77.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.35 0.595 . . . . 0.0 109.816 177.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.798 HD13 HD12 ' A' ' 31' ' ' ILE . 22.6 tp -57.29 -39.91 76.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.041 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.0 mm -63.02 -37.37 79.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.335 0.588 . . . . 0.0 110.358 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 17.9 mt-10 -67.83 -41.68 82.66 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.476 ' HE ' ' HG3' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -64.14 -32.43 74.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.559 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 68' ' ' LEU . 74.6 mt -61.09 -46.3 96.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.648 0.261 . . . . 0.0 110.682 178.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -65.78 -33.51 76.03 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.904 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 5.9 mm-40 -61.03 -49.92 75.44 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.81 176.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.694 ' HG3' HD12 ' A' ' 35' ' ' ILE . 79.8 mm-40 -55.62 -31.23 62.11 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.889 -178.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.752 HD23 HG23 ' A' ' 81' ' ' ILE . 86.8 mt -57.9 -46.83 84.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.979 0.419 . . . . 0.0 110.562 173.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -83.67 -50.26 8.36 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HD2' ' CD ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -73.6 -42.47 61.49 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -175.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.432 ' CG ' ' HE2' ' A' ' 36' ' ' LYS . 56.2 t-80 -95.47 -29.86 14.17 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.608 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.93 23.19 33.48 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 119.842 -1.17 . . . . 0.0 112.568 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.752 HG23 HD23 ' A' ' 76' ' ' LEU . 6.3 tt -72.5 146.63 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.556 ' O ' HD11 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -117.2 119.61 35.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.195 0.522 . . . . 0.0 111.794 -175.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.431 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 71.7 mt -153.85 116.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -82.44 151.66 4.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.345 0.593 . . . . 0.0 110.292 -175.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.41 -30.09 23.86 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.661 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.448 ' HB2' HG23 ' A' ' 49' ' ' THR . 2.3 t-20 . . . . . 0 N--CA 1.464 0.255 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.225 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.481 ' O ' HG22 ' A' ' 31' ' ' ILE . 24.6 ttt . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.27 0.557 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.708 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 26.1 Cg_exo -62.9 -30.87 77.57 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.037 2.491 . . . . 0.0 112.203 -172.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -58.31 -38.83 77.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.131 -177.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.698 ' O ' HG13 ' A' ' 35' ' ' ILE . 5.9 tp -67.11 -35.69 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -177.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.407 ' HG2' ' NH2' ' A' ' 71' ' ' ARG . 18.7 mt-10 -65.45 -45.93 81.84 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.586 0.707 . . . . 0.0 109.907 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.708 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 39.5 mtt180 -68.64 -37.9 80.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.286 -176.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.634 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 0.3 OUTLIER -66.07 -36.19 82.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.021 -177.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.698 HG13 ' O ' ' A' ' 31' ' ' ILE . 86.4 mt -60.88 -42.71 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.636 ' CD ' HD12 ' A' ' 81' ' ' ILE . 20.0 mmtm -65.74 -36.46 83.63 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.032 0.444 . . . . 0.0 110.278 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.465 ' HE3' HD21 ' A' ' 41' ' ' LEU . 45.3 tptt -64.13 -46.46 84.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.749 175.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.84 -44.22 93.81 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.585 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.566 ' HB ' HD11 ' A' ' 81' ' ' ILE . 1.5 mp -62.82 -35.93 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.977 177.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.716 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 22.8 t -67.06 -47.36 71.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.356 -0.537 . . . . 0.0 109.658 178.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.703 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 83.7 mt -59.62 -43.67 93.71 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.551 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.98 -37.39 93.16 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -177.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.585 ' HB2' HG23 ' A' ' 48' ' ' ILE . 25.7 tptt -70.04 -38.43 75.85 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 120.942 0.401 . . . . 0.0 110.342 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.716 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -61.06 -36.92 80.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.733 0.778 . . . . 0.0 109.965 173.056 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.933 ' HE3' ' HA ' ' A' ' 56' ' ' ALA . 74.4 mmtt -67.52 -30.38 70.03 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.383 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.31 -63.45 0.3 Allowed Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.668 175.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -126.76 155.22 43.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.228 0.537 . . . . 0.0 110.593 -175.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.585 HG23 ' HB2' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -86.33 88.28 2.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.352 0.596 . . . . 0.0 109.634 176.376 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.628 ' O ' HG12 ' A' ' 53' ' ' ILE . 9.8 t -158.23 163.4 37.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.926 -171.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -60.04 -39.14 84.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.92 0.391 . . . . 0.0 110.982 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -57.69 -45.43 85.65 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.461 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.786 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -73.26 -31.08 63.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.493 -179.511 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.628 HG12 ' O ' ' A' ' 49' ' ' THR . 46.3 mm -61.66 -50.13 81.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.235 0.54 . . . . 0.0 110.103 173.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.403 ' HA ' ' CD1' ' A' ' 57' ' ' PHE . 10.7 t70 -59.11 -38.21 79.04 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.489 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.786 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 10.7 ptmt -75.65 -18.31 59.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.101 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.933 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -75.7 -23.09 56.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.126 177.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 54' ' ' ASP . 63.3 m-85 -61.95 142.84 95.01 Favored Pre-proline 0 N--CA 1.464 0.268 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.509 176.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.529 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 96.3 Cg_endo -84.02 137.11 27.15 Favored 'Cis proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.584 -1.423 . . . . 0.0 112.818 0.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.529 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 56.9 Cg_endo -102.81 -152.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 124.466 3.444 . . . . 0.0 110.953 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.77 13.31 28.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 178.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.14 117.15 6.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.013 0.435 . . . . 0.0 111.168 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -81.88 -25.81 34.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.363 173.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.61 125.76 1.48 Allowed Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -106.56 144.95 32.49 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.543 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 16.9 t70 -150.0 157.52 43.24 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.85 -174.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.6 m -63.63 -26.78 68.83 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.861 0.362 . . . . 0.0 111.161 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -60.72 -33.44 72.9 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.568 ' O ' HG13 ' A' ' 72' ' ' ILE . 25.1 tp -54.57 -39.29 67.62 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.027 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.6 mm -62.33 -42.67 96.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.233 0.539 . . . . 0.0 109.868 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 11.8 mt-10 -66.83 -45.53 77.99 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.543 ' HD2' ' OE2' ' A' ' 74' ' ' GLU . 18.4 mmm-85 -65.65 -34.46 78.26 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.482 -1.235 . . . . 0.0 111.89 -174.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 68' ' ' LEU . 71.1 mt -61.1 -50.07 82.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.59 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 18.7 m170 -69.07 -34.9 75.89 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.544 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.543 ' OE2' ' HD2' ' A' ' 71' ' ' ARG . 43.4 mt-10 -60.67 -49.01 79.24 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 175.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -64.73 -31.94 73.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.953 0.406 . . . . 0.0 110.675 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.656 ' HA ' HG22 ' A' ' 81' ' ' ILE . 16.5 tp -64.66 -42.37 95.45 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.755 176.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -82.2 -52.15 7.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.948 0.404 . . . . 0.0 111.836 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -75.54 -44.91 41.06 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.586 -174.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -95.5 -17.02 21.8 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.315 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.44 23.78 57.85 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.698 -1.239 . . . . 0.0 113.348 173.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.656 HG22 ' HA ' ' A' ' 76' ' ' LEU . 4.5 tt -71.61 124.05 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 117.605 0.702 . . . . 0.0 110.64 -171.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.413 ' HA ' HD22 ' A' ' 82' ' ' ASN . 10.5 m120 -78.42 117.08 19.3 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.463 0.649 . . . . 0.0 111.414 -175.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.556 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 5.6 tp -161.91 139.48 2.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.5 HG12 ' CB ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -110.22 154.25 11.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-O 121.004 0.43 . . . . 0.0 110.443 -175.377 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -83.2 -23.68 32.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.068 -175.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.482 ' H ' HG13 ' A' ' 84' ' ' VAL . 3.3 t30 . . . . . 0 N--CA 1.464 0.258 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.464 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.8 mtm . . . . . 0 N--CA 1.442 -0.842 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.76 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 50.0 Cg_exo -52.63 -33.21 57.81 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.923 2.415 . . . . 0.0 112.663 -173.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -25.0 58.88 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.076 -173.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 68' ' ' LEU . 9.5 mm -69.76 -46.51 74.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 174.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -61.91 -45.24 94.59 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.094 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.76 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 29.7 mtm180 -61.79 -43.15 99.42 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.866 176.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.498 HH12 ' HB2' ' A' ' 64' ' ' PHE . 73.8 ttt180 -58.66 -36.1 73.62 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.517 -178.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 31' ' ' ILE . 63.6 mt -58.44 -51.71 68.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.498 ' HD3' HD12 ' A' ' 81' ' ' ILE . 1.4 mppt? -69.28 -40.14 77.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.52 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.8 mmtm -59.22 -38.42 79.9 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.114 0.259 . . . . 0.0 110.721 177.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.54 ' HB3' HD12 ' A' ' 53' ' ' ILE . 30.8 mt -65.34 -49.79 68.07 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.12 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.642 HG12 HG12 ' A' ' 81' ' ' ILE . 1.5 mp -62.77 -34.93 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.238 0.542 . . . . 0.0 109.72 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.8 m -67.0 -47.99 69.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.4 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.585 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 72.3 mt -59.49 -39.22 83.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.632 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.707 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -65.83 -34.21 88.04 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HD2' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -71.73 -29.84 64.97 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 122.042 0.925 . . . . 0.0 109.184 -177.241 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.506 ' N ' ' HE2' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -75.69 -46.03 33.5 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.736 -1.574 . . . . 0.0 110.428 174.559 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.772 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . 72.4 mmtt -68.17 -33.62 74.8 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.96 -174.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.47 -66.15 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.384 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -142.25 164.17 30.86 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -175.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.732 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -89.25 79.99 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.889 -170.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 1.104 ' HB ' HG13 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -139.0 154.32 48.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.402 -169.501 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -57.29 -39.28 75.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.515 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -68.27 -35.56 78.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.673 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.832 ' HB2' HG23 ' A' ' 49' ' ' THR . 9.4 t0 -71.61 -34.43 69.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.302 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 49' ' ' THR . 49.2 mm -58.87 -49.32 83.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.57 0.7 . . . . 0.0 110.196 174.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -61.03 -32.9 72.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.473 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.772 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -75.61 -25.43 56.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.312 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.69 -23.74 60.91 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.789 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.531 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 64.2 t80 -64.26 138.17 97.34 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.652 176.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 6.0 Cg_exo -80.04 137.22 40.98 Favored 'Cis proline' 0 C--N 1.347 0.48 0 C-N-CA 124.151 -1.187 . . . . 0.0 112.543 0.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.54 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 57.2 Cg_endo -105.61 -158.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 124.723 3.615 . . . . 0.0 111.266 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.81 16.5 22.06 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.892 -177.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.54 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 13.5 p90 -58.85 121.46 11.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.653 0.74 . . . . 0.0 111.726 -170.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -80.81 -18.51 47.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.814 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.32 135.9 3.93 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -174.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.498 ' HB2' HH12 ' A' ' 34' ' ' ARG . 78.8 t80 -112.87 138.6 49.48 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.258 174.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -158.53 153.85 25.73 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.3 t -63.24 -25.64 68.42 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.282 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 71' ' ' ARG . 10.2 m120 -60.92 -31.36 70.89 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.33 177.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.64 ' HB2' HD12 ' A' ' 31' ' ' ILE . 48.8 tp -58.84 -40.47 84.33 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.047 176.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.1 mm -63.85 -46.46 94.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.947 0.404 . . . . 0.0 110.565 -177.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -69.4 -34.11 74.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.758 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -68.26 -41.21 81.43 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.555 -176.571 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.592 HG12 HG23 ' A' ' 35' ' ' ILE . 76.2 mt -60.75 -45.11 98.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.705 0.288 . . . . 0.0 110.938 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.493 ' HA ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -63.98 -41.46 97.52 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.456 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.523 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 12.8 pt-20 -69.69 -34.09 73.44 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.991 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 71' ' ' ARG . 63.7 mm-40 -61.48 -29.86 70.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.563 0.22 . . . . 0.0 111.115 173.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.724 HD21 HG22 ' A' ' 83' ' ' ILE . 98.2 mt -60.04 -49.03 79.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.829 0.347 . . . . 0.0 110.909 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -82.95 -50.12 8.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.202 0.525 . . . . 0.0 111.752 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 8.8 ttmt -69.8 -44.75 69.4 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.205 -175.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -96.13 -25.61 15.8 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.525 -174.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.59 21.59 53.34 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 119.93 -1.129 . . . . 0.0 112.011 -175.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.654 HG23 HD23 ' A' ' 76' ' ' LEU . 9.8 tt -72.49 145.35 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -178.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.72 136.17 53.18 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.309 -173.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.724 HG22 HD21 ' A' ' 76' ' ' LEU . 1.6 tp -162.42 129.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.134 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 1.104 HG13 ' HB ' ' A' ' 49' ' ' THR . 2.2 p -97.57 151.03 4.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.832 -175.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -93.74 -26.49 16.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.06 0.457 . . . . 0.0 110.316 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 63.7 t30 . . . . . 0 N--CA 1.464 0.238 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.983 176.097 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.581 ' O ' HG22 ' A' ' 31' ' ' ILE . 22.3 ptt? . . . . . 0 CA--C 1.536 0.415 0 CA-C-O 120.781 0.324 . . . . 0.0 111.618 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.47 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 4.7 Cg_exo -80.87 -27.29 3.16 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.315 2.01 . . . . 0.0 111.19 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.587 ' HB2' ' OE1' ' A' ' 62' ' ' GLU . 13.5 pt20 -69.03 -29.63 67.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.604 -177.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.674 ' O ' HG13 ' A' ' 35' ' ' ILE . 10.0 tp -69.05 -36.42 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.044 -176.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -65.2 -46.31 81.23 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.121 0.486 . . . . 0.0 110.046 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 61.1 mtp180 -60.74 -45.03 95.85 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.117 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.431 ' HD3' ' OE1' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -63.33 -31.39 72.53 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.886 -176.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 31' ' ' ILE . 63.6 mt -58.68 -48.35 86.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.82 176.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.48 ' CD ' HD12 ' A' ' 81' ' ' ILE . 1.9 mppt? -67.54 -33.84 75.87 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.909 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.431 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 16.6 tptp -63.24 -40.36 97.21 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.211 176.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.618 ' HA ' HD12 ' A' ' 41' ' ' LEU . 5.9 mp -70.24 -40.14 74.62 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.443 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.686 HG12 HG12 ' A' ' 81' ' ' ILE . 1.5 mp -63.3 -34.53 67.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.997 174.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.419 ' C ' ' HE3' ' A' ' 44' ' ' LYS . 45.5 t -61.06 -43.06 99.46 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.824 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 89.9 mt -58.24 -46.15 86.47 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.992 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.671 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -60.67 -32.29 78.15 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.12 -39.72 48.42 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.935 0.874 . . . . 0.0 109.273 -175.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.824 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 4.4 ptpt -76.68 -36.94 56.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.092 -176.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.71 ' HB2' ' OD1' ' A' ' 52' ' ' ASP . 30.8 mmmt -72.05 -20.98 61.59 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.733 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.23 -72.97 0.21 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.025 -0.989 . . . . 0.0 113.589 174.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -143.93 145.96 32.63 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.386 0.136 . . . . 0.0 110.741 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.554 ' HB ' HD13 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -66.91 108.51 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 122.042 0.925 . . . . 0.0 109.816 -176.038 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.744 HG22 ' H ' ' A' ' 51' ' ' GLU . 54.5 m -160.71 145.51 14.22 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.597 -173.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -57.73 -39.99 78.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.216 0.531 . . . . 0.0 110.474 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.744 ' H ' HG22 ' A' ' 49' ' ' THR . 44.4 mm-40 -68.37 -33.59 74.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.627 177.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.71 ' OD1' ' HB2' ' A' ' 45' ' ' LYS . 10.0 t70 -71.72 -32.55 67.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.365 0.603 . . . . 0.0 109.71 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 49' ' ' THR . 50.0 mm -61.4 -49.42 84.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.419 0.628 . . . . 0.0 109.776 170.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -33.47 69.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.54 176.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.702 ' HD3' ' CG ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -75.12 -24.29 58.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.993 -179.516 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.492 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -71.91 -19.7 61.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.311 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.523 ' CD2' ' HD3' ' A' ' 59' ' ' PRO . 55.3 t80 -63.79 133.05 95.42 Favored Pre-proline 0 C--O 1.235 0.317 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.44 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.502 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 53.9 Cg_endo -69.88 127.44 11.0 Favored 'Cis proline' 0 C--N 1.35 0.605 0 C-N-CA 123.392 -1.503 . . . . 0.0 112.165 1.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.523 ' HD3' ' CD2' ' A' ' 57' ' ' PHE . 13.9 Cg_endo -96.74 -165.65 0.1 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 123.74 2.96 . . . . 0.0 110.711 -172.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -98.35 15.23 25.32 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.402 -175.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.457 ' CD1' ' HD2' ' A' ' 59' ' ' PRO . 9.6 p90 -62.87 126.49 27.5 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.291 0.567 . . . . 0.0 111.121 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.587 ' OE1' ' HB2' ' A' ' 30' ' ' GLN . 48.7 mt-10 -80.82 -24.84 38.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.874 176.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.21 126.94 1.53 Allowed Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -106.31 123.72 48.48 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 117.523 0.662 . . . . 0.0 109.801 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 20.7 t70 -147.23 162.16 39.46 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.07 -175.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.8 t -64.37 -31.38 72.56 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.2 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -62.2 -34.46 76.5 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.248 0.547 . . . . 0.0 109.816 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.604 ' O ' HG13 ' A' ' 72' ' ' ILE . 32.9 tp -59.94 -42.18 93.46 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.749 177.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.2 mm -59.62 -43.48 91.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.033 0.444 . . . . 0.0 110.745 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -67.99 -40.97 82.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.581 ' HG3' ' CD1' ' A' ' 35' ' ' ILE . 9.5 tpp180 -66.43 -32.88 74.52 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.019 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.604 HG13 ' O ' ' A' ' 68' ' ' LEU . 76.0 mt -61.37 -50.59 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.852 -0.158 . . . . 0.0 110.629 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.572 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 22.1 p80 -67.1 -33.51 75.62 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.136 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -59.45 -49.52 77.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.344 0.593 . . . . 0.0 109.604 174.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.587 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 59.8 mm-40 -66.71 -28.98 68.86 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.821 176.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.008 ' HA ' HG22 ' A' ' 81' ' ' ILE . 13.5 tp -69.58 -51.55 34.29 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.363 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -84.49 -53.03 5.7 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.286 0.565 . . . . 0.0 111.625 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -76.29 -38.94 55.43 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.052 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.587 ' HB2' ' HA ' ' A' ' 75' ' ' GLU . 3.1 t60 -94.62 -16.42 23.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.577 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.24 23.03 42.1 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.398 -0.906 . . . . 0.0 114.106 172.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.008 HG22 ' HA ' ' A' ' 76' ' ' LEU . 7.9 tt -75.34 145.63 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 117.727 0.763 . . . . 0.0 109.322 -176.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.462 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.9 OUTLIER -108.31 128.06 54.41 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -173.393 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.683 HG12 HG13 ' A' ' 39' ' ' ILE . 9.2 mm -162.14 119.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 124.37 1.068 . . . . 0.0 108.61 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -88.17 152.36 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 CA-C-O 121.671 0.748 . . . . 0.0 109.454 -179.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -79.03 -31.44 44.64 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.146 -177.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.554 ' HB2' HG23 ' A' ' 49' ' ' THR . 11.8 t-20 . . . . . 0 N--CA 1.464 0.242 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.05 176.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.456 -0.141 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.424 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 22.8 Cg_exo -63.88 -25.32 67.5 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.566 2.177 . . . . 0.0 111.546 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -66.6 -24.8 66.38 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.57 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.532 HG23 HD13 ' A' ' 68' ' ' LEU . 8.1 mm -65.22 -43.94 95.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.503 0.192 . . . . 0.0 111.494 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -69.71 -37.52 76.6 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 49.9 mtp180 -66.26 -34.12 77.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.792 175.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.595 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 2.0 tpm_? -59.06 -39.31 81.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.534 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.807 HD11 ' HG3' ' A' ' 71' ' ' ARG . 22.7 mt -59.54 -49.0 85.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.275 0.559 . . . . 0.0 109.857 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.673 ' HD2' HD12 ' A' ' 81' ' ' ILE . 14.3 mmmt -65.69 -36.2 82.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.173 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.584 ' HD2' ' HA ' ' A' ' 34' ' ' ARG . 48.3 mttm -60.96 -41.68 96.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.378 174.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 70.8 mt -67.41 -42.27 83.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.591 -176.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.641 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.6 mp -68.62 -34.91 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.981 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.666 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 32.2 t -66.44 -47.5 72.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.966 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 96.9 mt -60.15 -40.02 88.4 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.781 -177.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.538 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -67.0 -38.42 92.75 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.501 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 11.2 tptt -73.35 -34.89 65.87 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.874 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.666 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -62.6 -45.2 93.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.089 173.714 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.814 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . 45.3 mmtm -69.23 -35.23 75.94 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.82 -177.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.9 -65.99 0.1 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.086 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -137.0 158.57 44.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.416 0.627 . . . . 0.0 111.154 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.8 OUTLIER -83.64 88.98 2.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.334 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.548 HG23 ' H ' ' A' ' 52' ' ' ASP . 10.6 t -153.61 155.24 35.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.829 -176.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -58.35 -41.98 85.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.043 0.449 . . . . 0.0 111.215 -173.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.68 -32.64 72.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.882 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.653 ' OD1' ' HB2' ' A' ' 45' ' ' LYS . 11.1 t0 -71.61 -39.26 70.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.214 0.53 . . . . 0.0 110.223 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.1 mt -60.23 -45.42 96.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.355 0.598 . . . . 0.0 110.017 173.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.0 -34.36 69.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.325 176.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.814 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -75.73 -23.05 56.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.092 -178.006 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.784 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -69.63 -18.93 63.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.571 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.434 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 80.5 t80 -62.74 137.14 96.58 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 176.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.497 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 90.0 Cg_endo -85.49 140.25 28.21 Favored 'Cis proline' 0 C--N 1.346 0.396 0 C-N-CA 123.594 -1.419 . . . . 0.0 113.441 1.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.604 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 37.3 Cg_endo -103.65 -157.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.744 0 C-N-CA 124.742 3.628 . . . . 0.0 110.896 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -98.09 14.52 27.24 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.044 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.604 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 10.1 p90 -61.51 125.9 25.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.464 0.649 . . . . 0.0 110.826 -174.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -79.08 -30.14 43.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.686 174.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.28 126.79 1.48 Allowed Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -108.2 144.57 35.47 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 24.3 t70 -142.66 161.37 38.24 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.32 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -63.07 -30.93 71.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.953 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -61.07 -34.08 74.35 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.124 0.488 . . . . 0.0 110.268 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.654 ' O ' HG13 ' A' ' 72' ' ' ILE . 58.1 tp -60.58 -39.42 87.99 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.906 177.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.6 mm -62.89 -41.43 92.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.244 0.545 . . . . 0.0 110.314 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.417 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 17.6 mt-10 -68.25 -36.99 80.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.902 0.858 . . . . 0.0 108.959 177.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.807 ' HG3' HD11 ' A' ' 35' ' ' ILE . 23.0 tpt180 -70.06 -33.99 72.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.153 -178.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.654 HG13 ' O ' ' A' ' 68' ' ' LEU . 86.2 mt -61.0 -50.38 80.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.002 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.417 ' CD2' ' HA ' ' A' ' 70' ' ' GLU . 34.3 p80 -66.73 -31.94 72.92 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.91 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.688 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 25.6 mt-10 -58.54 -53.38 59.01 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 121.377 0.608 . . . . 0.0 109.773 173.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 47.3 tp10 -59.88 -33.52 71.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.529 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.856 ' HA ' HG22 ' A' ' 81' ' ' ILE . 9.0 tp -66.57 -49.56 65.98 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.809 177.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -83.9 -53.35 5.65 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -173.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 34.3 pttt -76.97 -40.1 48.11 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.575 -176.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -93.8 -21.14 19.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.059 -176.582 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.32 25.24 24.38 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.358 -1.401 . . . . 0.0 114.772 172.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.856 HG22 ' HA ' ' A' ' 76' ' ' LEU . 5.4 tt -73.06 119.59 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 118.847 1.324 . . . . 0.0 109.628 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -81.8 126.94 32.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.434 0.635 . . . . 0.0 111.505 -171.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.641 ' HB ' HG13 ' A' ' 39' ' ' ILE . 4.8 tp -167.87 140.02 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.464 -176.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -100.73 153.4 4.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -92.62 -29.73 15.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.491 -174.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.47 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 24.0 t-20 . . . . . 0 N--CA 1.466 0.351 0 O-C-N 123.939 0.774 . . . . 0.0 110.192 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 112.231 -0.347 . . . . 0.0 112.231 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.8 p -129.5 -160.15 1.01 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 60.0 68.51 0.77 Allowed 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.364 0.602 . . . . 0.0 109.851 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.56 ' HB3' HG12 ' A' ' 31' ' ' ILE . 65.9 mtt -130.74 76.47 77.2 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.487 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.487 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 15.5 Cg_exo -67.94 -25.07 38.97 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.661 2.241 . . . . 0.0 111.105 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.454 ' HB2' ' OE2' ' A' ' 62' ' ' GLU . 12.3 pt20 -66.2 -25.1 66.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.389 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.576 ' O ' HG13 ' A' ' 35' ' ' ILE . 28.8 mm -65.17 -49.88 76.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.587 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -55.69 -46.54 77.6 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.202 0.525 . . . . 0.0 110.492 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 12.6 mmm180 -67.56 -44.34 78.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.025 -177.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.707 HH11 HD22 ' A' ' 68' ' ' LEU . 29.6 ttm180 -61.74 -37.93 86.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.215 -175.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 31' ' ' ILE . 89.8 mt -59.83 -46.32 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.687 ' HD3' HD12 ' A' ' 81' ' ' ILE . 26.5 mmtm -67.03 -37.29 83.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.27 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.535 ' HD2' ' HA ' ' A' ' 34' ' ' ARG . 94.4 mttt -62.57 -40.93 98.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.875 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.625 ' HB3' HD13 ' A' ' 53' ' ' ILE . 73.8 mt -64.93 -45.84 84.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.664 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.683 ' HB ' HD11 ' A' ' 81' ' ' ILE . 1.6 mp -66.37 -35.38 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 121.033 0.444 . . . . 0.0 109.953 177.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.694 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 33.3 t -65.96 -42.09 90.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.922 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.713 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 93.3 mt -60.15 -43.12 95.99 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.474 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.41 -35.23 89.87 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -36.82 83.36 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.888 -0.656 . . . . 0.0 109.703 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.694 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -68.78 -41.13 79.2 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.883 0.849 . . . . 0.0 110.03 175.141 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.713 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 70.3 mmtt -68.95 -31.56 70.53 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.014 -1.448 . . . . 0.0 111.277 -176.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.54 -58.8 0.44 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.246 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -119.68 146.81 45.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.119 0.485 . . . . 0.0 110.667 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.06 86.48 2.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.347 0.594 . . . . 0.0 109.697 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.458 ' O ' HG13 ' A' ' 53' ' ' ILE . 10.0 m -141.79 148.08 38.33 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.407 -170.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -57.12 -42.24 80.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.061 0.458 . . . . 0.0 110.119 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.41 ' H ' HG22 ' A' ' 49' ' ' THR . 35.1 mt-10 -70.06 -32.68 70.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.697 177.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.746 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 1.3 m-20 -68.23 -29.44 68.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.266 0.555 . . . . 0.0 111.3 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.625 HD13 ' HB3' ' A' ' 38' ' ' LEU . 17.7 mt -65.71 -44.02 93.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 121.075 0.464 . . . . 0.0 110.187 170.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.33 -39.36 75.69 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.497 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.746 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.66 -15.43 59.18 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.832 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.697 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -75.39 -18.49 59.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.073 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.521 ' CD2' ' HD3' ' A' ' 59' ' ' PRO . 43.6 t80 -50.1 136.01 21.81 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.829 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.498 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 71.5 Cg_endo -75.03 137.72 51.95 Favored 'Cis proline' 0 C--N 1.345 0.374 0 C-N-CA 123.528 -1.447 . . . . 0.0 112.836 1.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.521 ' HD3' ' CD2' ' A' ' 57' ' ' PHE . 17.0 Cg_endo -98.87 -165.25 0.07 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 124.141 3.227 . . . . 0.0 110.245 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -97.38 13.92 28.04 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.012 0.434 . . . . 0.0 110.734 -176.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.427 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 5.2 p90 -63.25 120.74 12.12 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.625 0.726 . . . . 0.0 111.358 -173.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.454 ' OE2' ' HB2' ' A' ' 30' ' ' GLN . 2.3 mp0 -80.93 -22.26 39.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.736 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.02 146.96 14.2 Favored Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 -174.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -100.99 120.57 40.37 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.484 173.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -134.67 132.64 39.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.715 0.293 . . . . 0.0 110.61 -170.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.8 m -63.78 -31.94 73.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.405 0.622 . . . . 0.0 109.746 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.544 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 14.0 m120 -62.31 -38.67 90.33 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.643 175.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.707 HD22 HH11 ' A' ' 34' ' ' ARG . 52.2 tp -59.69 -39.01 83.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.613 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.7 mm -61.08 -46.53 96.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.557 0.218 . . . . 0.0 111.107 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 14.3 pt-20 -70.59 -34.56 72.3 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.669 177.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.549 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 19.4 mmt180 -70.41 -32.62 70.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.512 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 68' ' ' LEU . 82.4 mt -61.75 -49.56 83.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.834 0.35 . . . . 0.0 110.143 175.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.528 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 77.3 m80 -67.46 -34.92 78.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.753 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -67.62 -48.88 65.48 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.699 177.129 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -58.6 -29.52 66.52 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.004 0.43 . . . . 0.0 110.624 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.919 ' HA ' HG22 ' A' ' 81' ' ' ILE . 2.9 tp -57.6 -44.82 85.71 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.299 173.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -84.02 -52.66 6.13 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.753 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 3.6 ptmm? -72.93 -39.77 66.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -93.1 -26.98 17.22 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.942 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.16 23.09 23.31 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.77 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.919 HG22 ' HA ' ' A' ' 76' ' ' LEU . 6.2 tt -74.33 123.5 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 117.731 0.765 . . . . 0.0 110.108 -174.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -82.51 118.26 23.12 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.974 -0.454 . . . . 0.0 111.306 -172.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.638 ' HB ' HG13 ' A' ' 39' ' ' ILE . 5.5 tp -156.95 137.61 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.12 152.2 10.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.265 0.555 . . . . 0.0 110.789 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 87' ' ' GLU . 51.0 mm-40 -88.23 -25.91 22.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.974 -176.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.408 ' HB2' ' CG2' ' A' ' 49' ' ' THR . 5.3 t30 77.57 -12.49 1.06 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 124.202 0.939 . . . . 0.0 109.799 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' A' ' 85' ' ' GLU . 6.2 tp10 -82.1 130.59 59.47 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.964 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.22 69.12 3.28 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.17 1.913 . . . . 0.0 112.236 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.77 15.55 10.96 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.974 0.893 . . . . 0.0 109.905 175.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -120.63 79.7 1.52 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.46 -1.246 . . . . 0.0 107.741 172.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.18 154.38 46.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.606 -170.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -139.8 -80.88 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.91 0.386 . . . . 0.0 111.499 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.434 ' O ' HG12 ' A' ' 93' ' ' ILE . 14.6 tt -106.75 12.91 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 121.574 0.702 . . . . 0.0 111.124 -172.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.8 m 57.24 56.13 5.39 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.223 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.91 63.16 0.99 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.33 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.762 0 CA-C-O 118.884 -0.953 . . . . 0.0 111.638 179.206 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.885 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -113.91 -33.41 5.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.922 0.361 . . . . 0.0 111.861 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -87.91 50.16 1.94 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.25 0.548 . . . . 0.0 110.506 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.595 ' O ' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -172.08 77.27 0.47 Allowed Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.647 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.627 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 9.3 Cg_exo -72.01 -36.32 6.08 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.625 2.217 . . . . 0.0 112.492 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.462 ' HB2' HH21 ' A' ' 34' ' ' ARG . 5.1 pp0? -64.96 -32.88 74.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.156 -174.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.698 HG13 HD13 ' A' ' 68' ' ' LEU . 10.7 tp -71.98 -35.52 54.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.62 -47.38 66.82 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.219 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 22.5 mmm180 -62.96 -35.37 79.93 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.552 ' HG2' ' CD1' ' A' ' 61' ' ' PHE . 6.4 tpp180 -60.63 -37.03 80.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.978 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 31' ' ' ILE . 30.9 mt -60.48 -44.87 97.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.517 ' HA ' ' HB ' ' A' ' 39' ' ' ILE . 2.2 mppt? -67.95 -34.03 75.8 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.014 175.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -58.59 -42.56 88.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.168 0.509 . . . . 0.0 109.931 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.615 HD12 HG23 ' A' ' 53' ' ' ILE . 4.1 mm? -70.08 -35.05 73.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.723 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.667 HD11 HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -60.69 -37.97 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.236 0.541 . . . . 0.0 109.738 173.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.671 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 36.6 t -66.97 -48.38 68.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.028 176.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.696 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 91.5 mt -60.8 -45.93 92.51 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.055 -176.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.08 -39.04 84.34 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -175.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.44 -34.15 67.58 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.671 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -61.34 -41.23 96.71 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.918 172.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 31.7 mmtp -68.41 -21.7 64.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.485 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.01 -66.1 0.25 Allowed Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.363 -0.923 . . . . 0.0 112.522 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -142.57 171.67 13.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.16 0.505 . . . . 0.0 111.116 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.496 HG22 ' CD1' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -87.63 86.16 2.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.453 0.644 . . . . 0.0 109.952 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.608 ' O ' HG12 ' A' ' 53' ' ' ILE . 9.7 m -143.26 145.62 32.9 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.525 -171.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -60.6 -34.94 74.95 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.571 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 32.1 mt-10 -67.63 -35.03 78.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.092 176.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.692 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 11.8 m-20 -71.68 -30.32 65.57 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.444 0.64 . . . . 0.0 110.972 176.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.615 HG23 HD12 ' A' ' 38' ' ' LEU . 50.9 mm -66.5 -45.34 89.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.566 0.698 . . . . 0.0 109.818 169.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.512 ' HA ' ' CE2' ' A' ' 57' ' ' PHE . 21.4 t70 -57.43 -36.89 71.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.715 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.692 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 5.9 ptpt -77.88 -16.58 58.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.781 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.561 ' HA ' ' NZ ' ' A' ' 45' ' ' LYS . . . -76.82 -19.17 57.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.796 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.568 ' CD1' ' HG3' ' A' ' 59' ' ' PRO . 19.8 m-85 -66.62 147.32 99.03 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.933 178.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 2.9 Cg_exo -76.1 143.46 76.65 Favored 'Cis proline' 0 C--N 1.342 0.214 0 C-N-CA 123.955 -1.269 . . . . 0.0 112.358 0.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.698 ' HG2' ' HD2' ' A' ' 61' ' ' PHE . 53.1 Cg_endo -100.92 -173.0 0.11 Allowed 'Trans proline' 0 N--CA 1.438 -1.757 0 C-N-CA 124.328 3.352 . . . . 0.0 110.772 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -98.65 16.53 21.72 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.698 ' HD2' ' HG2' ' A' ' 59' ' ' PRO . 36.4 m-85 -58.43 119.48 7.06 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.925 0.393 . . . . 0.0 110.404 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.58 -20.93 45.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.335 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.71 124.63 1.28 Allowed Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -112.88 144.51 42.32 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 18.2 t70 -149.56 160.74 43.24 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.867 -172.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 t -62.97 -32.22 73.5 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 120.975 0.416 . . . . 0.0 110.982 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.425 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 3.3 t-20 -61.69 -31.86 72.02 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.698 HD13 HG13 ' A' ' 31' ' ' ILE . 26.6 tp -54.63 -38.79 67.26 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.052 175.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.9 mm -61.9 -40.79 88.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.31 0.576 . . . . 0.0 109.866 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.574 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 15.7 mt-10 -68.14 -41.08 82.16 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.539 ' HD2' ' HA ' ' A' ' 68' ' ' LEU . 85.9 mtt180 -60.05 -38.75 83.72 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.939 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 68' ' ' LEU . 80.5 mt -61.3 -51.1 76.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.809 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.574 ' CD2' ' HA ' ' A' ' 70' ' ' GLU . 27.9 p80 -69.0 -32.33 71.81 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.543 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 47.3 mt-10 -59.2 -49.46 77.78 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' OE1' ' NZ ' ' A' ' 36' ' ' LYS . 20.9 mm-40 -63.89 -34.22 77.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.666 175.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.526 ' HA ' HG22 ' A' ' 81' ' ' ILE . 18.2 tp -57.48 -41.94 81.64 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.346 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -84.46 -49.82 8.32 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -71.97 -44.69 63.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.05 -26.67 15.96 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.361 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.02 23.44 32.54 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.908 -1.139 . . . . 0.0 112.985 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.526 HG22 ' HA ' ' A' ' 76' ' ' LEU . 11.9 tt -72.32 119.25 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.625 0.726 . . . . 0.0 110.909 -170.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -99.99 118.58 36.69 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.872 -170.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.667 HG12 HD11 ' A' ' 39' ' ' ILE . 3.3 mt -146.16 128.21 8.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 86' ' ' ASN . 0.4 OUTLIER -95.27 153.31 3.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.823 -172.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.443 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 8.0 mm-40 -87.11 -23.72 24.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.926 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.501 ' N ' HG13 ' A' ' 84' ' ' VAL . 60.2 t30 77.25 18.84 1.37 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.939 177.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.489 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 9.9 pt-20 -104.04 128.19 27.69 Favored Pre-proline 0 N--CA 1.448 -0.536 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.899 171.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 11.1 Cg_exo -71.68 -22.35 24.19 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.373 2.715 . . . . 0.0 113.248 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 57.61 56.76 4.69 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.56 0.695 . . . . 0.0 109.257 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -114.61 93.74 4.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.259 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -138.58 72.71 1.41 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 172.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -118.81 -59.87 1.82 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.646 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.7 mm -77.74 -34.27 19.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.157 175.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.9 m 71.83 -53.31 0.69 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.666 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -151.78 142.07 22.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.139 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.92 0 CA-C-O 118.796 -1.002 . . . . 0.0 111.568 -178.894 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.685 0 N-CA-C 112.063 -0.415 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.3 p -83.63 -4.66 58.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.6 0.238 . . . . 0.0 111.261 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.3 m80 70.37 22.97 5.12 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.858 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.744 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 87.9 mtp -114.5 -54.42 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.916 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.744 ' HD3' ' HB2' ' A' ' 28' ' ' MET . 43.7 Cg_exo -59.05 -34.24 98.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.107 1.871 . . . . 0.0 112.412 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.515 ' HB2' HH21 ' A' ' 34' ' ' ARG . 21.1 pt20 -67.09 -25.12 66.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.683 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.636 ' O ' HG13 ' A' ' 35' ' ' ILE . 26.6 mm -69.81 -46.07 75.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.227 175.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -55.69 -45.06 77.87 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.254 0.55 . . . . 0.0 110.009 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 2.9 mmp_? -64.93 -39.76 94.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.022 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.945 ' HD2' ' HA ' ' A' ' 61' ' ' PHE . 5.5 tpp180 -67.16 -39.21 86.46 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.232 -173.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.636 HG13 ' O ' ' A' ' 31' ' ' ILE . 41.5 mt -61.14 -44.87 99.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.613 ' HD3' HD12 ' A' ' 81' ' ' ILE . 14.5 mmtp -66.87 -38.77 86.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.207 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.58 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 54.9 mttm -61.02 -43.36 99.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.9 175.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.513 ' HB3' HD12 ' A' ' 53' ' ' ILE . 65.9 mt -63.73 -47.13 82.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.391 -177.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.541 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -63.41 -34.76 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.066 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.441 ' C ' ' HE3' ' A' ' 44' ' ' LYS . 33.1 t -65.57 -47.89 74.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.551 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.923 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 71.2 mt -59.22 -47.07 86.7 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.636 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.33 -35.81 92.17 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -74.99 -38.79 61.55 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.509 0.671 . . . . 0.0 109.878 -173.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.923 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 3.9 ptpt -70.55 -26.17 63.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.485 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 69.4 mmtt -86.95 -4.48 59.18 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.981 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.88 -71.78 0.3 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.78 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -141.14 164.83 29.21 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 121.213 0.53 . . . . 0.0 111.928 -170.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -85.24 85.27 2.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.22 0.533 . . . . 0.0 109.764 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 51' ' ' GLU . 5.9 m -142.92 146.6 34.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.404 -171.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.33 -36.12 77.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.065 0.46 . . . . 0.0 110.112 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.521 ' H ' HG22 ' A' ' 49' ' ' THR . 32.9 mt-10 -67.42 -34.36 77.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.183 0.516 . . . . 0.0 110.118 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.766 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 1.5 m-20 -67.2 -30.03 69.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.282 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.513 HD12 ' HB3' ' A' ' 38' ' ' LEU . 39.1 mm -60.08 -50.24 80.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.448 0.642 . . . . 0.0 110.341 173.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.36 -38.24 90.4 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.344 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.766 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -75.41 -14.97 60.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.716 -178.277 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.85 -18.92 60.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.117 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.422 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 80.4 t80 -58.69 134.55 86.32 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.813 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 57.9 Cg_endo -72.87 132.16 25.31 Favored 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 123.591 -1.42 . . . . 0.0 112.024 -1.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 19.2 Cg_endo -98.61 -158.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.732 0 C-N-CA 124.259 3.306 . . . . 0.0 111.11 -173.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.509 ' H ' HD11 ' A' ' 41' ' ' LEU . 2.5 t70 -98.96 14.19 29.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.325 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.945 ' HA ' ' HD2' ' A' ' 34' ' ' ARG . 4.3 p90 -69.68 120.13 14.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.386 0.612 . . . . 0.0 111.251 -172.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -82.38 -23.55 34.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.651 172.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.74 125.74 1.5 Allowed Glycine 0 N--CA 1.436 -1.34 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -176.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -113.27 134.26 54.69 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.468 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.432 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 18.4 t70 -151.59 155.28 38.11 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.4 m -63.05 -27.91 69.73 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.94 0.4 . . . . 0.0 111.371 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -61.34 -32.7 72.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.382 0.611 . . . . 0.0 109.937 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.622 ' O ' HG13 ' A' ' 72' ' ' ILE . 63.9 tp -60.66 -39.11 87.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.084 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.6 mm -62.82 -46.65 95.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.791 0.329 . . . . 0.0 110.884 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.454 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 9.4 pt-20 -68.41 -32.55 72.67 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.491 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 5.9 tpp180 -70.2 -35.96 74.28 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.341 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 68' ' ' LEU . 72.0 mt -59.92 -50.94 78.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.762 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.565 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 26.5 p80 -68.69 -33.48 74.04 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.618 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -60.01 -50.54 73.33 Favored 'General case' 0 C--O 1.22 -0.499 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.712 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.571 ' OE1' ' HD2' ' A' ' 78' ' ' LYS . 8.3 mm-40 -65.72 -25.71 67.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.226 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.011 ' HA ' HG22 ' A' ' 81' ' ' ILE . 7.9 tp -56.0 -47.62 77.41 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.066 174.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -83.56 -50.5 8.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.525 0.678 . . . . 0.0 111.199 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.571 ' HD2' ' OE1' ' A' ' 75' ' ' GLU . 23.7 ttmt -68.18 -43.58 77.83 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.998 -172.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.63 -24.68 17.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.772 0.32 . . . . 0.0 110.329 -177.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.37 22.56 24.22 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.114 -1.041 . . . . 0.0 113.27 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.011 HG22 ' HA ' ' A' ' 76' ' ' LEU . 10.0 tt -75.66 146.32 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 117.407 0.603 . . . . 0.0 110.219 -174.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.14 128.31 51.8 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.095 -0.378 . . . . 0.0 110.867 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.541 ' HB ' HG13 ' A' ' 39' ' ' ILE . 4.7 tp -167.25 137.87 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -109.61 151.68 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.253 -177.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -89.66 -23.92 21.75 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.497 ' HB2' HG23 ' A' ' 49' ' ' THR . 63.5 t30 75.83 2.48 3.69 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.505 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.515 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 41.5 mt-10 -115.38 127.51 26.74 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.857 174.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.515 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 9.2 Cg_endo -91.79 152.53 3.4 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.266 2.644 . . . . 0.0 111.743 175.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -79.76 66.41 5.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.354 0.597 . . . . 0.0 110.211 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 50.22 51.83 15.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.862 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.405 ' HB3' ' HA ' ' A' ' 94' ' ' SER . 41.9 mt-10 -84.74 145.9 27.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.346 177.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -109.39 -47.71 3.35 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.822 0.344 . . . . 0.0 110.734 -173.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.788 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -100.11 20.8 2.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 172.092 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.405 ' HA ' ' HB3' ' A' ' 91' ' ' GLU . 22.5 p 48.37 35.43 5.71 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.535 -174.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.38 32.61 0.98 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.529 0 CA-C-O 118.021 -1.433 . . . . 0.0 110.413 -168.409 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.718 0 N-CA-C 112.039 -0.425 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 t -137.54 127.82 26.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 57.07 66.94 1.06 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.573 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.547 ' O ' HG22 ' A' ' 31' ' ' ILE . 59.4 mtt -131.36 83.84 58.14 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.205 178.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.89 -24.64 53.4 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.767 2.312 . . . . 0.0 111.382 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -60.66 -31.45 70.68 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.2 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.626 ' O ' HG13 ' A' ' 35' ' ' ILE . 10.5 tp -69.75 -35.46 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.476 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.84 -42.62 76.91 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.168 0.508 . . . . 0.0 110.238 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -63.65 -38.59 91.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.083 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -60.56 -35.01 75.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.103 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.68 HG23 HG12 ' A' ' 72' ' ' ILE . 52.1 mt -60.37 -46.98 94.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.059 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.664 ' HD3' HD12 ' A' ' 81' ' ' ILE . 28.2 mmtm -66.68 -37.28 84.42 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.237 0.541 . . . . 0.0 109.969 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.567 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 15.9 tptm -64.49 -44.39 91.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.409 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.511 HD22 ' HZ ' ' A' ' 61' ' ' PHE . 16.5 tp -67.06 -45.55 77.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.029 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.569 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -62.7 -34.68 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.892 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.697 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 23.2 t -67.1 -45.43 77.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.071 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.634 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 90.0 mt -59.38 -42.9 92.74 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.541 -176.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.469 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -66.69 -34.83 88.64 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.379 -0.915 . . . . 0.0 110.844 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 10.4 tptm -68.43 -38.7 81.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.46 0.648 . . . . 0.0 109.798 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.697 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -66.03 -41.48 90.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.424 175.245 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.813 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . 73.9 mmtt -68.2 -32.71 73.12 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.424 -177.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.66 -65.6 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.552 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -144.16 155.15 43.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.831 0.348 . . . . 0.0 110.84 -175.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.472 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -73.99 91.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.552 0.691 . . . . 0.0 110.66 -178.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.637 HG22 ' H ' ' A' ' 51' ' ' GLU . 86.6 m -149.07 145.43 27.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.93 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -58.25 -39.37 78.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.803 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.637 ' H ' HG22 ' A' ' 49' ' ' THR . 15.8 mm-40 -64.16 -39.03 93.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.531 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.653 ' CG ' ' HD3' ' A' ' 55' ' ' LYS . 9.9 t0 -72.17 -36.96 69.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.372 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.46 HG23 HD11 ' A' ' 38' ' ' LEU . 26.6 mt -59.92 -45.63 94.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.967 0.413 . . . . 0.0 110.659 172.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -59.59 -31.41 69.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.652 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.813 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -74.71 -26.84 60.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.005 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.616 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -66.74 -19.61 65.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.628 -176.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.462 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 18.2 m-85 -50.99 134.95 28.9 Favored Pre-proline 0 N--CA 1.468 0.451 0 O-C-N 123.236 0.335 . . . . 0.0 111.249 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.499 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 15.4 Cg_exo -68.78 140.32 56.76 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 123.971 -1.262 . . . . 0.0 112.445 1.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 26.5 Cg_endo -98.69 -168.51 0.1 Allowed 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 124.288 3.326 . . . . 0.0 110.957 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.431 ' HB2' HD11 ' A' ' 41' ' ' LEU . 17.0 t70 -98.44 12.08 36.16 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.196 0.522 . . . . 0.0 111.504 -175.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.511 ' HZ ' HD22 ' A' ' 38' ' ' LEU . 41.5 m-85 -70.95 121.29 17.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.076 0.465 . . . . 0.0 111.67 -174.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -79.11 -30.43 43.76 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 165.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.96 125.91 1.4 Allowed Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 173.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -107.72 143.58 36.04 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 117.438 0.619 . . . . 0.0 110.592 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 15.6 t70 -141.5 159.75 41.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.193 -173.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.5 m -61.37 -26.86 68.11 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.015 0.436 . . . . 0.0 111.346 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.67 -33.54 72.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.7 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.604 ' O ' HG13 ' A' ' 72' ' ' ILE . 35.6 tp -55.64 -41.14 73.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.111 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.4 mm -64.05 -40.37 88.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.265 0.555 . . . . 0.0 109.952 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -67.78 -42.73 81.23 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.456 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 10.6 tpt180 -67.89 -34.72 77.2 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.148 -174.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.68 HG12 HG23 ' A' ' 35' ' ' ILE . 76.8 mt -60.62 -48.72 87.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.577 ' HA ' HD12 ' A' ' 76' ' ' LEU . 40.6 t-80 -66.18 -34.64 78.49 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.21 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.32 -49.33 78.24 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 71' ' ' ARG . 34.2 mm-40 -63.67 -29.55 70.77 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.482 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.845 HD21 HG22 ' A' ' 83' ' ' ILE . 77.0 mt -60.9 -50.19 74.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.887 0.375 . . . . 0.0 111.161 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -84.34 -49.74 8.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.191 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -71.88 -44.16 64.22 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 -176.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -96.29 -24.52 16.16 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.449 -172.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.34 21.71 47.46 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.224 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.78 HG23 HD23 ' A' ' 76' ' ' LEU . 5.1 tt -73.82 146.94 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 117.717 0.758 . . . . 0.0 108.991 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -115.3 127.33 55.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.183 0.516 . . . . 0.0 111.81 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.845 HG22 HD21 ' A' ' 76' ' ' LEU . 5.4 tp -155.95 132.45 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.674 176.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -99.12 151.07 4.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -92.08 -24.99 18.98 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.426 ' HB2' HG23 ' A' ' 49' ' ' THR . 16.2 t-20 72.03 8.06 5.89 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.636 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -82.01 127.21 72.77 Favored Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.408 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.57 127.78 7.45 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.329 2.019 . . . . 0.0 112.651 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.14 16.76 21.71 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.469 0.652 . . . . 0.0 109.808 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.88 71.5 10.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.89 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -145.38 141.24 28.29 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 175.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -177.35 -71.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 123.637 0.586 . . . . 0.0 109.874 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.7 tt -96.25 -20.53 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.157 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.1 m 61.23 38.09 16.87 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.815 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.85 -6.67 59.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.521 -174.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.318 -1.268 . . . . 0.0 111.601 178.715 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.613 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.2 p -71.31 118.96 14.77 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -77.79 -10.28 59.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.442 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 48.6 tpp -154.27 74.47 6.07 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 121.125 0.488 . . . . 0.0 110.797 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.88 -25.0 6.57 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.931 2.421 . . . . 0.0 112.298 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.461 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 11.5 pt20 -69.57 -26.77 64.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.136 -176.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.641 ' O ' HG13 ' A' ' 35' ' ' ILE . 7.5 mm -66.61 -39.58 84.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.26 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.483 ' HG2' ' HE ' ' A' ' 71' ' ' ARG . 40.6 mt-10 -62.72 -45.47 92.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.071 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 26.2 ptt180 -68.9 -32.4 72.02 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.016 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.593 ' HD3' HD13 ' A' ' 68' ' ' LEU . 29.9 ttt-85 -59.3 -37.42 77.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.165 176.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.648 HD13 ' HA ' ' A' ' 72' ' ' ILE . 45.3 mt -65.55 -44.59 93.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.02 0.438 . . . . 0.0 110.227 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HD3' HD12 ' A' ' 81' ' ' ILE . 1.3 mppt? -66.65 -34.52 78.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.022 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.494 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 96.4 mttt -58.34 -44.6 88.81 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 173.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.543 HD11 ' NH1' ' A' ' 34' ' ' ARG . 48.0 mt -59.26 -50.37 74.25 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.22 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.956 HD11 ' HB ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -61.99 -34.98 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.519 -177.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 71.1 m -67.18 -47.89 69.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.736 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.6 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 96.6 mt -59.69 -42.08 92.16 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.316 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.33 -37.07 85.81 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.155 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.604 ' HG2' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -71.6 -34.0 69.5 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.345 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.54 ' N ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -68.74 -39.44 80.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.28 174.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 1.04 ' HE3' ' HA ' ' A' ' 56' ' ' ALA . 72.2 mmtt -68.67 -26.89 65.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.02 -178.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.42 -63.74 0.3 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.035 177.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -132.37 161.45 33.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.94 0.4 . . . . 0.0 110.916 -173.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.604 HG23 ' HG2' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -84.73 84.27 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.742 HG23 ' H ' ' A' ' 52' ' ' ASP . 4.8 t -150.93 153.81 35.96 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.226 -174.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.43 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 36.3 t80 -63.55 -29.26 70.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.087 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.21 -39.2 86.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.242 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.742 ' H ' HG23 ' A' ' 49' ' ' THR . 0.8 OUTLIER -71.73 -30.36 65.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.87 176.156 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.572 HG12 ' O ' ' A' ' 49' ' ' THR . 44.8 mm -59.44 -48.89 85.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.01 0.434 . . . . 0.0 110.095 172.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -58.66 -36.32 73.96 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.431 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.83 ' HD3' ' HB3' ' A' ' 45' ' ' LYS . 10.4 ptmt -75.92 -17.76 59.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.041 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.04 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -71.32 -18.65 62.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.392 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 87.6 t80 -56.05 135.49 74.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.333 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 5.9 Cg_exo -75.07 139.54 62.22 Favored 'Cis proline' 0 C--N 1.346 0.437 0 C-N-CA 123.749 -1.355 . . . . 0.0 111.779 -1.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 15.1 Cg_endo -98.2 -173.37 0.17 Allowed 'Trans proline' 0 N--CA 1.436 -1.911 0 C-N-CA 123.738 2.958 . . . . 0.0 110.802 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -97.73 18.9 14.6 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.45 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.412 ' HB2' ' NH2' ' A' ' 34' ' ' ARG . 13.6 p90 -57.01 119.05 5.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 122.05 0.928 . . . . 0.0 110.948 -168.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -81.29 -26.36 35.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.555 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.51 132.68 2.67 Favored Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -112.12 123.89 51.24 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 117.673 0.736 . . . . 0.0 109.82 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 0.9 OUTLIER -159.69 168.57 25.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.026 0.441 . . . . 0.0 112.07 -175.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 t -64.75 -28.63 69.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.406 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 71' ' ' ARG . 5.2 m120 -62.02 -33.85 75.13 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.825 0.345 . . . . 0.0 110.127 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.593 HD13 ' HD3' ' A' ' 34' ' ' ARG . 23.1 tp -65.54 -47.34 76.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.133 172.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.2 mm -58.3 -46.31 89.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.896 0.379 . . . . 0.0 110.812 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 8.6 pt-20 -67.71 -35.01 78.0 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 15.1 tpt180 -71.06 -36.61 72.35 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.169 -174.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.648 ' HA ' HD13 ' A' ' 35' ' ' ILE . 79.7 mt -60.86 -50.36 80.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.539 0.209 . . . . 0.0 110.534 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.506 ' HA ' HD12 ' A' ' 76' ' ' LEU . 45.6 t60 -65.38 -35.64 81.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.868 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 38.8 mt-10 -59.7 -49.27 78.4 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.427 ' HG3' HD12 ' A' ' 35' ' ' ILE . 8.4 mm-40 -64.26 -29.66 70.75 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.693 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.886 HD23 HG23 ' A' ' 81' ' ' ILE . 93.9 mt -64.16 -52.66 57.94 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.134 0.493 . . . . 0.0 111.659 176.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -86.01 -50.04 7.36 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.124 -175.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -74.28 -42.41 59.62 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.21 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -95.09 -32.56 13.05 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.525 -174.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.86 21.41 21.17 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.921 -1.133 . . . . 0.0 114.226 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.886 HG23 HD23 ' A' ' 76' ' ' LEU . 4.8 tt -72.9 139.96 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 119.292 1.546 . . . . 0.0 108.023 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.57 136.46 53.26 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.787 -175.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.956 ' HB ' HD11 ' A' ' 39' ' ' ILE . 18.9 tt -168.04 126.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.369 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -98.75 155.34 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-O 121.439 0.638 . . . . 0.0 110.094 -169.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.577 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 1.7 pm0 -85.29 -22.72 28.45 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.557 173.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.562 ' N ' HG13 ' A' ' 84' ' ' VAL . 64.0 t30 74.91 8.6 4.14 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 114.427 -1.261 . . . . 0.0 110.113 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.577 ' HG2' ' HB2' ' A' ' 85' ' ' GLU . 14.6 pt-20 -118.86 137.29 24.83 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.169 174.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 2.5 Cg_endo -82.12 15.32 2.01 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.888 2.392 . . . . 0.0 112.195 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 71.04 -62.06 0.46 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.999 0.812 . . . . 0.0 111.322 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -145.48 91.87 2.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.425 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 73.09 162.94 0.27 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.803 0.811 . . . . 0.0 112.902 175.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -170.36 -49.27 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.394 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.8 tt -71.99 -24.34 22.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.409 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 m 64.93 61.95 0.76 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.928 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -162.77 -57.85 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.54 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.611 -1.105 . . . . 0.0 111.914 179.679 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.951 0 N-CA-C 112.573 -0.211 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.2 m -121.81 78.14 1.43 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.078 0.466 . . . . 0.0 109.776 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -92.42 -33.67 14.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.629 -175.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.486 ' HG2' HG12 ' A' ' 31' ' ' ILE . 33.8 ttp -139.9 75.33 30.42 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.187 0.518 . . . . 0.0 110.683 -174.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -62.16 -23.82 75.81 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.476 2.784 . . . . 0.0 112.773 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.523 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 11.3 pt20 -59.86 -25.4 65.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.32 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.555 ' O ' HG13 ' A' ' 35' ' ' ILE . 17.2 mm -68.94 -48.88 67.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.829 0.347 . . . . 0.0 110.102 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -56.08 -45.29 79.41 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.172 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 10.4 ptm180 -67.92 -38.42 82.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.901 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.612 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -67.37 -38.05 84.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.676 -175.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 31' ' ' ILE . 75.6 mt -59.97 -43.56 92.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.178 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.626 ' HD3' HD12 ' A' ' 81' ' ' ILE . 19.9 mmtm -66.38 -36.06 81.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.491 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.496 ' HB3' ' HE2' ' A' ' 37' ' ' LYS . 32.1 mtpt -68.72 -38.09 79.97 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.177 176.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 82.8 mt -61.29 -47.73 84.65 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.407 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.61 ' HB ' HD11 ' A' ' 81' ' ' ILE . 1.5 mp -62.64 -34.75 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.185 0.517 . . . . 0.0 109.814 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.0 t -66.2 -48.1 71.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.956 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.525 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 95.1 mt -59.85 -36.45 76.88 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.244 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.49 -38.99 95.39 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.476 ' HB2' HG23 ' A' ' 48' ' ' ILE . 33.1 tptt -65.61 -39.58 91.68 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.303 0.573 . . . . 0.0 109.577 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.54 ' N ' ' HE2' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -63.07 -42.92 99.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.218 173.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.986 ' HE3' ' HA ' ' A' ' 56' ' ' ALA . 71.6 mmtt -68.09 -26.31 65.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.681 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.83 -64.07 0.32 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.747 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -130.94 158.22 40.84 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.682 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -87.86 79.05 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.681 -175.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 1.036 ' HB ' HG13 ' A' ' 84' ' ' VAL . 5.1 t -147.0 160.02 42.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -168.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -56.05 -37.74 69.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.248 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -67.91 -38.99 83.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.394 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.695 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -71.88 -29.89 64.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.363 176.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.672 HG12 ' O ' ' A' ' 49' ' ' THR . 49.4 mm -59.21 -49.64 82.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.417 0.627 . . . . 0.0 109.66 171.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -62.03 -34.22 75.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.154 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.816 ' HD3' ' HB3' ' A' ' 45' ' ' LYS . 11.4 ptmt -75.86 -21.33 57.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.906 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.986 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -76.5 -20.41 56.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.287 0.565 . . . . 0.0 110.08 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.531 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 72.7 t80 -72.5 140.46 81.95 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.449 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.503 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 73.8 Cg_endo -79.83 127.28 14.19 Favored 'Cis proline' 0 C--N 1.345 0.362 0 C-N-CA 123.423 -1.49 . . . . 0.0 112.525 -2.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.531 ' HD3' ' CD1' ' A' ' 57' ' ' PHE . 72.3 Cg_endo -105.53 -139.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.889 0 C-N-CA 124.657 3.572 . . . . 0.0 110.887 -176.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.455 ' H ' ' HB2' ' A' ' 59' ' ' PRO . 21.0 p-10 -97.63 16.69 19.72 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -173.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.612 ' HA ' ' HD3' ' A' ' 34' ' ' ARG . 14.0 m-85 -57.42 118.28 4.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.189 0.519 . . . . 0.0 111.519 -173.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.99 -24.74 40.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.974 172.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.17 127.26 1.6 Allowed Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -99.07 131.79 44.86 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.63 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 7.3 t70 -147.36 138.59 23.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.833 0.349 . . . . 0.0 110.587 -169.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.9 m -63.47 -35.78 81.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.241 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.53 ' HB3' ' OD2' ' A' ' 65' ' ' ASP . 0.5 OUTLIER -62.17 -33.0 73.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.112 176.142 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.63 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 33.3 tp -56.49 -39.59 73.5 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.795 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.9 mm -63.7 -40.64 89.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.999 0.428 . . . . 0.0 110.296 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.632 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 15.8 mt-10 -67.2 -40.82 86.55 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -65.13 -35.23 80.45 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.942 -176.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 68' ' ' LEU . 82.2 mt -60.16 -49.95 82.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.47 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.632 ' CE1' ' HA ' ' A' ' 70' ' ' GLU . 4.7 p-80 -67.41 -31.57 71.87 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.471 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.587 ' HB3' ' HE3' ' A' ' 78' ' ' LYS . 32.8 mt-10 -60.99 -50.49 73.16 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.553 ' OE2' ' HD2' ' A' ' 78' ' ' LYS . 23.2 mm-40 -62.07 -31.5 71.93 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.971 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.718 ' HA ' HG22 ' A' ' 81' ' ' ILE . 15.1 tp -58.09 -45.36 87.31 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.536 175.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -83.52 -51.67 7.14 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.587 ' HE3' ' HB3' ' A' ' 74' ' ' GLU . 18.8 ptpt -74.06 -42.49 60.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.676 0.274 . . . . 0.0 111.189 -174.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -94.84 -21.13 18.89 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.302 -175.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.94 24.35 41.82 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.863 -1.16 . . . . 0.0 112.971 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.718 HG22 ' HA ' ' A' ' 76' ' ' LEU . 7.6 tt -73.78 123.36 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 117.447 0.623 . . . . 0.0 110.44 -173.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.424 HD22 ' HA ' ' A' ' 82' ' ' ASN . 11.8 m120 -80.48 120.22 24.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.154 0.502 . . . . 0.0 111.794 -172.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.0 tp -156.69 115.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 122.073 0.94 . . . . 0.0 110.16 -178.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.036 HG13 ' HB ' ' A' ' 49' ' ' THR . 2.3 p -86.37 154.77 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.739 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.0 -31.57 14.19 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.725 0.298 . . . . 0.0 110.616 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.409 ' N ' HG22 ' A' ' 84' ' ' VAL . 61.5 t30 70.08 7.71 6.34 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.766 170.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.67 128.84 75.92 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.872 0.368 . . . . 0.0 110.782 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -73.89 94.27 0.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.908 2.405 . . . . 0.0 112.205 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -62.72 -30.89 71.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.312 175.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -93.46 75.68 4.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.446 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 64.86 -97.15 0.05 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 123.973 0.796 . . . . 0.0 110.996 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -147.46 -68.49 0.25 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 15.0 tt -101.7 -1.53 9.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.049 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.0 m 69.24 48.12 0.68 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.181 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.13 -34.04 38.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.818 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.739 -1.034 . . . . 0.0 112.1 178.709 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.0 m -98.76 16.7 21.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.9 0.381 . . . . 0.0 111.164 -175.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -91.89 -19.57 22.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.997 -175.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.444 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 20.7 ptp -141.74 60.6 11.61 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 28' ' ' MET . 19.9 Cg_exo -66.12 -29.72 47.62 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.352 2.035 . . . . 0.0 111.609 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -64.29 -25.92 68.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.704 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.737 HG23 HD13 ' A' ' 68' ' ' LEU . 18.4 mm -63.67 -49.01 84.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.043 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -55.37 -45.28 76.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.554 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -68.85 -37.75 79.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.231 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.564 HH21 ' HG3' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -67.6 -38.98 84.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.1 -177.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.605 HG13 ' O ' ' A' ' 31' ' ' ILE . 70.8 mt -61.22 -39.31 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-O 120.76 0.314 . . . . 0.0 110.519 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.626 ' HD3' HD12 ' A' ' 81' ' ' ILE . 21.2 mmtm -65.55 -35.41 80.77 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.363 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.564 ' HG3' HH21 ' A' ' 34' ' ' ARG . 13.0 mmmm -67.92 -39.07 83.59 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.525 175.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 78.4 mt -61.81 -48.76 79.17 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.117 0.484 . . . . 0.0 110.438 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.592 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -65.09 -35.27 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.378 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -66.9 -48.45 68.65 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.229 0.538 . . . . 0.0 109.759 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.664 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 83.1 mt -62.01 -41.15 97.77 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.872 -177.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.23 -35.1 87.65 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -69.05 -44.27 72.97 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.467 0.651 . . . . 0.0 109.728 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.523 ' N ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -60.93 -38.04 84.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.701 174.021 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 28.2 mmtp -69.52 -20.45 63.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.258 -177.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.03 -63.3 0.33 Allowed Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.897 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -135.92 150.74 49.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.994 0.426 . . . . 0.0 111.076 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.461 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -80.79 86.02 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 172.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.561 HG23 ' H ' ' A' ' 52' ' ' ASP . 5.4 t -151.07 158.73 44.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.128 -176.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -57.24 -39.8 76.28 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.374 0.421 . . . . 0.0 110.693 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -62.61 -41.15 98.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.825 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.821 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -71.05 -29.35 65.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.788 -176.09 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.4 mm -59.38 -50.39 80.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.358 0.599 . . . . 0.0 109.987 171.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.4 -39.91 84.91 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.809 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.821 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.73 -15.48 59.11 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.902 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HA ' ' NZ ' ' A' ' 45' ' ' LYS . . . -79.18 -19.55 50.6 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.435 175.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.425 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 73.7 t80 -60.86 137.16 93.51 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.027 175.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.538 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 13.1 Cg_endo -88.38 139.3 17.01 Favored 'Cis proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.609 -1.413 . . . . 0.0 113.07 3.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.676 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 27.7 Cg_endo -100.29 -150.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 124.458 3.439 . . . . 0.0 110.189 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.2 15.86 21.5 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.815 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.676 ' CD1' ' HD2' ' A' ' 59' ' ' PRO . 4.3 p90 -58.58 118.64 5.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 122.144 0.973 . . . . 0.0 111.038 -168.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -81.43 -22.28 38.31 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.267 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.75 126.6 1.5 Allowed Glycine 0 N--CA 1.434 -1.488 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -109.66 135.62 50.33 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 13.8 t70 -149.04 158.16 43.96 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.281 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 p -63.89 -35.65 81.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.962 0.41 . . . . 0.0 111.045 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -62.01 -34.79 76.85 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.737 HD13 HG23 ' A' ' 31' ' ' ILE . 26.7 tp -60.29 -40.23 89.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.213 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.451 ' O ' ' HD2' ' A' ' 73' ' ' HIS . 48.4 mm -64.25 -40.98 90.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.914 0.388 . . . . 0.0 110.288 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.7 -40.21 84.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 14.2 tpt180 -61.03 -34.91 75.59 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.671 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 68' ' ' LEU . 82.5 mt -60.84 -45.83 97.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.451 ' HD2' ' O ' ' A' ' 69' ' ' ILE . 74.1 m-70 -59.9 -44.2 94.4 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.243 0.545 . . . . 0.0 110.061 175.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -59.31 -47.34 85.76 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.389 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.474 ' C ' HG22 ' A' ' 81' ' ' ILE . 30.0 mm-40 -55.64 -29.8 59.88 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.881 HD21 HG22 ' A' ' 83' ' ' ILE . 53.7 mt -60.45 -48.92 79.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.27 0.557 . . . . 0.0 110.91 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -83.99 -48.49 9.89 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.309 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -70.9 -46.27 62.83 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.44 -173.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.51 -24.37 15.16 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.898 -177.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.1 20.79 41.11 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.44 -0.885 . . . . 0.0 112.995 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.86 HG23 HD23 ' A' ' 76' ' ' LEU . 7.5 tt -76.05 147.08 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.428 HD22 ' HA ' ' A' ' 82' ' ' ASN . 6.8 m120 -116.94 133.31 56.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.339 0.59 . . . . 0.0 112.378 -177.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.881 HG22 HD21 ' A' ' 76' ' ' LEU . 5.2 tp -167.68 130.85 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.576 -1.193 . . . . 0.0 107.978 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.488 HG12 ' CB ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -88.27 155.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 120.919 0.39 . . . . 0.0 109.995 -177.332 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 39.6 mt-10 -94.53 -23.07 17.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.711 -170.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 6.4 t-20 81.75 -4.07 1.56 Allowed 'General case' 0 N--CA 1.465 0.315 0 O-C-N 124.525 1.14 . . . . 0.0 109.676 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 31.0 mt-10 -83.89 129.91 57.23 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.481 174.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 51.7 Cg_exo -54.8 119.53 6.62 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.938 2.425 . . . . 0.0 112.347 -178.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -72.95 -38.58 66.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.069 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -133.97 80.41 1.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.095 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 88' ' ' PRO . 9.0 tp10 -122.63 150.96 41.97 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.595 ' HG3' HG13 ' A' ' 93' ' ' ILE . 9.1 pt-20 -146.83 -59.61 0.29 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.6 -177.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.595 HG13 ' HG3' ' A' ' 92' ' ' GLU . 31.6 mt -100.82 -1.05 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.35 0.595 . . . . 0.0 110.48 -175.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.5 m 65.89 29.98 10.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.293 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.74 128.17 54.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.285 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.812 -0.993 . . . . 0.0 111.818 -178.758 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.8 t -152.81 161.65 42.29 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -122.88 132.74 54.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.063 0.458 . . . . 0.0 110.914 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.4 mtt -120.82 115.9 31.83 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.19 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.79 -27.8 73.34 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.494 2.129 . . . . 0.0 111.368 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.513 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 28.4 tt0 -68.83 -35.43 76.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.607 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.678 ' O ' HG13 ' A' ' 35' ' ' ILE . 9.1 mm -68.12 -48.38 74.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.676 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -60.45 -46.07 91.4 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.469 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 10.8 ptm180 -66.29 -33.15 75.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.505 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.83 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -69.84 -34.53 73.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.518 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.796 HG23 HG12 ' A' ' 72' ' ' ILE . 62.5 mt -58.69 -51.38 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.462 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.509 ' N ' ' HD3' ' A' ' 36' ' ' LYS . 1.8 mppt? -69.28 -35.78 76.4 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.632 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -64.97 -43.68 91.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.985 0.421 . . . . 0.0 109.882 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.477 ' HG ' HG23 ' A' ' 53' ' ' ILE . 6.0 tp -66.73 -45.5 78.46 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.343 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.502 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.4 mp -62.11 -35.48 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.545 ' C ' ' HE2' ' A' ' 44' ' ' LYS . 53.9 m -67.92 -48.58 65.58 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.191 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.72 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 79.5 mt -59.46 -40.08 85.72 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.929 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.54 -34.38 88.21 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.466 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -73.43 -38.21 65.61 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -177.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.545 ' HE2' ' C ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -64.5 -29.95 70.99 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.49 174.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.72 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 74.5 mmtt -74.73 -11.6 60.21 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.039 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.06 -68.3 0.31 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.285 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.73 170.95 14.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.894 0.378 . . . . 0.0 110.382 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.77 85.88 2.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.198 0.523 . . . . 0.0 109.793 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.557 HG22 ' H ' ' A' ' 51' ' ' GLU . 4.9 m -141.17 146.6 37.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.101 -175.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.463 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 90.8 t80 -60.33 -33.71 72.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.172 0.51 . . . . 0.0 109.908 174.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.557 ' H ' HG22 ' A' ' 49' ' ' THR . 35.9 mt-10 -67.59 -37.33 82.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.574 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 1.025 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.2 m-20 -65.2 -31.27 72.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.006 0.432 . . . . 0.0 110.679 174.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.477 HG23 ' HG ' ' A' ' 38' ' ' LEU . 32.0 mm -64.96 -49.84 77.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.167 0.508 . . . . 0.0 110.545 172.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -61.63 -32.78 72.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.803 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 1.025 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 2.9 ptmt -74.69 -17.27 60.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.017 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.507 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -77.67 -19.76 54.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.514 -175.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.489 ' HA ' ' CD ' ' A' ' 59' ' ' PRO . 44.5 m-85 -59.57 130.81 88.09 Favored Pre-proline 0 N--CA 1.462 0.171 0 O-C-N 123.322 0.389 . . . . 0.0 111.23 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.524 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 3.9 Cg_exo -77.03 123.93 10.07 Favored 'Cis proline' 0 C--O 1.234 0.315 0 C-N-CA 123.998 -1.251 . . . . 0.0 112.33 0.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.529 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 34.8 Cg_endo -100.93 -156.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.687 0 C-N-CA 124.361 3.374 . . . . 0.0 110.751 -177.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -97.73 12.81 32.53 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.023 0.44 . . . . 0.0 111.459 -177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.529 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 3.7 p90 -66.17 120.62 13.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.273 0.559 . . . . 0.0 109.919 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.565 ' HG3' HH11 ' A' ' 34' ' ' ARG . 43.4 mt-10 -81.42 -23.62 37.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.378 0.609 . . . . 0.0 110.346 177.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.29 127.63 1.66 Allowed Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -100.84 136.87 40.02 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.58 -0.448 . . . . 0.0 109.819 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.512 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 10.3 t70 -150.0 142.71 24.62 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.1 t -63.74 -27.13 68.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.56 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -66.06 -33.59 76.15 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.99 0.424 . . . . 0.0 109.898 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.58 HD13 HG23 ' A' ' 31' ' ' ILE . 46.2 tp -59.63 -40.69 88.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.669 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.3 mm -60.83 -41.62 89.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.09 0.471 . . . . 0.0 110.48 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.27 -43.5 73.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.553 0.692 . . . . 0.0 109.156 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.626 ' HG3' HD11 ' A' ' 35' ' ' ILE . 11.5 tpp180 -62.41 -36.51 82.58 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.638 -176.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.796 HG12 HG23 ' A' ' 35' ' ' ILE . 79.9 mt -64.72 -48.22 85.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.505 176.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.518 ' HA ' HD12 ' A' ' 76' ' ' LEU . 32.9 m80 -63.09 -41.12 99.32 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.386 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.25 -42.84 99.68 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.926 -0.309 . . . . 0.0 110.224 176.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.419 ' C ' HG22 ' A' ' 81' ' ' ILE . 10.3 mt-10 -64.53 -28.55 69.72 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 178.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.009 HD23 HG23 ' A' ' 81' ' ' ILE . 78.4 mt -56.97 -47.99 79.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.071 0.462 . . . . 0.0 110.77 176.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -83.87 -50.34 8.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.949 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -74.11 -43.28 58.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.058 -173.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -95.68 -21.85 17.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.246 0.546 . . . . 0.0 110.474 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.11 20.35 57.57 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.936 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.009 HG23 HD23 ' A' ' 76' ' ' LEU . 7.1 tt -75.58 146.58 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.455 HD22 ' HA ' ' A' ' 82' ' ' ASN . 5.3 m120 -113.89 129.18 56.62 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.632 -177.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.878 HG22 HD21 ' A' ' 76' ' ' LEU . 7.3 tp -159.59 121.33 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 172.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -96.84 158.84 3.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.466 0.65 . . . . 0.0 111.274 -168.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -87.17 -22.93 25.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.961 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.519 ' HB2' ' CG2' ' A' ' 49' ' ' THR . 66.2 t30 75.77 4.3 3.89 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.396 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -124.87 134.21 25.48 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.595 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HB2' ' OE2' ' A' ' 90' ' ' GLU . 37.6 Cg_endo -68.28 123.39 10.52 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.747 2.298 . . . . 0.0 110.924 173.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.75 5.45 51.82 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -169.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.477 ' OE2' ' HB2' ' A' ' 88' ' ' PRO . 6.7 pm0 -74.9 139.48 43.13 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.152 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 59.22 35.91 23.63 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.789 -175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -134.45 -64.81 0.67 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.507 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 50.8 mt -71.95 -17.2 19.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.136 0.494 . . . . 0.0 110.21 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.0 m 69.09 28.1 5.12 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.812 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -158.64 149.34 20.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.211 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.253 -1.304 . . . . 0.0 111.478 -177.604 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.676 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.4 t -117.09 130.05 56.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.828 0.347 . . . . 0.0 111.751 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 75.8 m80 53.9 30.92 12.35 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.157 171.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.879 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 59.2 ttp -128.07 -64.33 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.439 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.621 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.879 ' HD3' ' HB3' ' A' ' 28' ' ' MET . 17.3 Cg_exo -66.18 -32.53 42.48 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 121.85 1.7 . . . . 0.0 111.669 -176.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.548 ' HA ' ' HG2' ' A' ' 33' ' ' ARG . 19.3 pt20 -67.59 -27.6 67.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.92 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.728 ' O ' HG12 ' A' ' 35' ' ' ILE . 34.4 mm -69.29 -51.54 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.64 -44.52 85.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.928 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.548 ' HG2' ' HA ' ' A' ' 30' ' ' GLN . 23.6 ptt180 -69.01 -37.02 78.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.334 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.675 ' NH1' HD11 ' A' ' 38' ' ' LEU . 4.6 tmt_? -67.49 -41.68 84.15 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 121.27 -0.172 . . . . 0.0 111.126 -177.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.728 HG12 ' O ' ' A' ' 31' ' ' ILE . 20.0 mm -59.67 -48.15 88.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 121.18 0.514 . . . . 0.0 110.077 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.413 ' HD3' HD12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -67.39 -35.12 78.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.8 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 37' ' ' LYS . 40.5 mtpt -60.21 -38.5 83.53 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.029 -0.269 . . . . 0.0 110.87 175.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.675 HD11 ' NH1' ' A' ' 34' ' ' ARG . 71.9 mt -59.64 -43.75 93.74 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.197 0.523 . . . . 0.0 110.249 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.718 HD11 HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -61.86 -39.19 82.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.267 178.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.622 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 25.0 t -67.37 -49.68 62.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.993 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.602 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 87.7 mt -68.81 -41.94 77.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.978 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.81 -38.49 85.36 Favored Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -63.73 -44.99 91.93 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.622 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -58.26 -38.36 76.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.492 173.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.914 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -69.32 -21.96 63.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.274 -178.123 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.26 -57.51 0.51 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.507 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.446 ' HB2' ' OD2' ' A' ' 52' ' ' ASP . 99.3 m-85 -134.12 163.36 29.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.121 0.486 . . . . 0.0 110.528 -174.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -96.86 85.7 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.533 0.682 . . . . 0.0 109.552 174.022 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 27.0 p -139.41 159.84 41.22 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.645 -175.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -57.69 -37.91 74.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.065 0.46 . . . . 0.0 110.003 176.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -66.14 -46.09 78.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.418 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.767 ' HA ' ' CG ' ' A' ' 55' ' ' LYS . 5.1 m-20 -66.7 -31.43 72.09 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.664 HG12 ' O ' ' A' ' 49' ' ' THR . 48.6 mm -63.99 -48.77 84.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.369 0.604 . . . . 0.0 109.963 172.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.553 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 21.4 t70 -61.93 -37.05 83.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.58 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.767 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.34 -15.26 59.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.73 178.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.433 ' HB1' ' CB ' ' A' ' 41' ' ' LEU . . . -76.68 -18.9 58.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.907 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.658 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 24.2 m-85 -68.12 165.2 35.23 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.389 176.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.658 ' HA ' ' HB3' ' A' ' 57' ' ' PHE . 96.7 Cg_endo -82.57 157.07 77.31 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 123.895 -1.294 . . . . 0.0 112.672 -0.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 49.2 Cg_endo -104.49 -173.99 0.07 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.6 0 C-N-CA 124.425 3.416 . . . . 0.0 111.359 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -98.56 16.5 21.67 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.745 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.811 ' HE2' HD22 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -59.58 124.13 19.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.979 -169.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -79.12 -13.44 59.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.372 -170.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.12 125.55 1.38 Allowed Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -105.98 130.65 53.87 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.564 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 11.7 t70 -148.91 155.04 40.29 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -176.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.1 t -63.73 -25.9 68.41 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.21 0.529 . . . . 0.0 110.99 176.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.468 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 29.1 t-20 -60.7 -33.32 72.69 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.112 0.482 . . . . 0.0 109.867 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.811 HD22 ' HE2' ' A' ' 61' ' ' PHE . 26.0 tp -54.37 -38.37 66.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.074 173.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.9 mm -62.03 -38.06 79.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.2 0.524 . . . . 0.0 110.125 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.677 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 6.7 mm-40 -66.27 -45.06 81.81 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 26.5 mmt180 -60.27 -38.26 83.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.393 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.62 HG13 ' O ' ' A' ' 68' ' ' LEU . 79.3 mt -61.26 -51.29 74.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.807 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.677 ' CE1' ' HA ' ' A' ' 70' ' ' GLU . 4.5 p-80 -68.73 -30.88 69.6 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.405 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.581 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 44.0 mt-10 -59.33 -50.26 74.65 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.699 173.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.692 ' HG3' HG13 ' A' ' 35' ' ' ILE . 8.3 mm-40 -60.4 -29.85 69.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 120.952 0.406 . . . . 0.0 110.677 176.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.684 ' HA ' HG22 ' A' ' 81' ' ' ILE . 19.3 tp -61.54 -45.29 94.79 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 174.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -83.36 -53.06 6.01 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.581 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 49.1 pttt -74.54 -38.07 62.86 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -173.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.41 -24.82 17.18 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.881 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.9 23.99 43.42 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.746 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.684 HG22 ' HA ' ' A' ' 76' ' ' LEU . 8.0 tt -72.55 121.97 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.429 0.633 . . . . 0.0 111.001 -169.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.533 ' O ' HD11 ' A' ' 39' ' ' ILE . 19.7 m120 -99.72 117.25 33.66 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -171.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.718 HG12 HD11 ' A' ' 39' ' ' ILE . 1.8 mt -149.34 132.25 6.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -90.09 153.9 3.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -177.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -87.47 -31.98 19.71 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.033 0.444 . . . . 0.0 110.949 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.4 ' H ' HG13 ' A' ' 84' ' ' VAL . 42.3 t30 69.86 15.99 7.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.269 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.0 mm-40 -76.35 136.99 68.07 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.595 177.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 8.3 Cg_exo -72.65 142.59 36.28 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.827 2.352 . . . . 0.0 111.87 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -81.9 71.23 8.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.462 0.649 . . . . 0.0 109.473 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' A' ' 94' ' ' SER . 10.7 tp10 -126.71 133.03 51.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.647 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.425 ' HA ' ' OE1' ' A' ' 91' ' ' GLU . 6.2 mm-40 -90.65 -45.31 8.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.175 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 179.64 86.14 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 O-C-N 123.633 0.583 . . . . 0.0 110.787 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 15.7 mm 58.1 36.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.778 0.799 . . . . 0.0 110.155 174.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.409 ' H ' ' CD ' ' A' ' 90' ' ' GLU . 19.4 m 59.17 56.07 4.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.109 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.23 124.67 24.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.647 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 119.03 -0.872 . . . . 0.0 111.476 -178.289 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 112.434 -0.266 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.4 p -99.49 39.21 1.32 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.922 -0.163 . . . . 0.0 111.263 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.6 t60 71.49 -59.7 0.54 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.311 0.644 . . . . 0.0 109.918 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.484 ' HB2' HG12 ' A' ' 31' ' ' ILE . 65.1 mtt -147.46 105.85 3.78 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.513 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 36.3 Cg_exo -57.8 -27.11 76.79 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.74 2.293 . . . . 0.0 111.638 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.542 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 14.9 pt20 -64.27 -25.07 67.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.092 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.646 ' O ' HG13 ' A' ' 35' ' ' ILE . 23.9 mm -68.46 -48.34 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.278 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -56.0 -46.36 78.76 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.085 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 21.5 mmm180 -67.25 -40.88 86.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.243 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -66.87 -36.36 82.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.187 -175.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.646 HG13 ' O ' ' A' ' 31' ' ' ILE . 74.7 mt -59.89 -44.38 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.599 ' HD3' HD12 ' A' ' 81' ' ' ILE . 26.5 mmtm -67.32 -35.77 80.1 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.142 0.496 . . . . 0.0 110.118 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.611 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 39.7 ttmt -65.99 -38.27 88.07 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.535 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.696 HD11 ' CZ ' ' A' ' 61' ' ' PHE . 93.4 mt -61.08 -50.57 72.74 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.041 0.448 . . . . 0.0 110.085 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.543 ' HB ' HD11 ' A' ' 81' ' ' ILE . 1.5 mp -66.19 -35.14 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.336 -177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' A' ' 37' ' ' LYS . 22.7 p -70.22 -43.37 70.8 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.263 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.641 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 78.4 mt -58.82 -35.41 72.83 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.676 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.59 -32.97 85.96 Favored Glycine 0 CA--C 1.496 -1.152 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.38 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -30.45 65.86 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.565 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.87 -43.73 74.76 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.167 171.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.641 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 32.3 mmmt -66.97 -31.94 72.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.555 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.46 -63.86 0.31 Allowed Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.353 175.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -142.77 154.33 44.13 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.441 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER -81.93 105.36 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.364 0.602 . . . . 0.0 111.089 -177.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.7 HG23 ' H ' ' A' ' 52' ' ' ASP . 2.5 t -155.48 158.34 38.39 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.393 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -56.81 -29.9 63.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.288 0.566 . . . . 0.0 109.753 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -63.56 -42.18 98.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.498 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.727 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -64.54 -37.67 88.35 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.008 -176.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.501 HD12 ' HB3' ' A' ' 38' ' ' LEU . 40.8 mm -59.77 -49.18 84.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.577 0.703 . . . . 0.0 109.772 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -66.93 -34.58 78.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.294 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.727 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 9.5 ptmt -76.46 -20.38 57.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.051 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.2 -19.59 60.48 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.527 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.503 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 39.9 t80 -55.47 139.09 67.79 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.756 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 57' ' ' PHE . 22.9 Cg_exo -66.07 145.3 68.83 Favored 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 124.011 -1.245 . . . . 0.0 112.247 -0.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 14.7 Cg_endo -95.12 -175.33 0.35 Allowed 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 123.743 2.962 . . . . 0.0 110.029 -173.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -98.5 12.73 34.21 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.225 0.536 . . . . 0.0 111.127 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.696 ' CZ ' HD11 ' A' ' 38' ' ' LEU . 32.0 m-85 -63.64 117.78 7.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.066 0.46 . . . . 0.0 111.999 -176.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -82.22 -21.88 36.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.177 170.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.15 127.98 1.69 Allowed Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -104.4 145.06 30.8 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.982 0.391 . . . . 0.0 110.58 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.632 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 11.0 t70 -145.18 156.11 43.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.561 0.22 . . . . 0.0 110.732 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.5 m -63.49 -34.55 78.01 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.212 0.529 . . . . 0.0 111.021 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -61.49 -32.01 72.01 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.983 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.632 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 11.5 tp -56.4 -43.27 79.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.351 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.5 mm -61.56 -47.29 94.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.892 0.377 . . . . 0.0 110.57 -176.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -69.93 -33.74 72.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.868 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.1 tpp85 -70.74 -33.52 70.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.291 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 68' ' ' LEU . 80.2 mt -61.7 -50.54 79.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 176.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.496 ' HA ' HD12 ' A' ' 76' ' ' LEU . 15.4 t-80 -67.1 -34.34 77.42 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.547 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.549 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 36.2 mt-10 -58.87 -50.13 75.16 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 173.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.569 ' HG2' ' HE3' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -59.62 -35.19 73.87 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.494 -179.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.872 HD21 HG22 ' A' ' 83' ' ' ILE . 81.5 mt -58.97 -52.2 66.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.05 0.452 . . . . 0.0 111.776 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -85.15 -48.46 9.13 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.251 0.548 . . . . 0.0 112.383 -177.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 18.3 ttmt -71.9 -44.48 63.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.988 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -96.43 -26.96 15.13 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.146 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.26 21.39 35.38 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 119.865 -1.16 . . . . 0.0 113.516 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.803 HG23 HD23 ' A' ' 76' ' ' LEU . 6.5 tt -73.15 144.85 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.432 ' HA ' HD22 ' A' ' 82' ' ' ASN . 2.7 t-20 -113.67 128.61 56.49 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.93 -0.708 . . . . 0.0 112.193 -173.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.872 HG22 HD21 ' A' ' 76' ' ' LEU . 7.0 tp -156.11 133.18 2.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -102.7 166.72 2.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -174.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -93.63 -33.56 13.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.659 0.743 . . . . 0.0 109.592 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.556 ' N ' HG13 ' A' ' 84' ' ' VAL . 24.0 t30 68.74 17.71 8.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 113.864 -1.516 . . . . 0.0 109.981 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 7.6 mm-40 -72.6 135.76 81.1 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.199 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 52.8 Cg_exo -54.91 105.14 0.13 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.246 2.631 . . . . 0.0 112.408 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -88.44 38.42 0.86 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.533 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -150.38 90.76 1.68 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.959 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -125.09 60.07 1.22 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.393 0.616 . . . . 0.0 110.953 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -75.53 -71.39 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.2 mt -104.02 -34.1 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.2 t 74.28 -49.78 0.67 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.493 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.2 88.32 2.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.018 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.756 0 CA-C-O 119.08 -0.844 . . . . 0.0 111.681 177.853 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.5 p -84.81 -32.85 23.1 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 51.3 60.94 3.5 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.515 0.674 . . . . 0.0 110.454 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.623 ' O ' HG22 ' A' ' 31' ' ' ILE . 47.7 ttm -143.73 81.05 12.3 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.198 -178.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -60.78 -24.6 79.32 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.816 2.344 . . . . 0.0 112.792 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.508 ' HG3' ' HG2' ' A' ' 28' ' ' MET . 1.5 pp0? -64.58 -29.59 70.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.31 -174.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.623 HG22 ' O ' ' A' ' 28' ' ' MET . 11.3 tp -70.22 -45.85 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.861 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.825 ' HG2' ' HD3' ' A' ' 71' ' ' ARG . 25.6 mt-10 -70.85 -41.2 71.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.753 0.311 . . . . 0.0 110.771 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 11.7 ptt180 -62.22 -32.53 73.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.587 HH11 HD22 ' A' ' 68' ' ' LEU . 25.1 ttm180 -64.29 -37.81 88.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.039 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.535 HG22 ' CD1' ' A' ' 81' ' ' ILE . 15.6 mm -60.33 -50.48 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.641 ' HD3' HD12 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -68.21 -35.24 77.67 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.482 179.021 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.53 ' HG2' ' HB2' ' A' ' 60' ' ' ASP . 2.6 tppp? -64.7 -42.35 95.35 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.42 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.675 ' HB3' HD12 ' A' ' 53' ' ' ILE . 75.3 mt -59.66 -48.53 81.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.948 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.082 HD11 ' HB ' ' A' ' 83' ' ' ILE . 0.5 OUTLIER -65.71 -36.55 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.419 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.651 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 47.6 t -68.09 -50.37 55.38 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.824 -176.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.682 HD12 ' HB3' ' A' ' 59' ' ' PRO . 36.2 mt -69.39 -41.56 76.28 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.016 -176.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.04 -39.99 94.99 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.89 -40.33 72.28 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.651 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -59.93 -37.32 79.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.186 174.458 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.678 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 73.5 mmtt -68.56 -31.98 71.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.784 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.11 -68.0 0.17 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.584 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -132.4 163.86 27.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.369 0.604 . . . . 0.0 111.534 -171.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.502 HG22 HD12 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -93.51 84.07 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.808 178.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.793 HG23 ' H ' ' A' ' 52' ' ' ASP . 10.0 t -155.45 158.28 38.31 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.452 -174.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.411 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 17.9 t80 -57.38 -37.06 72.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.883 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -64.31 -41.75 96.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.512 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.793 ' H ' HG23 ' A' ' 49' ' ' THR . 0.9 OUTLIER -71.97 -29.99 64.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.348 177.338 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.675 HD12 ' HB3' ' A' ' 38' ' ' LEU . 45.4 mm -59.47 -49.02 85.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.176 0.512 . . . . 0.0 110.321 172.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.789 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 16.9 t70 -58.52 -37.94 76.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.459 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.692 ' CG ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.29 -15.51 59.4 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.794 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.81 -20.02 33.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.996 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.834 ' HD1' ' HD3' ' A' ' 59' ' ' PRO . 16.3 m-85 -61.7 145.35 92.01 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.163 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.497 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 22.3 Cg_endo -95.8 128.71 3.66 Favored 'Cis proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.275 -1.135 . . . . 0.0 112.104 -3.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.834 ' HD3' ' HD1' ' A' ' 57' ' ' PHE . 77.5 Cg_endo -106.6 -108.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.944 0 C-N-CA 123.667 2.911 . . . . 0.0 112.785 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.53 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -100.45 10.86 40.62 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -170.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.789 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 12.9 p90 -79.52 117.87 20.86 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 118.891 -1.124 . . . . 0.0 110.186 -177.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.456 ' HB2' ' NE2' ' A' ' 30' ' ' GLN . 97.8 mt-10 -81.11 -26.08 36.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.587 173.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.57 127.26 1.59 Allowed Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -76.18 135.45 39.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 117.402 0.601 . . . . 0.0 109.38 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 10.6 p-10 -151.5 151.2 31.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.983 0.421 . . . . 0.0 111.472 -168.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.7 m -64.02 -29.66 70.79 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.146 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.605 HD21 HG12 ' A' ' 31' ' ' ILE . 1.7 t30 -61.49 -33.85 74.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.426 177.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.587 HD22 HH11 ' A' ' 34' ' ' ARG . 46.3 tp -56.36 -41.89 76.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.964 175.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.4 mm -59.95 -42.97 91.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.007 0.432 . . . . 0.0 110.327 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 12.6 mt-10 -68.85 -43.9 74.49 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.825 ' HD3' ' HG2' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -59.51 -40.98 88.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.029 -174.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.565 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 82.7 mt -61.11 -49.48 84.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.512 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.472 ' HA ' HD12 ' A' ' 76' ' ' LEU . 32.2 m170 -65.9 -38.46 88.8 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.439 -177.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 51.4 mt-10 -62.75 -47.14 84.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.455 177.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 79' ' ' HIS . 12.1 mm-40 -59.35 -29.6 67.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.84 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.702 HD23 HG23 ' A' ' 81' ' ' ILE . 91.6 mt -58.04 -48.03 81.33 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.783 0.325 . . . . 0.0 110.397 175.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -84.32 -52.03 6.53 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 19.8 pttp -73.23 -37.56 66.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -174.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.43 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 30.5 t60 -94.03 -34.73 12.91 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.548 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.79 22.59 30.43 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.837 -175.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.702 HG23 HD23 ' A' ' 76' ' ' LEU . 6.6 tt -72.73 138.73 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -175.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -117.06 124.67 49.85 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.387 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.082 ' HB ' HD11 ' A' ' 39' ' ' ILE . 19.8 tt -159.3 132.49 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.753 -174.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.541 HG12 ' HB ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -98.24 154.27 3.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.121 0.486 . . . . 0.0 110.729 -172.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -86.43 -34.63 20.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.438 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 76.81 -11.16 1.22 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.211 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 79.2 mm-40 -96.32 141.53 23.26 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.532 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 23.3 Cg_exo -64.06 133.07 36.71 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.858 2.372 . . . . 0.0 112.266 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -76.75 -20.9 55.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.754 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 66.85 24.5 9.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.823 -1.08 . . . . 0.0 112.609 171.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -107.02 80.0 1.38 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 171.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -98.76 -78.37 0.5 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.1 tp -119.39 -9.43 11.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.358 176.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.5 m 63.29 -82.27 0.02 OUTLIER 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.303 -174.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.03 -43.98 0.47 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.248 0.547 . . . . 0.0 109.688 176.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 117.998 -1.446 . . . . 0.0 110.622 -178.795 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.177 -0.369 . . . . 0.0 112.177 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.0 p -72.2 136.74 46.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.857 0.36 . . . . 0.0 110.666 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -123.67 -35.53 2.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.476 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.464 ' SD ' HG12 ' A' ' 31' ' ' ILE . 54.7 ttm -169.24 99.1 0.5 Allowed Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -177.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.713 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 57.7 Cg_exo -52.63 -32.74 55.79 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.984 2.456 . . . . 0.0 112.521 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -58.72 -39.22 80.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.766 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.669 ' O ' HG13 ' A' ' 35' ' ' ILE . 16.7 mm -67.69 -45.33 84.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.677 177.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -56.54 -45.17 81.32 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.861 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.713 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 14.4 mmt180 -65.36 -39.53 92.43 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.444 0.64 . . . . 0.0 109.918 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.463 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -66.26 -35.85 81.47 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.23 -176.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.669 HG13 ' O ' ' A' ' 31' ' ' ILE . 62.6 mt -59.57 -44.11 92.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.619 ' HD3' HD12 ' A' ' 81' ' ' ILE . 48.2 mmtt -67.02 -42.38 85.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.56 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.62 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 8.7 mtpm? -62.14 -39.15 91.64 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.488 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.613 HD11 ' HZ ' ' A' ' 61' ' ' PHE . 55.2 mt -60.43 -47.74 84.8 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.461 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.66 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.4 mp -62.28 -35.37 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.075 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.61 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 22.5 t -67.02 -47.48 71.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.206 177.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.726 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 88.6 mt -59.96 -44.96 94.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.682 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.61 -37.07 84.53 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.448 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 15.4 tptm -65.33 -43.88 89.54 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.206 0.526 . . . . 0.0 110.08 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.61 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -59.32 -35.37 73.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.538 174.459 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.97 ' HE2' ' HA ' ' A' ' 56' ' ' ALA . 44.1 mmtm -68.62 -25.27 64.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.829 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.22 -62.31 0.31 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.432 -0.89 . . . . 0.0 113.076 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -134.71 157.75 45.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.995 0.426 . . . . 0.0 110.261 -175.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -81.12 86.43 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-O 121.077 0.465 . . . . 0.0 109.814 175.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.696 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 10.1 t -152.11 153.33 33.69 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.386 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -61.42 -30.31 70.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.984 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -67.49 -38.02 83.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.341 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 1.0 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -71.99 -31.53 66.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.163 176.245 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 49' ' ' THR . 49.0 mm -60.88 -49.75 83.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.383 0.611 . . . . 0.0 110.072 172.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -57.02 -38.9 73.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.346 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 1.0 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 7.4 ptmt -75.83 -15.75 60.19 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.979 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.97 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -77.14 -18.84 57.59 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.929 -178.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.631 ' CD1' ' HG3' ' A' ' 59' ' ' PRO . 18.5 m-30 -61.0 145.67 88.95 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.509 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 7.0 Cg_exo -73.82 144.61 81.55 Favored 'Cis proline' 0 C--N 1.347 0.496 0 C-N-CA 124.26 -1.142 . . . . 0.0 112.53 0.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.715 ' HG2' ' CD2' ' A' ' 61' ' ' PHE . 37.4 Cg_endo -104.4 -157.47 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.565 0 C-N-CA 124.64 3.56 . . . . 0.0 111.054 -176.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.44 11.16 37.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.846 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.715 ' CD2' ' HG2' ' A' ' 59' ' ' PRO . 23.2 m-85 -63.14 117.64 6.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.28 0.562 . . . . 0.0 112.254 -171.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -81.61 -21.93 38.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.666 168.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.57 126.9 1.54 Allowed Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -103.25 144.85 30.8 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 117.091 0.445 . . . . 0.0 110.384 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -151.36 156.33 40.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.841 0.353 . . . . 0.0 110.962 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 m -63.07 -24.57 67.97 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.285 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.664 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 26.2 t30 -57.23 -38.55 73.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.197 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.537 ' O ' HG13 ' A' ' 72' ' ' ILE . 27.8 tp -57.47 -39.86 77.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.414 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.5 mm -62.25 -41.54 91.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.162 0.506 . . . . 0.0 110.192 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -68.17 -42.1 80.51 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.678 0.752 . . . . 0.0 109.107 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 13.5 mmt180 -68.34 -34.63 76.45 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.503 -174.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 68' ' ' LEU . 75.6 mt -61.59 -49.0 86.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.676 0.274 . . . . 0.0 110.754 177.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -64.09 -39.53 94.26 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.092 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -59.11 -49.8 76.47 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.405 ' C ' HG22 ' A' ' 81' ' ' ILE . 18.0 mm-40 -56.59 -29.76 62.43 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.868 HD23 HG23 ' A' ' 81' ' ' ILE . 85.9 mt -58.65 -50.08 75.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.92 0.391 . . . . 0.0 111.247 176.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -85.1 -48.06 9.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.512 0.673 . . . . 0.0 111.617 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -69.61 -45.17 69.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.533 -173.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.97 -31.69 11.68 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.963 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.92 22.04 19.1 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.264 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.868 HG23 HD23 ' A' ' 76' ' ' LEU . 6.8 tt -73.69 145.56 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 118.507 1.153 . . . . 0.0 108.188 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -116.73 130.31 56.65 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.091 -0.644 . . . . 0.0 112.457 -174.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.691 HG22 HD21 ' A' ' 76' ' ' LEU . 4.2 tp -168.49 133.79 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.24 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -91.95 150.46 3.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -96.29 -23.15 16.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.882 0.372 . . . . 0.0 110.487 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 60.1 t30 76.4 5.17 3.62 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.503 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -103.55 128.63 27.02 Favored Pre-proline 0 N--CA 1.454 -0.266 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.546 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -88.14 144.49 6.03 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.599 2.199 . . . . 0.0 111.933 173.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -104.12 -9.49 18.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.193 0.52 . . . . 0.0 110.052 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.653 ' HG3' ' H ' ' A' ' 91' ' ' GLU . 6.9 pt-20 -85.01 -64.44 1.16 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.221 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.653 ' H ' ' HG3' ' A' ' 90' ' ' GLU . 38.0 tt0 -83.24 72.41 10.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.532 0.682 . . . . 0.0 110.393 -177.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -152.03 -59.7 0.16 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.835 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.6 tt -74.86 -43.14 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 171.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.1 m 49.07 64.31 1.78 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.267 0.556 . . . . 0.0 111.78 177.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -112.95 158.6 20.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.45 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.493 -1.171 . . . . 0.0 111.536 179.87 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 111.981 -0.447 . . . . 0.0 111.981 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.7 t -94.49 124.29 38.43 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -94.62 25.52 3.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.037 0.446 . . . . 0.0 110.856 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 45.7 ttm -149.21 72.7 10.12 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.365 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.74 -24.76 76.93 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.443 2.762 . . . . 0.0 113.159 -174.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -60.55 -25.77 66.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.417 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.617 ' O ' HG13 ' A' ' 35' ' ' ILE . 26.1 mm -66.44 -49.94 71.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 177.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -54.84 -45.9 74.55 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.156 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -66.94 -42.47 85.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.286 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.699 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -63.19 -40.21 96.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.212 -175.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.695 HD13 ' HA ' ' A' ' 72' ' ' ILE . 54.2 mt -59.51 -40.53 82.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.011 0.434 . . . . 0.0 109.934 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.732 ' HD3' HD12 ' A' ' 81' ' ' ILE . 32.5 mmtm -66.89 -39.49 87.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.696 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.498 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 87.7 mttt -64.76 -43.61 92.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.978 176.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.79 -44.03 97.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.334 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.566 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -62.88 -36.09 74.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.38 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.417 ' C ' ' HE3' ' A' ' 44' ' ' LYS . 48.9 m -66.28 -46.32 77.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.099 0.476 . . . . 0.0 110.023 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.709 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 97.6 mt -58.89 -47.32 85.37 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.219 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.16 -33.71 86.73 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.487 ' HB2' HG23 ' A' ' 48' ' ' ILE . 12.2 tptt -73.39 -40.0 64.67 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.414 -0.893 . . . . 0.0 109.44 -174.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.709 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 5.4 ptpt -75.98 -31.77 59.15 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.752 -177.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 41' ' ' LEU . 66.8 mmtt -76.83 -9.75 58.9 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.105 177.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.69 -70.31 0.31 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.883 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -133.97 148.44 51.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.222 0.534 . . . . 0.0 111.455 -168.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -78.53 86.83 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.237 0.541 . . . . 0.0 109.901 176.029 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.683 HG23 ' H ' ' A' ' 52' ' ' ASP . 8.9 t -156.75 158.21 36.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.467 -175.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -63.62 -30.48 71.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 110.871 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.5 -41.11 93.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.557 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.929 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -71.95 -29.13 63.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.04 177.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.582 HG12 ' O ' ' A' ' 49' ' ' THR . 48.1 mm -59.4 -50.59 79.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.157 0.503 . . . . 0.0 109.972 172.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.515 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 0.5 OUTLIER -57.58 -34.43 69.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.69 177.493 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.929 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 4.5 ptmt -75.81 -18.86 59.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.025 -178.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.97 -20.11 42.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.547 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.515 ' CD2' ' HA ' ' A' ' 54' ' ' ASP . 80.2 m-85 -62.67 142.95 96.81 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.872 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.477 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 86.3 Cg_endo -84.24 143.19 41.13 Favored 'Cis proline' 0 C--N 1.345 0.362 0 C-N-CA 123.394 -1.502 . . . . 0.0 112.779 -1.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.591 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 39.8 Cg_endo -103.87 -156.72 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 124.785 3.656 . . . . 0.0 111.104 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -97.98 16.03 22.23 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.177 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.699 ' HA ' ' HD3' ' A' ' 34' ' ' ARG . 7.0 p90 -58.43 121.21 10.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 122.083 0.944 . . . . 0.0 111.723 -167.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -79.33 -24.93 42.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.408 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.1 127.34 1.59 Allowed Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -111.1 128.81 56.0 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -153.0 157.87 41.19 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 -175.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -27.05 65.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.513 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.434 ' OD1' ' HD2' ' A' ' 71' ' ' ARG . 10.5 t-20 -61.52 -35.16 76.92 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.335 176.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.657 ' O ' HG13 ' A' ' 72' ' ' ILE . 57.6 tp -64.08 -39.53 94.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.891 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.2 mm -64.06 -46.78 92.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.712 0.291 . . . . 0.0 110.701 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.483 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 16.6 pt-20 -68.99 -33.1 73.13 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.586 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 42.4 mtt180 -72.27 -29.59 64.03 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.18 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.695 ' HA ' HD13 ' A' ' 35' ' ' ILE . 64.3 mt -58.87 -50.56 79.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.542 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 30.7 p80 -69.82 -32.79 71.42 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.986 176.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 71' ' ' ARG . 13.4 mt-10 -59.48 -50.25 74.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.981 0.419 . . . . 0.0 110.452 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.731 ' HA ' ' HG2' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -67.86 -27.42 66.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.688 178.07 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.937 ' HA ' HG22 ' A' ' 81' ' ' ILE . 12.6 tp -56.54 -45.31 81.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.863 172.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -83.1 -51.55 7.43 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.731 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 11.7 ptpt -72.06 -39.1 69.29 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -173.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -94.14 -32.13 13.87 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.635 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.37 24.87 15.09 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.421 -1.371 . . . . 0.0 113.131 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.937 HG22 ' HA ' ' A' ' 76' ' ' LEU . 5.9 tt -72.23 144.44 13.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 117.202 0.501 . . . . 0.0 109.858 -174.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.407 ' HA ' HD22 ' A' ' 82' ' ' ASN . 10.4 m120 -102.6 123.14 45.77 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.337 -177.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.566 ' HB ' HG13 ' A' ' 39' ' ' ILE . 4.5 tp -162.31 137.15 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.53 HG12 ' HB ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -103.14 156.09 5.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.115 0.483 . . . . 0.0 110.353 -176.31 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 7.0 mm-40 -89.83 -25.36 21.09 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.733 -175.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.534 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 8.3 t30 80.56 -12.17 1.06 Allowed 'General case' 0 N--CA 1.463 0.183 0 O-C-N 124.571 1.17 . . . . 0.0 110.185 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -86.65 129.11 54.05 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.316 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.5 129.05 23.98 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.661 2.241 . . . . 0.0 112.388 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -89.03 -3.04 58.82 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.238 0.542 . . . . 0.0 109.697 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.639 ' HB3' ' OXT' ' A' ' 96' ' ' GLY . 32.9 mt-10 67.31 -148.3 0.16 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.805 172.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.404 ' HG2' ' OXT' ' A' ' 96' ' ' GLY . 31.5 mm-40 -48.22 -39.25 20.6 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.675 ' HG3' ' H ' ' A' ' 93' ' ' ILE . 5.0 pt-20 -172.02 -72.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.85 0.357 . . . . 0.0 110.664 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.675 ' H ' ' HG3' ' A' ' 92' ' ' GLU . 1.4 pp -120.9 50.52 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.155 0.502 . . . . 0.0 110.175 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.9 m 60.36 60.73 1.94 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.016 -174.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -107.64 5.83 27.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.545 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.639 ' OXT' ' HB3' ' A' ' 90' ' ' GLU . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.532 -1.149 . . . . 0.0 111.892 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.799 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 p -71.57 145.58 48.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.678 0.275 . . . . 0.0 110.54 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -142.62 -65.27 0.4 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.659 0.266 . . . . 0.0 111.501 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.545 ' O ' HG22 ' A' ' 31' ' ' ILE . 28.0 ttt -149.78 87.13 5.18 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-O 121.007 0.432 . . . . 0.0 110.029 -173.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.63 -24.48 75.01 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.837 2.358 . . . . 0.0 112.742 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.643 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 23.6 tm0? -65.58 -39.17 91.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.963 0.411 . . . . 0.0 110.857 -175.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.664 HD11 ' HB2' ' A' ' 68' ' ' LEU . 10.4 tp -71.89 -38.78 66.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.207 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.31 -40.52 74.15 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.964 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 3.2 ptm180 -61.32 -36.04 79.03 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.699 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.623 ' HD2' ' HA ' ' A' ' 61' ' ' PHE . 48.1 ttp85 -65.07 -35.76 82.18 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.812 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.607 HD13 ' HA ' ' A' ' 72' ' ' ILE . 21.8 mt -60.48 -45.2 97.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 110.579 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.509 ' HD3' HD12 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -67.11 -39.71 86.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.371 177.474 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 33' ' ' ARG . 14.4 mmmm -61.75 -39.6 92.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.185 0.517 . . . . 0.0 109.616 176.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 54.9 mt -63.59 -46.82 84.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.359 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.586 HD11 ' HB ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -62.06 -35.57 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.41 -178.443 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 91.6 p -67.61 -45.89 74.13 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.689 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.737 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 96.4 mt -59.26 -45.8 90.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.219 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.74 -34.82 78.74 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -42.04 87.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.04 0.924 . . . . 0.0 109.068 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.456 ' N ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -64.1 -39.99 95.25 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 113.815 -1.539 . . . . 0.0 110.583 175.115 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.765 ' HE2' ' HA ' ' A' ' 56' ' ' ALA . 45.4 mmtm -67.91 -31.5 71.32 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.774 -178.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.01 -67.55 0.17 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.236 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -137.63 171.18 14.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.851 0.358 . . . . 0.0 110.733 -171.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.656 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -83.55 86.07 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 122.486 1.136 . . . . 0.0 108.863 173.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.58 ' O ' HG12 ' A' ' 53' ' ' ILE . 6.0 m -145.79 151.74 38.43 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.258 -174.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -59.43 -36.02 75.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.962 0.41 . . . . 0.0 110.113 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.537 ' H ' HG22 ' A' ' 49' ' ' THR . 35.5 mt-10 -58.71 -40.99 85.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.484 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.692 ' HA ' ' CD ' ' A' ' 55' ' ' LYS . 5.2 m-20 -71.68 -32.35 67.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.233 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 49' ' ' THR . 39.6 mm -66.89 -49.65 72.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.79 0.805 . . . . 0.0 109.781 174.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.64 -33.74 76.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.278 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.692 ' CD ' ' HA ' ' A' ' 52' ' ' ASP . 15.6 ptmt -76.33 -19.99 57.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.985 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.765 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -74.2 -18.95 60.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.875 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -57.25 132.55 81.0 Favored Pre-proline 0 N--CA 1.466 0.352 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.119 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 57.2 Cg_endo -71.85 133.4 28.68 Favored 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 123.707 -1.372 . . . . 0.0 112.705 0.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.554 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 35.2 Cg_endo -101.51 -157.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 124.347 3.365 . . . . 0.0 111.27 -175.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -97.17 13.62 28.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.622 -175.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.623 ' HA ' ' HD2' ' A' ' 34' ' ' ARG . 8.2 p90 -63.06 120.15 10.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.453 0.644 . . . . 0.0 110.933 -175.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.587 ' HB2' ' NE2' ' A' ' 30' ' ' GLN . 24.5 mt-10 -79.55 -26.74 41.32 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.8 135.52 3.74 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -95.64 130.04 42.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 117.452 0.626 . . . . 0.0 110.018 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -137.01 145.3 43.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.567 -171.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.6 t -65.36 -27.1 68.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.674 0.749 . . . . 0.0 109.682 170.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -61.15 -32.24 71.96 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.819 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.664 ' HB2' HD11 ' A' ' 31' ' ' ILE . 3.3 tm? -54.38 -41.85 69.68 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.467 176.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 23.0 mm -65.31 -42.68 94.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-O 121.687 0.756 . . . . 0.0 110.052 -177.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.651 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 12.4 mt-10 -64.63 -45.05 88.48 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.562 ' HG2' HG23 ' A' ' 31' ' ' ILE . 15.5 tpt180 -71.16 -32.09 68.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.949 -170.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.607 ' HA ' HD13 ' A' ' 35' ' ' ILE . 24.3 pt -63.63 -46.66 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.597 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.536 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 28.5 p80 -68.52 -33.3 73.88 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 118.976 -1.089 . . . . 0.0 111.918 177.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.69 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 4.2 mm-40 -65.06 -50.02 67.81 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.974 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.6 ' HG3' HD12 ' A' ' 35' ' ' ILE . 4.0 mm-40 -63.0 -28.22 69.95 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.899 176.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.58 ' HA ' HG22 ' A' ' 81' ' ' ILE . 11.3 tp -57.73 -40.89 80.68 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.116 172.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -83.79 -51.77 6.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.69 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 9.8 ptmm? -72.33 -42.82 64.96 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -174.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.448 ' HB2' ' OE1' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -95.62 -22.7 17.43 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.136 -178.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.56 23.98 41.02 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.242 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.58 HG22 ' HA ' ' A' ' 76' ' ' LEU . 6.0 tt -73.52 119.93 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.633 0.73 . . . . 0.0 111.492 -170.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.82 129.12 36.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.668 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.656 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 17.7 tt -173.5 131.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -175.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -90.84 151.82 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 121.179 0.514 . . . . 0.0 110.227 -173.636 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -90.74 -23.47 20.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.042 -172.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 4.1 t-20 83.44 -11.59 0.9 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.542 1.151 . . . . 0.0 109.666 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -62.95 135.06 95.97 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.339 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.8 120.22 7.88 Favored 'Trans proline' 0 N--CA 1.466 -0.13 0 C-N-CA 122.639 2.226 . . . . 0.0 111.833 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -40.61 86.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.882 -174.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -133.85 -24.56 1.7 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.602 0.239 . . . . 0.0 111.564 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.493 ' HA ' ' OG ' ' A' ' 94' ' ' SER . 5.5 mm-40 -83.32 71.52 10.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.259 0.552 . . . . 0.0 111.174 -177.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -105.4 -81.45 0.54 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.6 tp -93.86 -30.43 4.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.493 ' OG ' ' HA ' ' A' ' 91' ' ' GLU . 31.8 m 46.33 61.84 2.56 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.729 174.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.57 144.65 37.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.05 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.755 0 CA-C-O 118.967 -0.907 . . . . 0.0 111.351 178.524 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.87 0 N-CA-C 112.29 -0.324 . . . . 0.0 112.29 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.3 m -73.53 -24.48 60.14 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.886 0.374 . . . . 0.0 111.15 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -86.27 83.19 7.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.133 0.492 . . . . 0.0 110.114 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.579 ' HB3' HG12 ' A' ' 31' ' ' ILE . 59.7 mtt -128.78 74.63 80.59 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.253 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.478 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 33.2 Cg_exo -60.26 -25.39 80.01 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.322 2.014 . . . . 0.0 111.018 173.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 10.6 pt20 -59.18 -35.02 72.82 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.895 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.579 HG12 ' HB3' ' A' ' 28' ' ' MET . 36.7 mm -66.44 -42.9 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.204 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.453 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 38.6 tt0 -58.02 -45.75 86.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.106 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 31.9 mmt-85 -66.06 -44.19 85.26 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.994 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.663 ' HD3' ' O ' ' A' ' 60' ' ' ASP . 0.1 OUTLIER -64.91 -37.89 89.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.559 -173.154 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.569 HD12 ' HG3' ' A' ' 75' ' ' GLU . 70.0 mt -64.67 -37.79 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.581 ' HD3' HD12 ' A' ' 81' ' ' ILE . 15.9 mmtm -66.74 -35.7 80.74 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.142 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.703 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 34.6 mtpt -65.63 -40.99 93.16 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.352 175.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.568 HD13 ' HE2' ' A' ' 61' ' ' PHE . 14.6 tp -59.66 -50.0 75.55 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.586 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.5 mp -61.95 -34.93 65.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.212 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.695 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 23.1 t -66.11 -44.63 83.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.768 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 77.6 mt -58.8 -37.53 76.57 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.81 -38.62 89.61 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.443 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 13.7 tppt? -67.94 -35.24 78.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.194 0.521 . . . . 0.0 110.149 178.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.695 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -69.92 -38.54 76.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.688 0.756 . . . . 0.0 109.717 175.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.715 ' HB3' ' HD3' ' A' ' 55' ' ' LYS . 29.8 mmtm -68.6 -29.04 67.47 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.809 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.39 -65.92 0.26 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.849 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -136.14 157.21 47.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.053 0.454 . . . . 0.0 110.947 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.9 86.58 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.17 0.51 . . . . 0.0 109.981 177.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.792 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 8.5 t -153.78 155.64 36.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.599 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -57.58 -40.4 78.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.424 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.9 -34.34 76.46 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.745 0.307 . . . . 0.0 110.891 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.96 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -72.52 -30.94 64.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.932 0.396 . . . . 0.0 111.057 174.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.4 mm -64.49 -49.2 81.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.213 0.53 . . . . 0.0 110.169 171.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -57.32 -33.73 68.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.762 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.96 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 1.2 ptmt -76.66 -22.08 54.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.31 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.46 -19.27 42.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.003 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 67.6 t80 -56.41 140.69 72.49 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.399 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.479 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 86.3 Cg_endo -83.49 148.69 61.43 Favored 'Cis proline' 0 C--N 1.347 0.456 0 C-N-CA 123.781 -1.341 . . . . 0.0 112.904 0.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.575 ' HG2' ' HD2' ' A' ' 61' ' ' PHE . 36.7 Cg_endo -102.43 -160.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 124.412 3.408 . . . . 0.0 110.432 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.663 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 22.8 m-20 -97.8 11.26 37.85 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.575 ' HD2' ' HG2' ' A' ' 59' ' ' PRO . 60.2 m-85 -62.79 118.32 7.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.42 0.629 . . . . 0.0 111.217 -175.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -82.36 -12.12 58.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.563 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.62 124.28 1.33 Allowed Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -114.78 136.37 53.15 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.835 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 31.7 t70 -160.63 168.32 25.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.743 -0.208 . . . . 0.0 110.57 178.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.0 m -58.5 -32.31 68.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.681 0.277 . . . . 0.0 111.097 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.458 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . 5.1 t-20 -61.26 -34.08 74.58 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.153 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.614 ' O ' HG13 ' A' ' 72' ' ' ILE . 54.5 tp -58.96 -41.6 87.86 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.549 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.69 -39.41 83.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.247 0.546 . . . . 0.0 110.241 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 16.6 mt-10 -68.15 -42.98 79.29 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -64.58 -32.8 74.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.458 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.614 HG13 ' O ' ' A' ' 68' ' ' LEU . 80.3 mt -61.6 -51.35 73.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.583 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.497 ' CD2' ' HA ' ' A' ' 70' ' ' GLU . 29.4 p80 -68.77 -32.77 72.76 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.041 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -59.29 -47.24 86.11 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.569 ' HG3' HD12 ' A' ' 35' ' ' ILE . 25.2 mm-40 -64.31 -32.9 74.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.883 0.373 . . . . 0.0 110.859 175.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.661 ' HA ' HG22 ' A' ' 81' ' ' ILE . 22.3 tp -60.98 -46.77 89.4 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.922 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -82.62 -51.57 7.62 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -73.31 -45.22 56.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.265 -174.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -96.44 -16.24 21.3 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.65 -176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.74 24.5 49.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 119.678 -1.249 . . . . 0.0 113.835 171.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.661 HG22 ' HA ' ' A' ' 76' ' ' LEU . 7.8 tt -72.35 119.59 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 117.99 0.895 . . . . 0.0 110.716 -173.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -81.31 125.02 29.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.033 0.444 . . . . 0.0 111.119 -172.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.586 ' HB ' HG13 ' A' ' 39' ' ' ILE . 3.6 tp -166.61 123.15 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.426 -176.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.792 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -89.79 152.36 3.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -95.38 -25.36 16.31 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.935 0.397 . . . . 0.0 110.246 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.418 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 56.1 t30 72.71 -0.73 3.23 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.027 -177.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.6 153.96 81.6 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 50.4 Cg_exo -55.04 -53.32 6.14 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 122.982 2.454 . . . . 0.0 114.404 -173.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -177.71 -47.87 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.717 -167.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -150.78 30.06 0.66 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.375 -0.829 . . . . 0.0 108.993 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.497 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . 52.8 mm-40 -124.88 28.73 6.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.658 -172.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -64.81 -63.4 1.13 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.592 HG13 ' H ' ' A' ' 95' ' ' ALA . 21.4 pt -112.91 -15.94 9.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.387 167.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.0 t 66.72 8.96 6.32 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.203 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.592 ' H ' HG13 ' A' ' 93' ' ' ILE . . . -104.11 45.75 0.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.089 0.471 . . . . 0.0 110.359 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.181 -1.344 . . . . 0.0 111.314 179.316 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 112.101 -0.4 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 27' ' ' HIS . 9.7 p -83.44 -28.84 28.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.39 0.138 . . . . 0.0 111.323 -177.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.404 ' HB3' ' O ' ' A' ' 26' ' ' SER . 4.7 t60 71.67 -59.14 0.56 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.267 0.627 . . . . 0.0 111.607 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.567 ' CG ' ' HG2' ' A' ' 30' ' ' GLN . 58.7 tpp -170.32 130.67 0.9 Allowed Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.435 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 65.9 Cg_exo -53.61 -26.95 39.38 Favored 'Trans proline' 0 N--CA 1.477 0.51 0 C-N-CA 123.496 2.797 . . . . 0.0 113.635 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.567 ' HG2' ' CG ' ' A' ' 28' ' ' MET . 10.7 pt20 -64.91 -25.4 67.87 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 121.224 -0.19 . . . . 0.0 110.56 177.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.798 HD12 HD13 ' A' ' 68' ' ' LEU . 36.1 mm -65.4 -46.58 89.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.348 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.583 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -55.62 -47.27 76.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.41 177.505 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 33.7 mtp180 -67.69 -44.92 76.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.47 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.915 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -58.38 -47.21 84.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.905 -173.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.694 HD12 ' HG3' ' A' ' 75' ' ' GLU . 56.9 mt -64.51 -37.3 79.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.119 -177.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 24.7 mmtm -68.18 -35.12 77.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.173 0.511 . . . . 0.0 110.372 176.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.548 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 8.0 mttm -66.05 -37.7 86.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.459 174.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 89.0 mt -61.58 -38.2 86.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.813 174.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.556 HD11 ' O ' ' A' ' 82' ' ' ASN . 0.3 OUTLIER -62.63 -35.21 69.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.471 177.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 14.0 m -64.78 -44.3 90.44 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.02 ' HA ' ' HE2' ' A' ' 44' ' ' LYS . 61.7 mt -59.29 -47.16 86.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.697 174.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.612 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -68.41 -33.01 76.28 Favored Glycine 0 CA--C 1.509 -0.298 0 CA-C-O 121.972 0.762 . . . . 0.0 112.114 -173.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.77 -43.92 52.34 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 122.872 1.32 . . . . 0.0 107.954 -174.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 1.02 ' HE2' ' HA ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -77.21 -26.88 53.19 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 112.669 -2.06 . . . . 0.0 110.879 -172.44 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.537 ' HB2' ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -76.48 -32.89 58.64 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.14 174.258 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.67 -64.03 0.25 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.725 173.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -134.15 147.53 50.82 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.705 -0.291 . . . . 0.0 110.893 -170.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.431 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -73.93 100.25 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.282 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.651 ' O ' HG12 ' A' ' 53' ' ' ILE . 91.6 m -156.18 145.01 20.29 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.861 -171.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -60.03 -39.83 87.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.213 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.565 ' H ' HG22 ' A' ' 49' ' ' THR . 39.5 mt-10 -68.3 -34.23 75.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.991 177.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.991 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 10.2 t70 -71.38 -37.8 71.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.102 0.477 . . . . 0.0 110.931 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.651 HG12 ' O ' ' A' ' 49' ' ' THR . 42.4 mm -59.8 -46.46 93.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.565 0.697 . . . . 0.0 109.839 173.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.405 ' O ' ' HD1' ' A' ' 57' ' ' PHE . 35.2 t70 -63.01 -32.41 73.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.247 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.991 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -74.49 -17.09 60.82 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.864 -178.356 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.41 ' HB1' ' HB3' ' A' ' 41' ' ' LEU . . . -66.32 -16.81 64.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.519 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.489 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 36.1 p90 -42.9 134.84 2.91 Favored Pre-proline 0 N--CA 1.472 0.645 0 O-C-N 123.825 0.703 . . . . 0.0 112.106 -176.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 57' ' ' PHE . 21.9 Cg_exo -66.0 140.7 48.29 Favored 'Cis proline' 0 C--N 1.346 0.416 0 C-N-CA 123.668 -1.388 . . . . 0.0 112.14 -2.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 13.1 Cg_endo -95.86 -169.28 0.15 Allowed 'Trans proline' 0 N--CA 1.44 -1.632 0 C-N-CA 123.999 3.132 . . . . 0.0 110.204 -175.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.548 ' OD2' ' HD3' ' A' ' 37' ' ' LYS . 19.9 t70 -98.34 5.14 48.49 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.985 0.421 . . . . 0.0 111.349 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.915 ' HA ' ' HD3' ' A' ' 34' ' ' ARG . 57.3 m-85 -64.65 118.23 8.58 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -171.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -80.89 -31.85 35.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.155 166.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.95 126.1 1.43 Allowed Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -113.96 144.38 43.17 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.938 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 1.7 p30 -147.76 164.37 33.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.627 0.251 . . . . 0.0 110.966 176.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 m -65.53 -32.29 73.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.735 0.303 . . . . 0.0 111.432 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.441 ' HA ' ' OE2' ' A' ' 70' ' ' GLU . 26.2 t-20 -62.39 -34.67 77.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.35 0.595 . . . . 0.0 109.816 177.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.798 HD13 HD12 ' A' ' 31' ' ' ILE . 22.6 tp -57.29 -39.91 76.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.041 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.0 mm -63.02 -37.37 79.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.335 0.588 . . . . 0.0 110.358 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 17.9 mt-10 -67.83 -41.68 82.66 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.476 ' HE ' ' HG3' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -64.14 -32.43 74.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.559 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 68' ' ' LEU . 74.6 mt -61.09 -46.3 96.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.648 0.261 . . . . 0.0 110.682 178.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -65.78 -33.51 76.03 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.904 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 5.9 mm-40 -61.03 -49.92 75.44 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.81 176.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.694 ' HG3' HD12 ' A' ' 35' ' ' ILE . 79.8 mm-40 -55.62 -31.23 62.11 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.889 -178.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.752 HD23 HG23 ' A' ' 81' ' ' ILE . 86.8 mt -57.9 -46.83 84.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.979 0.419 . . . . 0.0 110.562 173.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -83.67 -50.26 8.36 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HD2' ' CD ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -73.6 -42.47 61.49 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -175.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.432 ' CG ' ' HE2' ' A' ' 36' ' ' LYS . 56.2 t-80 -95.47 -29.86 14.17 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.608 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.93 23.19 33.48 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 119.842 -1.17 . . . . 0.0 112.568 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.752 HG23 HD23 ' A' ' 76' ' ' LEU . 6.3 tt -72.5 146.63 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.556 ' O ' HD11 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -117.2 119.61 35.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.195 0.522 . . . . 0.0 111.794 -175.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.431 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 71.7 mt -153.85 116.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -82.44 151.66 4.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.345 0.593 . . . . 0.0 110.292 -175.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.41 -30.09 23.86 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.661 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.448 ' HB2' HG23 ' A' ' 49' ' ' THR . 2.3 t-20 73.21 -4.97 2.05 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.225 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 34.1 mt-10 -108.81 129.9 23.38 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.796 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 72.5 Cg_exo -49.72 -75.33 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.715 2.943 . . . . 0.0 115.122 -169.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -166.58 17.31 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -170.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -101.92 135.58 43.23 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.274 -0.571 . . . . 0.0 110.935 -175.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -63.13 -64.7 0.83 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.146 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 177.15 -46.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.406 -176.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.5 pt -102.22 39.11 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.955 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.2 t 60.99 -88.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.995 -175.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.54 127.93 46.08 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.673 -1.07 . . . . 0.0 112.29 -177.075 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.91 0 N-CA-C 112.327 -0.309 . . . . 0.0 112.327 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.1 t 61.9 80.03 0.24 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.235 0.541 . . . . 0.0 111.455 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -76.12 -25.36 55.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.348 175.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.481 ' O ' HG22 ' A' ' 31' ' ' ILE . 24.6 ttt 58.98 62.74 4.07 Favored Pre-proline 0 C--O 1.233 0.206 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.656 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.708 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 26.1 Cg_exo -62.9 -30.87 77.57 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.037 2.491 . . . . 0.0 112.203 -172.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -58.31 -38.83 77.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.131 -177.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.698 ' O ' HG13 ' A' ' 35' ' ' ILE . 5.9 tp -67.11 -35.69 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -177.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.407 ' HG2' ' NH2' ' A' ' 71' ' ' ARG . 18.7 mt-10 -65.45 -45.93 81.84 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.586 0.707 . . . . 0.0 109.907 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.708 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 39.5 mtt180 -68.64 -37.9 80.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.286 -176.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.634 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 0.3 OUTLIER -66.07 -36.19 82.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.021 -177.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.698 HG13 ' O ' ' A' ' 31' ' ' ILE . 86.4 mt -60.88 -42.71 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.636 ' CD ' HD12 ' A' ' 81' ' ' ILE . 20.0 mmtm -65.74 -36.46 83.63 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.032 0.444 . . . . 0.0 110.278 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.465 ' HE3' HD21 ' A' ' 41' ' ' LEU . 45.3 tptt -64.13 -46.46 84.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.749 175.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.84 -44.22 93.81 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.585 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.566 ' HB ' HD11 ' A' ' 81' ' ' ILE . 1.5 mp -62.82 -35.93 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.977 177.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.716 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 22.8 t -67.06 -47.36 71.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.356 -0.537 . . . . 0.0 109.658 178.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.703 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 83.7 mt -59.62 -43.67 93.71 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.551 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.98 -37.39 93.16 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -177.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.585 ' HB2' HG23 ' A' ' 48' ' ' ILE . 25.7 tptt -70.04 -38.43 75.85 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 120.942 0.401 . . . . 0.0 110.342 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.716 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -61.06 -36.92 80.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.733 0.778 . . . . 0.0 109.965 173.056 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.933 ' HE3' ' HA ' ' A' ' 56' ' ' ALA . 74.4 mmtt -67.52 -30.38 70.03 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.383 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.31 -63.45 0.3 Allowed Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.668 175.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -126.76 155.22 43.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.228 0.537 . . . . 0.0 110.593 -175.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.585 HG23 ' HB2' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -86.33 88.28 2.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.352 0.596 . . . . 0.0 109.634 176.376 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.628 ' O ' HG12 ' A' ' 53' ' ' ILE . 9.8 t -158.23 163.4 37.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.926 -171.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -60.04 -39.14 84.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.92 0.391 . . . . 0.0 110.982 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -57.69 -45.43 85.65 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.461 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.786 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -73.26 -31.08 63.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.493 -179.511 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.628 HG12 ' O ' ' A' ' 49' ' ' THR . 46.3 mm -61.66 -50.13 81.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.235 0.54 . . . . 0.0 110.103 173.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.403 ' HA ' ' CD1' ' A' ' 57' ' ' PHE . 10.7 t70 -59.11 -38.21 79.04 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.489 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.786 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 10.7 ptmt -75.65 -18.31 59.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.101 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.933 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . . . -75.7 -23.09 56.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.126 177.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 54' ' ' ASP . 63.3 m-85 -61.95 142.84 95.01 Favored Pre-proline 0 N--CA 1.464 0.268 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.509 176.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.529 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 96.3 Cg_endo -84.02 137.11 27.15 Favored 'Cis proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.584 -1.423 . . . . 0.0 112.818 0.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.529 ' HD3' ' HA ' ' A' ' 58' ' ' PRO . 56.9 Cg_endo -102.81 -152.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 124.466 3.444 . . . . 0.0 110.953 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.77 13.31 28.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 178.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.14 117.15 6.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.013 0.435 . . . . 0.0 111.168 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -81.88 -25.81 34.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.363 173.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.61 125.76 1.48 Allowed Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -106.56 144.95 32.49 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.543 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 16.9 t70 -150.0 157.52 43.24 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.85 -174.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.6 m -63.63 -26.78 68.83 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.861 0.362 . . . . 0.0 111.161 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -60.72 -33.44 72.9 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.568 ' O ' HG13 ' A' ' 72' ' ' ILE . 25.1 tp -54.57 -39.29 67.62 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.027 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.6 mm -62.33 -42.67 96.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.233 0.539 . . . . 0.0 109.868 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 11.8 mt-10 -66.83 -45.53 77.99 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.543 ' HD2' ' OE2' ' A' ' 74' ' ' GLU . 18.4 mmm-85 -65.65 -34.46 78.26 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.482 -1.235 . . . . 0.0 111.89 -174.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 68' ' ' LEU . 71.1 mt -61.1 -50.07 82.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.59 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 18.7 m170 -69.07 -34.9 75.89 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.544 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.543 ' OE2' ' HD2' ' A' ' 71' ' ' ARG . 43.4 mt-10 -60.67 -49.01 79.24 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 175.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -64.73 -31.94 73.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.953 0.406 . . . . 0.0 110.675 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.656 ' HA ' HG22 ' A' ' 81' ' ' ILE . 16.5 tp -64.66 -42.37 95.45 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.755 176.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -82.2 -52.15 7.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.948 0.404 . . . . 0.0 111.836 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -75.54 -44.91 41.06 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.586 -174.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -95.5 -17.02 21.8 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.315 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.44 23.78 57.85 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.698 -1.239 . . . . 0.0 113.348 173.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.656 HG22 ' HA ' ' A' ' 76' ' ' LEU . 4.5 tt -71.61 124.05 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 117.605 0.702 . . . . 0.0 110.64 -171.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.413 ' HA ' HD22 ' A' ' 82' ' ' ASN . 10.5 m120 -78.42 117.08 19.3 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.463 0.649 . . . . 0.0 111.414 -175.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.556 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 5.6 tp -161.91 139.48 2.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.5 HG12 ' CB ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -110.22 154.25 11.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-O 121.004 0.43 . . . . 0.0 110.443 -175.377 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -83.2 -23.68 32.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.068 -175.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.482 ' H ' HG13 ' A' ' 84' ' ' VAL . 3.3 t30 78.78 23.05 0.62 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.464 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 7.5 mm-40 -96.56 127.83 38.36 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.092 175.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 6.3 Cg_endo -88.06 99.77 0.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.016 2.477 . . . . 0.0 111.342 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -79.54 70.82 6.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.112 0.482 . . . . 0.0 111.402 -176.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 55.65 92.9 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.839 170.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -90.23 88.24 7.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.053 0.454 . . . . 0.0 110.009 175.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -113.95 -71.07 0.77 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.8 mt -96.69 -35.37 5.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.581 175.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.8 t 69.5 -70.12 0.15 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.99 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -166.48 -179.02 4.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.192 -1.338 . . . . 0.0 111.761 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 71.2 m -77.44 73.27 4.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.232 0.539 . . . . 0.0 111.708 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.435 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 37.5 t-80 -83.12 123.96 30.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.8 mtm -110.3 96.28 25.82 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.76 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 50.0 Cg_exo -52.63 -33.21 57.81 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.923 2.415 . . . . 0.0 112.663 -173.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -25.0 58.88 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.076 -173.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 68' ' ' LEU . 9.5 mm -69.76 -46.51 74.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 174.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -61.91 -45.24 94.59 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.094 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.76 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 29.7 mtm180 -61.79 -43.15 99.42 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.866 176.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.498 HH12 ' HB2' ' A' ' 64' ' ' PHE . 73.8 ttt180 -58.66 -36.1 73.62 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.517 -178.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 31' ' ' ILE . 63.6 mt -58.44 -51.71 68.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.498 ' HD3' HD12 ' A' ' 81' ' ' ILE . 1.4 mppt? -69.28 -40.14 77.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.52 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.8 mmtm -59.22 -38.42 79.9 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.114 0.259 . . . . 0.0 110.721 177.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.54 ' HB3' HD12 ' A' ' 53' ' ' ILE . 30.8 mt -65.34 -49.79 68.07 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.12 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.642 HG12 HG12 ' A' ' 81' ' ' ILE . 1.5 mp -62.77 -34.93 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.238 0.542 . . . . 0.0 109.72 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.8 m -67.0 -47.99 69.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.4 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.585 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 72.3 mt -59.49 -39.22 83.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.632 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.707 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -65.83 -34.21 88.04 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HD2' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -71.73 -29.84 64.97 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 122.042 0.925 . . . . 0.0 109.184 -177.241 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.506 ' N ' ' HE2' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -75.69 -46.03 33.5 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.736 -1.574 . . . . 0.0 110.428 174.559 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.772 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . 72.4 mmtt -68.17 -33.62 74.8 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.96 -174.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.47 -66.15 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.384 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -142.25 164.17 30.86 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -175.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.732 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -89.25 79.99 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.889 -170.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 1.104 ' HB ' HG13 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -139.0 154.32 48.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.402 -169.501 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -57.29 -39.28 75.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.515 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -68.27 -35.56 78.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.673 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.832 ' HB2' HG23 ' A' ' 49' ' ' THR . 9.4 t0 -71.61 -34.43 69.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.302 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 49' ' ' THR . 49.2 mm -58.87 -49.32 83.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.57 0.7 . . . . 0.0 110.196 174.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -61.03 -32.9 72.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.473 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.772 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -75.61 -25.43 56.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.312 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.69 -23.74 60.91 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.789 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.531 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 64.2 t80 -64.26 138.17 97.34 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.652 176.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 6.0 Cg_exo -80.04 137.22 40.98 Favored 'Cis proline' 0 C--N 1.347 0.48 0 C-N-CA 124.151 -1.187 . . . . 0.0 112.543 0.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.54 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 57.2 Cg_endo -105.61 -158.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 124.723 3.615 . . . . 0.0 111.266 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.81 16.5 22.06 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.892 -177.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.54 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 13.5 p90 -58.85 121.46 11.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.653 0.74 . . . . 0.0 111.726 -170.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -80.81 -18.51 47.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.814 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.32 135.9 3.93 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -174.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.498 ' HB2' HH12 ' A' ' 34' ' ' ARG . 78.8 t80 -112.87 138.6 49.48 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.258 174.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -158.53 153.85 25.73 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.3 t -63.24 -25.64 68.42 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.282 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 71' ' ' ARG . 10.2 m120 -60.92 -31.36 70.89 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.33 177.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.64 ' HB2' HD12 ' A' ' 31' ' ' ILE . 48.8 tp -58.84 -40.47 84.33 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.047 176.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.1 mm -63.85 -46.46 94.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.947 0.404 . . . . 0.0 110.565 -177.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -69.4 -34.11 74.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.758 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -68.26 -41.21 81.43 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.555 -176.571 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.592 HG12 HG23 ' A' ' 35' ' ' ILE . 76.2 mt -60.75 -45.11 98.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.705 0.288 . . . . 0.0 110.938 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.493 ' HA ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -63.98 -41.46 97.52 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.456 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.523 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 12.8 pt-20 -69.69 -34.09 73.44 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.991 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 71' ' ' ARG . 63.7 mm-40 -61.48 -29.86 70.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.563 0.22 . . . . 0.0 111.115 173.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.724 HD21 HG22 ' A' ' 83' ' ' ILE . 98.2 mt -60.04 -49.03 79.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.829 0.347 . . . . 0.0 110.909 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -82.95 -50.12 8.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.202 0.525 . . . . 0.0 111.752 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 8.8 ttmt -69.8 -44.75 69.4 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.205 -175.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -96.13 -25.61 15.8 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.525 -174.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.59 21.59 53.34 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 119.93 -1.129 . . . . 0.0 112.011 -175.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.654 HG23 HD23 ' A' ' 76' ' ' LEU . 9.8 tt -72.49 145.35 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -178.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.72 136.17 53.18 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.309 -173.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.724 HG22 HD21 ' A' ' 76' ' ' LEU . 1.6 tp -162.42 129.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.134 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.104 HG13 ' HB ' ' A' ' 49' ' ' THR . 2.2 p -97.57 151.03 4.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.832 -175.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.504 ' HB2' ' HG3' ' A' ' 87' ' ' GLU . 25.5 mm-40 -93.74 -26.49 16.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.06 0.457 . . . . 0.0 110.316 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 63.7 t30 69.28 22.36 6.68 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.983 176.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.529 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 33.5 mt-10 -60.68 128.58 88.75 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.529 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 9.0 Cg_exo -72.41 132.82 19.77 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.523 2.815 . . . . 0.0 114.182 -168.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -90.81 84.18 5.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.497 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -78.89 -34.99 44.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.448 -178.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -145.74 -66.9 0.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.143 0.497 . . . . 0.0 110.137 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -153.46 46.15 0.65 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.103 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 93' ' ' ILE . 26.3 mt 62.21 18.12 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.36 -178.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.3 m 51.99 46.59 26.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.939 176.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.14 162.73 32.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.547 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 CA-C-O 118.841 -0.977 . . . . 0.0 111.536 178.513 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.878 0 N-CA-C 111.951 -0.459 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.4 m -110.74 -34.87 6.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.081 0.467 . . . . 0.0 110.682 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -93.46 -23.66 18.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.356 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.581 ' O ' HG22 ' A' ' 31' ' ' ILE . 22.3 ptt? -136.92 63.37 44.75 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.618 178.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.47 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 4.7 Cg_exo -80.87 -27.29 3.16 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.315 2.01 . . . . 0.0 111.19 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.587 ' HB2' ' OE1' ' A' ' 62' ' ' GLU . 13.5 pt20 -69.03 -29.63 67.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.604 -177.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.674 ' O ' HG13 ' A' ' 35' ' ' ILE . 10.0 tp -69.05 -36.42 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.044 -176.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -65.2 -46.31 81.23 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.121 0.486 . . . . 0.0 110.046 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 61.1 mtp180 -60.74 -45.03 95.85 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.117 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.431 ' HD3' ' OE1' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -63.33 -31.39 72.53 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.886 -176.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 31' ' ' ILE . 63.6 mt -58.68 -48.35 86.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.82 176.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.48 ' CD ' HD12 ' A' ' 81' ' ' ILE . 1.9 mppt? -67.54 -33.84 75.87 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.909 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.431 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 16.6 tptp -63.24 -40.36 97.21 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.211 176.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.618 ' HA ' HD12 ' A' ' 41' ' ' LEU . 5.9 mp -70.24 -40.14 74.62 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.443 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.686 HG12 HG12 ' A' ' 81' ' ' ILE . 1.5 mp -63.3 -34.53 67.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.997 174.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.419 ' C ' ' HE3' ' A' ' 44' ' ' LYS . 45.5 t -61.06 -43.06 99.46 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.824 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 89.9 mt -58.24 -46.15 86.47 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.992 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.671 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -60.67 -32.29 78.15 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.12 -39.72 48.42 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.935 0.874 . . . . 0.0 109.273 -175.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.824 ' HE3' ' HA ' ' A' ' 41' ' ' LEU . 4.4 ptpt -76.68 -36.94 56.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.092 -176.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.71 ' HB2' ' OD1' ' A' ' 52' ' ' ASP . 30.8 mmmt -72.05 -20.98 61.59 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.733 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.23 -72.97 0.21 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.025 -0.989 . . . . 0.0 113.589 174.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -143.93 145.96 32.63 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.386 0.136 . . . . 0.0 110.741 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.554 ' HB ' HD13 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -66.91 108.51 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 122.042 0.925 . . . . 0.0 109.816 -176.038 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.744 HG22 ' H ' ' A' ' 51' ' ' GLU . 54.5 m -160.71 145.51 14.22 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.597 -173.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -57.73 -39.99 78.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.216 0.531 . . . . 0.0 110.474 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.744 ' H ' HG22 ' A' ' 49' ' ' THR . 44.4 mm-40 -68.37 -33.59 74.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.627 177.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.71 ' OD1' ' HB2' ' A' ' 45' ' ' LYS . 10.0 t70 -71.72 -32.55 67.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.365 0.603 . . . . 0.0 109.71 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 49' ' ' THR . 50.0 mm -61.4 -49.42 84.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.419 0.628 . . . . 0.0 109.776 170.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -33.47 69.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.54 176.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.702 ' HD3' ' CG ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -75.12 -24.29 58.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.993 -179.516 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.492 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -71.91 -19.7 61.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.311 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.523 ' CD2' ' HD3' ' A' ' 59' ' ' PRO . 55.3 t80 -63.79 133.05 95.42 Favored Pre-proline 0 C--O 1.235 0.317 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.44 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.502 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 53.9 Cg_endo -69.88 127.44 11.0 Favored 'Cis proline' 0 C--N 1.35 0.605 0 C-N-CA 123.392 -1.503 . . . . 0.0 112.165 1.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.523 ' HD3' ' CD2' ' A' ' 57' ' ' PHE . 13.9 Cg_endo -96.74 -165.65 0.1 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 123.74 2.96 . . . . 0.0 110.711 -172.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -98.35 15.23 25.32 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.402 -175.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.457 ' CD1' ' HD2' ' A' ' 59' ' ' PRO . 9.6 p90 -62.87 126.49 27.5 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.291 0.567 . . . . 0.0 111.121 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.587 ' OE1' ' HB2' ' A' ' 30' ' ' GLN . 48.7 mt-10 -80.82 -24.84 38.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.874 176.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.21 126.94 1.53 Allowed Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -106.31 123.72 48.48 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 117.523 0.662 . . . . 0.0 109.801 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 20.7 t70 -147.23 162.16 39.46 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.07 -175.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.8 t -64.37 -31.38 72.56 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.2 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -62.2 -34.46 76.5 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.248 0.547 . . . . 0.0 109.816 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.604 ' O ' HG13 ' A' ' 72' ' ' ILE . 32.9 tp -59.94 -42.18 93.46 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.749 177.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.2 mm -59.62 -43.48 91.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.033 0.444 . . . . 0.0 110.745 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -67.99 -40.97 82.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.581 ' HG3' ' CD1' ' A' ' 35' ' ' ILE . 9.5 tpp180 -66.43 -32.88 74.52 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.019 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.604 HG13 ' O ' ' A' ' 68' ' ' LEU . 76.0 mt -61.37 -50.59 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.852 -0.158 . . . . 0.0 110.629 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.572 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 22.1 p80 -67.1 -33.51 75.62 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.136 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -59.45 -49.52 77.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.344 0.593 . . . . 0.0 109.604 174.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.587 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 59.8 mm-40 -66.71 -28.98 68.86 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.821 176.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.008 ' HA ' HG22 ' A' ' 81' ' ' ILE . 13.5 tp -69.58 -51.55 34.29 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.363 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -84.49 -53.03 5.7 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.286 0.565 . . . . 0.0 111.625 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -76.29 -38.94 55.43 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.052 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.587 ' HB2' ' HA ' ' A' ' 75' ' ' GLU . 3.1 t60 -94.62 -16.42 23.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.577 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.24 23.03 42.1 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.398 -0.906 . . . . 0.0 114.106 172.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.008 HG22 ' HA ' ' A' ' 76' ' ' LEU . 7.9 tt -75.34 145.63 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 117.727 0.763 . . . . 0.0 109.322 -176.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.462 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.9 OUTLIER -108.31 128.06 54.41 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -173.393 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.683 HG12 HG13 ' A' ' 39' ' ' ILE . 9.2 mm -162.14 119.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 124.37 1.068 . . . . 0.0 108.61 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -88.17 152.36 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 CA-C-O 121.671 0.748 . . . . 0.0 109.454 -179.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -79.03 -31.44 44.64 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.146 -177.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.554 ' HB2' HG23 ' A' ' 49' ' ' THR . 11.8 t-20 76.46 -1.96 2.8 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.05 176.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -77.27 127.7 82.5 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.498 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.7 -71.56 0.04 OUTLIER 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 123.28 2.653 . . . . 0.0 114.016 -168.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -163.03 25.54 0.09 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.454 0.645 . . . . 0.0 109.875 -177.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -93.41 88.98 6.15 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.163 -174.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.834 ' HB3' ' HA ' ' A' ' 94' ' ' SER . 0.7 OUTLIER -95.73 -166.13 1.39 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.756 179.112 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -92.16 -53.2 4.34 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.984 -0.448 . . . . 0.0 109.88 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.444 HG22 ' OE2' ' A' ' 91' ' ' GLU . 10.9 tp -92.41 -14.21 8.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.834 ' HA ' ' HB3' ' A' ' 91' ' ' GLU . 49.6 m 60.17 42.67 15.08 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 113.855 -1.52 . . . . 0.0 111.799 176.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.06 -33.42 4.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 119.09 -0.839 . . . . 0.0 111.509 -177.107 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.727 0 N-CA-C 112.393 -0.283 . . . . 0.0 112.393 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.6 m -83.74 77.94 9.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.957 0.408 . . . . 0.0 111.641 -174.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -139.96 18.03 2.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.175 0.512 . . . . 0.0 110.053 175.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.0 mmm -130.9 71.22 82.52 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.135 -177.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.424 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 22.8 Cg_exo -63.88 -25.32 67.5 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.566 2.177 . . . . 0.0 111.546 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -66.6 -24.8 66.38 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.57 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.532 HG23 HD13 ' A' ' 68' ' ' LEU . 8.1 mm -65.22 -43.94 95.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.503 0.192 . . . . 0.0 111.494 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -69.71 -37.52 76.6 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 29' ' ' PRO . 49.9 mtp180 -66.26 -34.12 77.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.792 175.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.595 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 2.0 tpm_? -59.06 -39.31 81.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.534 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.807 HD11 ' HG3' ' A' ' 71' ' ' ARG . 22.7 mt -59.54 -49.0 85.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.275 0.559 . . . . 0.0 109.857 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.673 ' HD2' HD12 ' A' ' 81' ' ' ILE . 14.3 mmmt -65.69 -36.2 82.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.173 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.584 ' HD2' ' HA ' ' A' ' 34' ' ' ARG . 48.3 mttm -60.96 -41.68 96.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.378 174.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 70.8 mt -67.41 -42.27 83.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.591 -176.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.641 HG13 ' HB ' ' A' ' 83' ' ' ILE . 1.6 mp -68.62 -34.91 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.981 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.666 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 32.2 t -66.44 -47.5 72.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.966 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 96.9 mt -60.15 -40.02 88.4 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.781 -177.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.538 ' HA2' ' OD1' ' A' ' 52' ' ' ASP . . . -67.0 -38.42 92.75 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.501 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 11.2 tptt -73.35 -34.89 65.87 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.874 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.666 ' HE3' ' O ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -62.6 -45.2 93.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.089 173.714 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.814 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . 45.3 mmtm -69.23 -35.23 75.94 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.82 -177.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.9 -65.99 0.1 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.086 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -137.0 158.57 44.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.416 0.627 . . . . 0.0 111.154 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 0.8 OUTLIER -83.64 88.98 2.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.334 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.548 HG23 ' H ' ' A' ' 52' ' ' ASP . 10.6 t -153.61 155.24 35.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.829 -176.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -58.35 -41.98 85.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.043 0.449 . . . . 0.0 111.215 -173.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.68 -32.64 72.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.882 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.653 ' OD1' ' HB2' ' A' ' 45' ' ' LYS . 11.1 t0 -71.61 -39.26 70.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.214 0.53 . . . . 0.0 110.223 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.1 mt -60.23 -45.42 96.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.355 0.598 . . . . 0.0 110.017 173.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.0 -34.36 69.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.325 176.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.814 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -75.73 -23.05 56.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.092 -178.006 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.784 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . . . -69.63 -18.93 63.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.571 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.434 ' CD1' ' HD3' ' A' ' 59' ' ' PRO . 80.5 t80 -62.74 137.14 96.58 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 176.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.497 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 90.0 Cg_endo -85.49 140.25 28.21 Favored 'Cis proline' 0 C--N 1.346 0.396 0 C-N-CA 123.594 -1.419 . . . . 0.0 113.441 1.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.604 ' HD2' ' HD1' ' A' ' 61' ' ' PHE . 37.3 Cg_endo -103.65 -157.25 0.03 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.744 0 C-N-CA 124.742 3.628 . . . . 0.0 110.896 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -98.09 14.52 27.24 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.044 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.604 ' HD1' ' HD2' ' A' ' 59' ' ' PRO . 10.1 p90 -61.51 125.9 25.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.464 0.649 . . . . 0.0 110.826 -174.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -79.08 -30.14 43.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.686 174.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.28 126.79 1.48 Allowed Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -108.2 144.57 35.47 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 24.3 t70 -142.66 161.37 38.24 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.32 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -63.07 -30.93 71.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.953 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -61.07 -34.08 74.35 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.124 0.488 . . . . 0.0 110.268 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.654 ' O ' HG13 ' A' ' 72' ' ' ILE . 58.1 tp -60.58 -39.42 87.99 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.906 177.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.6 mm -62.89 -41.43 92.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.244 0.545 . . . . 0.0 110.314 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.417 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 17.6 mt-10 -68.25 -36.99 80.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.902 0.858 . . . . 0.0 108.959 177.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.807 ' HG3' HD11 ' A' ' 35' ' ' ILE . 23.0 tpt180 -70.06 -33.99 72.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.153 -178.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.654 HG13 ' O ' ' A' ' 68' ' ' LEU . 86.2 mt -61.0 -50.38 80.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.002 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.417 ' CD2' ' HA ' ' A' ' 70' ' ' GLU . 34.3 p80 -66.73 -31.94 72.92 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.91 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.688 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 25.6 mt-10 -58.54 -53.38 59.01 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 121.377 0.608 . . . . 0.0 109.773 173.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 79' ' ' HIS . 47.3 tp10 -59.88 -33.52 71.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.529 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.856 ' HA ' HG22 ' A' ' 81' ' ' ILE . 9.0 tp -66.57 -49.56 65.98 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.809 177.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -83.9 -53.35 5.65 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -173.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 34.3 pttt -76.97 -40.1 48.11 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.575 -176.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -93.8 -21.14 19.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.059 -176.582 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.32 25.24 24.38 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.358 -1.401 . . . . 0.0 114.772 172.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.856 HG22 ' HA ' ' A' ' 76' ' ' LEU . 5.4 tt -73.06 119.59 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 118.847 1.324 . . . . 0.0 109.628 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -81.8 126.94 32.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.434 0.635 . . . . 0.0 111.505 -171.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.641 ' HB ' HG13 ' A' ' 39' ' ' ILE . 4.8 tp -167.87 140.02 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.464 -176.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -100.73 153.4 4.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -92.62 -29.73 15.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.491 -174.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.47 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 24.0 t-20 74.18 -7.11 1.71 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.939 0.774 . . . . 0.0 110.192 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 43.0 tt0 -88.66 128.38 52.82 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.509 -177.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 4.0 Cg_exo -81.36 159.34 19.91 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.256 2.638 . . . . 0.0 111.682 176.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -109.69 -8.29 14.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.869 0.366 . . . . 0.0 111.245 -175.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 90' ' ' GLU . 1.7 mp0 -70.64 -27.4 64.03 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -74.54 65.24 1.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.123 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -122.18 -58.59 1.71 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 45.8 mt -95.11 65.98 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 166.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 m -67.09 -64.72 0.8 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.257 -173.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.41 -50.69 8.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.406 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.399 -1.223 . . . . 0.0 111.361 179.784 . . . . . . . . 0 0 . 1 stop_ save_